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Abstract 
Improving Community Pharmacy Consultations for People with 
Depression 
Adel Alshammari 
 
Keywords Community Pharmacy / Consultation Skills / Patient Satisfaction / 
Depression / Medicines Adherence / Consumer Medicines Information / 
Continuing Professional Development / Medical Simulation. 
 
Aims 
 
The aims of this study were to increase community pharmacists’ willingness and 
confidence to provide consultations for people with depression, and to enhance 
patients’ awareness of the pharmacists’ developing role. 
 
Research Design  
 
To observe pharmacist-patient consultations, the researcher developed a 
patient scenario. Pharmacist knowledge and attitude questionnaires were 
adapted, and a skills observation checklist was developed. Assessments of 
patient satisfaction levels took place before and after pharmacist training, which 
included a simulated consultation and action planning. The consultations were 
both video recorded and observed. Participants undertook a short interview with 
the researcher and each pharmacist developed his/her own plan for continuing 
professional development (CPD). An exploration of the interview transcripts was 
undertaken qualitatively. A University Ethics Panel approved the project. 
 
Results 
 
There were twenty-two pharmacists who took part in the study, comprising 
eighteen males and four females. MPharm students comprised one female and  
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two males, and community pharmacists made up three females and sixteen 
males. 
 
The quantitative results: It was found that pharmacists possessed appropriate 
knowledge (the mean score was 75%, which showed that the pharmacists were 
aware of the safety and action of anti-depressants). The mean score for attitude 
was 54%, which tends towards the positive. When observing the simulated 
consultations, the mean score for initiating a consultation session was recorded 
at 28%. This indicates that the pharmacists were not very interested in initiating 
rapport with patients. However, the highest mean score calculated was 61%, 
which corresponded with closing a consultation. For data collection and action, 
the mean scores were 42% and 35%, respectively, and this indicates the need 
for improvement in these areas. 
 
The qualitative findings: The pharmacists demonstrated good knowledge about 
anti-depressants and held positive attitudes towards people with depression. 
However, the pharmacists were not very willing to exercise the responsibilities 
of their extended role or provide additional services for patients. The 
pharmacists lacked certain skills and opportunities to be able to enhance the 
patients’ satisfaction. The pharmacists in this study needed to improve their soft 
skills in some areas and engage in mutual discussion with patients in order to 
enhance patients’ expectations with the service provided. 
Conclusion/discussion 
The knowledge and attitude of pharmacists were good, but their consultation 
skills could be improved. Although simulated consultation allowed pharmacists 
to review their skills and practice the apparent impact on patient care was 
limited. This study has enable greater understanding of pharmacist strategies 
when consulting people with depression, and the findings could be used by 
those developing training programmes for enhancing pharmacists skills. 
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Glossary of Terms 
  
Adherence The extent to which a patient’s behaviour coincides with the 
health-related advice given - in this perspective, the 
behaviour the patient adheres to may be: taking a medicine, 
changing their lifestyle, or going on a diet (RCP and RCP 
PSCH, 2003) 
Attitude 
 
An individual's favourable or unfavourable feelings towards 
performing the behaviour (Fox, 2005). 
Communication The exchange of advice, opinions, and beliefs – 
representing not only spoken words, but also the things 
conveyed through inflexion, vocal quality, facial expression, 
body posture and other behavioural processes (Roter et al., 
1998). 
Compliance The extent that patient behaviour follows physicians’ 
recommendations (National Council on Patient Information 
and Education, 2007). 
Concordance An agreement reached after negotiation between a patient 
and a health care professional that respects the beliefs and 
wishes of the patient in determining whether, and how, 
medicines are taken (National Council on Patient 
Information and Education, 2007). 
Consultation Consultation is pharmacists-patients discussion about 
therapy with the intention to assess patient medication 
related needs. It includes exploring patients concerns and 
expectation of medications, and involve in shared decision 
with professional to solve medication related problems 
(Abdel-Tawab et al., 2011). 
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Interpersonal Skills that facilitate the pharmacists’ effective communication 
with the patient (Ramesh, 2004). 
 
Intention Measuring the probability that an individual will undertake 
certain behaviours (Fox, 2005). 
Self-confidence When the pharmacist understands his/her ability to manage 
patients, and monitors diseases, and has the insight to make 
decisions with certainty about the outcome of the 
intervention (NICE, 2009). 
Therapeutic 
Alliance 
Comprises the active and collaborative contribution between 
clinicians and patients, together with participation from other 
health care providers and close family members (Wagner et 
al., 2001). 
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The Organisation of the Study 
 
The study comprised six chapters as outlined below: 
 
 The First Chapter: Described the background, introduction to depression 
and the treatments related and satisfaction of patients to the provision of 
care, and research strategy. 
 The Second Chapter: Provided an overview of the definitions of adherence 
and related factors, patient related factors, and pharmacist related factors, 
including the attitude and skills of pharmacists. 
 The Third Chapter: Described the aims, methodology and methods used in 
the research 
 The Fourth Chapter: Described the findings (quantitative and qualitative).  
 The Fifth Chapter: Included initial interpretation of qualitative findings 
 The Sixth Chapter: Discussion (the integration qualitative and quantitative 
results, implication for the research, future work, strengths and limitations 
and conclusion). 
 
 
 
 
1 
Chapter 1  Background and Introduction 
 
 The Background to this Investigation 1.1
 
The idea for this investigation arose after the researcher finished his Master’s 
degree in Egypt. The research study for the Master’s degree was an evaluation 
of particular anti-depressants and it focused on clinical efficacy. Dealing with 
people with depression was a new experience for me, and some difficulties 
were experienced in collecting data, especially in the early stages of the study. 
People with depression need professionals to embrace their concerns and 
understand their expectations, but I needed to focus on data collection, and so it 
seemed as if our aims were going in different directions. Furthermore, the 
patients hardly talked to professionals and other people in the community about 
their concerns and feelings, which made their conditions worse. 
 
One major issue was noticed was that clinicians were busy and lacked the time 
to talk to patients. Furthermore, many health care providers focused on types of 
medication rather than on the quality of their relationship with patients, and the 
patients struggled to find someone who would listen to their concerns. 
Therefore, patient needs often remained unmet. Moreover, although the role of 
the pharmacist as a member of the health care team was founded in the 
educational curriculum, it was absent from real clinical practice in Egypt and in 
Kuwait. Health care policy and practices empowered physicians over other 
professionals, so pharmacists did not have sufficient opportunity to interact with 
patients and, perhaps, did not feel this was their role. The interest was  whether 
this physician/pharmacist relationship was apparent in other healthcare systems 
outside of my home country of Kuwait. 
 
The first plan for this research was to focus on the impact pharmacists had on 
adherence to anti-depressants, with a view to comparing the UK to Kuwait. In 
the UK lots of patient information is available, from the NHS, professional  
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bodies, charities, and manufacturers of antidepressants, and the pharmacists’ 
concern is helping the patient to read, understand and (as necessary) accept 
the content of these leaflets. Pharmacists can play a role offering advice and 
sign-posting of patients, but NICE states that pharmacists should not assume 
that the patient information leaflets (PILs) meet the needs of each patient 
(NICE, 2009 A). Pharmacists also need to address the concerns that patients 
may have after reading the PILs. Addressing patients’ beliefs and worries 
requires the pharmacist to have a good attitude, knowledge and skills (NICE, 
2009 A). Many investigations show that pharmacists are reluctant to speak to 
patients and lack confidence when consulting with people with depression 
Rickles et al., 2010). When Aaltonen et al. (2010) conducted a study to 
compare and contrast the barriers experienced by pharmacy students in 
different countries when consulting people with depression, students reported 
that they lacked adequate knowledge about depression. The outcome of the 
study was in line with a British study (Landers et al., 2002) in which the 
pharmacists stated they had minimal involvement in identifying the symptoms of 
depression, or discussing symptoms with patients. Moreover, the participants 
stated that they had little experience recognising the symptoms and signs of 
depression. 
 
Thus, the plan was changed to focus on and explore the current and ideal 
‘consultation’ between the pharmacist and the patient, in order to make 
suggestions to improve the standard of care. 
 
Exploring and understanding optimal health care practice requires a review of 
NICE guidelines and understanding their recommendations in relation to 
pharmacy consultations. In addition, the development of consultation practice 
requires an assessment of the current standard of care and its distance from 
the ideal situation. It is necessary to help pharmacists reflect on their current 
practice, and encourage them to make necessary improvements. This study 
sets out to achieve this. 
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 Introducing the Study 1.2
1.2.1 The Definition of Depression 
 
Depression is a state of low mood that is heterogeneous, varies in complexity 
and severity, and affects the patient psychologically and physically. The patient 
with depression may typically feel sadness, irritability and have low self-esteem 
and suicidal thoughts. Furthermore, they may lack motivation and the ability to 
derive pleasure from pursuits previously enjoyed. Physical symptoms may 
manifest themselves as insomnia, parasomnia, changes in appetite and 
consequent weight gain or loss, a loss of energy and libido, menstrual 
irregularities, chronic pain, and psychomotor retardation or agitation (WHO, 
2012). These symptoms may be prevalent over a period of weeks, months, or 
years, and may have an impact on family, social and work life. The number and 
severity of symptoms identify the type of depression experienced. Mild 
depression accounts for 70% of all cases, moderate depression 20% of cases, 
and severe depression for 10% of all cases (NICE, 2011). If a patient feels they 
have depression, then the patient should approach their GP if they experience 
any the above symptoms for most of the day, every day, and for more than two 
weeks. In the UK, depression is classified on the following scale: mild 
depression - has some impact on daily life; moderate depression - has a 
significant impact on daily life; and severe depression - makes it almost 
impossible to get through daily life (NICE, 2012 A). 
 
1.2.2 The Prevalence and Incidence of Depression 
 
Depression is a mental disorder that is prevalent throughout the world. Globally, 
it is estimated that depression affects 350 million people of all ages (Marcus, 
2012) and is considered the second leading cause of loss relating to ‘disability 
adjusted life years’. It is a major contributor to the Global Burden of Disease 
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(GBD) (Ferrari et al., 2013). The GBD is the cumulative disease burden 
produced by all diseases around the world and GBD statistics use the term 
‘disability adjusted life years’ (DALY) to facilitate comparisons to calculate an 
estimate of life years lost and life years lived due to specific diseases, 
incorporating other epidemiological data. An analysis of the 2010 study 
indicates that one of the leading causes of ‘years lived with disability’ (YLD) is 
major depressive disorder, which appears in the top ten diseases for all 
countries (Vos et al., 2013). Between 1990 and 2010, there was a reported 
increase of 37% in DALYs (Murray et al., 2013). 
 
Depression has a high prevalence worldwide. It affects 400 million people of 
different ages throughout the world. The prevalence of mild depression and 
anxiety in the United Kingdom is approximately one in every five adults (British 
Psychological Society, 2013). In the UK, incidence rates of depression occur in 
3% to 6% of the adult population (NICE, 2011). It is hypothesised by McCrone 
et al. (2008) that by 2026 the number of British people diagnosed and requiring 
treatment for depression will rise to 17% of the population (to 1.45 million) and 
that service costs to treat depression will rise from £1.68 billion to £2.98 billion. 
However, these values do not indicate an actual rise in the rates of depression, 
but are relative according to rising population numbers. In 2007, depression 
accounted for nearly £6 billion of lost earnings. Furthermore, limitations to 
McCrone et al’s analysis include the fact that only primary diagnoses of 
depression are considered, and certain patient groups are not included in this 
study, including those with learning disabilities, those receiving informal care, 
and those in the criminal justice system. It is impossible to ignore the absence 
of this missing data because it reduces the projected impact of depression on 
the general population, service usage, the cost of services, and the economy as 
a whole. NICE clinical guidelines (2009 B) state that, “depression is two to three 
times more common in people with a chronic physical health problem.” This 
suggests that the 20% of the population who suffer from conditions such as 
cancer, heart disease, and diabetes, musculoskeletal, respiratory, or 
neurological problems may also suffer from depression. 
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1.2.3 The Causes of Depression 
 
As indicated in numerous families, twins, and adoption studies, genetic factors 
play an important role in the development of MDD. Studies on twins suggest a 
heritability of 40% to 50%, and family studies indicate a twofold to threefold 
increase in the lifetime risk of developing MDD among first-degree relatives 
(Lohoff, 2010). Additionally, biological factors can contribute to depression. 
Communication between neurons takes place via special sites of contact known 
as synapse, which are located in the nerve endings. Messages transmit 
between neurons using amnion acid via neurotransmitters such as serotonin, 
dopamine and noradrenaline. When the mood regulating neurotransmitters fail 
to function in a normal way, the signals deplete or disrupt before they transmit 
to the next nerve cell (Royal College of Psychiatrists, 2012).  
 
Life events and significant life changes can often be a precipitative factor of 
depression. Bereavement, divorce, illness, employment problems including loss 
of employment, financial problems, or stress following trauma may all trigger an 
episode of depression. Additionally, adverse psychosocial factors resulting from 
deficient parent nurture, emotional and physical abuse, neglect and parental 
separation may induce childhood or retarded adult depression (Moy, 2009). 
Certain psychological factors can also put people at risk of depression, for 
example, people with low self-esteem who consistently view themselves and 
the world with pessimism, or those who easily overwhelmed by stress may be 
prone to depression (Grohol, 2015). 
 
1.2.4 Prognoses 
 
The opportunity to develop depression in children is considered unusual. An 
estimated 0.2-2 % of children develops depression before puberty and it is 
equally among boys and girls. However, after puberty, the tendency to develop 
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 depression among girls is three to four time with boys and 3-4% of teenagers 
suffer from depression (Wasserman, 2011). The average recurrence rate of 
depression is twice in a patient’s life. Individuals with a history of three previous 
episodes of depression are 90% more likely to have fourth, and due to this high 
relapse rate, guidelines recommend that individuals with a history of multiple 
depressive episodes receive medication for the rest of their lives (American 
Medical Association, 2012). A cohort study conducted in Netherlands finds a 
high number of pain locations associated with depression, such as pain of the 
joints, and longer periods of duration of pain (for 90 days or more) among 
people with depression. The daily use of pain medication and experiences of 
more severe pain at baseline levels are associated with a significantly increased 
risk of having a depressive or anxiety disorder (Gerrits et al., 2012). A survey 
conducted on older people in Canada who had history of depression finds that 
people with major depression who were smokers or had low levels of mastery 
were at an increased risk of repeated episodes of depression (Colman et al., 
2011). A study by Clancy et al. (2013) uses semi-structured interviews to 
explore the experiences of smokers with self-reported depression in Australia. 
In this study, low moods, anxiety and stress are triggers for smoking, and many 
participants described a close relationship between their mood and their 
smoking behaviour. However, one of the limitations of this study is that 
interviews took place over the telephone. 
 
1.2.5 Risk Factors Relating to Depression 
 
Depression is a risk factor in the development of a range of physical illnesses, 
such as cardiovascular disease, for example. When a person has both 
depression and a chronic physical health problem, functional impairment is 
likely to be greater than if a person just has depression or a physical health 
problem alone (NICE 2009 B).  
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A cohort study conducted in the USA that focuses on psychosocial factors and 
health outcomes among patients with stable coronary heart disease finds that 
patients with depression are associated with an increased risk for 
cardiovascular disease. Tests for both somatic and cognitive symptoms were 
undertaken using a patient health questionnaire. However, the participants in 
this study were mainly older men and, therefore, the results may not be 
generalisable to women or to other patient populations (Hoen et al., 2010).  
 
Another cohort study carried out by Linke et al (2009) examines patients with 
myocardial ischemia who have undergone evaluation at baseline for a history of 
cardiovascular-related problems. Tests on their depressive symptoms were 
undertaken using the Beck Depression Inventory and the results indicated that 
somatic but not cognitive symptoms of depression significantly predicted 
cardiovascular events. However, the participants in this study were all women. 
Win et al. (2011) tested the risk of cardiovascular mortality due to physical 
inactivity and depression in the USA, the study showed that community-dwelling 
older adults with high depression scores were at an increased risk of 
cardiovascular mortality. In this study, individuals with symptoms of depression 
are at 67% greater risk of cardiovascular mortality than individuals who scored 
low depression. One drawback of this study, however, is that it focuses only on 
elderly patients. Furthermore, Pan et al. (2011) find that diabetes and 
depression are significant risk factors for all-causes of CVD mortality, whereas 
the coexistence of these conditions is associated with a much higher risk. The 
authors also observed a strong monotonic relation between diabetes severity 
and CVD mortality rates. However, the information regarding diagnosed 
diabetes and depression used in this study is undertaken using self-reporting.  
 
1.2.6 The Management of Depression 
 
Cleare et al. (2015) describes how we can manage depression according to the 
severity of symptoms as follows: For symptoms on the mild to moderate scale, 
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e.g. for mild major depression (few symptoms beyond the minimum and mild 
functional impairment) and moderate major depression (more than minimum 
number of symptoms and moderate functional impairment), cognitive behaviour 
therapy (CBT) - behavioural activation and interpersonal psychotherapy (IPT) 
are recommended as alternatives to anti-depressants. CBT for acute treatment 
is necessary with psychological treatment as a mono-therapy for recurrent 
depression.  
 
For people with mild to moderate depression who have not benefited from low-
intensity psychosocial intervention, practitioners are recommended to discuss 
different treatments with patients and provide anti-depressant first line 
medications such as selective serotonin reuptake inhibitors (SSRI) (NICE, 2009 
A) see (Appendix-1). Treatments take place within primary care and should 
include education about depression, an examination of lifestyle, and 
suggestions for lifestyle changes. Aspects of lifestyle advice might include 
teaching problem-solving techniques, considering relationships with significant 
others, offering specific assistance as required, and providing supportive 
monitoring. There is no evidence for the necessary use of pharmacological or 
psychological treatments in this group unless the symptoms persist beyond 
eight weeks, then non-medical treatments with cognitive interpersonal 
psychotherapy (IPT), behaviour therapy (CBT), or a selective serotonin 
reuptake inhibitor (SSRI), in addition to supportive management may assist 
(Ellis et al., 2003).  
 
For people starting to take anti-depressants, practitioners may consider suicide 
risk and toxicity in overdose, and explain that symptoms of anxiety may initially 
worsen. Practitioners must explain that anti-depressants take time to work and 
that anti-depressants work best when they continue for at least 6 months 
following the remission of symptoms, because sticking to this timeframe greatly 
reduces the risk of relapse (NICE, 2015 B). Practitioners can also refer patients  
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to self-help groups and it is wise to consider this course of treatment too. A link 
with an organisation or well established group can offer the necessary 
resources and support, and patients can interact in a non-stigmatising and 
welcoming venue to engage in recovery focused treatment in an a confidential 
atmosphere (Scottish Intercollegiate Guidelines Network, 2010).  
 
1.2.7 Patients Seeking Help 
 
In order to satisfy the information needs of patients, particularly those who need 
access to coping strategies it is useful to guide people with depression to a 
variety of resources. Many people with depression will need more information 
and support than general practitioners are able to provide due to the limitations 
of GPs’ skills and time (Barney, et al., 2011).  
 
A study by Khazaal et al. (2008) of elderly outpatients who had psychiatric 
diseases in Switzerland finds that two thirds of patients who used the internet to 
access information were partially satisfied with the information they found. 
Reasons for using the internet included finding out information about 
medications, and finding out general information about health issues. One of the 
drawbacks of this study, however, was that the participants had a professional 
education and this meant they had privileged access to and understanding of 
the internet.  
 
A study by Byers et al. (2012) of older dwelling patients with a 12-month+ 
anxiety or mood disorder found that the great majority did not use mental health 
services. The incidence of non-use was high across all income groups and  low 
perceived need groups, and not using services was associated with patients 
with mild mood or anxiety disorders but no chronic pain or minor cognitive 
complaints. These findings suggest that low perceived needs, moderate 
resources, and low motivation to use mental health care services explains why 
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patients do not seek services, despite patients having diagnosable mood and 
anxiety disorders. Furthermore, in a study by Tanskanen et al. (2011) patients  
describe remaining unaware of their psychosis until they had contact with 
mental health services. This study used semi-structured interviews with patients 
who had initiated meetings with doctors in the UK and who were subsequently 
prescribed anti-psychotic medications. The patients describe how difficult it was 
to seek help because doing so was often complicated, prolonged, and involved 
various attempts of intervention by family, friends and community organisations. 
In some cases, patients sought help without the service users’ knowledge 
and/or consent. However, the mean age of participants in this study was 26 
years. 
 
A study undertaken in Australia by Schrank, et al. (2010) uses semi-structured 
interviews with schizophrenia patients to assess whether the internet is a good 
place to search for information about this illness. Most patients said the internet 
offered them anonymity and shielded them from the effects of social 
hierarchies. They also said that the internet helped them to overcome issues 
relating to stigma when interacting with health care professionals and others. 
However, in a cross sectional study by Borzekowski et al. (2009) of patients in 
the USA who had serious mental illnesses, one third reported using the internet, 
but those who used the internet said their usage was infrequent. One drawback 
of this study, however, is that over a third of the participants had not reached 
high school level education, and this might account for their approach to internet 
usage when seeking information about illnesses. 
 
In semi-structured interviews undertaken by Anderson et al. (2013) with patients 
who had experienced first episode psychosis in Canada, twelve participants 
made comments relating to the stigma surrounding mental illness and said they 
experienced this when seeking help for their psychotic symptoms. Although 
none of the patients described a situation in which they were directly 
stigmatized, many used words and descriptions that indicated they had 
internalised society's stigma against people with mental illnesses. However, the 
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patients in this study covered those with effective (psychotic) and non-effective 
(depression) who may hold different beliefs about stigma. Similarly, a study by  
Yap, et al., (2013) of Australian young people identifies family, friends and 
relatives as people to rely on for support if mental health becomes a problem. 
Embarrassment and concerns about stigma and outcomes after having 
consulted a health care professional rated highly as barriers to seeking help. 
However, this study relies on a vignette approach and so the respondents might 
have actually decided to do something different when genuinely faced with 
mental health problems. 
 
A focus group conducted by Uebelacker, et al. (2012) with Spanish patients 
who had depression finds that barriers to receiving care for depression include 
stigma from the community, attitudes toward depression that include ignoring or 
expecting depression to disappear, and expecting people to tackle depression 
themselves. One drawback of this study, however, is that its participant sample 
was Latino patients. To investigate how cross national differences relating to 
attitudes and stigma impact on seeking professional and informal help, 
Reynders et al. (2014) devised a questionnaire targeting the population of 
Netherlands and Flanders. They find that people from the Dutch are more 
inclined to seek help from general practitioners and psychiatrists if they had 
experienced mental health issues. In comparison to Flemish people, people 
from the Netherlands showed positive attitudes towards seeking help, but 
Flemish people were more sensitive to self-stigma and feelings of shame 
surrounding mental illness. The authors suggest that organisational factors (the 
accessibility and availability of mental illness) play an important role in peoples’ 
decisions to seek help from health care professionals. However, the results 
were calculated using a self-reporting method and did not actually assess 
mental health symptoms. 
 
When Bristow et al. (2011) organised semi-structured interviews with people 
who had mental disorders, the authors found that patients were reticent to seek 
help generally, not only relating to consulting their GP, but because they feared 
issues of stigma generally because they had a mental health issue. However, 
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this study was limited to homeless peoples and minority groups. Holm et al. 
(2014) report that patients with depression sometimes think that health care 
providers do not believe them when they say they have physical health 
problems, and just assume that patients are imagining these symptoms 
because they have depression. Patients in the UK said that this kind of 
discrimination adds levels of shame and worry relating to their illness. However, 
one drawback of this study is that it focuses only on community health care 
centres. 
 
1.2.8 Satisfaction with Anti-depressants 
 
Addressing non-adherence is not about getting patients to take more medicines 
per se, rather it is about starting with an exploration of patient perspectives of 
medicines and the reasons why they may not want to take them or are unable 
to use them. Healthcare professionals have a duty to help patients make 
informed decisions about treatment and use appropriately prescribed medicines 
to their best effect (NICE, 2009 C).  
 
Patients who were surveyed in the Kingdom of Saudi Arabia indicated they 
were highly satisfied with the anti-depressants they received (Aljumah et al., 
2014). Among the patients who recorded satisfaction were those who reported 
experiencing side effects after using anti-depressants. However, the study did 
not find any evidence of a correlation between beliefs about medicines and the 
relationship of the patient with their health care providers. The author suggested 
that possibly, the relationship patients had with their pharmacists and GPs 
might have affected the results towards positive conclusions. In a study by 
Tranulis et al. (2011), 60% of patients prescribed with psychotic drugs took their 
medicines without engaging in a mutual discussion with a health care 
professional. Semi-structured interviews revealed that patients were often 
passive and took medications based on trust in what their health care providers 
told them. However, patients who took part in this study only belonged to one 
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clinical setting. Dolovich et al. (2008) finds that Canadian patients think their 
relationship with their physician is important in relation to adherence and if they  
want to discuss issues about their medications. Some patients in the study felt 
disconnected from their physicians and said that physicians do not listen to 
them and do not communicate well with them. However, this study does not 
focus exclusively on mental illness but surveys those with physical disease also.  
 
Similarly, with patients interviewed in the USA by Anderson and Roy (2013) 
physicians were sometimes dismissive, did not pay enough attention to 
patients, and did not foster good relationships with patients. The authors claim 
that the relationship with their health care provider influences a patient’s 
adherence to their medications, but this study does not survey physicians, only 
patients. The findings suggest that concordance, or shared decision making 
with regards to medicine taking, is only occurring to a limited extent; in only a 
quarter of consultations were patients given treatment options or provided a 
rationale for a proposed medication/treatment. In only a fifth of consultations did 
the prescriber (pharmacists, general practitioners and nurse) elicit the patient’s 
preference for treatment and in a quarter did the patient express a treatment 
preference. This is despite the suggestive evidence found in this study that 
spending longer discussing treatment options was associated with greater 
patient satisfaction, adherence. However, a randomised controlled study 
conducted with a 6-month follow-up. Participants were randomly allocated to 
two groups: 1) intervention group (IG) and control group (CG) to people with 
major depressive disorder. After 6 months, IG patients showed statistically 
significant increases of up to 18 % in adherence to antidepressants and 6 % in 
treatment satisfaction, and a decrease of 8 % in concern beliefs and general 
beliefs about medicines (Aljumah and Hassali, 2015). 
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 The Search Strategy 1.3
 
Researchers can use many different databases. In the current study the 
researcher focused on using four databases: ’Web of Science’, PsycINFO, 
 Medline, and the Cochrane Library. (Appendix-3) outlines the full research 
strategy. Web of Science, PsycINFO and Medline are databases covering 
medical, scientific and psychological publications, while the Cochrane Library 
contains a systematic review of meta-analyses. The search terms used in these 
four databases include both free terms and MeSH terms. The free terms include 
truncation while the Subject Librarian suggested MeSH terms without 
truncation. The results of the database searches was in 2012, where 153 
articles and 2 systematic reviews were found. Of these 153 articles, 23 were 
included because they are relevant to the current research. All studies 
published in the databases were included except personal experience and non-
English language articles. Furthermore, theses and books were included. 
Relevant randomised controlled studies for the current research offer similarity 
to the circumstances of United Kingdom culture, (e.g. Europe) even though 
studies conducted in Middle Eastern countries compare with the United 
Kingdom.  
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Chapter 2   Literature Review 
 
This chapter explores the work undertaken by previous researchers about 
medicine adherence and/or compliance among patients who visit pharmacies. 
Adherence encompasses a range of patient behaviours relating to the collection 
and taking of medications according to recommendations made by health care 
professionals. Matters relating to adherence also encompass individual and 
autonomous patient views about taking medications. Scientists divide non-
adherence into two types: unintentional non-adherence, such as forgetting to 
take medications; and intentional non-adherence, which may be triggered by 
experiences of stigma or other beliefs a patient holds about certain medications. 
One of the roles of the pharmacist is to encourage adherence to medications in 
collaboration with other health care professionals. Patients benefit when 
providers liaise with other health care professionals to co-ordinate adherence 
and a health care plan. However, many obstacles exist that act as a barrier to 
the effective collaboration between pharmacists and other healthcare 
professionals, and, sometimes, pharmacists find these obstacles challenging to 
overcome. 
 
This chapter also explores the role of the pharmacist, the work of the pharmacy, 
and the attitudes of pharmacists towards mental illness in comparison to 
physical illness. The chapter describes the extended role of the pharmacist (as 
outlined and recommended in international guidelines) for building relationships 
with patients and exploring medications from the perspective of the patient’s 
agenda. Furthermore, the chapter explores the knowledge pharmacists must 
show about anti-depressants and how the pharmacist must work to try to satisfy 
patient needs. When trying to place the patient at the centre of care, 
pharmacists encounter challenges. This subject is debated in previous research 
and in studies into the ability of the pharmacist to engage with people with 
depression. 
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  An Overview of Adherence 2.1
Adherence to anti-depressant medication is low in people with depression. 
Previous research explains and explores possible reasons for poor adherence. 
Interian et al. (2007) find that poor patient adherence to anti-depressant 
medication is attributed to patient beliefs about use of medication being an 
admission of their inability to successfully cope with their mental state. Barney 
and Griffiths (2011) state that patients are concerned about the stigma attached 
to taking anti-depressants, and they think it is a personal weakness having to 
resort to such medication.  
 
Patients are concerned about how others might respond to their diagnosis of 
depression. Houle et al. (2013) reports that the treatment preferences of 
patients suffering from depression can affect adherence and clinical outcomes. 
Their research finds that of those patients suffering with depression the majority 
favour psychotherapy (41%) over taking an anti-depressant (31%). NICE 
guidance states that non-adhering patients are not deviant because limitations 
within the delivery of health care may be the reason for non-adherence. Failure 
to involve patients in the decision to commence medication and a lack of on-
going support are some of the reasons cited for non-adherence. Exploring the 
patient’s ideas, beliefs and perspectives on anti-depressants may form the 
basis of discussion to improve adherence (NICE 2009 C). The following section 
will discuss the different behaviours involved in adherence. 
 
2.1.1 The Behavioural View of Adherence 
 
In order to maximise the effectiveness of medicines in several acute diseases it 
is particularly important that patient take their medicine according to the proven 
dosage regimen. Fundamentally, Buxton (2011) states that compliance can be 
defined (to a particular regimen) as the level to which individuals take their 
treatment as prescribed. Another description of adherence relates to the 
behaviour the patient adheres to which might be taking a medicine, changing 
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lifestyle, or going on a diet (Pignone and Salazar, 2013). To make sure that 
specific treatments work effectively it is important to take drugs on time, every 
time (Cauldbeck et al., 2009). Adherence is the capability of the individual to 
visit the clinic as scheduled, take the medication as instructed, change their way 
of life, and follow the recommended investigations (RCP and RCP PSCH, 
2003). A further definition of adherence focuses on the extent to which the 
patients’ behaviour matches agreed recommendations for the prescriber (Julius 
et al., 2009). The term ‘adherence’ can be used as a synonym to (compliance) 
which indicates matching to the recommendations made by physicians, 
including dosage, timing and the frequency of anti-depressants taking (Cramer, 
et al., 2008 B). This context assumes increased patient involvement in choosing 
the regimen; in other words, the patient agrees to take the medicine, however 
they may not take it precisely as prescribed. 
 
Therefore, behaviourally, adherence comprises two components: the level or 
frequency of the treatment used during the period of therapy, and the 
persistence in taking the medication during the whole period. WHO (2003) 
states that adherence is not only based on the patient’s agreement with health 
advice about the risk itself, but other important influences on adherence are: the 
clinician’s skill and capability to convey to the patient that the medication is 
useful; and the patient’s observation of the clinician’s trustworthiness, 
sympathy, enthusiasm and concern. 
 
It is apparent from previous research, that the definitions of adherence (so far 
considered) do not include impact on clinical outcomes. Agreement with health 
care instructions can be nil, irregular, over-used or under-used. However, 
complete adherence is only justifiable if the prescribed dose is essential to 
provide full benefit, particularly if there are considerable side effects. The next 
section will consider the relationship between adherence and outcomes. 
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2.1.2 The Individual View 
 
Fisher (1992) views non-adherence as an assessment of the patient to achieve 
a therapeutic objective. Haynes et al. (1979) define adherence as the level to 
which patient behaviour agrees with instructions from health care providers. The 
emphasis is that of ‘blaming the victim’ when patients do not comply with the 
physicians’ orders and on the paternalistic role of the physician and the 
subservience of the patient (Cipolle, et al., 2012). Mullen et al. (1997) are critical 
of the theory that high adherence is synonymous with a willingness to obey 
doctor’s orders, believing that this shows disrespect for human autonomy. 
Agreement with the provider has been also criticised (NCPIE, 2007) as an 
excessively arbitrary approach which stigmatises the application of independent 
judgement by patients as ‘deviant behaviour’. Focusing on ‘fulfilment’ of the 
doctor’s intentions indicates the physician is exerting authority effort with a 
patient to make them ‘‘surrender’’ to their therapeutic directives. The issues 
surrounding the debate on adherence improvement is highlighted by Mitchell 
(2007) who justifies that poor patient engagement in the therapeutic regimen 
might be a consequence of one or more factors, including improper 
understanding of the regimen, the value of medical advice, or a lack of self-
management. Alongside patient’s involvement in a decision to adhere with a 
regimen, the professional’s involvement levels are important. This is one of the 
earliest papers to suggest the importance of a non-judgmental approach to 
adherence. Simply, the degree of adherence to treatment is not something that 
is open to judgement or anticipation beforehand, rather the professional should 
try to convince the patient to adhere to treatment and then the patient should 
decide (Dunbar et al., 1979). 
 
This section focuses on definitions of ‘adherence’ that are relatively old simply 
because the term has not developed further, and many new studies refer to the 
same definitions. In our research, The term ‘adherence’ will be used in the 
context of patients bringing in a prescription to the pharmacists with aim of 
taking medications that fit to their lifestyles and health conditions. The patients 
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used in our research had mild to moderate depression and were capable of 
making decisions about their medications. Moreover, one of the responsibilities 
of the pharmacist is to check that a patient agrees to their medications, 
especially because adherence to anti-depressants is influenced by many factors 
that will be discussed in the next section.  
 
 Types of Adherence 2.2
 
Adherence measures the extent to which patient behaviour follows agreed and 
prescribed treatment plans in terms of dosage and frequency. Non-adherence is 
one of the main reasons for the failure of clinical objectives and sub-optimal 
medical outcomes (Cramer et al., 2008 A). The main obstacle faced when 
promoting adherence is that patients hold different attitudes about their 
treatments, and these attitudes can turn into behaviours affecting their 
adherence to treatments. Therefore, investigators usually divide non-adherence 
related behaviour into two groups: intentional behaviour and unintentional 
behaviour. 
 
2.2.1 Unintentional Non-adherence 
 
There is no clear definition of unintentional non-adherence. It ranges from 
incomplete to total non-use. Rau (2005) presumes that this behaviour is the 
consequence of a passive process not significantly associated with conscious 
beliefs. However, the failure to understand treatment regimens due to language 
problems has been identified as a significant cause of unintentional non-
adherence (Rau, 2005), but, unintentional discontinuation of treatment is also 
caused by other factors apart from language problems. Sahm et al. (2009) claim 
that the number of patients who discontinue their anti-depressants 
unintentionally ranges from between 20% and 50%, and many investigators find 
that incidents of discontinuation can relate to access to medicine, patient 
schedules, and patient memory. When Clifford et al. (2008) performed a cross-
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sectional survey in the UK, of patients starting new medications for a chronic 
conditions they explored beliefs about medicines using the Necessity–Concerns 
Framework. They assessed self-reported adherence using telephone interviews. 
The similarities found between adherers and unintentional non-adherers 
suggest that beliefs about specific medicines are not associated with 
unintentional non-adherence when patients start a new medicine for a chronic 
condition. Clifford et al. (2008) argue that unintentional non-adherence might be 
associated with forgetfulness, but they did not demonstrate this in their study. 
However, the patients were elderly and had chronic diseases.  
 
Other research proposes that there is likely to be more unintentional non-
adherence rather than pure forgetfulness or carelessness (people who have a 
low perceived necessity for their medication may see it as more likely to forget 
to take it). A study conducted on Japanese patients illustrates this theory (Iihara 
et al., 2008). In 2009, Miasso et al. published a cross sectional, descriptive, 
qualitative and quantitative study exploring the opinions of patients with Bipolar 
Affective Disorder. The study finds that just over half the participants were 
forgetful and careless regarding taking their medications, but the majority of the 
patients were satisfied with their health care service. However, many of the 
participants who took part in this study were elderly and might have had 
cognitive behavioural reasons to account for why they could not adhere to 
medications. Another cross-sectional study by Awwad et al. (2015) evaluates 
patient knowledge of and adherence to medications as a score out of seven. 
This study finds that patients are modestly knowledgeable about adherence 
regimes, with about 60% scoring equal to or greater than four. Youth, higher 
education levels, taking fewer medications, and having fewer diseases were 
significant predictors of possessing a greater knowledge of medications.  
 
In a cross sectional study of non-adherence by Gadkari and Mchorney (2012) 
undertaken in the USA using patients over the age of forty years, 70% of 
patients self-reported three instances of unintentional non-adherence behaviour   
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during the previous six months, with 62% of patients stating that they did not 
take their medications due to forgetfulness. This study shows a strong 
correlation between age and unintentional non-adherence: the older the patient, 
then the lower the chance of unintentional non-adherence became (Gadkari and 
Mchorney 2012). Likewise, in a study by Tang et al. (2013), Chinese patients 
taking antiepileptic medicines reported forgetfulness as the main reason for 
unintentional non-adherence to their antiepileptic drugs. However, the finding 
showed that patients discontinue their medications when experienced seizure-
free for a period (48.9%). This argument may indicate that patient were not 
accurately educated about the benefit of persistence to their medications, but 
the weakness of this study is that it targets one hospital only. Furthermore, Da 
Silva Barreto et al. (2015) find a high correlation between non-adherence and 
dissatisfaction with health care services, physicians, and other health care 
professionals, but the majority of the patients studied in this research were 
elderly. 
 
Therefore, previous research reveals no single specific main factor that leads to 
unintentional non-adherence, and a variety of different cognitive and non-
cognitive factors can lead to unintentional non-adherence. 
 
2.2.2 Intentional Non-adherence 
 
For some patients, taking treatment regularly might not be appropriate for their 
lifestyle, or for the conditions in which they work. Patients cite several reasons 
why they intentionally do not take medications including: workloads, concerns 
about the side effects of treatment, and fear of dependence. Additionally, some 
patients exhibit a mixture of intentional and unintentional behaviours, as noted 
by Eliasson et al. (2011). A study by McHorney (2009) suggests that intentional 
non-adherence has a variety of causes, including the symptoms or severity of 
the disease, regime complexity, experiences of medication, prescription error, 
and patient beliefs about their medication. However, the mean age of  
 
 
 
22 
participants in McHorney’s study is fifty-nine years. When Wouters et al. (2014) 
studied non-adherence to anti-depressants in primary care, the results showed 
that worries about or previous experience of side effects were more likely to be 
associated with non-adherence behaviour, but in this study the authors do not 
mention the severity of depression experienced by patients.   
 
Van Geffen et al. (2007) claim that patients can experience early side effects 
from taking anti-depressants before they perceive the efficacy of their drugs, 
and this can lead to non-adherence. However, intentional non-adherence can 
occur not only due to the failure to collect a repeat prescription or the cessation 
of previous treatment, but by ignoring the advice of the health care provider or 
changing dosage without informing the care provider. According to Osterberg 
and Blaschke (2005), nearly 15% of patients do not collect repeat prescriptions 
and 50% of these patients cease taking their medication within the first six 
months of treatment. Osterberg and Blaschke find that patients are more likely 
to stop taking their medications if the medications do not match the patient’s 
needs.  
 
Therefore, in summary, although different factors are associated with intentional 
non-adherence in depression, the main cause listed for intentional non-
adherence is the fear of or experience of side effects. The next section will 
explore patient related factors that have an impact on adherence to treatments. 
 
 Patient Related Factors 2.3
 
Many different factors can make a patient decide not to adhere to their course 
of treatment. Beliefs about stigmatisation and the personal attitudes of patients 
and pharmacy staff can have an impact on whether or not someone might 
adhere or not adhere to their medicines. The next section will discuss these 
factors. 
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2.3.1 Stigma Attached to Patients 
 
People with depression sometimes perceive stigma and this has a negative 
effect on their attitude and reactions towards treatment. Research by SANE 
(2014 A) finds that 55% of patients with depression in Australia feel that it is 
difficult for them to inform their employers if they need to take leave due to 
depression, and this percentage is even higher (72%) in Europe. In a report by 
SANE Media Centre (2011), 75% of four hundred twenty seven people with 
mental illness surveyed said they experienced public stigma or discrimination in 
2011, and these results are consistent with research carried out in 2006. 
Furthermore, SANE (2014 B) suggest that experience of this kind of prejudice 
has not declined over time. Indeed, Mental Health Care (2014) note that the 
number of patients who experience stigmatisation associated with mental health 
is high, and mental health patients think that the public holds stereotypical views 
about mental health. For example, in a survey conducted in the UK in 2012, 
88% of patients believed that the general public associate schizophrenia with 
violence.  
 
People with depression often feel uneasy when informing other people about 
their illness, and they report experiencing the same feelings when meeting with 
caregivers.  An Australian study by Knox et al. (2013) explores the perceptions 
and experiences of people with depression and their caregivers. It finds that 
patients often experience stigmatisation from staff in the pharmacy as well as 
from other patients in the pharmacy. However, it is worth noting that the authors 
do not explicitly use the term ‘pharmacist’ when referring to staff in the 
pharmacy, and, therefore, this research might refer to the different kinds of staff 
who work at a pharmacy not just pharmacists. Nevertheless, this is a worrying 
finding.  
 
In a survey of pharmacy students in Estonia, 86.4% believed that people with 
schizophrenia are unpredictable, and 47.5% believed that people with 
schizophrenia are dangerous (Volmer et al., 2008). Furthermore, 25% of the   
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students agreed or strongly agreed that negative attitudes can affect the 
consultation skills of pharmacists when they deal with people with depression. 
The authors suggest that some students are unaware that their attitude may 
limit their service. The study uses undergraduate students as participants, but 
the authors do not mention the stage at which students are at, or whether this 
has any bearing on how they perceive people with mental illness. 
 
In a study by Abo El Magd and Zamil (2013) which compares the attitudes of 
medical students (pharmacists and nurses) with the attitudes of non-medical 
students towards people with mental illness, nearly a quarter of the participants 
held negative attitudes about people with mental illness. The stereotypes held 
by the participants included the belief that those with mental health problems 
are dangerous and aggressive. However, the medical students showed more 
positive attitudes towards people with mental illness than did non-medical 
students. The authors suggest that medical students are more knowledgeable 
and have more awareness about mental illness and this means they engage in 
less stereotyping.  
 
Pollock and Grime (2002) find that pharmacists who are knowledgeable and 
have the skills to communicate effectively with people with depression are more 
able to reduce the stigma associated with depression. This study finds that 
developing knowledge about depression and treatments for depression can 
help to open up discussions with patients, and this helps patients to feel less 
stigmatised. The authors find that pharmacists are aware of the stigma attached 
to depression and mental illness, and that pharmacists know some patients are 
embarrassed when they visit pharmacies. In a study by Guillaumie et al. (2015), 
a focus group of pharmacists showed the willingness and the knowledge to help 
patients and to reduce stigma. The pharmacists studied were able to provide 
information about anti-depressants and treatments, they emphasised the 
benefits of anti-depressants, and they reduced the fear of side effects. Notably, 
however, the majority of the pharmacists in this study had experience in their 
job of more than fifteen years, and this might account for their more positive   
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attitudes towards depression. Furthermore, a study by Gable et al. (2011) 
undertaken in the USA, which explores perspectives about mental health held 
by pharmacy students, uses a control group and an intervention group. 
Students from the intervention group who were required undertake training 
about mental illness showed positive attitudes towards mental health in 
comparison with those students in the control group. However, the sample size 
used in this study was small.  
 
The difficulty experienced by pharmacists when they try to engage with patients 
is one issue that contributes towards patient perceptions of stigmatisation. In a 
study by Liekens et al. (2013), pharmacists disclosed that they feel social 
distance from patients with depression who visit the pharmacy even though they 
deal with many such patients on a daily basis. The authors find that the quality 
of communication between the pharmacist and the patient helps to remove 
stigma more than the amount of patients with depression who visit the 
pharmacy. A consumer-led mental health education study by O'Reilly et al. 
(2010 A) conducted in Australia finds that patients who engage more with 
pharmacists are more likely to experience reduced levels of stigma. The 
students said that when patients talk to them they could see that they often lead 
normal lives in spite of having depression. This study shows that patient 
engagement with students helps to eliminate prejudices surrounding the issue.  
 
In a study by Buhler and Karimi (2008), pharmacy students held negative 
attitudes about patients with depression, and some believed that patients with 
depression lacked willpower or lived immoral lifestyles. However, after the 
pharmacy students attended peer-level patient presentations and an 
educational course on depression, more of them were comfortable with the idea 
that patients with depression would benefit from taking anti-depressants. The 
authors suggest that undertaking peer-level patient presentations and a training 
course is effective to overcome perceptions of social distance experienced 
between pharmacists and people with depression.  
  
 
 
 
26 
To summarise this section, patients with depression often perceive feelings of 
stigmatisation, and pharmacy staff sometimes hold negative attitudes and 
prejudices about patients who have depression. Pharmacists are less willing to 
help reduce levels of stigma when they lack proper training. The evidence 
suggests that students who receive training about how to engage with people 
with depression become more aware of the stigma surrounding the illness and 
then make efforts to overcome it. 
 
2.3.2 Beliefs of Patients about Anti-depressants 
 
NICE (2009 C) explain that intentional non-adherence occurs when patients 
decide not to take their medications or not to follow therapeutic instructions. The 
patient’s understanding of their illness and their concerns about taking anti-
depressants influences these decisions. It is interesting to note that in a study 
by Houle et al. (2013) to assess the beliefs of Canadian patients recently 
prescribed with anti-depressants, 41% of people with depression said they 
favoured psychotherapy over taking anti-depressants, but 31% said they 
preferred to take anti-depressants. The study also finds that patients prescribed 
with anti-depressants had concerns about adherence to their medication 
because of the side effects of the drugs. Participants with a university degree 
said they were more likely to prefer using psychotherapy against those with less 
education. 
There are several theories associated with beliefs and behaviours about 
medication, for example Horne’s theoretical model. He stated that adherence to 
anti-depressants is influenced by the patient’s mental view of whether treatment 
is necessary and whether it will cause side-effects (Horne, 2003). 
There is a difference between general medicine beliefs and specific medicine 
beliefs that some patients exhibit. If the focus is on the anti-depressant, there 
are two specific perspectives for beliefs: necessity (the patient’s observed 
requirement for the medication); and concerns (the patient’s perceived 
likelihood for the medication to cause harm). The patient balances the 
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advantages of taking the medication relative to the harm by assessing a 
necessity-concern discrepancy; and, therefore, the extent of the adherence 
determined by these two concepts (Horne, 1999).  
To help providers, Aikens et al., (2005) translated the necessity-concern 
differential into a categorical perspective by splitting both belief dimensions at 
the median such as, accepting, ambivalent, sceptical and indifferent. 
In the accepting group, the level of the adherence is significant compared to the 
patients in the other three groups. Patients in the ambivalent and accepting 
groups exhibit significantly more adherence than the patients in the sceptical 
group. The indifferent group show no significant difference in adherence 
compared to sceptical patients. The authors found adherence is greater within 
individuals whose perceived need for anti-depressants exceeds their concern 
about taking them, and lower for individuals whose concern about taking 
treatment exceeds the perceived need. 
Several influences were analysed to assess the factors affecting beliefs about 
the treatment such as demographics and social factors. However, Aikens et al., 
(2005) concluded that the beliefs about necessity for and concerns about 
treatments for depression were the only variables that accounted for adherence, 
and these were the most important variables that influenced adherence. 
Nonetheless, multiple linear regressions were carried out by Brown et al., who 
revealed that, as well as concerns about anti-depressants, the severity of the 
depression has an impact on adherence. Furthermore, they identified that 
individuals who fail to remember to take their treatments had more fears about: 
taking the anti-depressants; the effect of drugs on them e.g. poisons, do more 
harm than good; and becoming more dependent on them (Brown et al., 2005). 
 
A study by Bradley et al. (2010) that studies high school, adult and adolescent 
students, finds that 48% of the participants did not favour anti-depressants as a 
treatment for depression due to their side effects. One drawback of this study, 
however, is that the participants self-reported the symptoms of depression using 
a questionnaire, and this did not necessarily mean they had received  
 
 
 
28 
 a diagnosis of depression from a professional, or that they had depression at 
all. Furthermore, in a national survey by Jorm et al. (2005) conducted in 
Australia, most people perceived anti-depressants as harmful but they also said 
that depression is one of the less serious mental illnesses. Those surveyed did 
not show strong concerns about whether or not anti-depressants are something 
that people with depression must have. In addition, they said that patients 
themselves might easily manage their depression. The findings show that the 
participants did not possess adequate information about the role of genetic 
factors and other social issues in the onset of depression.  
 
A national survey conducted in Italy in 2013 to assess people’s beliefs about 
treatment for depression finds that approximately 53% of participants believed 
that anti-depressants are important for people with depression. However, 64% 
of patients said that anti-depressants are addictive, and 55% said that anti-
depressants might cause serious side effects. The authors suggest that the 
majority of the respondents were aware of the symptoms of depression, but the 
authors do not explore levels of awareness among respondents about 
depression, and the authors rely heavily on self-reporting by participants in this 
study (Munizza et al., 2013).  
 
Van Geffen, et al. (2011) use semi-structured qualitative interviews to assess 
the beliefs of patients who use selective serotonin reuptake inhibitors in the UK. 
In this study, half of the patients held positive attitudes about selective serotonin 
inhibitors and did not feel doubts about taking anti-depressants. The 
respondents said it was necessary to take anti-depressants to recover from 
their depression and they felt that their anti-depressants were effective and 
safe. The participants were also satisfied with the role of the GP in their 
treatment both during initiation to and continuing use of SSRI treatment; the 
participants trusted their GPs throughout the process. However, the majority of 
the participants in this study were either unemployed or retired. 
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When Mardby et al. (2007) undertook a cross sectional study in Sweden of 
patients who had chronic diseases, patients endorsed negative beliefs about 
anti-depressants. Patients also endorsed negative beliefs about drugs used for 
chronic physical disorders and 46% of patients raised concerns about the length 
of time they had to take medications. The patients who took medications for 
chronic illnesses were keen to be reassured that their medications are not 
addictive and that they were safe. However, in comparison with the general 
Swedish population, university level education are over-represented. 
 
Chakraborty et al. (2009) recruited participants from a multi-speciality teaching 
tertiary hospital that provides major services in areas of North India and 88% of 
patients were concerned that anti-depressants could change ones’ personality. 
More than 36% of patients believed that anti-depressants were addictive, but 
the main demographic of those studied was unemployed people who may not 
possess knowledge about anti-depressants. However Kessing et al. (2005) also 
find that patients can believe that anti-depressants alter the personality. In this 
study, conducted in Denmark, 43% of the patients felt that anti-depressants 
might alter their personality and 56% agreed that they might become addicted 
to anti-depressants. These kinds of beliefs might influence patients not to take 
anti-depressants. 
 
Banerjee and Varma’s 2013 study finds that beliefs about mental illness do not 
vary significantly cross culturally. The authors’ cross sectional study uses adult 
patients who visited a psychiatric outpatient department as participants. In the 
study, 72.5% of patients believed that anti-depressants are addictive, and 
81.3% said their illness got worse after taking anti-depressants. However, the 
authors stress that the patients in this study lacked full awareness of their 
diagnosis. For example, some patients reported knowing about the symptoms 
they received treatment for but not the exact details of their illness. Therefore, 
they could not comprehend the explanations offered entirely. Nevertheless, the 
majority of participants had some education. In contrast, Aikens and Klinkman’s 
(2012) study finds that acute patients belief in their medication increased   
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positively over time as they gained experience using it. However, patients who 
took part in the study received follow-ups every two weeks. In this study, any 
concerns the patients had about the harmful nature of anti-depressants reduced 
after treatment during the acute phase had proceeded. Therefore, the authors 
of this study suggest that improvement in functional health can possibly change 
beliefs about treatment.   
 
To summarise this section, patients make decisions based on what they 
perceive to be the risks or the harmful nature of their medications. Beliefs about 
necessity influence patients’ adherence to anti-depressants. Nonetheless, the 
evidence suggests that the reductions in the fear of anti-depressants happen if 
the pharmacist can help to reassure patients and eliminate their concerns. 
However, this means that pharmacists must be skilled, confident and willing to 
help people with depression. The next section will explore the attitudes of 
pharmacists working in the pharmacy. 
 
 Pharmacist Related Factors 2.4
In order for pharmacists to be able to deliver their advice to people with 
depression appropriately, they should possess the knowledge, attitude and 
skills to consult these people confidently (NICE, 2009 B). 
 
 Collaboration with other health care professionals 2.5
Rigby (2010) argues that although the majority of pharmacists demonstrate 
good practice in primary care, there is evidence to suggest that greater 
collaboration by pharmacists with other health care professionals can improve 
patient care. Rigby suggests the use of MUR to improve services. Rigby 
describes how, in the 21st century, the role of community pharmacies are 
changing. In addition to dispensing, pharmacists are now required to provide 
professional advice. According to the Pharmacy Guild of Australia (2010) this 
change is occurring because of the increased need for pharmacists to   
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collaborate and engage with GPs and other health care professionals more 
frequently. However, Latif et al. (2013) suggests that many patients are not 
familiar with the existence of the MUR and neither do they understand its 
purpose. The authors find that professionals do not perceive MUR as a 
collaborative activity with GP services. Rather, when patients do have 
knowledge of the MUR, they think it is a quick pharmacy orientated check of 
medicines. The authors find that although GPs often signpost patients to their 
pharmacies, MURs are not initiated using this route and MURs are usually 
organised on an ad hoc basis by pharmacists. Latif et al. also explain that 
pharmacists lack adequate resources to implement MURs, and pharmacists do 
not experience regular dialogue with GPs in order to implement the service 
properly. A study by Youssef, et al. (2010) focuses on two pharmacies that 
share client characteristics in terms of levels of affluence in the patient 
catchment area and the volume of prescriptions dispensed. This study uses a 
series of semi-structured interviews and fifteen interventions that address 
patient perceptions and the side effects of drugs. In the study, 68% of patients 
said they learnt more about their medications as a result of an MUR, and half 
the patients learned about the side effects of drugs through the vehicle of MUR; 
but interviews prescriber pharmacists rather than community pharmacists which 
may not similar to the current research which are  community pharmacists. 
 
When McCann, et al. (2012) undertook a series of interviews with pharmacists, 
patients and physicians, patients thought of pharmacists mainly as experts in 
the field of drug interactions, contra-indications and dosage. Additionally, 
different professionals brought different strengths to the prescribing process and 
members of an inter-professional team can learn from other professionals. The 
authors argue that this situation results in better patient care. The only 
drawback of this study is that it interviewed prescribing pharmacists rather than 
community pharmacists. 
 
Rubio-Valera, et al. (2012) set up a focus group that included both physicians 
and community pharmacists recruited from two regions of Spain in order to   
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evaluate the affecting GP-Community Pharmacist collaboration. The study 
found that only professionals without previous experience of collaboration 
proved to hold troublesome attitudes towards collaboration. The health care 
professionals who had experience with community pharmacists showed positive 
attitudes towards collaboration. However, in this study the authors note that the 
two regions compared had different patient to physician ratios and this might 
imply that collaboration between professionals could vary between regions. 
 
When Lloyd et al. (2010) examined primary and secondary healthcare sectors 
in Northern Ireland, pharmacists and physicians took part to discuss the 
benefits of the supplementary pharmacist and the collaborating pharmacist. The 
physicians reported that supplementary pharmacists are able to improve patient 
care and the quality of continuity of care. However, concerns were raised about 
the encroachment of the supplementary pharmacist on the physician’s role, but, 
generally, the participating doctors were in favour of supplementary prescribing, 
and had already acted as mentors to pharmacists working in this role. 
 
When Patterson et al. (2015) conducted semi-structured interviews with 
physicians, nurses and other health care professionals, the study revealed 
different opinions about the benefits of integrating pharmacist services. In 
patient centred medical homes, some team members reported positive 
attitudes, while others did not feel that the pharmacist has an important role to 
play in their team. Some health care professionals had limited knowledge about 
a pharmacist’s training and the responsibilities of the pharmacist’s role were not 
clear. In contrast, the teams who already had experience of collaborating with 
pharmacists considered the pharmacist to be a core member of the team. 
 
In 2010, Duenas and Pringle published research that studied physicians 
recruited from different countries in a qualitative study. Their focus group 
included participants from internal, family and general medicine to assess 
opinions about pharmacist involvement in medication therapy management 
(MTM).  Physicians noted non-adherence when patients had an incomplete   
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understanding of their medications. The opinions of physicians about 
pharmacist collaboration varied between positive and negative, but physicians 
who already had experience dealing with pharmacists in collaboration reported 
more positive attitudes towards collaboration. One drawback of this study is that 
it did not recruit pharmacists into the focus group, and, therefore, the results 
might have been different with the consideration of pharmacists’ opinions. 
 
In order for pharmacists to be able to engage with and deliver advice to patients 
with depression they need to have the right knowledge, attitude and skills to 
consult people confidently (NICE, 2009 A). 
 
2.5.1 The Current Work of the Pharmacist 
In order for pharmacists to be able to engage with and deliver advice to patients 
with depression they need to have the right knowledge, attitude and skills to 
consult people confidently (NICE, 2009 A). 
 
The main role of a community pharmacist is to promote the best use of 
medicines to achieve a positive outcome. They must tailor advice to individual 
patient needs and support patients in order to prevent illnesses (Pharmaceutical 
Services Negotiating Committee (PSNC) 2015). However, previous research 
has raised questions about the attitudes and motivation of pharmacists to fulfil 
this role. For example, Cordina et al. (2008) find that community pharmacists 
are more competent and happy to dispense medicines and manage their 
workloads but they do not always perceive the extent of their role in 
pharmaceutical care activities and responsibilities. The authors find that not all 
pharmacists see themselves as providers of patient care, even though 
pharmacists often make efforts to improve their communications skills with 
patients. It is worth noting that the participants in the study by Cordina et al. are 
a sample of newly graduated pharmacists who might still be optimistic and 
positive about their vocation in comparison to other more experienced 
pharmacists.  
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Due to many different reasons, the extent to which pharmacists practice 
standard professional responsibilities as outlined in PSNC varies between 
countries and cultures. However, research shows that the basic role of the 
pharmacist as a dispenser of medicines and administrator of the ordering and 
supply of medications is a role understood and practiced internationally. 
However, many pharmacists prioritise this basic role over medicine optimisation 
work. In a study undertaken in Indonesia by Hermansyah et al. (2012) it was 
seen that pharmacists were given scope to place a greater emphasis on non-
professional activities, especially those activities that focused on treating 
medications as a commodity. In this study, the age group of 20 to 30 years of 
pharmacists recorded higher responses than the middle aged or elderly (53%, 
7% and 7% respectively). Therefore, age differences might influence the 
pharmacist’s attitude. Another element of influence is the type of management 
pharmacists experience in their pharmacies. Dunlop and Shaw (2002) note the 
idea that age groups demonstrate different attitudes. They report that younger 
pharmacists are more open to the idea of pharmaceutical care activities than 
older pharmacists are. In Dunlop and Shaw’s study, younger pharmacists are 
less likely to believe that other professionals do not support a pharmaceutical 
care role for the pharmacist. 
2.5.2 The Attitude of the Pharmacist towards People with Depression 
In a cross-sectional survey of community pharmacists by Rickles et al. (2010) 
undertaken in the USA, pharmacists are seen to be more willing to help patients 
who have physical diseases rather than mental illness. Some pharmacists 
studied were uncomfortable discussing symptoms of mental illness, even 
though the data revealed that these pharmacists had experience of dealing with 
patients with depression. However, the authors do not outline what type of 
experience the pharmacists’ have previously had, or whether this experience 
relates to dispensing anti-depressants or training in connection with managing 
people with depression. When Phokeo et al. (2004) studied a sample of 
randomly chosen community pharmacies in Canada, the pharmacist 
participants explained how difficult it is to talk about the symptoms of   
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depression with patients. The pharmacists who took part in this study said they 
were less willing to follow-up patients with depression in comparison to other 
patients who were taking cardiovascular medications, for example. The 
pharmacists also described their lack of adequate undergraduate training in 
mental health, and this might account for their increased levels of discomfort 
when dealing with patients with depression. Pharmacists note a lack of privacy 
as a reason for feeling discomfort when talking to patients. 
 
After analysing a series of audio recorded pharmacist-patient role play 
interactions (using simulated patients), Chong et al. (2013 A) conclude that 
pharmacists are happy to provide advice about the safe and effective use of 
anti-depressants but less keen to explore non-medical advice or the patient’s 
experiences with depression. The age group of 20 to 29 years showed more 
openness to undertaking medicine optimisation activities, and 80% of the 
pharmacists indicated they had the use of a private consultation room. In 
contrast, in a study by Cates et al. (2005) the pharmacist participants were 
more comfortable providing pharmaceutical advice to people with depression 
than to people with cardio vascular disease. However, the authors of this study 
do not state exactly why their participant pharmacists felt more willing to help 
patients with depression, although they suggest this might be due to 
perceptions about the needs of mentally ill patients in comparison to the needs 
of the physically ill. 
 
When O'Reilly et al. (2010 B) assessed pharmacist beliefs about the 
helpfulness of interventions for schizophrenia and depression in the UK, it was 
found that 95% and 91% of pharmacists respectively support the use of 
psychological treatments and lifestyle interventions. However, 92.9% of 
pharmacists also support the use of anti-depressants. The research also finds 
that some pharmacists can provide advice about anti-depressants without being 
optimistic themselves about the outcome of treatments. The pharmacists 
generally reported negative opinions about the general long-term outcomes for  
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people with depression and admitted the likelihood of discrimination against 
people with a mental illness.  
In research by Scheerder et al. (2008), pharmacists expressed positive attitudes 
towards people with depression. This research assesses the attitudes of 
pharmacists towards mental illness in comparison with physical illness. In this 
study, the participant pharmacists were less willing to provide tailored care to 
patients who had depression in comparison with people suffering from physical 
diseases. The authors state that the lack of training received by the participants 
about mental illness may have influenced the results (reported by 73% of the 
pharmacists). Similarly, in research by Guillaumie et al. (2015) participant 
pharmacists said they were knowledgeable about depression and could monitor 
anti-depressants and manage patients. However, again, the participants 
indicated they were more comfortable talking to patients with physical illness 
rather than mental illness. 
 
In summary, previous research shows that a lack of training about mental health 
issues is a problem area for community pharmacists. In several studies, 
pharmacists are more willing to provide services to patients with physical rather 
than mental illness. Moreover, pharmacists have many commitments and 
responsibilities that impact on their ability to spend time with patients generally. 
The next section will explore pharmacist competencies for building relationships 
with patients. 
2.5.3 Building Relationships with Patients 
Worley et al. (2007) find that patients are more prone to change their views 
about medications when influenced by their peers and friends. Worley et al. also 
finds that patients regard respect, trust and a caring attitude as important as 
interpersonal skills. Furthermore, The Royal College of Psychiatrists (2015) 
recommends that patients should be able to put their trust in their pharmacist 
because they have received specialist drugs training. 
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In a study by Riley et al. (2013) it was seen that pharmacists in the UK are more 
likely than nurses and physicians to respond to the cues and concerns of 
patients; 81% of pharmacists scored positive in comparison to nurses and 
physicians (72% and 52% respectively). However, the pharmacists surveyed in 
this research were ‘prescriber pharmacists’ who had already learned specialist 
skills for and had experience of interacting with patients. In contrast, Greenhill et 
al. (2011) find that community and hospital pharmacists are less likely to be 
competent in demonstrating the soft skills required for involving patients in a 
consultation. When Al Ghurair et al. (2012) issued self-reporting questionnaires 
in Canada to measure pharmacist expertise, relationship quality, patient 
satisfaction, and relationship commitment, patients viewed their pharmacist’s 
expertise as an important factor for sustaining a relationship with their 
pharmacist, but one of the limitations of this study is that it uses a convenience 
sampling technique.  
 
In a study by Liekens et al. (2014), two participant groups were set up in order 
to assess the communication skills of pharmacists. The intervention group 
received communication skills training relating to depression whilst the control 
group did not receive any training. The control group attended a one day 
depression related training programme that focused on the pharmacists’ 
counselling of unannounced ‘mystery shoppers’ who had just started using anti-
depressant therapies. The study explores the effective outcomes of open 
questions, and the pharmacists in the intervention group asked more questions 
about anti-depressants and lifestyle/psychosocial concerns compared to those 
in the control group. The intervention group had a little information about 
lifestyle and psychosocial issues but the control group had no information at all. 
The result was that patients working with the intervention group became more 
willing to ask questions. However, one of the limitations of this study is that it 
uses a small sample of respondents. Additionally, when Guillaumie et al. (2015) 
studied the opinions of community pharmacists working in Canada, pharmacists 
acknowledged the importance of reassuring and calming patients in order to 
reduce feelings of guilt. The pharmacists also understood that patients might be   
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embarrassed to come to the pharmacy to collect a prescription of anti-
depressants. The drawback of this study, however, is that it uses a focus group 
and this might have discouraged the participants from sharing their prejudices 
about people with mental health problems. 
 
In contrast, Pelicano-Romano et al. (2013) find that pharmacists often assess 
the quality of their communication according to the quantity of information they 
impart, rather than on building relationships with patients. The authors suggest 
that the pharmacists used closed questions in an attempt to overcome the 
cognitive impairment of patients, especially the elderly patients. In Anderson 
and Roy (2013), the majority of patients linked the quality of their experiences 
with anti-depressants to the quality of interaction they had with their physicians, 
and reiterated that if they have a good relationship with their physician then this 
facilitates open discussions about the side effects of medication. One of the 
limitations of this study, however, is that it uses secondary data sources 
comprising narrative interviews about peoples’ experiences of depression rather 
than their actual use of anti-depressant drugs. 
 
In Guerreiro et al. (2010) patients with physical diseases in Portugal report 
being satisfied with the quality of interaction with their community pharmacists 
who demonstrate collaborative care skills with patients. The patients rated 
interpersonal skills and building relationships highly and they described 
pharmacists as, ‘kind, and very nice’. Building this kind of relationship might 
help to influence the expectations of patients, and building a degree of trust and 
familiarity with health care professionals might influence patients to accept 
pharmaceutical advice. However, some patients in this study demonstrated 
active resistance when pharmacists tried to give advice, and the patients called 
on their own knowledge and the higher authority of general practitioners as 
justification for this resistance. Similarly, Salter et al. (2007) find that patients 
resist the involvement of pharmacists in their treatment because of attitudes 
held about the superior authority of GPs. This shows that some patients hold 
strong views about hierarchies within the health care profession and this can   
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have an impact on pharmacist relationships with patients. However, in this study 
the participants were elderly, and had chronic conditions. These circumstances 
might point to patients having especially strong relationships with GPs.  
 
Gidman et al. (2012) claim that patients are more likely to consult their GPs 
when they have health related concerns because they are more familiar with 
their GP as a person and because GPs have more in depth access to a 
patient’s medical history. In this study, patients recorded greater levels of trust 
with GPs than with pharmacists and said their relationship with their pharmacist 
was distant. 
 
To summarise this section, building a good relationship with patients is essential 
when pharmacists intend to deliver advice and information to patients. Trained 
pharmacists are more able to open up discussions and respond to patient cues, 
and patients become more involved with pharmacists who can tailor services 
and build effective relationships.   
 
The next section will explore the quality and quantity of information pharmacists 
give to patients. 
2.5.4 Provision of Information to Patients 
Crump, et al. (2011) describe how important it is that pharmacists are able to 
provide quality information that is tailored to individual patients and be proactive 
in providing patient-centred care. Additionally, Rosenthal et al. (2010) explains 
that, in recent years, community pharmacists have been encouraged to take on 
an expanded to include giving professional medicine optimisation advice. 
However, the quality and quantity of information and services provided by 
pharmacists worldwide can vary. Al-Arifi (2012) explains that in Saudi Arabia 
the professional role of the pharmacist has improved in recent years. Patients 
now experience higher levels of satisfaction and have a greater understanding 
of the pharmacist’s role in their health care team. However, the study does not 
discuss whether these improvements cover both OTC medicines and chronic   
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diseases. Moreover, Saudi Arabian patients still perceive the main role of the 
pharmacist to be that of a dispenser of drugs and provider of basic information 
about medicine. The authors note that some pharmacists lack a private room for 
consultations and this works as a barrier to providing enhanced services for 
patients. 
 
When Doucette et al. (2013) undertook research to explore the views of 
Canadian patients discharged from hospital the study found that nearly half of 
the patient participants could recall the interactions they had with pharmacists 
during their time in hospital. Out of the patients who could recall their dealings 
with a pharmacist, 89.1% said they were satisfied with their interaction and 
83.2% said they would accept offers of support given by pharmacists in the 
future. One drawback to this research, however, is that the study used a 
telephone survey that was conducted five to seven months after the patient’s 
discharge from hospital, and the long intervening period may have provided 
patients with opportunity to forget their experiences and the information they 
were given. 
 
In a study by Pelicano-Romano et al. (2013), community pharmacists spoke 
more often, and for a longer time than patients spoke during interactions. 
Reasons stated for this by the pharmacists included: checking their own 
understanding of information given, and trying to reassure patients. Dickinson et 
al. (2013) find that many patients prefer information tailored to their health 
needs and that tailoring information would help to reduce their concerns about 
diseases and medications. In a focus group of Canadian pharmacists set up by 
Guillaumie et al. (2015), pharmacists admitted that they did not take active 
action when patients experienced problems with adherence to treatment. They 
said they were more likely to provide a brief consultation at the counter to try to 
improve adherence. The authors suggest that a lack of tools for monitoring 
therapy is one barrier to providing quality care.  
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In 2004, Knapp, et al. surveyed patients who attended a cardiac rehabilitation 
clinic to find out about the risk factors connected with receiving verbal 
explanations about drugs in comparison to receiving numerical based factual 
information. In the study, 18% of patients felt they would experience side effects 
after receiving a verbal explanation whilst only 2.1% reported this perception 
after receiving numerical based information. However, no differences appeared 
between groups regarding their decision to take medication. One drawback of 
this study is that a time gap of a few months had elapsed between when the 
patients started to take medications and when they reported their responses. 
Dyck et al. (2005) finds that pharmacists can be imprecise when explaining the 
side effects of drugs generally, and they often use terms such as ‘sometimes’ 
and ‘possibly’. The authors suggest that pharmacists might not be fully aware of 
the frequency of side effects. In this study, it is not clear whether or not the 
pharmacists use these terms so as not to alarm patients, or to make it easier for 
patients to understand information.  
 
In a study by Hamrosi, et al. (2014) most of the participant patients were happy 
to receive advice about the side effects of medication either in the form of a 
general explanation or in numerical and factual form. The patients in this study 
indicated they were more likely to overcome their fear of side effects if the 
explanation focused on the positive effects of the medication rather than 
possible side effects. Additionally, Displenter et al. (2013) find that pharmacists 
think it is difficult to discuss the side effects of drugs with patients who take anti-
depressants, especially when the side effects might be severe, such as weight 
gain, for example. The authors claim that many health care professionals, 
including pharmacists, prefer not to tell their patients about the full side effects 
of drugs because they fear the patient will no longer want to take their 
medications. One drawback of this study, however, is that the patients used 
were from a narrow sample of inpatients in a psychiatric hospital. When Kairuz 
et al. (2013) created a hypothetical patient (scenario) in Australia to test 
pharmacists’ communication skills, the participant pharmacists tended to use 
the term ‘you’ frequently in an attempt to personalise information given, and to   
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try to reassure patients. However, Mohammad, et al. (2014) finds that 
Australian patients with low English proficiency can be confused and 
overwhelmed by the large amounts of information included in information 
leaflets, especially about side effects. Patients studied in the focus group said 
they relied on professionals for information about medications and other health 
related treatments. Furthermore, because the patients had not been newly 
diagnosed this might indicate that pharmacists behave in a paternalistic way 
with regular patients. The authors also find that pharmacists can behave in a 
paternalistic fashion with patients when they prescribed new medications. 
However, one drawback to this study is that it only focuses on ethnic minority 
groups. 
 
A study by Tarn et al. (2009) finds that older patients can become dissatisfied 
when pharmacist care providers do not explain side effects to them. The 
authors also find that there can be disagreements between pharmacists and 
patients about the kind of information patients expect to get from various health 
care providers. In this study, some pharmacists felt that physicians should be 
the ones to explain serious side effects to patients, but that pharmacists can 
explain mild side effects. To overcome this problem, the authors suggest that 
pharmacists should collaborate with other health care professionals to facilitate 
a comprehensive consultation and to reduce overlapping discussions. One 
drawback of this study however, is that it focuses on elderly patients only.  
 
Crump, et al. (2011) note disagreements about who should give out what 
information. The authors report disagreements between community pharmacists 
in New Zealand. In this study, some pharmacists were able to support patients 
by liaising with other health care providers; this kind of communication is 
essential for the continuity of care, medicine supply and adherence. 
Nonetheless, some pharmacists had difficulty in accessing and communicating 
with other health care providers. Furthermore, some pharmacists said they had 
limited access to consumer information, which reduced their ability to tailor 
information to patient requirements and this makes it especially challenging   
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when trying to tailor mental health information. In this study, the participant 
pharmacists appear to take paternalistic approach towards patients and do not 
tailor information to patient needs. They make assumptions about the correct 
amount of information given and the needs of patients. Explaining side effects is 
one area of performance weakness recorded. In this respect, pharmacists were 
less motivated to provide information to patients. However, the lack of an 
adequate model to use in order to explain the side effects of drugs increased 
the possibility of withholding information unintentionally. 
 
2.5.5 Engaging the Patient in the Consultation 
Watson (2003) explains that concordance is the process by which the 
pharmacist gains trust from a patient during a consultation, and this process is 
different from the process of adherence. Concordance incorporates a process 
of shared decision-making, and stands in opposition to paternalism. The Royal 
Pharmaceutical Society (2014) reports that patients need to receive advice 
about medications and about their wellbeing and pharmacists should put 
patients at the centre of care so that patients receive the benefits of pharmacist 
collaboration with other health care providers. In addition, pharmacists are 
responsible for educating and enhancing patient understanding of medicines 
and health conditions. Worley-Louis et al. (2003) reiterates that a patient 
centred approach can enhance the quality of pharmacist-patient relationships. 
 
When Liekens et al. (2012) assessed care for patients with depression by 
Flemish community pharmacists, they found that pharmacists were not 
confident to discuss depression and its treatment with patients, and pharmacists 
lacked the skills to offer quality consultations to patients. More than half of the 
participants said they only had basic skills in psychosocial communication. 
Similarly, in a study by Crockett and Taylor (2009), Australian pharmacists did 
not encourage patients into discussion, and the participants said they lacked 
knowledge to give proper advice. Participant pharmacists were concerned 
about giving the wrong information to patients. However, this study focuses on   
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a small sample of community pharmacists. A study by Desplenter et al. (2013) 
supports these findings; this study uses semi-structured interviews to assess 
practices for giving out information about anti-depressants to patients. The 
pharmacists who took part in this study said it was difficult to engage patients 
when discussing the negative actions of anti-depressants and this encouraged 
the pharmacists to take a paternalistic approach.  
 
In a study by Street et al. (2007) the participant physicians were patient-centred 
and conveyed positive emotions toward patients. As part of the research test, 
physicians were unaware that some patients needed more support. The 
pharmacists were successful in providing advice without patients having to state 
their problems, and the pharmacists displayed knowledge without giving out 
unnecessary information. In a study by Salter et al. (2007) of elderly patients 
who had undergone a home medicine review, some elderly patients rejected 
offers of advice from pharmacists. This might indicate that the negotiation of 
patient agendas must happen in the structure of the consultation. The drawback 
of this study, however, is that it only studies people with physical diseases. 
 
Malpass et al. (2011) note that patient agendas often remain unvoiced due to 
mutual misconceptions and because patients, pharmacists and GPs hold 
traditional views about the role of the pharmacist and the physician. Some 
patients believe that physicians are more knowledgeable about anti-depressant 
drugs than pharmacists are. GPs feel they are more knowledgeable than 
patients are, and, sometimes, GPs can overestimate the patient’s own sense of 
autonomy. One drawback to this study, however, is that the sample size is 
small. Similarly, when Pelicano‐Romano et al. (2013) studied how patients 
engage with community pharmacists, the pharmacists spoke more often than 
the elderly patients did during interactions. However, the study uses audio-
recordings, and does not explore non-verbal cues, so this might serve to limit 
the contextual depth of the data analysed. In a similar kind of study by Dyck et 
al. (2005) pharmacists relied on one way communication with the patients 
during discussions and patients responded frequently with short one syllable   
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answers ‘oh’ and ‘okay’, but it was not clear whether the patients understood 
the pharmacists’ explanations or whether they were just acknowledging the 
pharmacists words. However, in the study the participant pharmacists did not 
stop to check the patients ‘understanding but continued with their explanations, 
and just assumed that the patients had heard the information.  
 
A study by Boeni et al. (2015) confirms that the majority of community 
pharmacist-patient interaction still focuses on giving out advice about 
medication administration and dosage. The quantifiable results after 
observation using a checklist showed that nearly 6% of patients received 
counselling about adherence but that pharmacists did not engage with patients. 
The pharmacists used closed questions when consulting with patients and this 
behaviour limited the involvement of patients in making decisions about their 
treatment. The authors suggest that pharmacists must consider the patient’s 
beliefs and views, but the patients visiting for OTC and prescription medicines 
faced a series of closed questions. Similarly, after an analysis of twenty eight to 
thirty five consultations, Britten et al. (2000) recorded high levels of pharmacist-
patient misunderstandings. The majority of misunderstandings happened 
because patients had to listen passively to pharmacists. 
2.5.6 Summary of the Literature 
Non-adherence to anti-depressants is considered a serious issue, and there are 
many different reasons for both adherence and non-adherence. In this study, 
the pharmacists lacked the competency/confidence to build-up relationships 
with patients, mainly because they may demonstrate paternalistic behaviour 
towards patients. This inability to create good relationships with patients meant 
that the participants were less able to engage into mutual discussions with 
patients in order to improve adherence. This inability to facilitate the mutual 
sharing of information between patients and pharmacists contributed towards 
‘building barriers’ that prevented the participants from tailoring information to 
meet the needs of patients. 
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In this study, the researcher explored the performance of community 
pharmacists when offering consultations to people with depression. The study 
aimed to encourage participant pharmacists to reflect on their practices and 
assessed the outcomes of this reflection activity on patient satisfaction levels. 
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Chapter 3   Aim and Objectives  
 
In order to enhance the quality of care provided to patients, it is essential to 
evaluate the current work of the pharmacist and their ability to establish mutual 
discussions with patients. Moreover, encouraging pharmacists to reflect to their 
practice when they provide services enhances the patients’ awareness of 
pharmacist competency. 
 Aims and Objectives of the Study 3.1
The main aims of the investigation were: 
1. To evaluate and increase community pharmacists’ willingness and ability 
to perform an initial consultation for patients with depression; and 
2. To assess any changes that have taken place after intervention which 
relate to the patients’ views about satisfaction experienced. 
 
To achieve the aims, the specific objectives are as follows: 
 
1. To explore ideal levels of service, and to develop a suitable scenario for 
simulated practice; 
2. To explore pharmacy students/pharmacists’ existing prior knowledge and 
attitudes with respect to depression and its treatment;  
3. To determine the extent of patients’ satisfaction with their pharmacists;  
4. To observe and assess the skills of the participant pharmacists; 
5. To obtain feedback by means of interviews with participant pharmacists 
after the simulation sessions; 
6. To encourage the participants to increase the level of service they 
provide in their practice by making an ‘action plan’; and 
7. To assess the impact of any changes made to service provision on 
patient satisfaction. 
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 Methodology and Methods 3.2
 
3.2.1 Introduction 
 
The general aim of this research was to improve the consultations provided by 
community pharmacists for people with depression. The study consists of mixed 
quantitative and qualitative methods. Qualitative investigation is exploratory in 
nature. It aims to achieve an understanding of underlying opinions, beliefs and 
reasons. Qualitative study is well suited to explain phenomena within their 
context. The analysis of qualitative data can provide insights into a problem to 
promote ideas or hypotheses for potential quantitative studies. Qualitative 
methodology attempts to explore issues in depth and data collection methods 
vary from observation to interview (Dingwell and Murphy, 2003). Compared to 
quantitative methods, the sample sizes in qualitative research studies are small. 
Generally, recruitment for qualitative studies is considered sufficient when new 
participants no longer generate new ideas or add to prior understanding (so 
called ‘data saturation’) (Green and Thorogood, 2004). The next section will 
provide a more detailed explanation about the reasons for choosing qualitative 
methods and the tools used to analyse the qualitative data.  
 
Well-specified problems can be studied using quantitative methods by 
generating numerical data that can be analysed descriptively and statistically. 
Quantitative data collection methods are characterised by their structured 
nature, in comparison to qualitative methods. Quantitative data collection does 
not tend to explore in depth reasoning or underlying assumptions. There are 
many examples of quantitative methods including structured questionnaires (for 
administration or self-completion) and experiments (for example, controlled 
trials). Even though quantitative investigations tend to use numerical variables 
and qualitative investigation tends to produce language data (written or oral) 
this difference is not always apparent.  Quantitative investigations can produce   
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language data and qualitative studies can produce frequency counts. There are 
some methods used for data collection in quantitative studies (such as 
interview), which can also be used in qualitative studies. Therefore, it is not only 
the type of methods or kind of data that characterise quantitative or qualitative 
methodology but also the nature of the question. Qualitative studies tend to ask 
questions such as ‘Why?’ or ‘How?’ rather than ‘How many?’ or ‘How much?’ 
which are associated with a quantitative approach. Thus, qualitative studies can 
be exploratory prior to quantitative studies; they can aid the understanding 
quantitative findings or used in parallel with quantitative studies to understand 
phenomena in depth (Dingwell and Murphy, 2003). 
3.2.2 Theoretical Perspectives 
Positivism is a philosophy of science that proposes that one reality exists, and it 
exists in an exact way whether people understand it or not. People might have 
different interpretations of reality, but according to positivism, reality is stable 
and independent of the subjective ideas of people (Green and Thorogood, 
2004).  
 
This study uses objective methods to assess the performance of community 
pharmacists when they interact with people with depression. The first method 
used was to assess the knowledge of the community pharmacists’ management 
of depression. This includes their awareness of the actions and safety of anti-
depressants. This enabled the researcher to get feeling about that what the 
community pharmacists know, if they can provide information that can maximise 
the efficacy of treatment, and reduce the negative actions of medications. The 
second method used was to assess the attitudes of the pharmacists towards 
depression and the treatment of depression, and attitudes towards the role of 
the pharmacist and towards people with depression. The third method used 
assessed the competence of the pharmacists and included an assessment of 
the quality of information given out, and the behaviour of the pharmacists. A 
satisfaction questionnaire was used to assess the satisfaction of patients with  
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service provide by the pharmacists. All these methods employed using objective 
measurements.  
Positivism is suitable if the researcher is aiming to understand the behaviour of 
people. Natural science is inappropriate for studying the behaviour of people 
because the behaviour of people is unpredictable and contextual. Individuals 
make their own sense of their place in world, and they are more likely to change 
their behaviour when being observed. In order to understand how people 
interpret reality, observation sessions were used (Green and Thorogood, 2004). 
When the researcher assessed the views of participants, it was essential to 
remember that the participants might seek to justify their behaviour rather than 
express their deep beliefs (Dingwell and Murphy, 2003). The range of the 
interviews that can be used in research vary from structured, semi-structured to 
an un-structured form. Themes are then generated from interviews are either 
descriptive (numerical) or counts. Green and Thorogood state that structured 
interviews involve distributing structured questionnaires and interviewers have 
to ask pre-planned questions in a similar manner and sequence. This type of 
interview elicits objective facts from the respondents. Moreover, the researcher 
should stick strictly to the script to avoid any differences in self-presentation or 
changes in behaviour from the interviewees that might bias the responses. 
Thus, this technique of eliciting the information was not suitable to for use for 
understanding the perspectives of the pharmacists due to patients’ fixed 
responses (Green and Thorogood, 2004).  
 
To expand the scope of interviews, semi-structured interviews strike a balance 
between the structured and unstructured interview. In the semi-structured 
interview open-ended questions are used which allow a certain extent of 
flexibility for the interviewee to answer. Thus, the researcher can make use of 
cues and prompts to assist and guide participants into the research topic area. 
In this research after observing the pharmacist-simulated patient consultations, 
interviews took place with the participant to elicit more information. Interviews 
enable the researcher and the pharmacists to interpret their current practices, 
and the responses included opinions, beliefs and their intentions when   
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consulting people with depression. This provided rich and in depth data and 
encouraged the participant pharmacist to reflect on their consultation. 
Another approach used in qualitative research is the constructivist approach. 
This assumes that reality is socially constructed rather than clear understood. 
People construct their own understanding of the world, through a historical and 
social process. People tend to reflect on what they believe and perceive 
compared to new experiences, and, so they might gain new experiences and so 
change, of they may maintain the same perspectives and behaviours (Green 
and Thorogood, 2004). 
 
After the observations and interviews, an action plan designed, based on the 
pharmacist and patient consultations. Pharmacists were encouraged to 
construct their practices towards their learning needs. This helped the 
pharmacist reflect on the observation and their interview as it applies to real life. 
3.2.3 The Approach Used to Underpin Mixed Methods 
Mixed methods are the research tools used in the current research. The mixed 
methods approach places emphasis on gathering and analysing data, and it is 
about mixing both qualitative and quantitative data in a single research. 
Combining both methods makes for better understanding of research issues 
than using one approach alone (Creswell and Clark, 2011). The flexibility of 
mixed methods approach provides the researcher with practical ways to 
address a research question. Moreover, flexibility enables the researcher to use 
numeric and textual data.  
 
Using mixed methods combines inductive and deductive approaches, which 
enables researchers to use different tools for gathering data, rather than 
focusing on one technique (Creswell and Clark, 2011). A deep understanding of 
phenomena broadly results from analysing qualitative data, whereas 
quantitative data provides general results. Different pictures or perspectives 
arise from doing qualitative and quantitative research, and both of them have 
limitations. When doing qualitative research it might be hard to generalise the   
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findings, whereas quantitative approaches diminishes the understanding of any 
individuals under investigation. Inadequacy of data may arise because one type 
of method may not provide the full story, or the researcher may lack confidence 
in the ability of one type to address a complex problem (Green and Thorogood, 
2004; Creswell and Clark, 2011).  
 
In the current research, it was not thought possible to achieve a thorough 
understanding when using questionnaires to assess the practices of the 
pharmacists, so it was worth using qualitative methods to understand why the 
pharmacists behaved the way they did. This enabled a better assessment of 
pharmacists’ ability to place patients at the centred of the consultation. 
 
The methods used in the pilot and main stages were similar. They are therefore, 
explained as a single set of methods, but differences and necessary 
adaptations are highlighted.  
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 Methods of Data Collection Used in the Study 3.3
 
Figure 3.1 describes the initial stage of this project when the research intended 
to build up these methods to assess the current practice of community 
pharmacists. This stage includes piloting with pharmacy sandwich students 
(with intercalated training periods) and practitioners who contributed by giving 
feedback about their experience in practice, and the usefulness of these 
methods to encourage other community pharmacists to reflect on their practice. 
The second stage Figure 3.2 includes main methods in which the researcher 
applied these methods with community pharmacists (participants) and also 
assessed patients’ experience with service provided in the pharmacy. 
 
Methods shown below comprise three stages, as explained in the flowcharts for 
the pilot (Figure 3.1) and the main study (Figure 3.2). 
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Figure 3.1: Flow diagram showing the procedure used in piloting 
  
Stage-1: Explore ideal levels of 
the service and develop a 
suitable scenario for the 
simulated patient sessions. 
Stage -2: Pharmacy 
(sandwich) students and 
qualified pharmacists. 
Stage 3: Pre-simulation: 
knowledge and attitude 
questionnaire.  
 
Stage 4: Simulated patient 
observations and skills 
checklists each assessed 
by the researcher and the 
actor. 
Stage 5: Post-simulation 
interviews for feedback 
(audio recordings) using 
Gibb’s model for reflection. 
 
Baseline 
Piloting conducted 
 
 
 
 
 
5
5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Flow diagram showing the procedure used in the main method 
Stage 7: Pre-simulation: A- 
Knowledge and attitude 
questionnaire                                 
B- Patient satisfaction 
questionnaire before action 
plan. 
Stage-6: Qualified 
Pharmacists. 
Stage 8: Simulated 
patient observations and 
skills checklists. 
 
Stage 9:Post-simulation 
interviews for feedback. 
Stage 10: Action plan (CPD) 
developed by pharmacists  
Stage 11: Assessment of 
patient satisfaction after action 
plan implementation. 
Main method 
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The methods used in the pilot and main stages were similar and are explained 
as a single set of methods, but differences and necessary adaptations are 
highlighted.  
3.3.1 Ideal Levels of Service Explored 
The researcher searched previous research to find gaps in order to build up the 
methods. The search assessed the extent to which needs of patients were met 
by the community pharmacists. Patients are good indicator of quality and safety 
and are part of the treatment plans that health care professionals design.  
 
People Recovering from Depression 
 
In the past, clinical treatments offered to patients depended only on formal 
clinical assessment by health care professionals. However, the patient’s 
background and personal experience are now considered important factors in 
clinical decision-making (NICE, 2012 A). Furthermore, patients have regularly 
been engaged in independent advisory groups to evaluate care provision and 
make recommendations for changes in practice (NICE, 2012 B). Patient 
involvement focuses on aspects of health services that need to undergo change 
to enhance the quality of care, which includes increasing clinical and cost-
effectiveness. Patient experience is complex and multi-faceted. Factors 
associated with individual satisfaction include beliefs, social situation, ease of 
access to health care services, and relationships with health care providers. 
 
This range of factors provides opportunities to influence the patients’ experience 
of care, in order to facilitate shared decision-making (NICE, 2012 B). The above 
explanations carry two ideas. The first idea is the journey of patients when they 
experience depression and receive treatments, and the second idea 
encompasses coping mechanisms patients use to get relief. These two ideas 
provide the researcher with information about the difficulties people face when 
they are undiagnosed and how difficult it is to find support from health care 
professionals and/or their relatives. The second idea focuses on the motivation 
of patients to get relief where they lack help from health care professionals. This   
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information may enable the researcher to explore patients’ behaviour in relation 
to the current practices of community pharmacists. 
 
Therefore, the researcher began with a discussion with patients. The researcher 
had an exploratory discussion with a person who had a history of depression 
and was an employee at the University of Bradford. The aim of the discussion 
was to explore the most important information about the depression and its 
treatments. This colleague subsequently collaborated with the work. He is 
experienced in acting, and was willing to play the role of a simulated patient in a 
simulated scenario. During the initial discussion with the actor, the researcher 
focused on the information associated with the patient-pharmacist interaction. 
Furthermore, the discussion highlighted the interaction of the patient with a 
physician. The researcher also attended an undergraduate teaching session 
presented by a patient who had received treatment for depression and has lived 
with the condition for few years. Notes from the researcher exploratory 
discussion and the teaching session helped to outline the most important 
information to support scenario development for the simulated patient sessions.  
 
The Medical Charity ‘Mind’ 
 
To reflect the importance of patient experience when developing health care 
services (NICE, 2012 B), Further discussions was with people associated with 
‘Mind’ (a charity and self-help organisation for people with mental health 
problems). These patient advocates had experience of depression and its 
treatment, and they were actively engaged (through Mind) in self-help and 
helping others. 
 
The researcher attended a regular meeting of a recovery group to explain the 
researcher (tentative) research plans and seek feedback about the scenario for 
simulation (Appendix-4). The group also volunteered information about their 
experiences supporting patients in recovery, their attempts to encourage 
positive thinking, and support mechanisms for people with depression. The 
interview gathered more information about unmet needs when patients meet   
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with community pharmacists. Moreover, this interview helped me to realise 
patients’ expectations about the pharmacists’ responsibilities. The researcher 
took notes even though audio recording would have been a better method to 
use, but due to ethical issues, the researcher manually wrote the down the 
patients’ experiences of the service, the behaviour of the pharmacists in the 
pharmacy and the extent of the support by received pharmacists. This informal 
interview guided the researcher towards establishing the scenario when 
observing simulated patient sessions with the community pharmacists 
(explained later in more detail). Moreover, this interview was one approach that 
helped the researcher assess the satisfaction questionnaire. 
 
 
Professionals 
 
A final round of informal discussions took place with three pharmacy 
practitioners who had experience caring for people with depression and another 
mental health conditions. This was to elicit more information about the treatment 
of depression, typical patients and preferred consultation styles (Appendix-5). 
During the discussions, the practitioners raised concerns about their ability to 
constructively elicit and use personal information about patients. The 
practitioners were concerned that eliciting personal information might make the 
consultation uncontrollable. The concept of stigma is important when patients 
are collecting their anti-depressants from the pharmacy. With regard to the 
behavioural skills of pharmacists, these practitioners talked about their personal 
experiences and held a general view that some pharmacists were not fully 
competent to hold consultations for people with depression. 
 
The interview was informal, and was mostly about the current practices of the 
community pharmacists. The researcher focused on mental illness, and, 
especially people with depression. The discussion covered the willingness of 
the pharmacists as well as barriers to satisfying the needs of patients. Again, 
the researcher took notes because of ethical issue relating to the recording of 
interviews.   
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NICE Guidelines 
 
The NICE (2009 A) guidelines provide the expected standard of care for 
pharmacists and other practitioners. This ranges from screening and diagnosis 
to initial treatment and follow up. For example, if a professional suspects a 
patient is at risk of depression, then he or she can use screening questions to 
verify the need for referral or further assessment: 
 
 ‘During the last month, have you often been bothered by feeling down, 
depressed or hopeless’? 
 ‘During the last month, have you often been bothered by having little 
interest or pleasure in doing things’? 
 
The NICE guidelines consistently use the term ‘practitioners’ to refer to 
members of the multi-disciplinary team. In some cases NICE specifically 
mentions specialist practitioners and their roles. However, in most cases the 
practitioners referred to could be doctors, nurses, pharmacists or indeed other 
professional carers. The guidelines influence any professional who has direct 
clinical contact with adults with depression. It is up to each professional to judge 
the extent of their involvement in shared decision-making and develop their 
competence appropriately. Arguably, the role of pharmacists is under-
developed, because the profession fails to appreciate its role helping to 
implement quite general guidelines. However, pharmacists can develop roles in 
accordance with NICE recommendations, their own competencies and patient 
expectations. The scenario developed reflects these assumptions (NICE, 2009 
A). 
 
The trend of best practice is to enable patients to guide the clinical decision. 
NICE (2009 A) describes the competence of practitioners who deliver services 
to people with depression. The guidelines consider the balance between the 
practitioners’ ability to choose suitable anti-depressants and empower patients 
to take decisions about their treatments, whereas NICE (2012 B) focuses on the 
patients’ autonomy and legitimacy. The guidelines aim at encourage   
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professionals to make patients the owners of their treatment and enable them to 
make decisions about their health conditions. 
 
These guidelines provided good knowledge to the researcher about the 
standard of practice of care the pharmacist should practice. They also provide 
more information about the responsibilities and the extended role of community 
pharmacists. This helped the researcher to build an idea about the next 
scenario. The responsibilities of the pharmacists are not limited to advising 
patients about medications but screening patients at risk and engaging them 
into mutual discussion. 
 
Pharmacists who meet with people with depression and other professionals 
often results in patients who are less satisfied with the services provided by the 
pharmacist. Limited time, not engaging patients in discussion, and being 
unaware of the private consultation room, leads to low expectations about the 
role of the pharmacist. The interviewed professionals also outlined the difficulty 
when managing people with depression, especially when stigma attaches to 
these patients. It started to become clear that the recommendation by NICE, as 
described earlier, are not practiced generally by the community pharmacists. 
This encouraged the researcher to establish the scenario to achieve more 
feelings about this issue by means of surveying patients and professionals. 
3.3.2 The Scenario for Pharmacist-Patient Consultations 
The aim of the research is to enhance the willingness and confidence of the 
pharmacists to hold consultations for people with depression. Participating in a 
simulated scenario is one of the tools used to assess the competency of the 
pharmacists and provide feedback to them about their current practice. Running 
the scenario helps the researcher and the pharmacists to work together to 
explore shortcomings in the service delivered and identify steps needed to 
improve patient consultations. The simulated scenario developed was a short 
plot for the actor who played the role of ‘patient’ (Appendix-6). The scenario 
comprised: 
 Patient demographics (for example, age and gender)  
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 Causes and symptoms of depression 
 Treatment recommended by a medical general practitioner 
 Social and lifestyle factors 
 
When first developing the scenario, the plan was that the actor should not tell 
the pharmacist his diagnosis, so that the pharmacist tried to elicit this 
information. However, not revealing the condition did not necessarily assess the 
competency of the pharmacists, because some symptoms of and treatments for 
depression were similar to anxiety. This adds to the complexity of the scenario 
in the absence of a detailed medical history or personal experience with the 
patient. In real practice, my thought was that not revealing the diagnosis of 
depression would probably result in one of two actions: either pharmacists 
would give the medication to the patient without consultation; or pharmacists 
would try to provide general advice to avoid any mis-direction. 
 
A study by Guirguis (2011) conducted in the USA to assess the importance of 
using three prime questions (3PQs) when pharmacists communicated with 
patients in the pharmacy uses self-report surveys and focus groups to assess 
the perceptions and belief of pharmacists about the 3PQs. In the study, patients 
felt comfortable and were able to interact with the pharmacists who found 
positive reactions and were more involved with the patients. Reflecting on the 
findings of Guirguis (2011), if pharmacists are certain about the patient 
diagnosis, then they should ask the following questions: 
 What did the doctor tell you to use this medicine for? 
 Or, do you know what this medicine is for? 
A third question was excluded  ‘This antibiotic has several uses. What are you 
treating? This question was more suitable for physical illnesses rather than 
mental disease. Antibiotics treat infections for different conditions such as, 
infection in the chest or gastro intestinal system, unlike anti-depressants that 
are more likely to work in the brain. Nevertheless, clinicians sometimes do not 
tell the patients the purpose of treatment (Grimes and Barnett, 2014). Probably 
if patients did not know the purpose of anti-depressants, pharmacists could 
screen patients for depression. 
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The scenario was from different sources such as NICE Guideline (NICE, 2009 
A), my professional experience, and the discussions outlined above in 3.3.1. To 
set up the simulation, a prescription template was prepared for “Sertraline 20 
mg, once daily” and a dispensed pack was prepared. The prescription and 
dispensed pack added to the realism of the scenario, which took place in a 
purpose built room fitted out as a small community pharmacy. A computerised 
patient medication record (PMR) was available so that pharmacists could 
review the history of the patient. If the pharmacist offered the patient a private 
consultation, then suitable space was available to sit down. The action moved 
from the initial meeting space beside the dispensing bench to the consultation 
room. This action of offering confidentiality can encourage the patient to talk 
more comfortably, and the availability of consultation space provided further 
realism for the pharmacists. 
 
The researcher asked the patient to behave in a normal and neutral manner 
during the consultation, and not try to ‘test’ the pharmacist. However, the 
researcher mentioned that patient could ask appropriate open or closed 
questions if he felt that the pharmacist did not cover the information required, for 
example, side effects or the duration of treatment. The patient had experience 
of depression (as mentioned previously) and he could ask as many questions 
associated with the medicine or other non-medical treatment. Nevertheless, we 
hoped the scenario would be suitable and match what happens in real practice. 
 
3.3.3 Pharmacists’ Knowledge of People with Depression 
NICE guideline (2015 B) outlines the importance of pharmacists’ knowledge as 
one of the factors for improving patient health care. However, it was difficult to 
find any framework in the literature to assess pharmacists’ knowledge with 
helping people with depression. Many questionnaires exist to assess the 
knowledge of pharmacists but they are not adapted for the reasons shown 
below. 
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One study emphasises the practicality of the services to assess the knowledge 
of pharmacists, for example, the best method of supplying the medicine and 
presenting the information on the medicines (Hanafi et al., 2013). Another 
questionnaire was designed to quantify the side effects, and the reasons for 
under-reporting them by pharmacists (Khan, 2013). Explaining side effects is an 
important part of the advice, but pharmacists should provide other information 
about anti-depressants. The researcher asked some pharmacists who work as 
colleagues at the University of Bradford if they knew of any framework to 
assess pharmacists’ knowledge about depression and anti-depressants, but we 
did not find any such framework. 
 
A hand search of resources from the Royal College of Psychiatrists (RCP) took 
place. The RCP is the leading professional organisation for mental health care.  
An RCP information leaflet was then adapted to create a survey instrument to 
assess pharmacists’ knowledge about depression and anti-depressants. The 
RCP (2012) (Appendix-7) states that their information leaflet is suitable for 
patients who are recovering from depression and for anyone seeking further 
information about anti-depressants. Implicitly, this means that pharmacists can 
safely deliver advice and information to patients as explained in this leaflet; 
pharmacists do not necessarily have to provide all the information in the leaflet, 
but can tailor verbal information to the patients’ needs. Patients often prefer 
tailored verbal information, alongside or instead of simulated written information 
(Dickinson et al., 2013). Although the information in the RCP leaflet is intended 
for the general public, similar basic information is found in NICE guidelines 
(NICE, 2009 A). NICE guideline states that practitioners should explain fully the 
reasons for prescribing and providing information about taking anti-depressants; 
this includes anticipated side effects and the gradual development of the full 
anti-depressant effect.  
 
Landers et al (2002) show that the questions patients ask pharmacists about 
depression and anti-depressants are similar to information provided by the RCP 
and NICE. There is, therefore, broad support for the questions in the survey 
instrument that developed for this study.  
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The RCP leaflet was specific to anti-depressants and reviewed to highlight the 
most important content in relation to pharmacy practice. Excluded questions as 
listed below were less important in the current context. The aim was not to 
examine how pharmacists would answer all possible questions associated with 
depression and anti-depressants. The excluded questions were: 
 
1. What kind of anti-depressants have I been recommended? 
2. Do anti-depressants affect pregnancy? 
3. Do anti-depressants affect breast-feeding or breast-fed babies? 
4. What if the depression comes back? 
 
If necessary, pharmacists can answer these questions from information 
provided in the British National Formulary (BNF). They are important but do not 
directly apply to the majority of patients starting an initial course of anti-
depressants. When relevant, answering these excluded questions requires 
medical judgment (from GPs or psychiatrists), to determine the appropriateness 
of prescribing. Nevertheless, pharmacists have a vital role to signpost patients 
and suggest solutions to clinicians. The help pharmacists can provide is 
supported by NICE (2012 A), and pharmacists should discuss other optional 
treatments for people with depression such as psychological or social support. 
Moreover, pharmacists should offer help and information to patients and guide 
to sources of support. 
 
Some studies have found that pharmacists can find it difficult to decide which 
treatment is suitable for patients. Gawley et al. (2011) carried out an 
investigation in Canada to assess the opinion and knowledge of medical and 
pharmacy students. The investigation focused on pregnant women with 
depression. Medical students knew significantly more than the pharmacy 
students did about the effects of depression on the foetus, as well as the safety 
of anti-depressants during gestation. In my personal view, medical students 
study the effects of diseases on the human body more broadly than pharmacy 
students, and thus, medical students are more able and confident when 
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deciding if prescribed anti-depressants are suitable (or not) for patients with 
particular needs or co-morbidity. 
 
Nevertheless, if pharmacists collaborate more with clinicians this would promote 
the effective use of medicines. Al-Aqeel et al. (2012) studied the experience of 
psychiatrist interaction with pharmacists in Saudi Arabian hospitals. They found 
77% of psychiatrists expected that pharmacists were able to take responsibility 
to resolve any issues related to anti-depressants, and 75% agreed that 
pharmacists could educate people with depression about safety and optimal 
use of anti-depressants (Al-Aqeel et al., 2012). 
 
Questions and information from the RCP leaflet on anti-depressants underwent 
modification to allow option selection or semi-structured responses. This was to 
facilitate ease of completion (by pharmacists) and ease of analysis (by the 
researcher). 
 
3.3.4 Pharmacists’ Attitudes towards People with Depression 
A further questionnaire was adapted and developed to assess the attitudes of 
pharmacists towards patients with clinical depression (Appendix-8). Although 
some pharmacists offer information and advice to patients with depression, they 
are not convinced that the condition is treatable. The attitude of the pharmacist 
plays an important role in providing services to patients. Some pharmacists 
provide advice about anti-depressants without being optimistic about the 
treatment outcomes. O'Reilly et al. (2010 B) conducts an Australian survey to 
assess pharmacists’ beliefs about the helpfulness of interventions for 
depression. The percentage of pharmacists who preferred psychological 
treatments and lifestyle interventions was 95%, whereas 92.9% preferred anti-
depressants. The pharmacists showed positive attitudes towards both anti-
depressants and counselling for the treatment of depression, although, 
statistically, counselling scored higher. The scenario did not show if the patient 
had been on a medication for a long time, or any previous failure to take anti-
depressants. The presented cases were more likely of mild to moderate   
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symptoms, and this could explain the pharmacists’ preference of counselling 
over anti-depressants. 
 
In line with NICE (2007) pharmacists who have positive attitudes towards 
depression and people with depression, have positive feelings towards the 
consequences of intervention for these patients, the outcome of this positive 
attitude could increase adherence to anti-depressants or promote patients 
coping with their symptoms effectively. 
 
NICE (2012 B) states that pharmacists should be sensitive and avoid making 
assumptions about the individual, such as relying on their personal 
characteristics or appearance. Thus, the purpose of the attitude questionnaire is 
to assess the positivity or negativity of the participants’ attitudes as well as 
exploring how these attitudes affect health care services. 
 
Previous research about assessing pharmacists’ attitudes has already taken 
place. Scheerders et al. conducted a series of studies associated with 
pharmacists’ attitudes (Scheerders et al., 2011, Scheerders et al., 2009 and 
Scheerders et al., 2008). Scheerders et al. (2011) compare non-professional 
and professional attitudes toward depression in community health care in nine 
European countries. The survey instrument in this study was not suitable for 
adaptation, because of the comparative approach. The approach taken here 
took into account pharmacists’ attitudes only. Furthermore, the questionnaire 
was long, which would have made completion difficult for our participants. 
 
Scheerder et al. (2008) compared the attitudes of pharmacists with current 
(behavioural) practices in the pharmacy, and barriers to good practice. The 
authors emphasised a comparison between depression and other organic 
disorders such as asthma. The questionnaire was not suitable for adaption, 
however, because it does not cover all aspects of behaviour towards people 
with depression. Scheerder et al. (2008) focuses on medications to treat 
depression, but does not highlight any other treatments such as psychotherapy 
for patients. In contrast, to Scheerder et al (2008), the Royal Australian and   
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New Zealand College of Psychiatrists (RANZCP) state that the risk of 
depression can arise from biological disorders or psychological or social events 
(RANZCP, 2009).  This debate might indicate the need for a questionnaire to 
include different treatments for depression to assess the attitude of pharmacist. 
 
Scheerder et al., (2009) present a twenty-three item survey instrument about 
attitudes towards depression and anti-depressants, which was suitable for 
adaptation. The study explores community pharmacists' attitudes toward 
depression such as attitudes toward nature and treatment approaches for 
depression; attitudes toward the causes of depression; attitudes toward the 
pharmacists' role in depression care; and attitudes toward patients with 
depression. These components provide a clear picture about the attitudes of 
pharmacists towards depression and people with depression, which was most 
relevant to my research. However, the item called “Anti-depressants (ADs) are 
addictive” was excluded, because there is no clear evidence to support 
statements that anti-depressants are addictive. However, a study by Scheerder 
et al. (2011) reports that a large number of pharmacists believe that anti-
depressants are addictive. The item Children (below 12 years) cannot suffer 
from severe depression” underwent potential exclusion because the focus of the 
current research is treatment of adults. However, on second thoughts, it 
remained because it could show the negative attitude of pharmacists towards 
certain age groups, such as the elderly. 
 
Negative conceptions based on age can unduly influence pharmacists’ service 
provision, which should be evidence based. Scheerder et al. (2009) reports that 
9% of pharmacists think children do not suffer from depression. Although 
Scheerder et al. do not explain why some pharmacists’ think that children 
cannot suffer from depression. My opinion is that this attitude might arise from 
many factors such as culture, and is not evidence based. A question about age-
related depression helps to provide a clear picture about pharmacists’ attitudes. 
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3.3.5 Patients’ Satisfaction with Services Provided 
From a personal view, poor service can result in negative consequences for the 
pharmacy if not appropriately addressed when it occurs. Poor service has 
serious implications not only for patients but also for professionals and non-
medical work in the pharmacy. For example, if the pharmacist does not 
organise his/her workload effectively, this might affect the time provided for 
patients. Service provided might be poor due to inappropriate behaviour such 
as, weak communication skills, poor attitude, and a lack of knowledge. Failure 
to interact and deliver advice to patients appropriately can affect patient 
satisfaction. Thus, patient satisfaction is an important part of service evaluation. 
 
A number of patient satisfaction questionnaires were available in the literature 
and one was adapted to meet the needs of the current research. A study 
conducted in the UAE (Hasan et al., 2013) aims to assess patient satisfaction 
with community pharmacy. It covers many items concerning practice in the 
pharmacy such as, the consultation patients receive, the relationship between 
the patient and caregiver, accessibility of the service and product availability. 
However, it comprises largely of technical questions about medicine and self-
treatment. Focusing on medication-related problem might be normal as this 
country (the UAE) as part of the role of traditional pharmacy. Moreover, the 
questionnaire included questions about non-professionals, and the researcher 
thinks that they were not relevant to the objectives of the current work. 
 
Another questionnaire excluded took place in the UK. Tinelli et al. (2009) 
assesses the satisfaction of patients with community pharmacy. Even though 
the questionnaire covered many services in the pharmacy, a large number of 
items were associated with technical issues, concerning the mode, side effects, 
and dose of medications. Moreover, the questionnaire included many items 
concerning non-professional services, which were not relevant to the objective 
of my study such as, ‘I had to wait too long for my prescription to be completed’.  
Satisfaction with Pharmacist (SWiP) (Hernandez et al., 2000) was a 
questionnaire validated in the USA that assesses the satisfaction of patients 
with community pharmacists. It comprises seven items designed to evaluate the  
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 perceptions of patients about the pharmacist, especially, consultation 
behaviour, and collaboration with patients concerning medicine, awareness and 
responsiveness to patient needs and patient confidence in the pharmacist. The 
questionnaire assesses a uni-dimensional construct (face-to-face consultation 
with the patient) unlike some other questionnaires, which are multidimensional, 
and it assesses pharmaceutical services. Hernandez et al. conducted the study 
for people who have physical diseases but not depression. To make the SWiP 
more relevant to the current study concerning people with depression, NICE 
guidelines was involved (NICE, 2009 A) and previous informal interviews with 
patients who removed from depression to SWiP, so this could make the 
satisfaction representative of the pharmacists’ competency. 
 
The patient satisfaction questionnaire (Hernandez et al., 2000) (Appendix-9 and 
Appendix-14) which were the same but different colour, satisfaction 
questionnaire was distributed twice, before and after action planning. The 
participant pharmacists distributed the Satisfaction Questionnaire (Hernandez et 
al., 2000) to patients. The patients were not direct research participants, but 
rather their satisfaction ratings were an indicator of pharmacists’ performance. 
Distributing patient questionnaires twice, before and after implementing 
pharmacist action plans, can provide information about the degree of 
improvement in services delivery. 
 
New technology allows the undertaking of questionnaires online for practicality 
and anonymity. However, in the current study, it was difficult to contact patients 
because it is difficult to observe when patients would visit the pharmacy and it 
was difficult to monitor when consultations took place. Therefore, the 
participants handed out a paper-based questionnaire at the time of consultation. 
Patient responses were anonymous and held securely without any personal or 
sensitive information. Patients were able to complete questionnaires in private 
and without fear of identification. 
Questionnaires excluded duplicate replies to facilitate tracking. Each pharmacy 
had twenty numbered copies of the questionnaire for twenty patients: ten for 
completion both before and after action planning. Therefore, different patients   
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would be completing the questionnaire before and after action plan 
implementation. Patients had the option to return the questionnaire direct to the 
pharmacist or post it to the university, in a stamped addressed envelope. This 
maximised the options for the comfort, convenience and privacy of all patients. 
3.3.6 Capturing the Consultation ‘simulation’ 
Simulated Patients 
 
Simulated patients took part in this research. Now, a real and simulated patient 
are defined, and the researcher will show the advantages and disadvantages of 
using these types of patients in research: 
 
 Real patients are people who have medical problems and who use 
medical practices (Collins and Harden, 1998). 
 Simulated patients are people with a disease or without any actual 
condition who act as patients in a consistent way (Collins and Harden, 
1998). 
 
Simulated patient (SPs) might also be real patients or people who undergo 
different levels of training to provide consistent clinical scenarios. Simulated 
patients should not be distinguishable from real patients by experienced 
pharmacists or other health care providers. Using simulated patients can 
examine a great range of skills, including personal information gathering, 
physical examination and consultation. Simulated patients assess the skills of 
pharmacists when consulting people with depression (Collins and Harden, 
1998). Table 3.1 gives more information about the advantages and 
disadvantages of simulated and real patients for research and professional 
assessment purposes. 
 
The plan is to observe scenarios acted out by a simulated patient in the 
University of Bradford’s mock pharmacy. Although there are many settings 
where researchers can observe consultations, The researcher; will compare the 
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advantages and disadvantages between these different settings and justify the 
place have chosen for observing the simulation. 
 
Four different settings were considered (see Table 3.2): 
 
 University of Bradford’s mock pharmacy (Plan A) 
 Conducting observation in a real pharmacy with simulated patients (Plan 
B) 
 Conducting observation in a company training centre (Plan C) 
 Conducting observation in a real pharmacy with real patients (Plan D) 
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Table 3.1: Comparison of simulated and real patients 
 
 Real patients Simulated patients 
Advantages  They can express their abnormal 
symptoms such as depression in 
detail. 
 The real patient may not incur 
much cost, apart from travelling 
expenses. 
 They exhibit a great level of 
acceptability to students and 
staff. 
 The simulated patients trained to respond more consistently in 
the clinical investigation than the real patients, they can perform 
multiple investigations and are standardised for use in different 
settings. 
 The complexity of the scenario is controlled and it meets the 
training needs for students. 
 The performance of student might disturb the real patient more 
than the simulated patient. 
 The availability of the simulated patient could be higher. The 
real patient might find it difficult to attend different settings. 
 Simulated patient can simulate clinical symptoms if real patients 
are inappropriate such as counselling a patient with cancer. 
 Simulated patients might tolerate students under investigation 
more than real patients. 
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Disadvantages 
 The availability of real patients could 
be limited. 
 Student might unintentionally 
embarrass the real patient during the 
investigation. 
 A patient might be unwilling to 
participate because of the greater 
number of students in the 
investigation. 
 The behaviour of the real patient 
could change due to co-morbidity. 
 Different patients have different 
experiences, which will probably 
provide variance in the results. 
 
 Recruiting and training simulated 
patient is time consuming. 
 The cost of the simulated patient 
might be greater than a real 
patient. 
 It is difficult to standardise many 
physical signs such as heart 
beats in hypertension 
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Table 3.2: Comparison between different approaches used in the research 
 
 
Approach Pros Cons 
Plan A: 
Mock 
Pharmacy 
1. Look at available locations for observations. 
2. Mock pharmacy facilitates the consultation and brings 
technology to the mock pharmacy. This avoids restriction 
and policies present in the real pharmacy. 
3. Saves time of the actor coming to the same location. 
4. Quiet and relaxed environment compared to real medical 
health centres. 
5. Suitable for the actor to access the premises in the  
University 
1. Look at time constraints for pharmacists to 
attend the mock pharmacy. 
2. Environment is not as authentic as in the 
real pharmacy, such as factors like 
overcrowding of patients. 
Plan B: Real 
pharmacy, 
simulated 
patient 
1. Look at available location for observation. 
2. Look for authentic environment. 
3. Look at saving time of pharmacists. 
4. Look at suitability for the pharmacists to attend observation. 
1. Consultation time might not be suitable for 
the actor. 
2. Look at possible busy environment. 
3. It is difficult to arrange times slots for 
different pharmacists, as one pharmacist 
might not be ready after the previous one. 
  
 
 
 
7
5
 
 
Plan C: Company 
training centre 
1. Look at available of location for 
observation. 
2. Look at saving time of pharmacists 
because the plan is to invite pharmacist 
who work beside the training centre. 
3. Look for quiet environment. 
1. Time might not be suitable for the actor. 
2. Time may not be necessary suitable for 
every pharmacist to conduct the 
observation at the same day. 
3. There is no a dispensary area? 
Plan D: Real 
pharmacy, real patient 
4. Look for availability of location for 
observation. 
5. Look for authentic environment. 
6. Look at saving time of pharmacists by 
the researcher travelling to a community 
pharmacy. 
7. Look at suitability for the pharmacists to 
attend observation.  
 
4. Look at how many people with 
depression will attend in one day. 
5. Look for busy environment. 
6. Catching the behaviour of both parties at 
the dispensing desk and consultation 
room is difficult because some 
pharmacies do not have camera in the 
private area. 
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Real Pharmacy with Simulated Patients 
 
Conducting observations in a real pharmacy: Observing the ‘simulated 
patient’ in the real pharmacy may be more authentic because it is in an 
everyday practice environment, and it could save the time of pharmacists 
travelling to the University. However, the practice environment is busy and the 
participants (or researcher) are open to distraction by the flow of patients in the 
pharmacy. Furthermore, during observations of the ‘simulated patient’ in the 
consultation room, a real patient might need to have a consultation in the same 
room. This would inconvenience real patients by taking away their opportunity 
to have a consultation, or even cause patient harm. 
 
Training Centre with a Standardised Patient 
 
Conducting observations in a training centre: If a suitable training centre 
makes itself available, for example, a pharmacy chain’s training room, then this 
would be a practical option. It is possible to have a number of observations in a 
single day and the environment would be less stressful for the pharmacists. 
However, the environment would lack authenticity. Pharmacists would also 
need to be relieved from their normal duties. 
 
Real pharmacy Observation with Real Patients  
 
Real observation plan: Observing the actual interaction between pharmacists 
and patients in the natural environment would be ideal in many ways. However, 
it is hard to predict the number of patients diagnosed with depression who visit 
a particular pharmacy on a particular day. The presence of the researcher could 
also affect the response of patients during their initial consultations with 
pharmacists. 
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University of Bradford ‘Mock pharmacy’ with Simulated Patient 
 
Current work plan: Consultations between a simulated patient and different 
pharmacists conducted at the University of Bradford. Simulation provides a 
controlled environment for observing and an opportunity for participants to 
reflect back. The environment is also realistic (see Appendix-10: Photograph). It 
is more predictable and more controlled compared to a real pharmacy. A mock 
pharmacy is available to train and assess students studying at the University of 
Bradford. This environment can provide all the elements associated with 
professional practice, such as, consultation, non-professional work and 
prescribing OTC medicines. This pharmacy consists of shelves containing real 
medicines to allow the students to get involved with the same conditions as in a 
real pharmacy. There is another private room for consultation to allow the 
conditions to be confidential during pharmacist-patient communication. In 
addition, there is also a computer available which saves the medical record 
information of the patient such as, the name of medicines, dose etc.  
 
Interviews can provide accounts of pharmacists’ interactions with patients, but 
not a direct representation of pharmacists’ behaviour. Interviews establish a set 
of opinions but do not necessarily provide an accurate record of behaviours. 
Thus, using video enables the researcher to analyse the pharmacists-patients 
interaction. The researcher planned not to assess skills during the observations 
so as not to influence the pharmacists. Nonetheless, replaying the videos 
facilitated the researcher to assess the communication retrospectively and 
review the consultation repeatedly and this created a permanent record (Asan 
and Montague, 2014).  
 
In the current study, observing pharmacists’ interactions with the simulated 
patient ‘actor’ was an important objective. Simulated patients included real 
patients and actors who have learned to exhibit a health problem (Berger et al., 
2005). The simulated patient had a simple and practical background story and 
needs similar to real patient i.e. a plausible clinical scenario, which enhanced   
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the validity and monitored the outcome. With patient needs and behaviour 
simulated, the type of behaviour the pharmacist showed was easier to explore. 
Conducting the simulated patient in the clinical suit (Appendix-10) at the 
University of Bradford had advantages for the simulation. Moreover, the mock 
pharmacy was of the same standard as an actual pharmacy.  
3.3.7 Assessing Pharmacists’ Skills  
Pharmacists should be aware of the psychological, physical and social risk 
factors for clinical depression especially in the elderly. Pharmacists should have 
knowledge and competence to screen people who might be at high risk of 
depression (Canadian Coalition for Seniors’ Mental Health, 2006). 
 
The researcher assessed the pharmacist’s skills using observed simulation. The 
researcher assessed the skills of pharmacist based on what they did or did not 
do (objective) in the consultation, rather than seeking to explain what underpins 
these skills. The consultation process requires verbal and nonverbal 
communication skills. Therefore, demonstrating good communication skills 
during the consultation gained the patients’ confidence and helped motivate the 
patients to adherence to the recommended regimen (Ramesh, 2004). 
 
There are many tools used to assess students or health professionals and to 
provide feedback for the development of practice and services, and frameworks 
through which the researcher could assess the skills of the pharmacists. 
 
One of the frameworks is SEGUE, a framework published in 2001. It consists of 
32 communication skills that underpin appropriate medical consultation (Makoul, 
2001). Based on binary ratings of yes/no for each skill, investigators assess 
consultations. The scale is for multi-purpose use such as research, teaching 
and assessment, which makes the tool useful for learning purposes for students 
and teachers. This framework is suitable for medical students and their teachers. 
The researcher argues that two essential areas are missing which limit this 
tool’s ability to assess pharmacists’ skills. It lacks items to assess the 
pharmacists’ competency for the provision of information to patients. Providing   
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information related to medicines is an essential skill for competent pharmacists. 
Therefore, the skills associated with information giving require a clear presence 
in this tool. Another point is that, this tool does not include the balance between 
open and closed questions, which is important when eliciting more information 
and building up the relationship with the patients.  
 
Another tool used in the University but the researcher did not feel is suitable in 
my research, is the Calgary Cambridge model of communication. It is a tool for 
consultations in general practice to develop the skills practitioners might not 
learn at medical school. It is widely used in the UK among medical students, 
physicians and pharmacists. This tool consists of 71 skills and is a guide for 
both learning and assessing communication skills. It can be for both formative 
(for the provision of detailed feedback) and summative assessment (Kurtz and 
Silverman 1996).  
 
The researcher did not expect to observe all skills during the consultations, 
because the assessment varies according to the aim of the observation. 
Calgary Cambridge places emphasis on practice, fitted to the clinical setting of 
the physician, rather than medication-oriented problems suitable to pharmacist–
led consultations. Many of the skills require quite long interactions with the 
patient for the purpose of physical diagnosis and investigation, and a more 
private environment suits this scenario.  Calgary Cambridge was a good tool to 
assess the skills of the pharmacist. However, It was not used it in the current 
study because of the stated reasons, and because there is another tool for 
pharmacist led consultations. 
 
The Medication Related Consultation Frame Work (MRCF) (Abdel-Tawab et al., 
2011) (Appendix-11) is a validated tool. It is for learning and assessing skills 
used in a medication-related consultation. It provides key criteria explained 
below for a formative assessment tool, and used to identify pharmacists’ 
strengths and weaknesses when conducting medication-related and client-
centred consultations. The tool is for pharmacists who play an increasingly 
essential role in providing patient-centred approach, such as Medicines Use   
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Reviews and providing consultations. The tool may also be relevant to other 
professional groups such as a nurses involved in medication-related 
consultations.  
 
Assessing the Relevant Tool  
The tool comprises five sections: 
 
(A) Scene setting or Introduction - where the practitioner intends to 
initiate a relationship and engages the patient; 
(B) Data collection and problem identification - pharmacists obtain 
relevant information from the patients. Pharmaceutical care needs 
identified and prioritised. This was an important section that required 
the pharmacists to identify what medicines patients take, how they 
use them,  and explore concerns of the patients about the treatment;  
(C) Actions and solutions include a discussion on how the problems 
identified might be solved or prevented and to negotiate shared 
management strategies; 
(D) Closing section - pharmacists discussed possible plans with the 
patient, in case something becomes worse, negotiates and agrees a 
follow-up plan; the final section; and 
(E) Lists consultation behaviours demonstrated throughout the 
consultation. The assessments of individual activities and behaviours 
require a binary (yes/no) assessment. 
 
The intention was not to assess the skills of the participants during the 
consultation in order to reduce the impact on the participant, and to make the 
environment friendly, rather than testing the participants. 
 
3.3.8 Interview to Encourage Reflection 
Interviews took place with each participant (community pharmacist) after 
observation, but before the interview, the participants had opportunity to see 
their video. Offering the video helped the participants remember their behaviour   
 
 
 
81 
when communicating with the patient. However, it depends on each person if 
the participant is happy or otherwise or just takes part in the interview. The 
interview includes the simulated patients, participants and the researcher in the 
mock pharmacy (stated earlier). The researcher engages the simulated patients 
to encourage the participants to share the information and to exhibit their 
preference and values that we would not cover if the discussion takes place 
between the researcher and the participant. An interview between the 
researcher and each pharmacist was seen as a specific type of interaction, in 
which the researcher and each pharmacist produced data about their beliefs, 
ways of viewing the people with depression and the usual provision of care  
(Dingwell and Murphy, 2003). 
 
Many methods can capture data in qualitative and quantitative analysis, such as 
documentation and interview. Investigators might miss documenting some 
behaviour while observing patients. Some investigators rely on their memory 
and postpone some of their work and then this leads to loss or the inaccurate 
recording of data (Mack, 2005). However, in the current research audio 
recording was suitable to capture the data of the interviews because it is a 
reliable and reproducible tool. In the current study, interviews with pharmacists 
and the simulated patient took place to provide feedback. Recording allowed 
the researcher to dedicate full attention to the participants and provide an 
accurate, verbatim record of the interview, capturing the language used by 
participants. 
 
Gibbs Model of Reflection 
The researcher prepared to ask predetermined questions through which the 
information was obtained (based on Gibbs’ model of reflection) (Appendix-12). 
The interviews apply Gibbs’ reflective model (Gibbs, 1988) with the pharmacists 
and patient ‘actor’. Gibbs’ structure is clear and allows for description of the 
event, feelings about the event, evaluation of experiences, and analysis to 
make sense of the experience and examine their practice through action plan. 
Gibbs encourages the pharmacists to formulate an action to facilitate reflection   
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and so pharmacists look at their practice and what they would change in the 
future (learning through repetition). There are other models of reflection, such 
as John (2002) which provide good explanation and encourage to critical 
reflection, but there are many questions possibly irrelevant to the intended 
discussion of our research, such as questions about ethics. The framework is 
long and it may make discussion uninteresting because there are many 
questions associated with the feelings of other people that may be an 
advantage. The structure of the Gibbs model is similar to CPD and the next 
section will deal with and Gibbs less critical. Using Gibbs with the participants 
provided a good picture about practices and with the help of a simulated patient, 
in our study Gibbs is the pre-step before implementing CPD; Gibbs is thorough 
and provides critical thinking about the learning needs. 
3.3.9 Implementing an Action Plan in the Practice  
Medications play a vital role in preventing and treating disease. However, 
evidence shows that patients should make the best of their medications. Non-
adherence to medication needs the immediate involvement of pharmacists to 
support patients, and this develops medicine optimisation for example, reduce 
patients’ concerns and enhance their medication adherence. This is a patient-
centred approach that patients involved in decisions about their medications 
and in a mutual partnership with pharmacists. This approach can support 
patients to take responsibility for their treatment (Royal Pharmaceutical Society, 
2013 A). 
 
The General Pharmaceutical Council (2011) (CPD) (Appendix-13) is a continual 
process of lifelong learning: skills, knowledge and experience that the 
pharmacist can gain as they work. It follows a cycle of four stages: reflection, 
planning, action and evaluation. It is a record of what the pharmacists 
experience, learn and then apply. 
 
The participants were encouraged in the interview to reflect on their practice, 
guided by Gibbs model (previous section). The participants were aware of the  
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CPD because they practice this training in real practice. Participants had the 
option of undertaking an action plan when they had completed the interview.  
The Community Pharmacist has a unique position, in that they are accessible 
and in direct contact with patients. This position needs pharmacists who are 
able to deliver best practice to patients. In the beginning of building up current 
methods, the plan was to engage pharmacists in a short training course to 
reflect on their practice. However, due to ethical issue (avoid presumption that 
the pharmacists need training) the plan changed to encourage pharmacists to 
practice CPD as another method of reflection. It is a framework to ensure 
pharmacists are competent to provide high quality of service (Waterfield, 2008).  
 
CPD has become a practical activity due to increased knowledge in pharmacy 
practice. The new role of community pharmacists sways towards clinical 
emphasis and this makes the profession challenging. The challenge is to 
ensure pharmacists have skills and competencies in their practice, and this 
includes pharmaceutical knowledge and the confidence to make decisions in 
the practice (Waterfield, 2008). According to Waterfield (2008), Continuous 
Professional Development (CPD) follows a cycle of four stages: reflection, 
planning, action and evaluation. It is a record of what the pharmacists 
experience, learn and then apply: 
 
1. Reflection on Practice 
Pharmacists can determine their learning needs. Pharmacist’s own reflection 
focuses on what the pharmacist sees are his limitations and needs in their 
knowledge, skills or experience, and works towards developing or deciding how 
he would gain such professional abilities to keep up-to-date with what is new in 
the profession. In the current research, simulation provided good opportunity for 
participants to reflect on their skills when interacting with patients, they were 
encouraged to improve skills that were relevant to their practice and give advice 
and information for safe and effective therapeutic medications.  
 
Although personal reflection is the main mechanism for identifying CPD needs, 
peer group consultation, or involving a mentor may help achieve these from an   
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objective view. The peer group may help to make sure that the learning 
objectives cover a wide range of areas relevant to the pharmacist’s clinical, 
academic and professional developmental needs. 
 
2. Planning 
The pharmacist sets a time to achieve the leaning needs. At this stage 
pharmacists prioritise ‘urgent and immediate’ objective learning needs and 
make decisions to see if they can meet the needs, such as managing time. The 
researcher highlighted to the participants the importance of managing the time 
for CPD rather than making it loose. However, it was necessary to consider time 
pressures. Pharmacists assessed the importance of each learning need to their 
practice, organisation and other colleagues in the medical care setting. The 
pharmacists also decided what resources (time, finances, etc) are available for 
meeting the learning objectives. The pharmacist could then make a balanced 
plan for meeting not just short-term urgent needs but also the long-term needs 
of keeping up-to-date in the field, contributing to knowledge in the field and 
supporting colleagues and junior pharmacy trainees etc. 
 
Continuous reflection and planning is necessary for professional development 
as professional development and training needs may change with time as e.g. 
more medications are introduced the market and new guidelines are developed 
or updated. The researcher offered the participants help concerning source of 
information, for example published papers and any guidelines they would like to 
read. 
 
3. Action 
Pharmacists implement their CPD plan made during the reflection and planning 
stages. The plan takes place within a defined time and resources and the 
researcher is in regular contact with these participants to encourage them to act 
on this plan. An important part of this section is the need for the pharmacist to 
reflect again on what skills, knowledge and attitude he/she has gained and how 
effectively they achieved the intended objectives. The action stage may consist 
of case based discussions, attending conferences, attending topic discussions,   
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self-reading, etc within house or external training events. It is important that 
there is a variety of topics as well as topics relevant to the specialty covered 
and those that could help maintain professional developmental needs.  
 
4. Evaluation 
Evaluation is again a continuous process. Here the pharmacists assess their 
improvements, skills gained etc by rating the extent of learning objectives they 
have achieved. The pharmacists also need to assess how they could apply the 
achieved skills for improving the quality of service and effectiveness of clinical 
interventions. The evaluation may take different forms like note keeping, 
reflections, feedback from colleagues and feedback from patients, audits, 
research etc. Obviously, referring back to the needs of the pharmacist is the 
baseline for any assessment of a training event. 
3.3.10 Patients’ Satisfaction after Implementing an Action Plan 
Satisfaction is the extent to which the patient’s needs are met, how helpful, 
suitable and effective a service is (Chui, 2009). Tipton, states that patients have 
many satisfaction perspectives and patients assess their perceptions of a 
service relative to their expectations for that service. The expectation the patient 
holds for the service becomes the standard. Patients evaluate the discrepancy 
between their expectations and perceptions of the service. If the patient 
recognises that the service provided during consultation exceeds their 
expectations, they will be satisfied with the service. In contrast, if the 
consultation does not meet their expectations, they will be dissatisfied. The 
interesting thing is that their expectations may come from their own experience 
with that particular service, other services like it, and from the experiences of 
others (Tipton, 2009). 
 
At this step, the purpose of the questionnaire is to evaluate the improvement of 
the participant (community pharmacist) when providing services after 
implementing an action plan see (Appendix-14). The questionnaire has similar 
content to the previous questionnaire (3.3.5), but the time to assess the 
questionnaire by people with depression occurred after each consultation from   
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the participant. The researcher expects that when the community participant 
applied the action plan this may enhance the service provide to people with 
depression. Consequently, this may enhance patient satisfaction with the 
service. 
 
 Validity and Reliability 3.4
3.4.1 The Quantitative Approach 
The quantitative approach refers to the method used for the quantification of the 
measurement of human behaviour in social sciences research. Overall, the 
quantitative study of human behaviour encompasses a positivist view, and most 
behavioural research takes place within this paradigm. Therefore, as Smallbone 
and Quinton (2004) suggest, the instruments of measurement used for this kind 
of research must be valid and reliable. However, one of the drawbacks of this 
kind of study is that it is difficult to categorise social life objectively (Saks and 
Allsop, 2012). 
 
Pharmacists’ knowledge, attitudes and behaviours 
 
Reliability 
Using objective and simulated tests to measure human attributes or behaviour 
raises some research concerns. For example, it is essential that any test used 
is able to discriminate between individuals at the time the research happens 
and over time. Therefore, reliability is the extent to which measurements are 
consistent when performed by different individuals, on different occasions, 
under different conditions, and with supposedly alternative instruments for 
measuring the same thing (O'Leary, 2004). 
 
Even though the researcher brings their own beliefs and values to research, the 
role of the researcher is to gather and analyse data, and, therefore research 
aims need to be explicit and relevant at different phases of the research. 
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A researcher should be non-judgmental and express himself or herself as 
clearly as possible throughout the process of the research (Zohrabi, 2013). 
 
The knowledge questionnaire issued to the participants in this research 
included questions to assess the awareness of pharmacists (the participants) 
about the management of depression and to assess attitudes towards people 
with depression and the services they provide to patients. To assess the skills 
of the participants, the researcher distributed a checklist for use by the 
participants when they conducted consultations with patients. Furthermore, the 
participants gave a satisfaction questionnaire to their patients twice during the 
study. 
 
Pharmacists had questionnaires relating to knowledge and attitudes sent out to 
them before they attended observation sessions. The participant pharmacists 
were able to complete their questionnaires in private, away from the researcher, 
and this helped them become comfortable with the basis of the research and 
reassured them they were not under any time pressure to take part. This 
approach facilitated an objective investigation of the nature of communication 
between the pharmacist and the patient. As Murphy and Dingwall (2003) argue, 
observation is a good way of capturing interaction. Before conducting the 
observation sessions, the researcher put the participants at ease by reassuring 
them that all information they submitted would remain anonymous and 
confidential. This helped the researcher build up an initial rapport with the 
participants and create a friendly atmosphere. 
 
Video recordings enabled the researcher to assess the skills of the participants 
after the sessions had taken place using a checklist. Murphy and Dingwall 
(2003) suggest this technique. Video recordings allow the capture of the studied 
phenomena, which, in this case was participant and patient interactions during 
consultation. This provided a rich source of information, especially because the 
researcher was not able to deal directly with sensitive information. It captured 
interactions accurately and enabled the researcher to revisit consultations when 
assessing the participants’ skills. This helped to create reliable data. Moreover,   
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if research intends to assess non-verbal cues, then video recording is the best 
technique to use in order to capture complex phenomena or interactions.  
 
The Setting and Environment for Observing the Consultations 
 
The observation sessions were at a ‘mock pharmacy’ based at the University of 
Bradford. Over half of the participants who took part in the research were 
previous graduates of the University and were familiar with the concept of a 
mock pharmacy. The participants knew that the mock consultations would be 
about anti-depressants. The participants were given the opportunity to 
familiarise themselves with the mock setting of the pharmacy before the patient 
approached with a prescription. A computer was set up in the mock pharmacy 
where participants could access the medical and personal information of 
patients. In this scenario, the researcher played the role of a dispensing 
assistant; he assisted by opening the door and organising medication. 
 
Validity 
 
Validity is the extent to which the researcher has succeeded in measuring what 
he or she intended to measure. Validity is often further sub-divided into the 
categories of ‘internal’ and ‘external’ validity. Internal validity refers to when the 
researcher is confident about the cause and effect relationship demonstrated in 
the study undertaken, and external validity is the degree to which the results of 
the study can be generalised to other situations and to other people. 
Generalisation is more commonly associated with quantitative methods 
(Bowling, 2014). 
 
In the current research, the emphasis was on the qualitative approach in order 
to explore the experiences and beliefs of the participants. Therefore, the 
number of participants (pharmacists) studied was relatively small. Although the 
findings of qualitative research cannot be generalised statistically, they can be 
theoretically generalised in that the results should have the capacity to be 
applicable in other situations. In our research patients were recruited by the   
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pharmacists according to convenience rather than randomly. Therefore, it is 
probably more accurate to say that this type of research is characterised by 
transferability rather than its ability to be generalised. 
 
Patients’ Experiences with the Pharmacists 
 
Patients had a patient satisfaction questionnaire (Hernandez et al., 2000),  issued 
twice, both before and after the action plan (more detail later) (Hernandez et al., 
2000), and patients were recruited by the pharmacists. Patients had full 
anonymity and confidentiality in order to avoid the potential for bias when 
questionnaires were completed. 
 
Reliability 
 
According to Bowling (2009) participants who take part in research may feel 
anxiety when they are being observed or interviewed. One of the drawbacks of 
this set of circumstances is that participants may respond in the way they feel 
the researcher wants them to respond, rather than giving their true opinions or 
showing their true reactions. This is especially applicable to the volunteer 
patients who took part in this research, recruited by the participant pharmacists. 
There was a danger that the pharmacist’s presence may have swayed the 
opinions of the patients, and this is why confidential patient questionnaire was 
used, the researcher gave patient questionnaires to the participant pharmacists 
who then distributed them to their volunteer patients, and the patients had the 
option to complete the questionnaire in privacy and send it back in a sealed 
return envelope directly to the researcher. Keeping the questionnaires 
anonymous and confidential helped to alleviate any stress felt by the volunteer 
patients (Bowling, 2009). 
 
Validity 
 
The patients assessed their experience with the participants by completing a 
questionnaire. The researcher designed the questionnaire from those used in   
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other similar studies. It did not target specific patients. Furthermore, informal 
interviews happened with staff from the charity Mind in order to develop the 
questionnaire and make slight amendments in order to pursue the specific aims 
of this research. Additionally, an academic supervisor approved the 
questionnaire. Patients represented from both genders within the West 
Yorkshire area. The next section will discuss the reliably and validity of the 
qualitative data. 
3.4.2 The Qualitative Approach 
Qualitative methodologies, such as in-depth interview and observation, explore 
people’s lives and experiences, and examine subjective meanings that help to 
explain the processes of actions and decisions made, rather than seeking to 
measure or categorise behaviour or attitude. Therefore, in qualitative research, 
reliability relies on ‘trustworthiness’. 
 
Reliability 
Qualitative methods are consistent with interpretivist paradigms, in that they aim 
to record the type of data that will enable the researcher to reflect on subjective 
meaning and interpretation (O'Leary, 2004). 
 
Semi-Structured Interviews 
 
Semi-structured interviews took place with the participants to try to understand 
their opinions, perceptions and actions when consulting patients. The semi-
structured interviews encouraged the participants to talk freely and share 
opinions, as noted by Ritchie et al. (2003). Both the participants and the 
researcher work as pharmacists, and this facilitated a greater understanding of 
the work of pharmacists and their opinions and concerns. This may make the 
participants comfortable when participating in this study. 
 
During the interviews, the aim was to encourage the participants to establish 
their agenda by giving them the opportunity to speak, and by listening to them. 
This took place in a manner that suited the topic of the research. The qualitative   
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approach assumes there is no one single reality that can be uncovered (Legard 
et al., 2003). 
 
A model for reflection for gathering data used Gibbs’ model, including using 
open-ended questions. The interviews began with an introduction and 
participant agendas explored in a gradual fashion making sure that the topics 
explored were covered, and high levels of consistency maintained in relation to 
content (Green and Thurgood, 2004). 
 
Audio Recording 
 
Audio recording facilitated the gathering of data in a natural and non-intrusive 
way, as recommended by Legard et al. (2003). All the participants agreed to the 
recording of their interviews before they took part in the study, and this prepared 
them to be comfortable to talk. 
 
Ritchie et al. (2003) explain that audio recording enhances the reliability of data 
collection and facilitates the natural collection of detailed information. In the 
current research, audio recording captured the interviews verbatim, and this 
enabled the researcher to review the interviews afterwards by replaying the 
audio recordings.  
 
Observation 
 
The section of the thesis that covers methodology looks at the simulated patient 
consultations in detail. All the participant pharmacists received information 
letters before attending the observation sessions, and these letters included 
details of where the sessions were to take place at the University of Bradford. 
Many of the participants who took part in the research were previous University 
of Bradford graduates and, so, were familiar with directions to the University 
and the surroundings of the University. 
Murphy and Dingwall (2003) explain that reliability is concerned with the 
consistency and reproducibility of data. Therefore, to enhance the reliability of   
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the data the researcher recorded the consultations before verbatim transcription 
took place. Video recording enabled the researcher to assess the skills of the 
participants after the sessions had taken place. Murphy and Dingwall (2003) 
recommend this technique. During the consultations, the researcher kept busy 
in the dispensary in order to minimise the participants’ awareness of 
observation. However, all the participants had previous experience of 
undergoing observation as undergraduates when they undertook Objective 
structured clinical examination (OSCE) as part of developing their practice. 
 
To maximise the reliability of the data, it was important to keep detailed 
transcripts. In order to facilitate this process, the researcher recorded and 
reviewed transcripts to obtain accuracy. Moreover, the transferring of 
conceptual forms into ‘themes and categories’ from transcript to N Vivo 10 
software (QSR, 2014) was undertaken, so that the data could be easily moved 
and managed. The use of specialist software helped the researcher analyse the 
data and the unstructured text collected as part of the mock pharmacy sessions 
and interviews. This software helped the researcher with indexing and the 
retrieval function. Using N Vivo, the researcher was able to differentiate 
between relevant data in order to make a suitable initial analysis of the data, as 
recommended by (Pope, 2006). As it will stated later about the analysis of 
qualitative work involves, a thematic analysis (explained later) was undertaken 
based on the principles of framework analysis. Undertaking a thematic analysis 
comprises identifying a thematic framework, indexing, charting, and mapping. 
Comparing cases within the data allowed the researcher to look for regularities 
in the data (key themes) and to build typologies. Comparing data within a case 
enable the researcher to explore the contextual meaning of the account (Green 
and Thorogood, 2004; and Ritchie and Spencer, 1994). To enhance reliability, 
all key stages of the research underwent review and approval by the academic 
supervisor, and problems resolved if they arose. This happened in order to give 
the analysis greater weight and consistency. 
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Reflexivity 
The qualitative researcher tends to be less convinced about the feasibility of 
achieving standardisation and accepts that the social context in which the data 
is collected has an impact upon the data. Reflexivity when the researcher 
understands that the nature of their presence contributes to the data collected 
via interview or observation (Murphy and Dingwell, 2003). The presence of the 
researcher draws attention to the variability of the data associated with the 
participants. In the current research, the researcher tried to put the participants 
at ease before interviews and observations began. However, the nature of 
research means that the researcher has to extract data from the participants. 
O'Leary (2004) notes that variables such as age and social status are likely to 
affect the data collected, especially when the researcher does not take 
variables, such as these into consideration when planning the research. In the 
current research, the majority of the participants were in their twenties and 
thirties. To prevent inconsistencies, we set up simulated patient consultations 
and the pharmacists recruited to take part were comfortable with the conditions 
of observation and were motivated to engage in the research. Moreover, the 
researcher focused on exploring the current practices of the participants and 
plans for developing their practice. 
 
Validity 
Transferability refers to the degree to which the results of qualitative research 
can be generalised or transferred to other contexts or settings. From a 
qualitative perspective, transferability is primarily the responsibility of the one 
doing the generalising. The qualitative researcher can enhance transferability 
by doing a thorough job of describing the research context and the assumptions 
that are central to the research. This being the case, researchers and readers 
can then begin to make connections from the data between local and 
community-level behaviour and practices (Shenton, 2004). However, 
summarising data may change the meaning of the data and reduce its credibility 
(Saks and Allsop, 2012). Audio recording method was used and transcribed 
verbatim transcripts to avoid substantial summary and re-wording.  
Furthermore, to enhance the validity and reliability of the research. Multiple 
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theories were combined to produce more accurate, comprehensive and 
objective representations. The research used questionnaires (as described 
earlier), the observation of consultations, and interviews, in order to elicit 
enough information to facilitate a thorough understanding of the participants’ 
decisions, attitudes and motives (Murphy and Dingwell, 2003). 
 
 Sampling 3.5
3.5.1 Qualitative Sample 
Certain ethics must guide the researcher when observing and conducting 
interviews with patients in order to gather rich data. In this study, the researcher 
selected the sample demographic for specific reasons in order to facilitate the 
research (Holloway, and Wheeler, 2010). Purposeful targeting helped to recruit 
participants to study the relationship between the community pharmacist and 
people with depression who use a pharmacy. This deliberately non-randomised 
method sample aimed to sample people with specific characteristics. 
 
Community Pharmacists 
The researcher recruited participant pharmacists (Appendix-15) to show how 
they interacted with patients. In real life situations, not all pharmacists offer 
consultations to patients, but this study provided the opportunity for all 
pharmacists to be included in a consultation exercise. Sample sizes used in 
qualitative studies usually comprise between fifteen and fifty people (Smith, 
2002). However, because qualitative research requires a detailed and in-depth 
analysis of data, the sample size in this research reflected the need to reach 
saturation of the data. Saturation (more details will be explored later) is the point 
at which no new themes emerge from the data. 
3.5.2 Quantitative Sample 
Patients Recruited Before the Action Plan 
The patient satisfaction questionnaire assessed the patients’ satisfaction with 
the services provided by the participant pharmacists, and, for this reason, not   
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less than 100 patients took part. Therefore, every participant was required to 
recruit ten patients to take part, and this was done opportunistically (using 
convenience sampling) (Bowling, 2014). This facilitated an easier approach, 
whilst not aiming to generate a random group of respondents. 
 
Patients Recruited After the Action Plan 
This step involved inviting patients to complete a questionnaire after they had 
attended a consultation with the participants. This approach was useful because 
it was difficult for the researcher to recruit the required number of patients and 
to implement an action plan. This approach was favoured over a random 
method of sampling, which is valuable in quantitative studies in order to 
determine cause and effect. In real life situations, the pharmacy environment is 
not subject to control, so it is difficult to assess patient satisfaction. However, 
one of the obstacles faced was sample clustering (i.e. in relation to age, among 
other variables). The number of patients sampled during this phase was similar 
to the number sampled before the action plan in order to enable the researcher 
to compare statistically between the two groups. 
 Ethical Considerations 3.6
A code of ethics guides researchers and these ethics should include ensuring 
the safety, anonymity and confidentiality of the participants (Appendix-16; A and 
B). Researchers must take into account any form of harm that may result from 
the participant’s engagement with the research, especially in relation to 
participants sharing sensitive information about patients, and patient 
confidentiality. Participants might appear comfortable and exhibit their 
willingness to engage during the interview, but may letter regret having been so 
open. Therefore, participants must receive a clear explanation of the purpose of 
the research and assurances of confidentiality before they take part in a study 
(Murphy and Dingwall, 2003). To minimise risk participants are required to give 
informed consent to participate; they knew of the nature and details of the study 
before starting it via an information letter. The following clauses were included 
in the letter: 
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 You may find the role-play experience a little stressful, but we are not 
really judging your performance. 
 We will make a recording, but this will used only for research purposes 
and not for teaching or broadcast. 
 You may stop at any point for break or if you want to withdraw from the 
study. 
 All responses will be strictly confidential (the personal information is 
coded). Your personal data and video will be destroyed but not until the 
study has been completed and any papers published, which may be in 
about 3 years’ time. 
The researcher obtained ethical approval for this research from the University of 
Bradford, Local Research Ethics Committee (Appendix-17) on 11th April 2014 
in relation to pharmacist self-assessment of attitude and knowledge, 
observation of simulated practice and a patient satisfaction survey. During the 
piloting stage the participants (practitioners and MPharm students) received 
consent forms (Appendix-18) and participant information letters to enable them 
to gain a better understanding of the research. The second phase of the study 
was the consultation observation and interview. NHS ethical approval was not 
required because the research elements of the study only involved pharmacy 
staff. Although, these NHS employees provided NHS services, the study took 
place in their private time and/or on University premises; the participants were 
not NHS employees. NHS patients completed a satisfaction survey, but the 
intervention enhanced current practice/help pharmacists meet the 
recommended standard of care and the survey was thus service evaluation. 
The satisfaction survey collected no personal or sensitive data. Patients 
deemed able to have a consultation with their pharmacist had sufficient capacity 
to complete and return a survey form if they wished to do so. 
 
At the time of conducting the study, no NHS organisation was able to take 
responsibility for research governance in relation to pharmacy practice research 
because NHS re-organisation has not commissioned this service locally. The 
research supervisor and sponsor therefore took responsibility for the design and 
conduct of the research. The researcher got advice from the Chair of a local   
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NHS research ethics committee and the NHS organisation responsible for 
research governance in medical general practice (and the research protocol 
shares with them). These consultations raised no issues of concern. The 
information letter (Appendix-19) handed out to the participants stressed the 
destruction of all the data gathered after the completion of the research. Quotes 
used in the text of the thesis underwent a process of anonymisation and coding 
for confidentiality. Finally, the retrieval of the patient satisfaction questionnaires 
took place via pre-paid post or hand out to the related pharmacists who will 
send it to the researcher with full anonymity that there are no patients personal 
information are required. 
 Recruitment 3.7
The recruitment of participant pharmacists, MPharm Students, and people who 
had depression happened in three phases as follows:  
  
1- The Piloting Phase 
Three practitioners who worked at the University of Bradford and three 
pharmacy students (who were studying on a 5-year ‘sandwich’ pathway) took 
part in the study via email. This demographic helped to gather different 
experiences to enable the researcher to assess skills of pharmacists close to 
registration and those in practice for longer experience by means of 
questionnaire and observation.  
 
2- The Second Phase  
The researcher looked to increase the number of pharmacist participants in 
order to meet the objectives of the study. In order to do this the researcher 
distributed an advert at a local Centre for Postgraduate Pharmacy Education 
(CPPE) meetings in Yorkshire, and the researcher visited different pharmacies 
to meet face-to-face with pharmacists to solicit participation. Another advert was 
placed with a Locum agency pharmacy supplier and the response was not 
(initially) as high as expected. Eventually, enough participants agreed to take 
part to generate enough quality data and to meet the aims of the study. 
Participants received remuneration for their time (compensation equivalent to   
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being a locum). It took around three months to collect data from the participants. 
The duration of time in observation and interview was between one to two 
hours.  
 
3- The Third Phase 
Patients received invitations to fill in satisfaction surveys in connection with the 
services they received from their pharmacists. The patients who took part did 
not need to attend the research venue, or attend any interviews and 
observations. However, the patients taking part before and after the action plan 
were different. The patients were only required to complete two identical patient 
satisfaction questionnaires at the beginning and at the end of the research, and 
it was the responsibility of the pharmacist participants to recruit patients to 
complete the questionnaires. Patients responded from among those who visited 
the pharmacies where the participant pharmacists worked, and the pharmacist 
participants invited patients from the same pharmacies they worked in, in order 
to be able to track improvements in the skills of the participant pharmacist after 
implementing an action plan.  
 
 Analysis of Results 3.8
3.8.1 Quantitative Results 
Statistical Analysis: Three questionnaires and one checklist comprised this part 
of research. Two questionnaires assessed knowledge and attitude, and one 
checklist assessed skills. The third questionnaire was the Patient Satisfaction 
Questionnaire, provided to patients before and after the implementation of the 
CPD action plan. The original questionnaires were recorded manually by the 
participants (patient and recruited pharmacists), and then the researcher 
uploaded this data into Statistical Package for the Social Sciences (SPSS). 
However, because the questionnaires and interview sessions also included 
qualitative data collection, the statistical analyses of knowledge, attitude, and 
skills were very basic (that is, descriptive totals and prevalence only). 
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The Knowledge Questionnaire 
This was scored using a Yes/No style system; 1 = Yes (the answer is correct), 2 
= No (the answer is wrong), and 3 = Partial (part of the answer is correct). 
This questionnaire used percentages for assessment, and questions had three 
options (correct, wrong, and partially correct), then the highest or the lowest 
score built the discussion.  
 
The Attitude Questionnaire 
The aim of this questionnaire was to assess the attitudes of the community 
pharmacists towards the treatment of depression, the causes of depression, 
and the extended role of the pharmacist. The questionnaire comprised four 
parts, scored using a five point Likert scale. 1 = strongly disagree, 2 = disagree, 
3 = neither agree nor disagree, 4 = agree, and 5 = strongly agree. The scale 
was clustered to include disagree, undecided and agree, so that the researcher 
could be satisfied with the score to assess the attitudes of the pharmacists. The 
results of the questionnaire are in basic percentages and then mean percentage 
scores were calculated.  
 
The Skills Check List 
 
Part of the checklist for skills was scored as follows: 1 = Yes; 2 = No; 3 = Not 
applicable. However, the checklist comprised five sections and each section 
contained different items; scores relating to these items scored as ‘yes’ ‘not 
applicable’ and ’no’, and other sections scored using ‘fully’ ‘partially’ or ‘not 
achieved’. The final reflexive assessment of the entire consultation scored using 
the Likert scale: ‘poor’, ‘borderline’, ‘satisfactory’, ‘good’, and ‘very good’. 
 
The patient satisfaction questionnaire (before and after) the action plan 
 
The patient satisfaction questionnaire also used the Likert five points scale: 0 = 
not at all, 1 = a little bit, 2 = somewhat, 3 = quite a bit, 4 = very much.  
When the researcher analysed the findings, the scores were clustered into three 
categories (agree, neither agree or disagree, and disagree) to facilitate 
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practicality when presenting the results. The results compared as the highest 
and the lowest percentages of each item (service), and overall satisfaction 
questionnaire results were not normally distributed. However, the ratings for 
each item were ordinal in nature, and, therefore, the Mann-Whitney test was a 
suitable means of analysis. The analysis of the questionnaire results included 
frequency and groupings both before and after the implementation of the action 
plans, and this took place to establish any differences in median ratings. 
Statistically, a larger number of patients would provide for richer data collection 
and better outcomes, and so it assumed that 100 patients would be adequate 
for the purposes of the research. An increase of 10% in the proportion of 
patients who became satisfied demonstrated as a difference of 0.5 - of which 5 
in 100 represented a significant difference (Greasley, 2007). 
3.8.2 Qualitative Results 
Framework Analysis 
 
This particular approach (developed with rapid health policy analysis in mind) 
assumes that the researcher may hold predetermined ideas or have priori 
concerns. First, the framework approach is suited to analysing cross-sectional 
descriptive data, which enables the capture of different aspects of the 
phenomena under investigation. It includes interconnected stages in the 
framework approach that explicitly describe the processes that guide the 
systematic analysis of data from initial management through to the development 
of descriptive to explanatory accounts (Ritchie and Lewis, 2003). 
 
The management of ‘raw’ data collected using qualitative methods takes place 
in different ways, depending on the method used for data collection, for 
example, observation notes, video, audio recordings, or verbatim transcripts. 
These methods allow for rich data collection but do not necessarily provide 
clear meaning or sense, unless the data is analysed and managed in an 
appropriate way (Ritchie et al., 2003).  
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The steps in Framework analysis are: 
 
Identifying Initial Themes: 
 
Using the ‘Framework’ approach, management of data involves deciding how 
the data undergoes labelling, sorting and comparison under each theme 
(Ritchie and Spencer, 1994). The researcher should immerse themselves in the 
data and become completely familiar with the data set. During the familiarisation 
process, notes recorded in the margin of the transcript indicate any recurring 
ideas or themes (Ritchie et al., 2003). In our study, the researcher searched for 
themes linked to the objectives of the study, and, specifically, relating to the 
attitudes, knowledge and skills of the participant pharmacists. However, 
searching for emerging themes according to pre-determined ideas is not the 
only or main objective of the research; it is more important to see how new 
ideas emerge. This means it is necessary to apply a deductive and inductive 
approach. Recurring ideas gained from familiarisation undergo grouping and 
sifting into main and sub-groups of similar ideas or themes, and then grouping 
again in categories or themes (‘indexing’). These themes undergo the 
assignment to text and the core of each theme identifies according to categories 
that underlie each theme. Transferring conceptual form ‘themes and categories’ 
from the transcripts to NVivo10 software (QSR international) can then take 
place to facilitate easy data management.  
 
Indexing: 
After developing an initial conceptual framework, the next phase was to re-read 
transcripts line by line to gain a better understanding of the data. In order to do 
this, labelled text undergoes examination to check the fit into suitable 
categories. This stage is indexing and helps refine categories. When data 
overlaps into different themes, this implies an interconnection between themes 
and issues. This is possibly, when a pharmacist consults people with 
depression, different attitudes, experiences and other factors have an impact on 
the decisions made by the pharmacists 
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Charting: 
Summarising the data was the final stage. This stage helped to make the data 
more manageable, and it provided a clearer picture of the essence of the 
evidence for later representation. Moreover, it encouraged the researcher to 
thoroughly re-read the transcript for later representation as advised by Ritchie et 
al. (2003). The researcher decided that key terms, expressions and sentences 
should undergo retention from the participants’ own vernacular language style 
and that pursuing interpretations should not happen at this stage. At this stage, 
material could not undergo deletion for irrelevance, because some data is worth 
keeping for the later stages of analysis. The previous exercise of indexing 
facilitated the construction of a set of themes for charting, and the number of 
charts dictates the number of themes. Each main theme and sub-theme ‘group’ 
undergoes plotting onto a separate chart. Two types of chart can be used to 
present information: the case chart and the thematic chart. The researcher 
chose to use thematic charts because they were more versatile for comparison 
purposes to detect differences between elements in each theme.  
 
Mapping: 
The next step was to refine the categories and define dimensions. This involves 
looking across each theme to assess the range of experience, beliefs and 
values of the participants. This undergoes searching for consensus, and if no 
consensus emerges then it is possible to identify elements of difference in order 
to ‘discriminate’ in the typology. The power of typology lies in its ability to locate 
all cases demonstrating a series of related but independent categories. 
Following typology, the researcher was able to detect patterns, associations, 
clusters and sets of phenomena. Linkages and associations in the data created 
different patterns, for example, causes and effects. The different experiences of 
the participants led to specific results or outcomes. 
 
Associations between patterns emerge that assist a deep understating of the 
investigation. During the course of the study, the researcher expected to find 
matched sets of linkages, and these linkages sometimes crossed different 
categories, for example in ‘skills of the pharmacist’ proactive and passive   
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behaviours were noted, and these behaviours related to both the attitude of the 
participants and their engagement with patients. Furthermore, sub-group 
features disclosed patterns of association, for example, socio-demographic 
factors linked to experiences in practice. The researcher reviewed cases that 
fitted into a pattern and cases that did not, and this isolated the uniqueness of 
each case, as explained by Ritchie et al. (2003).  
 
The next chapter will describe the practice of the pharmacists with people with 
depression.  
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Chapter 4  Current Practices of the Pharmacists and the 
Patients’ Experiences 
 
For the purposes of clarity, the pharmacists and MPharm students who took 
part in this research are ‘participants’. This to avoid confusion as the term 
‘pharmacist/s’ is used for pharmacists in general (in previous research and in 
the literature review). The term “pharmacist(s)” refers to members of the 
pharmacy profession in general and relates to information from evidence based 
literature, books and health care guidelines. 
 
This chapter includes the pilot and main study. In the pilot stage, the 
participants did not complete patient satisfaction questionnaire for CPD except 
for one of the participants in the pilot who completed CPD. The researcher will 
illustrate the current work of the participants by analysing quantitative results 
through questionnaires and checklists. This data expresses numerically and in 
narrative style. Moreover, qualitative results are expressed as narrative 
 
Brief overview of the structure of the results 
 
The findings in this chapter are competencies demonstrated by the pharmacists 
who took part in this research. These competencies include participants’ 
knowledge about anti-depressants, basic attitudes of participants shown 
towards people with depression, and the skills demonstrated through 
observation. The participants went through an initial assessment 
(questionnaires, patients’ satisfaction questionnaire and skills checklist) and 
then learning activities (continuing professional development (CPD). A 
reassessment was undertaken after they had taken part in a short training 
through patients’ satisfaction as indicator for improvement.  
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The structure of this chapter is as follows: 
1. The participants’ knowledge about anti-depressants; 
2. The basic attitudes of the participants;   
3. The satisfaction levels and experiences of the patients at baseline; 
4. The skills demonstrated by the participants from observation; 
5. The motivation of participants to reflect in their practice; 
6. The reflection of the participants on current practice (CPD); 
7. Patients’ satisfaction with participants; 
8. A comparison of patients experiences with the participants. 
 
4.1 The Participants’ Knowledge about Anti-depressants 
This section illustrates the knowledge of the participants when managing people 
with depression. Before the results were described, the demographic factors of 
the participants will be shown as detailed in Table 4.1 below. The total number 
of participants was 22; eighteen participants (82%) were males, while the 
remaining four participants representing (18%) were females. Nineteen 
participants were pharmacists and three were MPharm students. Their ages 
were 18-50 Yrs. The majority were in the age range of between 18-30 yrs., a 
third between 31-40 yrs., and one participant was aged between 40-50 yrs. 
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Table 4.1: Summary of Demographics of the Participants 
 
Demographics  Number of 
Participants (22) 
 Gender Male 18 
 Female 4 
   
 Age(years) 18-30 14 
 31-40 7 
 41-50 1 
   
 Experience   
Participants 
Pharmacists 
  
Months Less than  one 
year 
2 
Years 1-10 13 
 11-20 4 
MPharm Students 1 year’s 
experience 
3 
   
 
 
4.1.1 Participants’ Awareness Level of Managing People with Depression 
 
The responses to key questions asked are below in Table 4.2. The responses 
list according to the number of participants who were able to answer questions 
correctly. The percentages presented throughout this study underwent rounding 
to the nearest percentage point. There were four questions in total: to which all 
participants answered either correctly or partially correctly, relating to: indication   
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of anti-depressants, duration of the medications, safety and recommendation of 
the medications. Table 4.2 represents the results of the awareness of the 
participants of depression and anti-depressants. Some questions included only 
one option for answer, either right or wrong answer, for example question 2, 4, 
5, 6, 7, 9, 10, and 12. Other questions may include more than one option of 
answers for example 1, 3,8,11 and 13 and they may carry as (right, wrong or 
partially correct). The questionnaire results have undergone aggregation 
because the number of the sample is small and it may not provide any 
significant difference. Moreover, it is similar to the form of the original adapted 
questionnaire.  
 
The results show that the participants have good knowledge about managing 
depression. Almost all of the participants indicated an awareness of the different 
types of anti-depressant, and how they work and drug indications (95%, 100% 
and 86% respectively). Approximately two thirds of the participants said they 
were aware of the duration of time people must take anti-depressants in order 
to achieve a full therapeutic effect. Almost the same percentage said they were 
able to make decisions about the effectiveness of older type anti-depressants in 
comparison with newer medications for depression. However, less than third of 
the participants (Q.6) did not answer the question satisfactorily, and did not 
know if newer medications have fewer side effects compared with older 
medications. Over one third of participants did not answer Q.7 correctly; they 
said that the harmful side effects of newer anti-depressants were the same or 
similar to those of older anti-depressants.  
 
It was a surprise to see that more than two thirds of the participants were 
partially correct when questioned about the nature of the side effects (Q.8) of 
both newer older anti-depressants: around 10% said that anti-depressants have 
no effect on a patient’s ability to drive, and over one third said that anti-
depressants are addictive. A minority of participants thought that there is a link 
between suicide and SSRIs, and a similar number were undecided on this 
issue. 
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Table 4.2: Awareness of the management of anti-depressant drugs 
Questions Correct Partially 
correct 
Incorrect 
1. State the names of three classes of anti-
depressant medication. 
21 (95%) 1(5%) 0 
2. What is the mechanism of actions for SSRI 
medication to treat depression? 
22(100%) 0 0 
3. State three clinical indications for SSRI medication 19(86%) 3(14%) 0 
4. After starting SSRI medication, how soon will a 
typical patient experience the full therapeutic 
effect? 
13(59%) 0 9(41%) 
5. Are newer classes of anti-depressant medication 
(e.g. SSRIs) more or less effective than older 
classes (e.g. TCAs)? 
14(64%) 0 8(36) 
6. Do newer classes of anti-depressant medication 
(e.g. SSRIs) have fewer side effects than older 
classes (e.g. TCAs)? 
17(77%) 0 5(23%) 
7. Do newer classes of anti-depressants medication 
(e.g. SSRIs) have less harmful side effects than 
older classes (e.g. TCAs)? 
14(64) 0 8(36%) 
8. Many side effects are common to both SSRIs and 
TCAs. Please mark (X) in the appropriate 
column(s) to show which medication causes which 
side effect(s). 
5 (23%) 17(77%) 0 
9. Do anti-depressant medications affect the patient’s 
ability to drive or operate machinery? 
20(91%) 0 2(9%) 
10. Can patients become addicted to anti-depressant 
medication? 
14(64%) 0 8(36%) 
11. Can SSRI anti-depressants, promote suicidal 
feelings? If ‘Yes’, then when? 
20(90%) 1(5) 1(5%) 
12. For a typical patient, how long is a course of anti-
depressant medication? 
14(64%) 0 14(36%) 
13. What other forms of treatment are recommended 
by NICE for depression? 
22(100%) 0 0 
Mean 75% 8% 17% 
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Furthermore, over one third of the participants did not answer correctly when 
asked about the average duration of time people must take anti-depressants as 
a course of treatment, but all of the participants were aware of the guidelines 
issued by NICE for depression. The greatest percentage of those who 
answered correctly focused on the use, indications and recommendations for 
treatment. However, one third of the participants were not aware of safety 
issues surrounding the use of anti-depressant medications, and one third of 
participants were not aware of the average duration of time people must take 
anti-depressants. These results might be because the physician usually makes 
these decisions.  
 
Some questions were not be answered correctly by all the participants on 
certain subjects, such as the safety of anti-depressants and the duration of a 
course of treatment using anti-depressants, knowledge level of the participants 
was relatively acceptable; a mean of 75% of participants gave correct answers. 
 
 The Basic Attitudes of the Participants 4.2
The questionnaire (see Section 3.3.4) aimed to explain the data about the 
attitude of the participants when intended to offer consultation to people with 
depression. The questionnaire clustered into three scales: Disagree (meaning 
positive feelings) undecided (neutral) and agree (negative feelings). There were 
22 participants scoring in this questionnaire and it is divided into four domains, 
the description of each domain will be described and at the end of the four 
domains with a narrative explanation linking these domains together.  
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4.2.1 Attitudes towards the Nature and Treatment Approach for 
Depression  
This section represents (treatment approach) (Domain 1).The majority of the 
participants expressed a positive attitude towards the nature and treatment of 
depression, see detailed Figure 4.1 represents the mean score of perception of 
participants in this domain. 
 
Most participants took the treatment of depression seriously and only a third 
demonstrated a less serious attitude towards depression. Most acknowledged 
that it was a real disease, and that children can suffer from depression. Most 
participants disagreed with the idea that those suffering from depression should 
be able to ‘pull themselves together’. Some perceived depression to be 
something that is under a patient’s control that is relieved without engagement 
with treatments. This attitude usually accompanied negative attitudes towards 
using professional options, the idea that anti-depressants were addictive; beliefs 
that patients with depression can get better without treatment; and the idea that 
it was possible to treat depression without professional intervention, i.e. it was 
better to use the support of relatives etc. The results illustrated that participants 
perceived depression is real disease, and the patient need support, but social 
support is more effective than anti-depressants which is harmful to the body.  
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Figure 4.1: Details of attitude of the participants attitudes towards the nature and treatment of 
depression ‘serious versus non serious’. 
 
4.2.2 Attitudes toward the Inevitable Course of Depression  
This section represents Domain 2. In Figure 4.2 (inevitable vs. malleable), over 
half of the participants showed a positive attitude towards the prognosis and the 
‘malleable’ causes of depression, while around third showed a negative attitude 
towards treatment approaches and believed there were ‘inevitable’ causes of 
depression.  Regarding the mechanical characteristics of depression, and 
whether or not depression has biochemical causes the number of participants 
who supported this idea and those who disagreed were equal. A third of the 
sample was undecided about this issue. Just less than a third showed 
pessimism about being able to achieve the complete cure of depression, and a 
quarter of the sample could not decide on whether it is possible that depression 
can be completely cured.  Moreover, a quarter of the participants favoured 
using anti-depressants to treat depression.   
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About half of the sample rejected the idea that complaints about depression 
were ‘normal’ in old age.  However, a third of the sample believed that 
complaints about depression were a ‘normal’ part of old age. 
 
 
Figure 4.2: Details of attitudes of the participants towards the causes of depression  
 
4.2.3 Attitudes towards Additional Role in Depression Care  
 
This section represents Domian 3. Figure 4.3 represents details of the attitudes 
of the participants about providing additional services for patients with 
depression. Overall, the participants held negative attitudes which associated 
with the pharmacist’s role in depression care. Half the participants said it was 
important to provide additional services, whilst a third felt that providing 
additional services was not necessary and quarter who undecided. Over two 
thirds of the sample believed that patients with depression do not receive all the 
necessary information they need about this disease, both from general   
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practitioners and psychiatrists, and this perpcetion was exhibited by half of 
participants who agreed that patient less interested to talk with them. The 
participants did not give the disese more attention and half of  them believed 
that depression was a disease just like any other disease. 
 
Over than two thirds of participants felt that physicians do not provide enough 
information about anti-depressants to patients and quarter were undecided 
about this. It is surprising to notes that the comparable number of participants 
did not decide if patient adhere to the recommendation or no, and less a third of 
the participants undecided if patients followed the instructions they received 
about antidepressants. 
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Figure 4.3: Details of attitudes of the participants towards providing additional service for people with depression
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4.2.4 Attitudes towards People with Depression  
 
This section represents Domain 4. Figure 4.4 shows how most 
participants had positive attitude toward people with depression. 
However, 32 % and 27% agreed and undecided respectively than anti-
depressants can change one's personality. The majority of participants 
rejected the argument that patients with depression put a strain on 
pharmacist services, for example, by making persistent enquiries about 
certain medications, the participants found that patients with depression 
did not place excessive demands on a pharmacist’s time.  The majority of 
participants found that it is possible to rely on patients with depression. 
However, the majority agreed that social event is the main cause of 
depression, while they were less giving genetics and other risk factors 
more attentions. The majority of the participants said that weakness of 
character was not the main cause of depression. 
 
 
Figure 4.4: Details of attitudes of the participants towards people with depression. 
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4.2.5 The Relationship between the four Domains 
Overall, Figure 4.5 shows that the participants held compassionate attitudes 
towards the nature of depression, its treatment, and people with depression.  
The lowest percentages were recorded when participants were asked to 
consider their role in providing additional services. 
 
The participants named various possible causes for depression. They said that 
the causes of depression are social problems or biochemical or psychological 
disturbances, but they perceived social problems as the most likely cause of 
depression. The participants felt that anti-depressants do not represent the best 
possible treatment option, but perceived that when patients take anti-
depressants they do experience benefits. Moreover, although the participants 
valued the efficacy of anti-depressants, they expressed reservations about their 
safety that more than third of the participants agreed that anti-depressants can 
change one personality (Domain 4). 
 
The results reveal that health care professionals appear to place a significant 
amount of professional distance between themselves and patients, the 
participants said that physicians sometimes do not provide satisfactory 
information, but, generally, the participants take no action about this (Domain 
3). This evidence may link to Domain 1 where half the participants stated that 
patients do not understand the information they are given about their anti-
depressants. Moreover, (in Domain 4), one third of participants were both 
undecided and had negative feeling about the impact anti-depressant on the 
patient’s personality. They said that anti-depressants are not as effective as 
other more social based treatments (Domain 3) and double the number of 
participants who favoured social treatment than anti-depressants. The scores 
for can be contrasted to those of Domain 4 where the participants scored highly 
in terms of their positive attitude towards patients, but less positively in their 
skills for managing patients (Domain 3). 
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Figure 4.5: Summary of the results of the four ‘attitude’ sections. 
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 The Satisfaction Levels and Experiences of the Patients at Baseline 4.3
The number of patients was 160 who indicated they were happy to take part in 
this stage of the research. Table 4.3 below shows the demographics of the 
patients who took part. The patients who took part in this stage of the research 
(before the action plan) were not the same patients as those who took part after 
the action plan (mentioned in the method of recruitment earlier). However, the 
patient demographics of the two groups share similar characteristics, and the 
patients surveyed came from the same area of West Yorkshire. Furthermore, all 
patients surveyed had diagnosed depression and were taking anti-depressants 
as part of their prescribed treatment. Nevertheless, one of the limitations of the 
study is the difficulties posed in trying to recruit the same patients. Different 
patients came in for the different stages of research mainly because of limited 
access to patients who visited the same pharmacy. The majority of the patients 
surveyed were aged between 20 and 29 years, and the fewest patients who 
took part were elderly. However, the number of females who took part was 
double that of males, and white patients represented two thirds of the patient 
demographic. This section will outline the results of the patient satisfaction 
questionnaires. See Section 3.3.5 for more details about methods of choice. 
 
Table 4.3: Patients’ demographic factors (before action plan) n=160 
 
  Age Number-
Percent 
Gender Number-
Percent 
Ethnicity Number- 
Percent 
20-29 30 (19%) Male 54 (34%) White 102 (64%) 
30-39 38 (24%) Female 106 (66%) Asian 40 (25%) 
40-49 50 (31%)   Black 11 (7%) 
50-59 29 (18%)   Mixed 6 (4%) 
60-69 10 (6%)   Other 1 (0.6%) 
Over  
60 
 3(2%)     
 100 Total 160 Total 100 
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4.3.1 The Experiences of Patients with the Services Provided  
Table 4.4 shows that patients who took part in this survey did not report high 
levels of satisfaction when interacting with the participants.  A high percentage 
of patients did not feel that the participants offered them privacy for 
consultation, and only half of the patients reported that the participants gave 
them instructions about the administration of medications. Patients 
demonstrated a lack of confidence in the participants’ knowledge. A quarter of 
patients did not feel that the participants dedicated enough time to offering 
services, and one third said that patients did not decide the right amount of 
time, this agrees with the low scoring by patients for talking about patients’ 
progress with treatment. Less than a third of patients agreed that the 
participants managed medication from GPs well but less than half of the 
patients agreed that participants were aware of their treatment related needs. 
 
Patients rated the participants low for explaining side effects; this links to 
(Section 4.1.1) the evidence showing that the participants did not answer 
questions about the side effects of anti-depressants satisfactorily. Furthermore, 
the participants were less willing to follow up patient progress, this may link to 
(Section 4.2.3; Domain 3) that participants less provide additional service to 
patients. 
 
Overall, patients were not satisfied with the kind of interaction they had with the 
participants.  The majority of the scores were fifty percent or less. 
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Table 4.4: Patient satisfaction before implementing the action plan 
  
Your opinions Agrees 
 
Neither 
agrees/neither 
disagrees 
Disagrees 
1. My pharmacist offers to talk to me in 
private 
 
55(34%) 38(24%) 67(42%) 
2. My pharmacist advises me on the 
proper use of my medicines. 
 
81(51%) 39(24%) 40(25%) 
3. My pharmacist advises me on the 
adverse side effects of my medicines. 
 
70(44%) 43(27%) 46(29%) 
4. I have confidence in my pharmacist’s 
knowledge about depression and its 
treatment. 
66(41%) 45(28%) 50(31%) 
5. I have confidence in my pharmacist. 
 
99(62%) 22(14%) 39(24%) 
6. My pharmacist is available to answer 
my questions. 
 
85(53%) 50(31%) 26(16%) 
7. My pharmacist is willing to talk to me 
about my symptoms of depression and 
progress with treatment. 
58(36%) 43(27%) 59(37%) 
8. My pharmacist helps with the 
arrangements necessary to obtain my 
medicines. 
 
91(57%) 43(27%) 26(16%) 
9. My pharmacist is aware of my 
treatment-related needs. 
72(45%) 45(28%) 43(27%) 
10. My pharmacist responds to my 
treatment-related needs. 
 
78(49%) 40(25%) 42(26%) 
11. I would recommend my pharmacist to 
other people with depression. 
89(56%) 30(18%) 41(26%) 
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 The Skills Demonstrated by the Participants from Observation 4.4
This section will present the results from participants during the observed 
consultation (Section 3.3.8). There are 22 participants observed. The checklist 
is divided into five divisions and each division includes statements by which 
researcher can assess the skills of the participants. The score in this checklist 
includes Yes; when the skill is performed and No when the skill is not 
performed; and not applicable if the performance not relevant to current 
observation condition. 
 
4.4.1 Initiating the Consultation (Skills Section 1) 
This part of the research aimed to examine the participants’ skills and 
behaviours in establishing therapeutic relationships with patients. The 
participants in Figure 4.6 demonstrated poor initial rapport with the patients; the 
mean (28%) demonstrated competence in this section. The majority of 
participants did not perceive that was necessary to make introductions to 
patients. Higher scoring participants invited the patient into a private 
consultation area, but the majority did not outline the purpose and the structure 
of the consultation to enhance patients’ expectations. The minority of 
participants were able to negotiate the agenda and encourage patients to be 
engaged in mutual discussion. It appeared that the participants were less 
interested to build initial relationships with patients to make patients comfortable 
and to raise their concerns. This possibly guides us to the next section about 
whether or not the participants able to elicit information from patients for 
expanded discussion. 
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Figure 4.6: Initiating consultation sessions 
  
 
4.4.2 Data Collection and Problem Identification (Skills Section 2) 
The majority of the participants (Figure 4.7) were successful in gathering 
medication information from patients. However, many did not try to gather 
information from patients about their social history. Some condition skills were 
not applicable because we assessed newly prescribed patients. Over two thirds 
of participants satisfactorily asked patient about the reason for prescribed 
medications in order to encourage patients to understand their illness and 
enhance their knowledge of the medication, while around two third of the 
participants who were able to discuss with the patient about the trigger cause of 
depression, who may think it is not their role. It is obvious from the data that just 
the minority of participants who identifies if patients had pharmaceutical 
problems. It appeared that the participants were less enthusiastic to elicit 
information about social information and less able to elicit information about the 
condition who thought it is not their role to, while they were more willing to 
receive information about the prescribed medications; but not the past 
medications. 
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Figure 4.7: Data collection and problem identification 
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4.4.3 Actions and Solutions (Skills Section 3) 
Few of participants demonstrated adequate skills in this section, see Figure 
4.8. There was a tendency for the participants to explain medication to patients 
without checking the patient’s ability to understand or follow through with the 
plan. The participants gave advice to patients not tailored to the patients’ risks 
and benefits. It is inapplicable to assess the participants for involving patients in 
designing a plan as this possibly the decision of the physicians.  Moreover, the 
participants tended to check the patients’ understanding of things said by simply 
by asking at the end of the discussion.  Furthermore, the majority of the 
participants used closed questions to assess patient understanding. The 
participants in this research were competitive when giving technical advice 
about anti-depressants, including aspects relating to efficacy and safety, and 
this implied that the participants perceived this role as important when advising 
about medication. 
 
Figure 4.8: Skills demonstrated for actions and solutions 
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4.4.4 Closing the Consultation (Skills Section 4) 
The participants had good skills to ensure that patients were signposted 
towards proper health support (Figure 4.9). Two thirds of participants they 
provided patients with opportunities to ask questions but the majority asked 
patient if everything is ‘OK’ while only two participants who asked the patient 
if they had any questions. However, only two thirds of the participants offered 
appointments to patients for follow up. 
 
Figure 4.9: Closing the consultation 
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4.4.5 Consultation Behaviour (Skills Section 5) 
The participants (see Figure 4.10) did not demonstrated good behaviour 
when interacting with patients.  Less half of participants listened actively to 
patients and this was demonstrated only when patients asked a question.  
The participants exhibited empathy during the consultation.  However, the 
participants did not score highly on planning the structure of the consultation 
and the same percentage scored for using open and closed questions. The 
participants were more directive and the closed questions were dominant 
behaviour. Guiding patients toward the agenda of the participants was more 
likely judgmental behaviour. The participants judging the information they 
intend to deliver, while this possibly lead to give information which were not 
necessarily meet the patients’ needs. Finally, two thirds of the participants 
did not manage their time effectively which influence by the agenda of the 
participants but not the patients. 
 
Figure 4.10: Behaviour demonstrated during the consultation 
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4.4.6 A Comparison of Consultations Behaviour across Sections 
 
Figure 4.11 shows that participants were not particularly motivated to initiate 
relationships with patients and from the beginning of the consultation, they 
did not indicate to patients that they wanted to prioritise patients’ concerns. 
However, they showed good skills when eliciting information from patients, 
but only in relation to prescribed medication rather than social history. The 
participants provide brief information about the reason for GPs prescribing 
anti-depressants, which enabled patients to understand their symptoms. 
Furthermore, the participants gave good basic information about anti-
depressants, but they explained the information as a fact and not articulated 
to individual patients. They scored low on checking patient understanding, 
and they were not enthusiastic to share information. The patients scored well 
on providing a safety net and supporting patients. However, the relationships 
forged between patient and participant was one way, and more likely to be 
paternalistic in style.  In addition, consultations tended to be limited to talking 
more about ‘technical’ information about anti-depressants drugs. The 
participants’ agenda was less likely to open the consultation and 
misunderstand the silence of patients. 
 Figure 4.11: Overview of the participants’ competence across sections  
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The above sections described surveys (attitude, knowledge and patients’ 
satisfaction questionnaire) and checklist provides good impression about the 
current practice of the participants. The quantitative results measure different 
performance of the participants, for example their skills and attitude, but the 
researcher thought that adding narrative text but describe quantitative style 
may provide more feeling both; about participants’ intention to engage in this 
study (Section 4.5) , and their intention to reflect on their practice (CPD) 
(Section 4.6). Describing the narrative in simplistic style, for example display 
the account in a table would support the researcher in the discussion 
Chapter 6.  
 
 The Motivation of the Participants to Participate in this Study 4.5
In the section the Gibbs’ model of reflection was used to promote and probe 
the participants, see (Section 3.3.9). There were 22 participants who stated 
about their motivation to engage in this study. All of the participants (Table 
4.5) were interested to reflect to on their practice. This is account resulted 
from recording output. They thought that this research is a good opportunity 
to enhance their practice and to give feedback. This may indicate that they 
need to change or enhance their attitude when meeting patients. They found 
the researcher is good opportunity to perceive about their usual service and 
the feedback from researcher and patient (simulated) both provide good 
insight into the participants’ practice. 
 
In addition, they mentioned that they need to enhance communication with 
patients, the majority of them were interested to enhance their skills for more 
confidence when they advising people with mental illness. It is more likely 
that these participant perceive mental illness challenging and they need 
regular feedback, which may tailor to their individual practice. Two of the 
participants thought the stigma attached to patients and this research may 
encourage them to take proactive action with people with depression. Two   
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participants mentioned that came to help the researcher. The majority of 
participants’ opinions seem that they lack regular training through which they 
assess their practice. It is possibly training about mental illness when 
involving of patients (simulated) was preferred for the majority. One 
participant said that before coming for observation he read about mental 
illness that made updated to his information.  
 
Over all it is likely that the participants lack regular training about mental 
illness. Table 4.5 shows the account of the participants. 
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Table 4.5: Reasons for engagement of the participants (community 
pharmacists) in this study. 
 
Participants 
 
The purpose of participating in this research as articulated in the words 
of the participants 
Part. 1 To reflect on practice about people with depression 
Part. 2 To reflect on practice 
Part. 3 To get more personal satisfaction with helping people who have mental illness 
 GPs do not always do their work appropriately 
Part.4 To enhance communication with patients who have depression. 
Part.5 To gain skills and confidence 
Part.6 To gain more confidence when meeting patients with mental illness 
Part.7 To make requests for assistance 
Part.8 To help me - interest is a good thing to make a difference. 
Part.9 Helping your research 
Part.10 More learning and feedback - We don’t really get audited by external bodies 
about the sort of points that you sort of get across, so I sort of felt if I just spoke 
to a patient, maybe that may highlight how I do things or maybe how I should 
change things in the practice. 
Part.11 To gain knowledge of where we stay 
Part.12 To reflect on daily work - Trying to be of some sort of assistance - If I can help 
anybody out - Helping the researcher in his study 
Part.13 I’m interested in mental health. During my training I did hospital training and 
we were on the mental health ward and I saw that the pharmacists could have 
a big impact there so that’s why I thought mental health is good to specialise 
in. 
Part.14 Well the study I thought you were doing was quite interesting and because 
maybe not a lot of people do come to the Pharmacy to discuss depression with 
us because it’s quite a condition where it’s taboo slightly, so it’s some research 
on that, if I could help out then this is something that I’d like to do. 
Part.15 I was asked and when I heard about some of the details, it’s just an 
opportunity for me to reflect on my own practice… it’s always good to …refresh 
your skills or update your skills or get new skills. I’ve been qualified five years 
so it’s always good to refresh. 
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Part.16 It’s good insight because we don’t really get to in Community Pharmacy. I own 
my own Pharmacy as well, so it’s good to see how or what benefit this can do 
in terms of treating patients. Sometimes you tend to wander off and see the 
bigger picture. It’s good to reflect on your actions and maybe we can reflect on 
some of the people that work for me as well, staff members and other 
pharmacists that work for me. 
Part.17 I participated because I was interested in knowing more about anti-
depressants myself. My knowledge is just what it is from university really, so to 
come to university was one thing, I just wanted to come back, and, secondly, it 
was because I wanted to participate and see how I’d perform today really 
about this. 
Part.18 Thursdays/Fridays I work in a prison and I notice that a lot of prisoners are 
prescribed anti-depressants, so about six months ago I started working and I 
think when I saw the research on anti-depressants I was like it might be useful. 
  
Part.19 Well the reason why I want to participate is because I’ve been a locum 
pharmacist for about two and a bit years and I just, this is a kind of taboo area 
if you understand what I mean with regards to medication that people take. 
From my experience, people don’t really like to talk about these kinds of things 
and what I wanted to do is I want to find out what I’m like when discussing this 
subject with patients.  
Part.20 Well one of the reasons, obviously my locum agency they asked me whether I 
was interested in it and because the anti-depressants we literally give out, 
that’s most of the medication that we give out so anything that I could learn 
more about anti-depressants it will be helpful. In Community Pharmacy as 
pharmacists we don’t get chance to go through the BNF so it helped me focus 
on that particular chapter again and read up again about it, so it has helped a 
lot. 
Part.21 To improve my consultation with patients who have depression. 
Part.22 I think all research is important especially when they can improve our services. 
We always can learn something new and even if you think that you know and 
you deal with the things, it’s always good to refresh the things like that so. 
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 The Reflection of Participants on Current Practice 4.6
In this research, an action-plan (CPD) provided short learning activities 
session for the participants after the initial interviews has taken place and 
after they had interview with the researcher. This tool encouraged the 
participants to reflect on their intentions in practice. This tool was adapted 
from pharmacists’ mandatory CPD recording system (General 
Pharmaceutical Council, 2011) (see Section, 3.3.9). 
 
The data in the Table 4.6 came from the practice of the participants when 
they applied CPD in the pharmacy. The documentation of their learning 
needs and application their practice encouraged the researcher to simplify 
the data in the table to give a good picture about their intention to practice. 
 
All of the participants (see Table 4.6) thought that their skills needed to be 
improved especially for offering consultation to people with depression. The 
data showed that the majority of the participants intended to balance 
between open and closed questions. They thought building relationships 
enabled them to share information and it is difficult without this relationship. 
The interview in this research helped them to reflect in their needs. This 
learning is more likely to make them more confident and provide better 
services. All of them rated learning need as ‘important to very important’ to 
them while the scoring was less when it is relevant other staff (moderate to 
low). Higher numbers of the participants said they used open and closed 
question. They try to listen to patients and respond to their cues. They said 
their goals were satisfactory achieved. A few of them said they need more 
time to practice and feel out the outcome. One participant said that two 
patients came again and thanked him. A brief explanation about the journey 
of the participants through their recording and practicing of learning is 
explained in the below table. 
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Table 4.6: Description the participants’ intention to develop in practice 
 
Practice  Resources  Individuals Patients 
Identifying 
learning 
needs 
  Majority: building 
relationships. 
 Enhance knowledge 
about anti-depressants 
and shared information 
with patients. 
  Some 
participants: 
Patients 
satisfaction. 
Relevance 
of learning  
to practice 
  Feedback from 
interview. 
 High demand for 
professional practice. 
 Prevalence of 
depression is high. 
 One participant: NICE 
recommendation. 
 
Methods 
used to 
identify 
learning 
needs 
 Critical incidents. 
 Feedback from 
users of 
service/product. 
 Appraisal.  
 Peer reviews/talking 
to colleagues,  
 Their own reading 
of medical literature. 
 One participant 
mentioned looking 
at leaflets on Mind 
website. 
  
Why is this 
learning 
important? 
  Majority: Knowledge 
about safety and use 
of anti-depressants. 
 Communicating 
(building relationships, 
structuring the 
consultation). 
 Some: dedicating 
more time to patients. 
 One participant: 
enhancing 
patients’ 
awareness of the 
pharmacist’s role. 
 
 One participant: 
non-medical 
staff and 
patients. 
Importance 
level 
  Most participants: very 
high –high. 
 Very high 
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Ways to 
achieve 
learning 
needs 
 Majority: NICE and 
BNF, self-reflection 
and colleagues.  
  One participant 
CPPE, cases 
 One participant: pre 
and post satisfaction 
questionnaire. 
  
Evaluation  1. The majority fully 
achieved. 
 More engagement 
 One participant : able to 
recognise symptoms of 
depression 
 One participant: more 
engagement. 
 One participant: advice 
of non-medical 
treatment. 
 One participant: partly 
achieved: still building 
his consultation 
 Some 
participants: 
Patients’ 
feedback that 
they were happy, 
patients 
appreciated time. 
Benefit   More confidence when 
meeting patients. 
 Signpost patients to 
other health 
organisations. 
 One participant more 
interest in helping 
patients. 
 One participant: 
received two 
patient feedbacks 
that were happy. 
 Some of 
participants: 
patients were 
more open to 
discussion. 
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The text below is not exact term of the participants, but the researcher 
described of what the participants stated. The description step is similar to 
there in CPD steps. 
4.6.1 The Description of CPD  
1- What do you want to learn? 
All the participants said they wanted to prioritise the development of their 
consultation skills. They mentioned areas such as ‘building a rapport with 
patients, increasing patient knowledge, increasing clinical knowledge of anti-
depressants and their side effects, building better relationships with patients, 
using open questioning techniques, and tailoring to the needs of each patient’. 
Participant 16 mentioned obtaining a better understanding of their role in 
seeking out additional therapies.  Participant 11 mentioned that the training 
had increased his sensitivity towards patients, which might lead to patient 
satisfaction. He also mentioned gaining knowledge and increasing staff 
awareness as key learning goals. 
  
2- How is this learning relevant to practice? 
Most participants said that the learning goals were relevant because the 
feedback they had received showed a need for them to improve their 
consultation skills. Participant 16 stated that the learning goals of understanding 
patient needs, providing counselling and advising would help his professional 
skills in community pharmacy. All the participants said these skills were 
important in professional practice. Participant 19 stated that improving 
consultation skills was important to him, because depression was a common 
ailment that he was required to deal with frequently in practice.  Participant 20 
said he wanted to be involved in a study on anti-depressants.  Participant 21 
said that the learning had inspired her to try to improve her skills; she wanted to 
help improve the way she counselled patients on anti-depressant drugs. 
 
Participant 13 said that learning key counselling skills with reference to BNF 
and NICE guidance was relevant, because this would enable him to engage 
with patients and promote a shared understanding of treatments.  
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All the participants felt that the learning goals were relevant because applying 
these goals would help them to provide a higher standard of care to patients; 
guide patients towards the best use of medication; promote better 
communication with patients; and allow them to engage with different 
individuals in the community. 
 
Participant 11 mentioned that learning new skills had helped to build his 
confidence, and this will increase patient confidence in him and in his ability to 
provide information and support with sensitivity. 
 
3- Methods Used to Identify the Need to Learn 
The participants said they used different methods to identify their learning 
needs, including: critical incident identification, feedback from users of a 
service/product, audit, appraisal, peer reviews and talking to colleagues, and 
their own readings of medical literature, for example, participant 7 mentioned 
looking at leaflets on the Mind website. 
 
4-  Why is this learning important? 
All the participants said that their learning goals were important because this 
would help them become more knowledgeable and competent when treating 
patients with depression. Some mentioned that it would allow them to offer 
more time and better advice to patients and build better relationships with 
patients.  Pharmacist 20 said that the learning would help him increase his 
knowledge about the ‘safe use of anti-depressants’. 
 
Participant 16 said that the learning goals would enable him to provide patients 
with a ‘better service’, and would increase the ‘patient’s confidence’ in 
approaching him as a first point of call. 
 
Participant 18 said that the training had allowed her to construct her 
consultations in a more effective and supportive way.  She also mentioned that 
she felt more ‘confident in supporting patients’ with depression at any stage, 
rather than just advising about medication. 
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Participant 19 stated that the learning would allow for full transparency 
between him and patients with depression.  Similarly, some participants 
mentioned that the learning had provided them with better skills and, therefore, 
in turn, the patients would be more open. 
  
Participant 12 stated it would make him a ‘better pharmacist ‘and improve his 
‘consultation skills.’ Participant 11 mentioned that training had a positive 
impact on the patient, the pharmacy and pharmacy staff.  Participant 8 stated 
that ‘better communication’ would improve advice and information he gave 
about MURs and NMS. 
 
5- The Importance of CPD (Continuing Professional Development) 
The importance of CPD was recorded as a mixture of none, low, moderate, high 
and very high.  Most pharmacists placed ‘very high’ importance on their learning 
goals; some recorded its importance as ‘high’, and a few recorded it as being of 
moderate, low or of no importance. 
 
The importance of CPD to the participants themselves was high or very high.  
Higher levels of importance were placed on the users of the service/products - 
‘very high’, whereas its importance to colleagues and their organisation was 
recorded as of moderate importance.  
 
6- What might you need to do in order to get the most from this 
learning?  
Participant 1 said he would need to practice with more patients in order to 
achieve his learning goals fully. He mentioned that he is obtaining a CPPE pack 
on depression, as well as reading case studies on depression.  Most 
participants said that following knowledge based NICE guidelines and BNF 
would be a good way to achieve learning. Most also mentioned learning through 
reading clinical pharmacy textbooks, using internet based learning, applying 
self-reflection, and asking colleagues for advice. 
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Participant 16 said they would be using patient satisfaction surveys, checking 
pre and post learning objectives, as well attending more workshops to gain 
better understanding of the skills of a pharmacist. 
 
Participant 19 mentioned talking to colleagues and attending workshops to 
achieve his learning goals.  Participant 22 said that she would like to engage in 
open learning, online courses and training with colleagues and staff as a way to 
achieve her goals. 
 
Participant 21 said that for patients suffering from moderate-to-severe 
depression she would consider offering one or more interventions guided by the 
person's preference, such as individually guided self-help based on the 
principles of cognitive behavioural therapy (CBT).  
 
7- Advantages 
The participants wrote down the advantages of their different learning options.  
Most noted the ease of using web based learning and NICE guidelines, and 
most participants listed the advantage of being able to provide additional 
therapies, such as counselling and exercise. 
 
Participant 13 said that attending a workshop with an actor and reflecting on the 
outcome would help him because he would be able to learn to ask open-ended 
questions and elicit more information.  He would be able to learn to tailor advice 
to individual patients, rather than offering generic advice. 
 
Most participants mentioned the advantage of talking to colleagues, which will 
enable them to obtain advice and in a friendly way.  Participant 8 said that 
gaining two-way feed-back was a practical way of receiving expert advice. 
 
8- What have you learned? 
All the participants said they had achieved or improved on their goals, and 
some noted the need for continuous improvement. Most of the participants 
improved their skills in the following areas: ‘communication skills, open style of   
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questioning, consultation, tailoring advice, counselling and listening skills’. 
However, participant 1 noted that although he had improved his skills, ‘building 
relationships’ was not something he could achieve in one meeting with a 
patient; this skill would need continuous improvement over time. Some 
participants learned the importance of spending ‘more time’ with patients 
suffering from depression, whereas others learned to recognise the ‘different 
symptoms’ of depression. 
 
Participant 18 said that she had learned to offer other techniques to support 
patients with depression e.g. using CBT, sleep, and hygiene, etc. She had also 
acquired knowledge on how to build effective and ‘supportive consultations’. 
She added that she now understood the importance of ‘body language and 
listening skills’ during consultation. 
 
Participant 19 learned the importance of being able to empathise with patients 
with depression, and is now able to obtain information delicately. Participant 20 
said that he had learned how to provide ‘safe effective advice’ to patients about 
anti-depressants and inform them of additional treatments such as exercise. 
 
Participant 15 and 7 both said they had learned to ‘tailor information’ to 
individual patients’ needs. Participant 11 said he had gained a deeper insight 
into depression and could approach patients using a more ‘sensitive/attentive 
approach’.  He also said that his confidence dealing with these patients had 
improved. 
  
9- Evaluation 
The participants gave a mark relating to the extent they felt they had achieved 
their learning needs, using the scale of ‘fully, partly, or not at al’l.  
Over half of the participants indicated they had achieved their learning needs 
‘fully’ and three participants said they had partly achieved their goals but that 
they needed to obtain continuing improvement.  
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Some participants, such as participant 12 said they had achieved their learning 
goals ‘fully’ and they were now able to recognise symptoms more easily.   
Participant 1 stated that they had ‘fully’ achieved their aims and had improved 
their confidence to initiate patient consultations and give out extra information; 
he said that patients would appreciate the extra time he would give to them.  
Pharmacist 18 also replied ‘fully’.  She stated that she now felt confident about 
supporting people with depression and that she could now offer advice to every 
patient without any hesitation.  She said she would now be able to encourage 
them to speak up about their issues first, listen to them carefully, and then 
advise accordingly. 
 
Participant 19 said he had been ‘slightly successful’ in achieving his goals but 
that he was still building his consultation skills.  Participant 20 marked ‘partly’ 
because he said he usually experienced good rapport with patients when talking 
about anti-depressants. 
 
Participant 21 indicated that she had ‘fully’ achieved her goals. She would be 
offering a private area to new patients to counsel them on side effects of drugs, 
and on how to manage their condition. She also said she would provide 
information on non-drug treatments to use alongside anti-depressants, such as 
group or individual counselling. 
 
Participant 11 said he had ‘fully’ achieved his goals and he is now more 
confident in himself and could tailor to suit the needs of each patient. 
Pharmacist 8 also marked ‘fully’ and said he would now be able to give better 
advice and MURs. 
 
Benefits to Practice 
Most participants said that the learning would benefit their practice.  They said 
they were now more confident in the subject area and could signpost patients to 
other organisations locally.  The majority of participant said they had learned 
better counselling skills, tailoring skills, patient rapport, and improved patient 
understanding.  
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Participant 18 said that two patients came back to see her after her first 
consultation with them and thanked her, stating that they felt much aware about 
their medication and more confident to tackle their depression.  She said that 
one patient also passed on good feedback that she had received more support 
from the pharmacy. Participant 19 said that the learning had enabled him to 
take more of an interest in the patients and their day-to-day lives, rather than in 
just the medication. Other participants were in agreement with this, and stated 
that their patients were now more open to discussions and asked for more 
advice and opinions. Participant 12 said that he had seen benefits to his 
organisation, was able to ‘recognise the symptoms of depression more easily’, 
and ‘could explain different methods of treatment more confidently’.  Similarly, 
Participant 15 said he was more self-aware and he could now ‘tailor’ to his 
patients’ needs. Participant 8 said he had improved his delivery of information 
and could now ‘engage patients’, which resulted in better consultations. 
 
The next section will show the satisfaction of patients after the action plan. 
 
 The Patients’ Satisfaction with Participants (learning activity) 4.7
This section describe the satisfaction of patients with participants who engaged 
in learning activity (CPD).The patients in this stage were not the same patients 
surveyed before implementing the action plan, due to reasons mentioned earlier 
(Section 4.3). One hundred and sixty patients were satisfied to take part and 
express their experiences with the services in the pharmacy. The most patients 
who expressed an opinion are middle aged and younger, whereas the least 
were elderly patients. The number of females doubled the males and the 
majority ethnicity was white patients. 
 
The number of the participants who took part in satisfaction experience was 
nineteen. Table 4.8 shows that patients were not satisfied with the service they 
received. Only a minority of patients perceived that the participants were willing 
to offer a private consultation, and the majority (two thirds) divided between 
being undecided and not knowing at all about this service. 
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Table 4.7: Patients’ demographic factors (after reflection of the participants). 
 
Age Categories 
(Years) 
Number 
Percent 
Gender Percent Ethnicity Number 
Percent 
After 
action 
plan 
20-29 35(22) Male 61(38) White 106(66) 
 30-39 37(23) Female 99(62) Asian 36(23) 
 40-49 46 (29)   Black 10(7) 
 50-59 27 (17)   Mixed 6(4) 
 60-69 13(8)   Other 1 (1) 
 Over 60 2(1)     
 Total 100.0  160 
(100) 
Total 100 
 
One quarter of patients did not feel that the participants provided enough 
information about the proper use of medications, and a slightly higher 
percentage was undecided about this. It was found that less than half of the 
participants did not provide adequate advice about the side effects of anti-
depressants, and the remaining participants were divided between being 
undecided about whether they provided adequate advice about anti-
depressants and stating they did provide good advice.  
 
Additionally, only about half of patients were confident in the knowledge 
possessed by the participants, and a third of patients said they were not aware 
of the levels of knowledge possessed by the participants. Furthermore, 
although two thirds of patients were confident that the participants were 
competent in their management of depression (which is good percentage but 
not high) a minority of patients were not confident about the participants’ 
behaviours and skills.  
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Less than half of patients wanted more time from the participants but saw that 
the participants had many other duties to perform. However, the participants 
were less interested to follow up patient improvement plans and adherence 
advice. Two thirds of patients either disagreed or were undecided about 
whether participants must take responsibility for initiating improvement plans, 
and the majority highlighted the lack of services offered if medications were not 
available in the pharmacy. Patients perceived that the participants were 
passive and unaware of their treatment related needs. Finally, less than two 
thirds of patients said they would recommend the services of the participants to 
other patients, and the remaining patients said that the services offered by the 
participants did not meet their needs. Overall confidence of the patients was 
good but the kinds of services that help patients feel more comfortable and 
those designed to promote adherence to medications were poor.  
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Table 4.8:  Patients’ experience after participants’ reflection on their current 
practice. 
 
The next section with describe the comparison between basic satisfaction of 
patient and their satisfaction after the participants received training sessions.
Your opinions Agree Neither 
agree 
nor 
disagree 
Disagree 
1. My pharmacist offers to talk to me in private. 59(37%) 37(23%) 64(40%) 
2. My pharmacist advises me on the proper use 
of my medicines. 
88(55%) 36(23%) 35(22%) 
3. My pharmacist advises me on the adverse 
(side) effects of my medicines. 
73(46%) 42(26%) 45(28%) 
4. I have confidence in my pharmacist’s 
knowledge about depression and its treatment. 
82(51%) 32(20%) 46(29%) 
5. I have confidence in my pharmacist. 104(65%) 19(12%) 37(23%) 
6. My pharmacist is available to answer my 
questions. 
96(60%) 40(25%) 24(15%) 
7. My pharmacist is willing to talk to me about 
my symptoms of depression and progress with 
treatment. 
66(41%) 41(26%) 53(33%) 
8. My pharmacist helps with the arrangements 
necessary to obtain my medicines. 
94(59%) 42(26%) 24(15) 
9. My pharmacist is aware of my treatment-
related needs. 
75(47%) 47(29%) 38(24%) 
10. My pharmacist responds to my treatment-
related needs. 
78(49%) 40(25%) 42(26%) 
11. I would recommend my pharmacist to other 
people with depression. 
91(57%) 27(17%) 42(26%) 
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 A Comparison of Patients’ Experiences with the Participants 4.8
 
The data in Table 4.9 includes (pre-post) engaging of participants in learning 
activity collected did not show any significant differences, especially in relation 
to age or ethnicity factors that might have impacted on increased or decreased 
satisfaction. The p-value was non-significant for all questions. 
 
In this section, whenever the term ‘before’ is used the researcher referring to 
results obtained before the action plan was implemented, and when the term 
‘after’ is used the researcher refers to results obtained after the action plan was 
implemented. The scores for the assessment of patient satisfaction varied from 
one quarter to two thirds see Table 4.9. 
 
The results showed that there was no significant difference in patient 
satisfaction levels relating to the issue of offering privacy after the action plan 
had been implemented. Slightly higher levels of satisfaction were recorded, but 
no significant change overall was recorded. Just over the half of the patients 
said that the participants provided advice about the administration of anti-
depressants and less than half were not surprised when this advice was 
administered. However, even after the implementation of training the 
participants were still not able to educate patients properly about the side 
effects of anti-depressants, but more than half the patients were satisfied about 
the information given out about side effects. The patients did not acknowledge 
the ability of the participants to manage their treatment, and those who 
recognised the experience of the participants in comparison to those who did 
not were comparable. However, confidence and trust levels among patients in 
relation to the service they received from the participants scored higher in 
comparison to other services, but the extra training did not serve to increase 
patient confidence in the participants’ skills. Although the participants were seen 
to change their attitude and dedicate more time to patients after their training, 
this did not appear to result in significantly higher satisfaction scores. Over one 
third disagreed that the participants devoted enough time to them.  
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It was also seen that the participants were not ready to follow-up patients or 
discuss adherence issues relating to anti-depressants. The percentage of 
patients who indicated that patients did not follow up was greater than the 
patients who agreed that the participants monitored their medications and 
symptoms adequately. Furthermore, other services offered in order to assist 
patients receive their medicines more easily did not make an impact on levels of 
patient satisfaction recorded. Overall, the patients expressed the view that the 
participants only asked about currently prescribed medications, and could not 
identify patients’ concerns or other medication related needs. This meant that 
less than half the patients did not recommend their friends to the participant 
pharmacists. 
 
Table 4.9 illustrates the comparison of patients’ satisfaction with the service 
provided by our participants. The term (before) refers before conducting action 
plan to our participants, and the term (after) refer to after action plan. 
 
The next chapter will discuss the reflection of the participants in practice.
 
 
 
 
1
4
7
 
 
Table 4.9: Met and unmet needs of patients 
 
Your opinions Agree Neither agree nor- disagree Disagree 
 Before  After Before After Before After 
My pharmacist offers to talk to me in private. 55(34%) 59(37%) 38(24%) 37(23%) 67(42%) 64(40%) 
Mean =35% 24% 41% 
My pharmacist advises me on the proper use of my 
medicines. 
81(51%) 88(55%) 39(24%) 36(23%) 40(25%) 35(22%) 
Mean =53% 24% 23% 
My pharmacist advises me on the adverse (side) 
effects of my medicines. 
70(44%) 73(46%) 43(27%) 42(26%) 46(29%) 45(28%) 
Mean =45% 27% 28% 
I have confidence in my pharmacist’s knowledge 
about depression and its treatment. 
66(41%) 82(51%) 45(28%) 32(20%) 50(31%) 46(29%) 
Mean =46% 24% 30% 
I have confidence in my pharmacist. 99(62%) 104(65%) 22(14%) 19(12%) 39(24%) 37(23%) 
Mean =64% 13% 23% 
My pharmacist is available to answer my questions. 85(53%) 96(60%) 50(31%) 40(25%) 26(16%) 24(15%) 
Mean =57% 28% 15% 
My pharmacist is willing to talk to me about my 
symptoms of depression and progress with 
treatment. 
58(36%) 66(41%) 43(27%) 41(26%) 59(37%) 53(33%) 
Mean =39% 27% 34% 
My pharmacist helps with the arrangements 
necessary to obtain my medicines. 
 
91(57%)  94(59%) 43(27%) 42(26%) 26(16%) 24(15%) 
Mean =58% 27% 15% 
My pharmacist is aware of my treatment-related 
needs. 
72(45%) 75(47%) 45(28%) 47(29%) 43(27%) 38(24%) 
Mean =46% 29% 25% 
My pharmacist responds to my treatment-related 
needs. 
78(49%) 78(49%) 40(25%) 40(25%) 42(26%) 42(26%) 
Mean =49% 25% 26% 
I would recommend my pharmacist to other people 
with depression. 
89(56%) 91(57%) 30(18%) 27(17%) 41(26%) 42(26%) 
Mean =57% 18% 25% 
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Chapter 5   Initial Interpretation of Qualitative Data 
 
The researcher would like to summarise the motivation of the participants for 
participating in this study. For more details see Section 4.5.  The majority of the 
participants who took part in this research said they were interested in 
enhancing their knowledge of depression. Time is one of the constraints that 
could affect the participants’ ability to improve their knowledge and practice. 
Furthermore, they said that a stigma attaches to people with depression, and 
they would like to become approachable practitioners for the benefit of their 
patients’ care. The participants also expressed a need to improve their 
confidence when communicating with people with depression. The participants 
talked about how they do not receive regular training in this area, which is a 
benchmark against which they can evaluate their work. They all said that taking 
part in this research was a good opportunity to gain peer review and that it 
would encourage them to reflect on their practice. The demographic of these 
participants and time associated consultation and interview with will be 
illustrated in the next section.  
 
The number of the participants was 22 persons. Community pharmacists were 
19 and the other three are MPharm students. The majority were male and four 
were female. The majority of participants age ranged from 18-30 yrs. and third 
of them were between (31-40) years. The experience of community pharmacists 
ranges between (1-20) years. The majority of experience is between 1-10 yrs., 
whereas the MPharm students had training for less than one year. The duration 
of the consultation ranges between (1-23) minutes and the duration of the 
interview ranges from 23-83 minutes. For more detail, see Table 5.1. 
 
In this Chapter, the results will be presented from the interviews conducted with 
the participating pharmacists immediately after their simulated medicines 
consultation. The chapter comprises the five themes that emerged from the 
interview data (The Attitude of the Participants, The Participants’ Engagement 
with Patients, Tailoring the Consultation, Staging Advice to Patients) see Table 
5.2 includes themes, categories and sub-categories, these elements are   
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defined to provide more meaning to them. For more information, see Appendix-
20.  
 
Table 5.1: Duration of the consultation and Interview with the participants 
 
   
Time of consultation   
Duration of the 
consultation 
All participants (2-23) Minutes 
Average of consultations 
of all participants  
All participants  (7) Minutes 
Time of interview   
Duration of the interview Community pharmacists (23-83) Minutes 
 MPharm Students (7-22) Minutes 
Average interviews of all 
participants 
 (36) Minutes 
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Table 5.2: The relationship between the themes, categories and sub-categories used in this research 
Theme Category Sub-category 
The Attitude of 
the Participants 
A. Nature of Depression (A1) Causes of Depression 
(A2) Coping with Depression 
 B. Managing People with Depression (B1) Positive Beliefs about Managing   Depression 
(B2) Negative Beliefs about Managing Depression 
 C. Stigma Associated with Depression 
 
(C1) Stigma Attached to Depression from the Perspective of 
Professionals 
(C2) Stigma Attached to Depression from the Perspective of Non-
pharmacy staff 
 D. Time Allocated for Providing Services to 
Patients 
 
(D1) Participants’ Perception of GPs’ time 
(D2) Experience of Time Constraints when Trying to Help Patients 
(D3) Dedicated Time to Help Patients 
 E. Privacy of Patients (E1) Offering Privacy 
(E2) Offering Less Privacy 
(E3) Environment of privacy compared to other health care setting 
Participants’ 
Engagement 
with Patients 
F. Training Needed to Engage with Patients 
G. Lack of Patient Knowledge about the Role of 
the Pharmacist. 
(F1) Role Perception 
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 H. Lack of Liaison with Other Health Care 
Professionals 
I. Organisational Barriers 
(H1) Hierarchy of Health Care Professionals 
Tailoring the 
Consultation 
J. Developing Skills in Practice  
 K. Initiating the Session (K1) Negotiating the Patient’s Agenda 
 L. Giving Information to patients 
 
(L1) Information Sharing about Anti-Depressants 
(L2) Giving Patients’ Opportunity to Talk 
(L3) Picking up the Patient’s Cue 
(L4) Checking Patients’ Understanding 
(L5) Less Information Sharing about Social  treatments 
Staging Advice 
to Patients 
M. Quality of Information at First Time 
Consultation 
 
 N. Relationship of Participants with patients (N1) Paternalistic Attitude 
(N2) Passive Behaviour of the Participants 
(N3) Building Relations ship with Patients 
(N4) Relationship Management for Regular Patients 
 O.  Follow Up Service  (O1) Accessibility of the pharmacist to the patient 
(O2) Advanced Services 
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This Chapter describes the diversity of opinion expressed by the participants. 
They shared their opinions and views about problems such as stigma, time 
pressures, privacy, organisational barriers, and relationships with other health 
care professionals. Before starting each theme, the researcher would like to 
describe the overview as introduction to each of theme, which may give to the 
reader feeling what to expect the content of each theme. Furthermore, the over 
view will be supported by external evidence. 
 The Attitude of the Participants 5.1
Attitude is how people react to various situations and how they explain to other 
people what they think about what they see (Cherry, 2014). This section places 
emphasis on the attitudes of the participants towards depression and towards 
patients generally. To clarify the picture of the participants’ performance 
(attitude) Figure 5.1 illustrates various influencing factors experienced by the 
participants when providing services to people with depression. 
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Figure 5.1: Willingness of the participants when supporting people with depression
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Overview of Attitudes of the Participants 
 
Depression has many symptoms that can vary from mild to severe and these 
symptoms influence the pharmacist’s perceptions when they interact with 
patients. These perceptions can include concerns about how patients cope with 
depression and how to manage patients (O'Reilly et al., 2010 B). Another issue 
that discussed in this section is stigma. The participants’ in this study perceived 
that patients suffering from depression often experienced different forms of 
stigma. The behaviour of a patient can trigger stigmatisation from professionals 
and non-professionals and the impact of stigma affects communication with 
patients Knox et al. (2013). Time pressures are an important factor that can 
affect pharmacists who practice. The participants in this study said that, often, 
physicians do not have time to deliver advice about anti-depressants and that 
some patients remain unaware of their diagnosis. The participants in this study 
were keen to help patients and dedicate their time to patient care, but a lack of 
time is a continuing major issue that often distracts the participants from 
providing better patient care Chong et al. (2013 C). With regard to privacy, the 
participants expressed different ideas about the meaning of privacy. However, 
the majority of the participants said they offer privacy because this enables 
them to give their patients more attention (Fleming et al. 2015).  
5.1.1 The Nature of Depression 
Half of the participants made comments in this section. It seems that our 
participants were more prone toward the social event to cause of depression. 
Furthermore, they stated that the coping of patients with depression have 
impact on their treatment’s decision. 
 
Causes of Depression (Sub-category A1) 
 
Participants 2, 8, 9, 13, 14, 15, 18, and 19 explained their opinions about the 
nature of depression. They mostly perceived that lifestyle was the main cause 
of depression. Participant 14 noted how the effects of physical illness cause 
depression.  
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Participant 8 said that social pressure; life events and neurotransmitters factors 
can trigger depression: life events may include economic issues and social 
isolation. He said that depression was multi-factorial.  
 
Participant 8: (8 yrs.; qualified; M): Well you’ve got your 
environmental factors, so it’s the surroundings and the people around 
them…also it is, it is a physiological factor as I was saying about 
Serotonin. 
 
Coping of patients with depression (Sub-category A2) 
 
The participants said that depression presented with many symptoms that make 
coping with the illness difficult. They noted reluctance among patients to receive 
information from their healthcare providers, and they expressed concerns about 
an absence of participation by patients in their treatment decisions. The 
participants compared the severity of depression with other physical health 
conditions; most of the participants held the attitude that physical diseases are 
not as severe as mental illness. 
 
Participants 2, 3, 9, 10, 13 and 15 thought mental illness is more intense than 
physical disease and they used the term ‘hard’ to articulate their idea of the 
intensity of depression. This possibly imply that the participant feel difficult to 
deal with people with depression. 
 
These participants said that depression can affect mood and that patients might 
feel they have less of a grasp on life, Participant 3 feel patients ‘full of 
fog’(These participants reported symptoms included a loss of interest and low 
energy. However, Participant 2 noted how people with depression often exhibit 
a variety of behaviours to cope with depression. Depression has many 
symptoms that make people feel sad and have low self-esteem. People who 
have depression are more likely to mask their symptoms than people do when 
they are suffering from physical disease. For example, they try to be happy 
when they are sad and be active when they feel weak (Richards, 2014).  
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Participant 2 said that some patients show some self-worth, but when it comes 
to discussing their concerns and feelings, depressed patients are more likely to 
be emotional. This could imply that these symptoms could be barrier for patients 
to talk with the participants. In agreement with, most patients who experience 
depression describe feelings of helplessness and hopelessness: they feel a loss 
of energy and are agitated and restless. Depression produces a negative 
impact on everyday life, either at work, or at home, and in the family (Van 
Geffen, et al., 2011 
 
Participant 2: (12 yrs.; qualified; M): So it depends on how good they 
are at disguising that and how good they are at; it depends on how 
they approach that… There’s some classic signs that people would 
be able to see across the street that someone’s depressed, but 
actually…because some people come in and they’re sort of all jolly 
and it’s… you can tell it’s an act. You can tell it’s not really that …for 
the two minutes it takes to have a conversation it’s quite easy not to 
appear depressed if you see what I mean.  
 
Participant 3 said that the symptoms of depression can have an impact on 
understanding the advice about their medications, patients are less interested in 
receiving information about non-medical treatment, and they are more likely to 
take medications if they understand their medications. This quotation below 
revealed that the goal of the participant is to encourage patients to take decision 
about their medication, especially when the severity of the symptoms is possibly 
a barrier for patients to take their medications. 
 
Participant 3: (15 yrs.; qualified; F): … patients who are pretty rock 
bottom…quite, they’re hard…in because you’re full of fog Their 
lifestyle issues would, are really so minimal in comparison to the 
here…If I said to you now, you’re rock bottom and you just need to 
know, kind of tell me how long it’s gonna take to kick in and what do I 
do – take one a day and I said and do you smoke?  Well, what?   
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What?  Stopping, I’m not stopping smoking right now!  What planet 
are you on? 
 
Participant 9 said that depressed patients are more likely to be introverted when 
interacting with other people and this introversion makes it hard for the 
pharmacist to be aware of their patients’ needs.  
 
Participant 9: (4 yrs.; qualified; M): They don’t want to speak to 
anyone, there’s no counselling involved so yes it’s… because the 
Mind might be saying something else but the heart’s saying 
something else, so they’ve got to control their emotions inside. 
 
Participant 10 said that the behaviour of patients who experience physical 
diseases varies in comparison to those who suffer from mental illness, and 
noted that patients who have physical diseases are more likely to raise their 
concerns with the participant than with patients who have depression. This 
participant thought that symptoms of depression cause people to be introverts 
within their community. This could indicate that the participant feel difficult to 
start conversation with introvert patients. 
 
Participant 10: (11yrs.; qualified; M): But if you have a mental issue, I 
can’t see that. If you’ve got a broken leg, I can see that looking at 
your leg…you need to go but where there’s sort of mental issues, I 
think that people still sort of hide them issues.  You know, sort of put 
happy faces onto other people like everything’s okay when 
everything isn’t okay… 
 
Participant 15 felt he was unaware of the behaviour of patients who are trying to 
cope with depression. This participant said he is less involved with patients and 
unaware of the coping behaviours of depression, but he also noted that patients 
are reluctant to talk about their experiences of depression. This possibly 
indicates that the participant less confident to engage with patients.  
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Participant 15: (3 yrs.; qualified; M): In terms of coping mechanisms, 
I’m not that much engaged in terms of what patients talk about with 
respect to things non-pharmaceutically. 
 
In summary, the symptoms of depression made the patients, introvert, passive 
and unwilling to communicate with the participants. Similarly, the participants 
perceive hindrance to manage people with depression. In consistence to, over 
half of pharmacists agreed that people with depression are less willing to talk. 
The authors suggested that these beliefs might have impact on pharmacist 
when communicating with patients, that pharmacist less likely to provide 
pharmaceutical care to patients (Liekens et al., 2012).  
5.1.2 Managing Depression 
This section will outline the different attitudes of the participants towards the 
treatment of depression in comparison to other physical diseases. Participants 1 
and 14 held positive attitude toward managing people with depression, they 
thought that depression is treatable in a shorter time span than physical 
diseases. Unlike, Participants 9, 10, 13, and 20 held less favourable attitude, 
they said that the severity of the side effects of depression are difficult to 
monitor, and felt that educating patients about their condition is harder when 
dealing with people who have mental illness in comparison to those who have 
physical diseases.  
 
Positive beliefs about managing depression (Sub-category B1)  
 
Only two participants felt that managing mental illness is similar to managing 
other physical diseases. Participant 1 attempted to correct incorrect perceptions 
held by patients about how mental illnesses are more difficult to treat than 
physical illnesses. His approach for building up self-esteem in patients was 
implied by his repetition of ‘I always’. He said that he always makes 
conversation with people who have depression and he tries to reassure them 
that they can be relieved of depression. Possibly, this participant feels that 
depression is associated with psychological and social factors are more   
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manageable than physical disorders that are more difficult to cure. However, 
this participant demonstrated a positive attitude towards providing services to 
people with depression.  
 
Participant 1: (5 yrs.; qualified; M): …look with diabetes you know 
lifelong treatment because you’re not going to all of a sudden, you 
know, cure your diabetes, and with blood pressure you’re on it more 
or less… it’s lifelong in that respect. 
 
Negative beliefs about managing depression (Sub-category B2) 
 
In contrast to the previous section, Participant 9 expressed negative beliefs 
about anti-depressants. She said that anti-depressants produce serious side 
effects that can possibly make patients worse, for example, give them suicidal 
intentions.  
 
Participant 9: (4 yrs.; qualified; F): You’re not causing any long term 
or any damage to the patient…but that does not necessarily mean 
that it’s actually going to benefit them in any way because they can 
still go and commit suicide, they can commit a crime.  
  
In agreement with Participant 9, Participant 13 said that treatments of physical 
diseases are easier to monitor compared to those for mental diseases.  
Participant 13 noted that there are standard measurements to assess relief for 
patients from hypertension for example, and these measurements include 
taking blood pressure that gives an indication of the recovery of the patients. 
Furthermore, this participant said that his knowledge about physical diseases is 
greater than that for mental illness that, he said, is difficult for him to assess 
when it comes to measuring the improvement of people with depression.  
 
Participant 13: (5 months; qualified; M): Because if the diabetes is 
controlled you do a blood test and blood sugar is controlled, it’s very 
easy, but how do you decide if this is working? You can’t...like if I   
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was counselling somebody on a diabetes drug like Metformin, it’s 
very clear what they need to know, but if it’s related to the Mind and 
to behaviour, you need a lot of time. 
 
The participants who held negative beliefs about the management of 
depression said it is difficult to deal with patients who had depression, and they 
thought that depression more intense than other physical diseases. Guillaumie 
et al. (2014) finds it is difficult for pharmacists to assess the relief of patients’ 
symptoms. The same study finds that pharmacists believe that depression is a 
challenging condition and that pharmacists feel more comfortable when having 
contact with a patient who has a physical disease. 
 
Bell et al. (2006 A) finds no difference in social distance scale among students 
of pharmacy and graduates toward people with depression. The workplace and 
having education about mental illness had less influence on the attitudes of 
these participants. A possible reason is that education at university is limited to 
the action and safety medications but practice in pharmacy focuses on the 
experience of patients with diseases (Bell et al., 2006 A). Van Geffen et al. 
(2011) identify patterns linked to the discontinuation or continuation of the 
medications. The study finds that patients discontinue anti-depressants when 
they are less involved in the decision-making. 
5.1.3 The Stigma Associated with Depression 
This section deals with the stigma that people attach to depression. All the 
participants felt that the level of stigma surrounding those who suffer from 
depression is high in the community. They said that this stigma has increased 
due to negative views held in the community towards patients with depression. 
Participants said that the stigma begins when patients visit professionals. The 
participants described different behaviours that patients might exhibit to try to 
reduce perceived prejudice by pharmacy staff and other patients in the 
pharmacy.  
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Stigma attached to depression from the perspective of professionals 
(Sub-category C1). 
 
Half of the participants except 2, 4, 7, 8, 9, 10, 15, 17, 19, 20 and 22 stated that 
patients experience stigma when meeting the participants. Participant 4 said 
she experienced instances where stigma had been attached to patients with 
depression. She said that professionals unintentionally stigmatise patients, for 
example through non-verbal behaviour. As a result, patients are more likely to 
misinterpret the behaviour of pharmacists and perceive that the pharmacist 
holds a negative attitude.  
 
Participant 4: (MPharm Student; F): Because you want to be really 
careful not to upset them. But you want to make them know that, you 
know, it’s nothing to be ashamed of because there’s quite a stigma 
attached to it. Because you don’t want people to think that, you think 
anything negative of it because anyone could be in that situation. 
 
Nonetheless, participant 4 said she is keen to encourage patients to eliminate 
their negative thinking about stigma and she tries to build self-esteem in 
patients. This kind of approach indicates that this participant has a positive 
attitude towards dealing with mental illness. Furthermore, Participant 15 said 
that feelings of stigmatisation emanate from the behaviour of professionals.  
 
Participant 15: (3 yrs.; qualified; M): I think I don’t want to labour the 
point, but if I place depression in the same category as diabetes, 
asthma, or gout for goodness sake...there’s no need for me to think 
that other people will think bad about me in that, because I think 
obviously when you suffer from diabetes or asthma people don’t look 
at you in a way that you’re weak.   
 
Participant 15 said that people with depression often self-stigmatise and these 
patients are more likely to interpret communication negatively when the 
pharmacist engages with them, especially if the pharmacist has to discuss   
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personal lifestyle. The self-stigmatisation patients demonstrate can distract a 
pharmacist during a consultation. This circumstance seems to arise more 
frequently in patients with depression rather than in patients who have physical 
diseases. This means that pharmacists are less likely to give advice about 
medications to patients who suffer from depression. 
 
Participant 19 said he came to this conclusion due to ‘non-verbal cues’ from 
patients.  He said that patients avoid eye contact and that could mean they are 
not ready to listen to instructions. The participant did not take the cues as 
advantage to start discussion to explore patients rather than the participants 
assumed that the meaning was clear. 
 
Participant 19: (3 yrs.; qualified; M): And then you could tell if they 
weren’t feeling, you know if there was a stigma because they’d be 
maybe looking away or maybe they’d, they’d you know, they’d be all 
hunched, maybe they wouldn’t want to speak freely. They wouldn’t 
have good contact. Or maybe they would say oh you know, I haven’t 
got much time or something.  That would indicate to me that they 
wouldn’t feel comfortable talking about it. 
 
Participant 22 said she made decisions not to engage fully with patients if the 
patients had already refused an offer of consultation. Patient 22 said that 
patients with depression are less willing to talk about their treatment. It is 
possible that that these patients are willing to talk when the participant is active 
and start the conversation. 
 
Participant 22: (10 yrs.; qualified; F): you see from my experience it 
will be like oh yes, I’m not feeling well.  Oh yes, but that’s home, 
that’s all home, but that will be okay if I take that medication.  I think 
that they don’t really want to discuss what’s really going on, why 
they’re in a situation like that, maybe because they feel a bit of 
shame as well.  
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Stigma attached to depression from the perspective of pharmacy staff (Sub-
category C2).  
 
A pharmacist’s role extends to consultation about medications with a patient 
and checking prescriptions. What might help is for non-medical personnel who 
work in the pharmacy to perform non-professional work; this might save the 
pharmacist time and enhance his or her practice. Nonetheless, the lack of 
qualifications non-medical staff might have to deal with people with depression 
can raise concerns. Non-medical personnel are usually the first people who 
meet patients in a pharmacy and they are the first people upon whom patients 
form an opinion about the whole pharmacy and, therefore, about whether or not 
to accept support (McMillan, et al., 2014).   
 
Participants 2, 4, 6, 9, 17, 19 and 21 believed that non-professional personnel 
influence patients to seek for help. Participant 6 commented on the stigma 
attached to people with depression. He said that patients experience emotional 
pressure when in the presence of other patients in the pharmacy who might not 
have depression, and this might increase their desire not to linger in the 
pharmacy. Furthermore, Participant 6 said that patients were likely to be 
concerned about the presence of non-medical staff serving in the pharmacy and 
this might lead to a communication barrier forming between patients and the 
staff in the pharmacy. For example, non-medical staff might hold negative 
attitudes about depression or show a lack of proper understanding about 
depression. This participant said that stigma using the consultation room might 
reduce stigma because this sends out a strong message that the pharmacist is 
not the person applying the stigma.   
 
Participant 6 said that without the option of privacy, patients might not stay in 
the pharmacy. However, it is likely that patients are not yet ready to listen to 
advice from pharmacists generally, and this influences the provision of care to 
patients. This participant raised another point from experience saying that 
feelings relating to stigmatisation might increase when patients are familiar with 
staff in the pharmacy, especially when they know these people in their   
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neighbourhood. He said that when his mother had depression, she found 
difficult to visit her local pharmacy and so she decided to collect her anti-
depressants from another pharmacy located some way from her home. His 
mother’s worries about stigmatisation encouraged her to collect her anti-
depressants from another pharmacy. 
 
Participant 6: (MPharm Student; M): …they don’t want to talk about it 
because they don’t want other people to know, and if it’s a local 
pharmacy as well, they may actually know these people that are in 
the store … I mean my mum knows everybody where she lives so it 
is worthwhile having a consultation room to the side where you can 
just remove that distracting environment, that possible anxious 
environment, for the patient. 
 
Participant 9 felt that the presence of non-professional staff in the pharmacy 
might increase feelings of stigmatisation for people with depression. This 
participant said that non-pharmacists usually do not offer any verbal support 
when serving customers and this might give the impression that pharmacy staff 
cannot help. This participant said that non-pharmacists are usually ‘very 
hesitant’ to offer any advice for professional reasons, but this can imply a 
cautious attitude generally about the pharmacy. Furthermore, this participant 
gave examples of how difficult it might be for staff to engage with people with 
depression in comparison to those who do not have mental illness. 
 
Participant 9: (4 yrs.; qualified; M) What it is, they don’t know how to 
handle…I find that my staff are kind of very hesitant…but when it 
comes to something like this, they kind of go hum I don’t know what 
to say, because you don’t know what they’re thinking, what the 
patient is thinking. 
 
To summarise this section, people with depression often perceive stigma. 
Feelings associated with this stigma can arise when they visit the pharmacy and 
the pharmacists noted that, sometimes, these patients are less likely to engage   
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with them. The opinions held by the participants reveal that they make negative 
stereotypes. The participants’ perception is their decision to communicate with 
patients rather than taking active role and explore patients. In accordance with, 
Lilja et al. (2008) argues that pharmacists misinterpret the silence of patients 
who might be more open to discussion more often than they realise. Moreover, 
enhancing the skills of non-pharmacists who serve in pharmacies could help to 
tackle the negative stigmatisation of mental illness and the negative feelings 
that are associated with stigma.  
 
Knox et al. (2013) use semi-structured interviews to find that some people with 
depression perceive stigmatisation in the behaviour of staff in the pharmacy and 
from other patients in the pharmacy. The study suggests that the negative 
attitudes of health care providers are reduced by enhancing their knowledge 
about mental illness. Possibly the awareness of mental illness could change the 
negative feeling about mental illness, Lam et al. (2015) find that practitioners 
who have a diploma in mental illness are more likely to hold positive attitudes 
towards mental illness than those who have not had any formal training.  
5.1.4 The Time Allocated to Providing Services in the Pharmacy 
This section explores three sub-categories in relation to the amount of time 
dedicated to helping patients in different medical settings. The first sub-category 
shows the participants’ perspectives of the physician’s time-line. The majority of 
participants felt that physicians do not have enough time to provide adequate 
information to them about depression and anti-depressants (Tarn et al., 2009). 
The second sub-category explores the pharmacists’ time constraints that affect 
the provision of care provided to patients (Barney et al., 2011).The third sub-
category illustrates the willingness of the participants to dedicate their time to 
helping patients (Latif and Boardman, 2008).  
 
Participants’ perception of GPs’ time (Sub-category D1) 
 
Participant 9’s comments agreed with those of Participants regarding 
physicians’ limitations of time. This participant said that the investigation   
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conducted by a physician in such a short space of time was not enough for 
physicians to involve the patient in discussions about their treatment. This short 
time span allocated for investigating patients and getting an understanding of 
their illness means that, often, people with depression experienced 
misunderstanding.  
 
Participant 9: (4 yrs.; qualified; M): It’s just ...it’s just common practice 
really…you have that 8-10 minute slot …by the time a prescriptions 
done, you know you’ve only got about 3-4 minutes diagnosis time 
and doctors do not really have much time from past experience to go 
through in detail what the patient is receiving, what they’re getting, 
what side effects they should be experiencing, nothing whatsoever 
and that is coming with the four yrs.’ experience that I’ve had and 
hence… 
 
In line with the comments made by Participant 9, Participant 10 said that time 
pressures mean that physicians are unable to provide medication advice to 
patients, and so patients are dissatisfied when they visit the pharmacy. 
However, the participant is usually keen to assess patients’ awareness about 
their anti-depressants and address important questions about anti-depressants.  
 
Participant 10: (11 yrs.; qualified; M): If someone has it for the first 
time…what I sort of find is that GPs don’t really have the time to 
really sit with them and say, look this is the medication, this is how it 
works, this is how you feel and…how long it will take to work, what 
they should do if they’re concerned about a problem, what other 
options are available?   
 
To summarise this section, patients are unlikely to engage about their treatment 
with their physicians. This is possibly because physicians work to tight time 
constraints and do not have time to educate patients about their medications. 
Time pressures affect the way professionals to communicate appropriately with 
patients. Anderson and Roy (2013) suggest that people with depression are   
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dissatisfied with their physicians, that they lack intention, and are dismissive. 
They find that physicians cannot conduct effective consultations for patients 
within a ten minutes timescale and some patients left the physician’s surgery 
without gaining much from their consultation. 
 
Experience of time constraints when trying to help patients (Sub-category D2) 
 
All the participants experienced time constraints. They all felt there are many 
commitments to meet in the pharmacy and these take priority over time spent 
with patients discussing medication. The participants’ said they prioritise 
dispensing and checking prescriptions, but do not develop verbal 
communications with patients. They said they spend only about a minute 
communicating drug information to people with depression. Participant 7 said 
that lack of time is a major obstacle in their practice. He said he is unable to 
help every patient thoroughly and this creates a barrier to providing a better 
service. Making time for interacting with patients becomes an issue unless the 
patient specifically asks for further information.  
 
Participant 7: (8 yrs.; qualified; M): But I may not have had, well, I 
may not have spent enough time with the patient…depends on how 
many other people are there or not…I would say timing, because 
there are other people waiting for their prescriptions… In a normal 
day-to-day pharmacy then unfortunately we’d love to spend more 
time with everybody…again probably not an excuse but timing.  So 
you get used to trying in that short time, getting as much information 
as you can. 
 
Participant 19 said that, when she is advising, her attention is usually on other 
patients and what he is going to do next. The interesting point was that this 
participant felt that she prioritised other patient who may need to collect their 
medications rather than spending time for one consultation. This approach 
might build-up negative feelings in patients and might make them reluctant to 
ask for any clarification associated with their treatment. Similarly, Participant 19   
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said she had less time to share information with patients than she wanted and 
so did not plan to dedicate more time to communicating with patients. This 
implies that patients are not being educated about their medication. 
 
Participant 19: (3 yrs.; qualified; F): What I meant by not having time 
is that you know, if there’s somebody else that needs serving or 
there’s about four or five prescriptions that need checking to go out 
immediately after this then obviously I would just make sure that 
prioritise(other patient not the one who need consultation), that I 
wouldn’t you know spend 10 to 15 minutes talking to one patient and 
then people are waiting you know in my experience people don’t like 
to wait in a Chemist so I would you know, I would prioritise it like that. 
 
Participant 20 explained that he plans only a short time for communication with 
patients and this amount of time is not enough to provide information about anti-
depressants. He said ‘it took two minutes’. This indicates that the patient’s 
agenda was less likely to influence time spent on giving out information. 
 
Participant 20: (29 yrs.; qualified; M): So that’s why they’re not in 
there… literally takes me two minutes, actually less than a minute to 
explain… you can’t, you don’t have time to take the patient in the 
consultation room… I don’t think any pharmacies turn down, we say 
okay. We’ll say to our healthcare assistants, can you just tell them 
we’ll be five minutes. We do what we have to do and we’ll just say to 
them, increase the waiting time. 
 
Participant 20 said he usually ignores patients when they ask for help because 
he is so busy and cannot be responsive to patients’ needs. He said it is likely 
that the patients know the kind of advice he can, as a professional, give but time 
pressures work to eliminate his concern for patients. 
 
Participant 22 said she is aware that her communication with patients is 
ineffective. She said her busy environment influences her and she is unable to   
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change her method of practice. She knows that the patients are not being 
educated about their medications. 
 
Participant 22: (10 yrs.; qualified; F): It might be like patient don’t 
want to know or maybe Pharmacist had no time to give the proper 
counselling, proper information. 
 
To summarise this section, the participants are only able to put aside a very 
short amount of time for providing consultation services to patients, and this 
means they are less likely to share relevant information with patients. Moreover, 
these time pressures prevent the participants from picking-up on non-verbal 
cues from patients. Likewise, patients are less likely to receive satisfactory 
advice that can help with the self-management of their drugs. This could mean 
that patient less expectation about the role of pharmacists, and possibly 
enhance patients’ expectation that the pharmacist role is for dispensing. In 
agreement to, the majority of the pharmacists in their study lacked the time to 
spend with patients to provide more advice. Time pressures are the main barrier 
to achieving patient satisfaction by Chong et al. (2013 C). Limited time is a 
barrier to effective consultation with patients by Hwang and Young (2015).  
 
Community pharmacists perceive a gap between the current and actual work in 
the pharmacy. Laliberté, et al. (2012) report that 86% of pharmacists’ believe 
time is the major obstacle to providing support and screening to patients and 
21% lack skills or knowledge. However, the study does not cover mental 
illnesses. 
 
Dedicated Time to Help Patients (Sub-category D3) 
 
The majority participants all expressed their will to provide services to patients 
and they said it is their responsibility to give patients advice. Their 
responsibilities can include understanding patients’ concerns about depression 
and helping to make sure patients benefit from anti-depressants. The 
pharmacists all said it was essential to be able to devote time to patients for   
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consultations. The information given in a consultation about anti-depressants, 
particularly with newly prescribed patients, helps a patient know what to expect 
when taking anti-depressants. 
 
Participant 1 expressed his keenness to help patients, but said this engagement 
with patients does not happen unless he specifically dedicates time to them. He 
said that he regularly finds time to spend talking to people with depression. He 
used the words ‘opportunity’ and ‘opportunistic’ when describing his behaviour. 
This indicates that he considers prioritising available time for patients as a good 
method of imparting information. He is committed to developing relationships 
with patients and he prioritises this activity over other commitments. 
 
Participant 1: (5 yrs.; qualified; M): I try to take more time out for my 
patients that are anti-depressants…I felt good opportunity, 
opportunistic, opportunity patients… presented with an anti-
depressant script especially because it’s first time, so take the 
opportunity to talk in a little bit more detail about the medication and 
the treatment plan. 
 
Although Participant 1 has many responsibilities at his pharmacy, he prioritises 
patients over all the other services he provides at the pharmacy. Nonetheless, 
spending time with patients does not necessarily ensure that the quality of 
information given out is good. His response indicates that patients appreciate 
his efforts, but this statement ‘may or may not be confirmed’ by his patients. If 
true, his patients might indeed be grateful for the time he spends with them and 
his advice, especially if this helps to alleviate particular concerns. However, we 
do not know how the participant has formed his judgment, so the perception of 
his patients’ satisfaction might be false. 
  
Participant 1: (5 yrs; qualified; M): …because they’ve, you know, 
appreciated that you’ve taken 20 minutes out of a busy day to…  
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Participant 2 talked about the importance of providing time for patients. He said 
that some patients experience issues and concerns about their medications and 
they probably lack the confidence to self-manage their medications. The 
participant said that providing sufficient time for patients helps him to listen 
actively to patients, and this means he can eliminate his patients’ concerns. The 
consequence of giving time to patients is that these patients feel satisfied and 
demonstrate verbal thanks, saying that they appreciate the pharmacist’s time. 
 
Participant 2: (12 yrs.; qualified; M): Some people are very grateful. 
Some people are like oh thank you, you’ve made me feel a lot better 
about it. I was worried about these tablets before, now I’m a lot 
happier. 
 
Participant 21 said it was important to spend time with patients suffering from 
depression to make them aware about the safe use of anti-depressants. This 
participant was willing to spend time with patients, especially if they had not 
taken anti-depressants previously. The participant said she wanted to make 
sure patients were ‘using their time as much as possible’ which could indicate 
that the participant perceives that it is important to check the patients’ 
understanding of the information.  
 
Participant 21: (2 yrs.; qualified; F): It was a new drug I knew that I 
needed to spend some time explaining what it was… the role of the 
pharmacist is important for using their time as much as possible to 
clarify any issues or answer any questions the patient might have. 
 
To summarise this section, allocating available time in practice can help the 
pharmacist check the patients’ understanding of the drugs taken and can help 
pharmacists to pick-up on patient cues. This approach also builds relationships 
with patients. The indications are that patients value the time dedicated to them 
for eliminating their concerns, and this enhances their experience of the service. 
However, participants who stated that they dedicated time to patients also 
stated in the previous section that they did not have enough time to offer   
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consultation to patients and dedicating time may distract them from their 
workload. Sheridan et al. (2012) find that time dedicated during the consultation 
is a poor proxy for quality when there is less engagement between patients and 
their health care providers.  
 
The next section will illustrate the role of privacy in practice. 
5.1.5 Privacy 
The majority of the participants reiterated the importance of patient privacy. This 
section will explore the decisions made by the participants’ relating to offering 
privacy. The participants expressed different opinions about the meaning 
‘privacy’. Some participants said that privacy meant preventing others in the 
pharmacy overhearing conversations between themselves and patients. The 
participants described role of privacy in communication. Participants noted the 
advantages of offering privacy when trying to build relationships with patients. 
However, one participant was less optimistic about the ‘privacy’ that can be 
offered to patients in pharmacies in comparison to the privacy that is offered in 
other clinical settings. 
 
Offering privacy to patients (Sub-category E1) 
 
Participant 4 believed that the number of other patients in the pharmacy at any 
one time is more likely to increase feelings of stigmatisation experienced by 
patients with depression. She said that patients are less likely to raise their 
concerns at the dispensing counter and consultation room provide a 
comfortable atmosphere for patients to talk in. This indicates that the 
pharmacist values the patient’s autonomy.  
 
Participant 4: (MPharm Student; F): If I sense a patient feels a bit 
nervous… I’d ask them if they’d want to go to a consultation room 
because in practice you’ll probably have loads of other people 
around and a queue of people and they might be worried that  
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someone’s going to hear them ….that they work with …or something 
…and…so give them more privacy. 
 
Participant 9 said that offering a consultation room means he can devote the 
right amount of attention to patients due to privacy, and that communication 
exchanges improved when it is possible to use eye contact. This participant 
explained that he is more likely to listen to patients and understand their 
concerns and this facilitates empathy with a patient.  
 
Participant 9: (4 yrs.; qualified; M): …if they haven’t had it before I 
invited them into the consultation room to make it more private and 
make it a bit more warm for them and keep as much eye contact as 
possible as well. 
 
Using a consultation room gave patients the opportunity to discuss issues with 
Participant 11. This participant said it helps to reduce the stigma felt by patients 
due to the presence of other staff and other patients in the pharmacy. He said 
that offering privacy has helped to change the perceptions of patients because 
they are able to move from the dispensing environment to a quiet environment 
in a consultation room. This participant said that offering privacy to patients 
helps patients feel respected. Moreover, Participant 11 said that using a 
consultation room means that no other people can overhear, and this includes 
non-medical staff. The participant implied that patients become concerned when 
overheard by others in the pharmacy. 
 
Participant 11: (18 yrs.; qualified; M): like I say it’s, you know from a 
setting into shop floor to a consultation floor already gives not just the 
patient the privacy, yourself the privacy as well so you feel a lot more 
comfortable in actual discussing what you need to discuss without 
feeling that the patients thinking one thing or thinking they’re being 
overheard or someone’s just walked in.   
  
 
 
 
174 
Participant 14 felt that offering a consultation room was not only about 
preventing others overhearing, but also about helping to build relationships with 
patients.  
 
Participant 14: (3 yrs.; qualified; M): One was the quiet room, 
consultation room so in a quiet, closed environment where the rest of 
the World is kind of sealed off.  You have more of a chance of 
engaging, more of a chance of talking and the patient can express 
themselves a bit more comfortably. 
 
Participant 14 said that patients are more likely trust a provider when the 
patient’s legitimacy and values are respected this could create good 
relationships through the engagement of patients with the pharmacist. Offering 
a consultation room provides more privacy, encourages patients to be 
comfortable, and encourages them to raise their concerns; patients feel that the 
consultation room offers them a closed environment, especially when they 
move from the counter to a confidential environment (Fleming et al., 2015). 
Nonetheless, most participants in this study said that a consultation room is not 
always used and they are more likely to offer privacy for first time patient visits.  
 
Offering less privacy (Sub-category E2). 
 
Workloads in the pharmacy had an impact on the decisions made by the 
participants. Participants 4, 7, 8, 10, 17 and 19 made comments on this section. 
Participant 7 said that it was important to maintain a balance between 
performing other commitments and offering a consultation room to patients. 
This participant said that the busyness of the pharmacy contributes more to his 
decision-making than the lack of desire to explore patient needs. 
 
Participant 7: (8 yrs.; qualified; M): So I mean normally I wouldn’t 
always take them into the private room but I’d have a quiet chat if; 
depends on how many other people are there or not but I would  
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always ask whether or not they’ve had the medication before and I 
would always say it can take a few weeks to start working. 
 
Participant 10 said that patients are not overly interested in using a consultation 
room, because this gives the impression that the patient’s condition is serious, 
and so this participant did not offer the opportunity for patients to receive 
information in a private room. 
 
Participant 10: (11 yrs.; qualified; M): But it’s sort of difficult because 
what I find is people that are feeling sort of low mood, sometimes it 
always quite hard to sort of say to them follow me in the consultation 
room because I think that sort of closes the actual space and I think 
people can sometimes feel; basically it’s like putting an animal in a 
cage. 
 
Participant 17 said that he offers privacy at the counter desk if no one else can 
over-hear the consultation. This participant used his perceptions to assess what 
the patient wanted rather than offering consultation room. He said that his 
pharmacy assistants are often busy with other commitments and this means 
they are not able to overhear consultations. Moreover, he said that the 
assistants at his pharmacy hand out a significant amount of anti-depressants 
and so they have a positive attitude towards people with depression anyway. 
Participant 17 is less aware that a consultation over the counter indicates to 
patients that patients tend to associate an over the counter chat with non-
professional services and a consultation room chat with professional services. 
This participant uses his perceptions to make decisions rather than offering 
every patient all options and services. 
Participant 17: (5 months.; qualified; M): I think it’s beneficial, 
especially when there’s other patients around so you have that 
confidentiality…but if it’s just the patient and the participant within the 
pharmacy at that point in time, I see no reason why you can’t speak 
over the pharmacy area…. I would have happily just had a 
discussion over the counter rather than taking them into the   
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consultation room…Other staff tend to be doing their own 
jobs…Generally speaking staff see this all the time anyway and they 
get to know their patients well.  
 
Participant 19 also explained that she does not offer private consultations to 
patients because she feels that communicating information at the dispensing 
desk is effective as long as no other patients can overhear the conversation. 
This participant also uses her own perceptions to drive judgments rather than 
offering patients a full range of options. 
 
Participant 19: (3 yrs.; qualified; F): And there’s other members of 
staff in the shop area doing the work that they, that they do so the 
reason why I stood there is because there was nobody else there.  If 
there was any other, anybody else there in the shop area where I 
served the patient, I would ask them do you wanna go into the 
consultation room because it’s a private thing. You know with 
medication, people, some people do like to talk about it in front of 
other people. Some people are fine with it. 
 
Environment of privacy compared to other health care settings 
(Sub-category E3) 
 
Participant 8 made a comparison between the privacy offered in pharmacies 
and the privacy offered in the physician’s surgery. He said that pharmacy 
premises are more accessible, whereas the context of privacy in the physician’s 
clinic is more private, quiet and comfortable. Moreover, in the pharmacy he 
experiences frequent interruptions by other staff during his consultations, and, 
due to this, he is unable to give his full attention to patients. 
 
Participant 8: (7 yrs.; qualified; M): So as I was saying, if we were 
…in the pharmacy and in that setting, I would probably have been 
disturbed at least two or three times in that conversation… 
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Participant 8 said that lack of full attention means that patients are sometimes 
reluctant to receive advice. Furthermore, he said that patients do not like being 
overhead by other people in the pharmacy. Offering private room is due to the 
participants’ decision rather than making part of practice. However, patients can 
exhibit concern that confidentiality has been breached when other patients are 
present in the pharmacy, especially if conversations overheard by others in the 
pharmacy (Hattingh et al., 2015). 
 
To summarise this theme, the majority of the participants in this study were 
confident dealing with patients with physical diseases but not with those who 
had mental illness. It became clear that some of the participants need more 
training about managing people with depression. Educating non-medical staff 
about mental illness helps to reduce the patient’s feelings of stigma. Liekens et 
al., (2012) find that 57% of pharmacists report that the main barrier to 
depression care is a lack of education about mental illness. In order to educate 
patients about coping strategies, patients need more advice than the 
pharmacists provide. Limiting time hinders pharmacist when they try to satisfy 
the needs of patients (Barney et al., 2011). 
 
The next section explores participants’ engagement with patients. 
 
 Participants’ Engagement with Patients 5.2
The participants identified their main role as advisors about medication; they 
said they are unwilling to give advice about matters that physicians deal with 
(Chong et al., 2013 C). However, they said that patients often lack an 
awareness of the extent to which the participants are familiar with giving advice 
about the drugs prescribed for mental illness, but participants were less eager 
to share information with patients (Olsson et al., 2014). Organisational barriers 
are another obstacle to effective communication with patients. Patients 
sometimes have their medicines changed without the pharmacist being aware. 
The participants also said that patients have access to various different 
pharmacies, and this means it is difficult to perform a follow-up.   
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(Chui and Stone, 2014) find that community pharmacists do not have access to 
the medical records of patients and so are unaware of the diagnoses made for 
patients. Moreover, the pharmacists expressed a lack of proper liaison with 
other health care professionals, which, they believe is essential for promoting 
the effectiveness of medication. The participants can also encounter many 
responsibilities and their therapeutic decisions often conflict with the advice 
given by other health care professionals (Cooper et al., 2009). 
  
 
 
 
179 
PARTICIPANT 
ENGAGEMENT 
WITH PATIENTS 
Role perception 
Lack of patient 
knowledge about 
the role of the 
participants 
Lack of liaison 
with other 
health care 
professionals 
Training 
needed to 
engage with 
patients 
Organisational 
barriers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Elements contributing towards the participants’ decisions for engagement with 
patients. 
5.2.1 The Training Needed to Engage with Patients 
Participants 1, 2, 3, 4, 6, 8, 9, 10, 11, 13, 14, 15, 17, 19, 21 and 22 made 
comments in this section. They exhibited limited relationships with patients. The 
participants all said they were less likely to hold two-way discussions with 
people prescribed new medication, one direction relationship and they did not 
give out advice about lifestyle. 
 
All participants said that holding two-way discussions with patients intimidated 
some patients and they noted that people with depression are sensitive, and so   
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opening a consultation without using appropriate communication might trigger 
emotions. The participants said they experience less involvement with patients 
who have depression and they were concerned about consequences when they 
open discussions. Participant 4 used the term ‘when I feel nervous’ which 
indicates that she did not feel confident when interacting with some patients. 
Participant 6 said ‘I’m going to struggle with making a decision’ and Participant 
8 shared the same concerns; ‘there was a little bit of apprehension’. 
 
Participant 8 said he is less decisive when interacting with patients and this 
means he engages with them less. This participant reported ’stepping back’ 
from consultations and this indicates that he does not become actively involved 
with talking to patients. He said ‘I don’t have the tools’ which shows that does 
not want to open up discussion with patients about medications, but just give 
one way advice about anti-depressants.  
 
Participant 8: (7 yrs.; qualified; M): …there was that little bit of 
apprehension. Am I going to get a positive or a negative reaction, so, 
again, that was probably sub-consciously in my Mind…but you’re 
always stepping back and thinking, right, I don’t want to go too far 
down this because I don’t have the tools, I don’t have the tools to 
counsel… it’s outside the boundaries of medication supply.  
 
Participant 9 revealed an awkward experience he had when he first began 
consultations with patients. Although he managed the situation, he said that his 
negative experience discouraged him from providing patient centred care. 
Participant 9 said that he is less confident when discussing lifestyle choices with 
patients. He said that opening up discussions was not in his agenda and he is 
more likely to give directive advice about medications without involving the 
patient in a mutual shared decision. Although involving patients in consultations 
can help to remove any uncertainties, this participant said he was less likely to 
engage in mutual shared decision making with patients. 
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Participant 9: (4 yrs.; qualified; M): Yes, it’s, there’s obviously finding 
it, they’re going through a certain obstacle in their life so I don’t try 
and talk about that…but try not to talk about it as much as 
possible…. because I don’t really tend to go into that much detail 
with…I don’t ask the patient why they’re here as such because it 
could be a death, it could be anything …to maybe lead onto further 
things. 
 
Participant 10 said he is less likely to engage in a two-way consultation with 
patients. He said that during the initial stages of treatment, patients were not 
ready to involve themselves in a mutual discussion. However, he made this 
judgment using his own perceptions rather than giving patients’ the opportunity 
to raise their needs.  
 
Participant 10: (11 yrs.; qualified; M): …but how do you change that? 
I mean sort of, you know, like I was saying, if you sort of put an 
animal in a cage it may heighten it you know? If I ask you a lot of 
personal questions, you’re going to turn round and say well it’s the 
first time we’ve met. 
 
Participant 14 talked about the difficulties in engaging in two-way discussions 
about taking anti-depressants. He said he lacks confidence when advising 
patients about their lifestyles. 
  
Participant 14: (3 yrs.; qualified; M): I didn’t want to say don’t take the 
medication because his lifestyle and the sleepless nights…I was 
giving information on how to take the medication, when to expect 
some results, and just when to see the doctor as well. 
 
Participant 19 explained that she does not like offering consultations in which 
she explores patient values. 
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Participant 19: (3 yrs.; qualified; F): I mean it was a new experience 
for me because like I said, the time I’ve been qualified I’ve never 
really had the experience to actually have a full consultation with 
somebody about. most of the time I just ask them if they’d had it 
before their medication and most of the time they say yes they’ve 
been on it for x amount of yrs. so I think most of the time I know that 
they probably know more about the medicine than I know because 
they’re the ones that are actually taking it. 
 
Participant 19 was aware that giving out non-medical information would benefit 
patients, but she lacks the confidence to make her patients the centre of the 
consultation. Cates et al. (2005) find that pharmacists are more comfortable and 
confident when providing pharmaceutical services to people with depression 
than to those with cardio vascular illness. In this study, the authors suggest that 
the particular participants involved may have had better perceptions about 
providing care to people with depression. Nonetheless, the authors find that 
greater experience in practice correlates with a more positive attitude towards 
providing pharmaceutical care to those suffering from mental illness. 
 
Role Perception (Sub-category F1). 
 
Participants 1, 2, 8, 9, 10, 15, 19 and 21 did not perceive themselves in the 
extended role recommended to provide mutual sharing with patients. Participant 
2 felt less self-efficacy when involving patients in discussions, but he said his 
role is to reinforce information to the patient about anti-depressants rather than 
to open up the discussion to include non-medication matters. He said that he 
did not have the skills to discuss a patient’s social life or lifestyle. 
 
Participant 2: (12 yrs.; qualified; M): what I know I can’t do is, I’m not 
a psychologist.  I’m not a counsellor.  I’m not a doctor.  I’m not 
necessarily able to influence those side of effects but I can influence 
on information about medication, about safety of it and about giving 
them a little bit more than they had already which means they’re   
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likely to take it.  If I’d say, just have a read of that leaflet, have a look 
at all of the side effects that are in there, they’re not gonna take it. 
 
Participant 11 said that he lacked proper training to be able to provide 
consultations that matched patient needs. He said he values communication 
skills during a consultation, but is less likely to be able to understand a patient’s 
body language, and, therefore, less likely to pick up cues from patients. He said 
that patients have different beliefs about anti-depressants and he does not have 
the skills to encourage two ways conversations.  
 
Participant 11: (18 yrs.; qualified; M): I’m not saying that Pharmacists 
aren’t trained well enough but you need to have a degree of skill in 
some sort of psychology or sociology side of things to understand.  
You don’t wanna be going into an area where very easily you could 
open a whole load of emotions.  
 
To summarise this section, the participants need more education about 
communication to match their extended role in practice. Chong et al., (2013 C) 
use audio recordings to assess the pharmacist–standardised patient interaction. 
The authors conclude that pharmacists mainly provide advice about the safe 
and effective use of anti-depressants and do not have a full understanding of 
patients’ medical conditions and other non-medical treatments. However, this 
practice is not congruent with how pharmacists see themselves, and this means 
that pharmacists face challenges when in practice. Noble et al. (2014) conclude 
that it is difficult for pharmacists to establish ways of communicating with 
patients. For example, patients do not understand why pharmacists ask them so 
many questions. Power (2010) argues that pharmacists lack a desire to carry 
out new responsibilities and are overly concerned about patients and other 
health care professionals. 
 
The next section will explore the extent to which patients understand the role of 
the pharmacist.  
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5.2.2 The Lack of Patient Knowledge about the Role of the Pharmacist 
Participants 1, 7, 10, 11, 15 and 20 said they do not believe that patients expect 
them to know much about mental health. They demonstrated that they are 
unable to open up to consultation, preferring to be directive in approach. The 
participants’ approach is more likely towards advising about medication only, 
and less about lifestyle. One participant marked out clearly the differences 
between the physician’s role and that of the pharmacist. 
 
Participant 1 thought that people with depression have lower expectations about 
the knowledge of the pharmacist about mental illness. Patients view the 
pharmacists merely as a dispenser, with physicians being the experts on anti-
depressants. This lack of awareness about the pharmacist’s role acts as a 
barrier to delivering information comfortably to patients. This implies that the 
participant does not take an active role with patients when they visit the 
pharmacy. 
 
Participant 1: (5 yrs.; qualified; M): …because I don’t know whether 
that’s, whether the patient sees the pharmacist as somebody who 
knows less. I think patients don’t have that expectation, that a 
pharmacist will be a specialist mental health pharmacist or you know, 
can give them that expert advice regarding psychiatry. It is a very you 
know, specialist area. 
 
Participant 7 said that patients visited the pharmacy when they wanted to collect 
their prescription, but they did not visit for additional support. This implies that 
patients view the pharmacist a dispenser and seller of medications and they are 
less aware that the pharmacist can promote adherence to medications. This 
lack of awareness about the extended role of the pharmacist works as a barrier 
to building the therapeutic relationship with patients.  
 
Participant 7: (8 yrs.; qualified; M): Patients always, only, come in 
when they’re ill, not always before they get ill…asking for advice. 
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Participant 11’s comments supported those of Participant 10 in that patients are 
unlikely to be aware of the extended role of the participant. Nonetheless, this 
participant believes he can support patients by providing signposting to 
appropriate health care providers, self-help groups, and eliminating any 
concerns associated with anti-depressants. 
 
Participant 11: (18 yrs; qualified; M): like the patient’s saying he’s got 
a good job, he’s got a house, he’s got no worries and then the 
doctors basically told him you’re depressed and there’s something 
wrong with you… So by the time they’re coming to you, they’ve 
already made all their assumptions…Sometimes they may not be 
aware that holding a quick chat with a pharmacist may sort of 
alleviate some of these anxieties or worries. 
 
Participant 20 said that people with depression are not keen to involve 
themselves with him because they perceive that the consultation ‘MUR’ is 
included in the role of physician rather than in the role of pharmacist. This 
results in patients not being receptive to consultations from pharmacists. 
However, although his patients have a low expectation of his abilities to 
undertake MUR, the pharmacist did not mention his patients’ perceptions to the 
researcher after the pharmacist had conducted a MUR.  
 
Participant 20: (3 yrs.; qualified; M): The patients don’t expect the 
pharmacist to ask those personal kinds of questions…something 
called a Medicine Use Review…whenever we ask, sometimes, some 
of the patients to come in for a MUR, the first thing they’ll answer is - 
oh it’s a doctor’s job - I’ve just had a consultation with the doctor, why 
do I need to chat with you? So that’s why sometimes pharmacists 
tend not to go down that road. 
 
To summarise this section, the patients’ lack of awareness makes the 
participants less motivated to build therapeutic relationships with patients. It is 
possible that participants who do not have enough time to discuss matters with   
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patients build up a barrier that reduces patients’ expectations. The expectations 
of patients are lower than the level of provision the pharmacists can offer, and 
some patients only visit the pharmacy to collect their medications without 
knowing that they can ask the pharmacist for a consultation. Therefore, patients 
are in a state of unawareness about the proper use of their medications, and 
they are not aware of the services pharmacists can offer in the pharmacy 
regarding consultation about medications (Olsson et al., 2014). Research 
carried out by Gidman et al. (2012) to assess public trust in community 
pharmacist services finds that patients felt that physicians had the authority to 
tell the pharmacist about medication decision.  
5.2.3 Lack of Liaison with Other Health Care Professionals 
A third of participants contributed in this section. Participants 2 and 11 said they 
do not have much contact with other health care professionals. They felt that 
collaboration with other physicians could improve therapeutic outcomes as well 
as providing opportunities to follow-up patients and enhance their quality of life. 
Participants 9, 11, 13, 14, 15 and 19 made comments about their relationships 
with other health care providers and noted that the professional authority of 
physicians influences the decisions they make. These participants said that 
their decisions sometimes clashed with those of the physicians but that ethical 
responsibility relinquishes to the physicians. 
 
Participant 11 made comments about collaboration with other health care 
professionals and noted that he does not get regular interaction with other 
health care professionals and this makes therapeutic management less 
successful. He said that physicians are less likely to signpost patients to their 
pharmacists, and, thus, patients are less likely to expect the pharmacist’s 
support. He said that community pharmacists have the knowledge to review the 
patient medication and enhance patient well-being. 
 
Participant 11: (18 yrs.; qualified; M): There needs to be some sort of 
triage sort of thing with doctors and, you know, pharmacists, and, you  
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know, psychotherapists, and things like that, because it’s very easy 
for patients to leave a GP surgery and not even go to the pharmacy. 
 
Hierarchy among health care professionals (Sub-category I1) 
 
Participants 1, 2, 8, 9, 10, 13 15, 19 and 21 made comments that their role was 
limited to dispensing and informing rather than exploring patient needs. 
Participant 9’s agenda was to advise patients about the safety of medications, 
rather than conduct shared consultations with patients. In agreement, 
Participant 13 showed good knowledge of anti-depressants but said he has little 
authority to liaise with patients’ about their treatments and this makes him feel 
less responsible for the treatments he hands out.   
 
Participant 13: (5 months; qualified; M): …but whether or not he is 
happy to be on this drug because if you’re not happy, doctors given it 
to you, it’s a difficult situation and to feel that you have take it but 
really it’s up to you if you want to take it or not. 
 
Participant 15 is less likely to be pro-active with patients when he is rejected 
physicians. Participant 15 said that patients are less likely to adhere to his 
advice when it conflicted with the physician’s advice. This implies that patients 
place more trust in their physicians even when the physician has not involved 
the patient in their treatment decision. This situation makes the participant less 
likely to be pro-active when dealing with patients. 
 
Participant 15: (3 yrs.; qualified; M): … This is my own experience in 
the Community that is and even when they do, they don’t understand 
well how it works or they just know that they have to take it.  They 
view it in the sense that, they take medicine based on trust in that the 
doctor has said I (patients) have depression.  He (physician) says I 
(patient) need to take this medicine to treat my depression therefore, 
I (patient) must take the medication.  A lot of it is based on trust. 
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To summarise this section, therapeutic collaboration is good practice for making 
patients the centre of the care. This would enable participants to monitor 
medications and follow-up with patients. Furthermore, collaboration provides 
motivation for the participants to contact other health care providers when 
patients experience health issues. The current lack of collaboration with other 
health care professionals results in participants relinquishing their therapeutic 
responsibility when their decisions conflict with those of other health care 
professionals. Pharmacists feel subordinated to the physicians’ decisions and 
they sometimes encounter conflict with physicians when they notice interactions 
between two medications, and this leads to ethical problems (Cooper et al., 
2009). 
 
Other health care professionals influence the decisions of the participants who 
are then less likely to decide upon therapeutic outcome. Physicians perform 
clinical assessments and make therapeutic decisions, and so they have more 
authority to take decisions about patients’ health conditions (Harding and 
Taylor, 2002). Conflicts between physicians and pharmacists have an effect on 
professional performance and pharmacists feel they have little power to make 
decisions, so instead they take orders from their physicians. This hierarchy 
creates a dilemma between pharmacists and physicians over some decisions 
(Kalvemark et al., 2004). 
5.2.4 Organisational Barriers 
The participants were optimistic to have more information about the 
backgrounds of patients. Participants 1, 2, 4, 7, 10, 11, 14, 15, 19 and 22 made 
comments that health care systems are not linked to pharmacies in the same 
way they are linked up in other health care settings. The lack of adequate 
software to maintain digital contact with other health care professionals acts as 
a barrier to the participants’ knowledge of the patients’ health issues, and this 
means that pharmacists are not always able to provide follow-ups for patients.  
Participant 2 raised concerns about a lack of information about the medical 
backgrounds of patients. Knowing the medical background of a patient can help 
the pharmacist to communicate therapeutic information to the patient properly.   
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However, this participant’s approach was to give directive advice without 
knowing the full background of a patient’s health needs. 
 
Participant 2: (12 yrs.; qualified; M): …and I don’t know enough about 
you as a person, your personal situation… so I think this is just some 
of the information you’d have probably already got from the doctor. 
 
Participant 15’s comments supported those of Participant 2. He said that the 
lack of a web-based system to connect to other health care professionals could 
act as a barrier to expanding discussions. He said that the causes of depression 
might result from physical and/or mental disorders, and so to involve the patient 
in care, the participant needs to know more about the patient’s medical history. 
He said that trying to explore medicines with patients without knowing their 
medical history is difficult. 
 
Participant 15: (3 yrs.; qualified; M):  …because obviously whatever 
that depressed episode may be…for starters I never even confirmed 
if it was a depressive episode or whether or not it’s something that’s 
been building …it could be, I don’t know, it could be seasonal 
affective disorder. 
 
Participants 22 said that organisational barriers proved to be a problem when 
she worked in different pharmacies, and these barriers decreased her 
opportunities to form friendly relationships with patients.  
 
Participant 22: (10 yrs.; qualified; F): … obviously whatever that 
depressed episode may be; for starters I never even confirmed if it 
was a depressive episode or whether or not it’s something that’s 
been building and he doesn’t know whether or not it’s just something 
that’s just happened. It could be, I don’t know it could be seasonal 
affective disorder.  It could be something that’s just happened out of 
the blue and he can’t explain it. 
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Participant 22 said that developing relationships with patients is a key factor for 
communicating comfortably. She indicated it was routine for her to try to 
develop communications with patients.  
 
To summarise this section, involving the participants in interdisciplinary teams 
would enhance their engagement with people with depression. In accordance, 
Chong et al. (2013 b) find that implementing web based networks across 
different clinical settings and including pharmacies is important to facilitate the 
accessibility of medical histories and, thus, improve communication between 
different health care providers. A lack of information about the history of patients 
acts as an organisational barrier for pharmacists. Chui and Stone (2014) find 
that community pharmacists do not have access to the medical records of 
patients and so are unaware of the diagnoses made for patients. 
 
 Tailoring the Consultation 5.3
The content of this theme discusses the skills required to deliver effective 
consultations. This theme deals with the behaviour of the participants when 
intend to negotiate patients’ agenda (Pharmacy Guild of Australia, 2010). 
Moreover, the participants perceived the importance of gathering information 
about medication history and current medication to assess the backgrounds of 
patients. Giving out information is included in this theme. The participants’ 
opinion is that it is essential to provide understandable advice to support patient 
adherence to their medications. NICE states that pharmacists must undertake 
medication review for people of different ages. Professionals must structure 
treatment to individuals with the objective of reaching agreement with patients 
about treatments, reducing medicine related problems, and optimising the 
impact of medications (NICE, 2015). 
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Figure 5.3: Tailoring the consultation to the patients’ needs’. 
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5.3.1 Developing Skills in Practice  
This section outlines the experiences of the participants when they meet with 
patients and use their skills in daily practice. Participants 2, 3, 8, 11, 14, 15 and 
21 took part in this section. They talked about building-up skills in practice 
unconsciously, but these skills play a vital part in helping participants to 
communicate with patients. 
 
Participant 8 felt that his skills have become routine and he does not feel he 
actively uses his skills. This implies that the participant does not think about 
how to use communication skills and is only aware of using skills when an 
incident occurs to make him reflect on the interaction, for example, a training 
session or an awkward consultation.  
 
Participant 8: (7 yrs.; qualified; M): … Okay initially my feelings were 
based on the nature of the medication so once I’d seen the patient 
had been dispensed Sertraline, again maybe not consciously, sub-
consciously there was right this is something important, this is 
something that I will have to kind of cater for with a little bit of tact so, 
that kind of choice of consultation room and privacy was the first 
thing that came to Mind.  I think right this is probably not a 
conversation I would have on this counter, let’s move it to a private 
setting. 
 
Furthermore, Participant 11 used the term ‘libido’ rather than ‘sexual 
dysfunction’ when talking about a patient when he picked-up on cues from the 
patient about the side effects of anti-depressants. The participant said patients 
make him conscious about using his communication skills, rather than being 
something he did consciously and regularly.  
 
Participant 11: (18 yrs.; qualified; M): ‘I think I felt, I felt that from your 
reaction as well.  I think I needed to sort of slip that in somewhere 
because there’s a tendency of being quite robotic towards you know,   
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counselling and feeding patients with information because you can 
have a step and go right that’s it, that’s all that, go away, thank you. 
 
Nonetheless, Participant 21 said she is less likely to build relationships with 
patients. The nature of locum pharmacy hinders the participants to contact with 
the same patients, which possibly she could not have the opportunity to reflect 
on her skills in the practice. This implies that the working in different pharmacies 
less encourages the participants to create professional relationship with 
patients. 
 
Participant 21: (2 yrs.; qualified; F): …. I think that’s the; I’d never 
actually thought about that.  I’ve never actually thought about the 
future (laughing) about you know cus it’s an ongoing treatment 
obviously so I said so myself it can take you know months for it to 
work or months for it you know last of the therapy so but I can see 
why perhaps I didn’t think of those because my actual role is like a 
locum Pharmacist so what I do is I work in one place.  I may not be 
there for another five weeks or something or never ever and so I 
don’t actually think about the ongoing relationship with a patient 
necessarily. 
 
To summarise this section, the participants developed skills during practice, but 
only demonstrated certain skills occasionally. Participants said they used a 
different approach for physical and mental health conditions, and this enables 
them to integrate their skills to every individual. Participants practiced their skills 
without being aware of using them. Therefore, unconscious competence 
becomes ‘second nature’ and exhibits itself when there is a need to deliver 
information to patients (Chapman, 2015).  
5.3.2 Initiating the Session 
Half of Participants 1, 4, 7, 10, 11, 14, 15, 17, 18, 19, 20 and 21 said they 
believe in the importance of building an initial rapport with patients. This initial 
communication enables the participants to offer a consultation and it helps the   
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participants to set their own agenda. Moreover, the participants felt that it is at 
this stage of interaction when they find out physicians provide the right 
information. This time helps the participants to take the patient and physician 
agenda into account. The participants who made comments gathered 
information about anti-depressants in order to enhance the patients’ 
expectations of their pharmacies and the therapies (Grimes and Barnette, 
2014). The participants said they are more likely to advise about the safety of 
medications, which they felt was essential, in order to show their competence, 
but they are less likely to advise about lifestyle, because they felt this was within 
the remit of physicians. 
 
Negotiating an Agenda (Sub-category K1). 
 
The majority of the participants saw the importance of good initial relationships 
with patients. Participant 1 said it is his responsibility to find out about the 
patient’s background because this knowledge can aid the patient’s experience 
with anti-depressants. This participant used the term ‘expert’ advice’ and 
explained that he has three yrs.’ experience dealing with mental health 
medication.  
 
Participant 1: (5 yrs.; qualified; M): Shall we have a, you know, talk 
about your medication?  Is there any expert advice that you want 
about your medication? Then again any questions, specific questions 
to treatment or illness that the patient might have. 
 
He said that building an initial rapport encourages patients to form their own 
agenda and decide what they would like to communicate during the interaction. 
The participant said this helps him to gather information about the patient’s 
ideas and concerns.  
 
Participant 8: (7 yrs.; qualified; M): …then again any questions, 
specific questions to treatment or illness that the patient might have. 
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Participant 8 said there might be sensitive information that patients might want 
to discuss and putting patients at ease might encourage them to raise hidden 
concerns. The participant felt this communication provides an opportunity to 
share information with patients. Participant 9 believes that the physicians do not 
have sufficient time to give advice about adherence to anti-depressants. 
 
Participant 9: (4 yrs.; qualified; M): … well my feeling was that 
obviously the patient hasn’t had it before, I need to go through in a lot 
of detail because I find that doctors do miss a lot of information off 
unfortunately. They don’t have time for it so they’ve got like 8-10 
minute consultation periods. 
 
Participant 9 felt that his role is to explore the patients’ agenda for structuring 
the consultation. This enabled the pharmacists to assess the information 
tailored to the patients. Likewise, participant 20 said that they hoped to assess 
the patient’s views about depression and their beliefs about anti-depressants, 
and this discussion gives patients the chance to discuss issues with the 
provider, and facilitates the communication of important information. 
 
Participant 20: (3 yrs.; qualified; M): …the patient said to me, I mean, 
like my first question was to him is, what’s your understanding of the 
illness and of the medication? 
 
To summarise this section, building an initial rapport with patients encourages 
the participant to understand the patient’s agenda and enhances the patient’s 
expectations. It also helps participants to structure the consultation. Grimes and 
Barnett (2014) find that pharmacists usually ask patients the reasons for visiting 
the pharmacy not only to establish initial rapport but to give the pharmacist 
opportunity to tailor information to the patient and decide the structure of the 
consultation. Guirguis (2011) notes how three main questions (What are you 
using this medication for? What did you see the physician for today? This 
medication has several uses, what are you treating?). These questions can 
open-up the consultation, and the pharmacist values the positive outcomes of   
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these questions. Guirguis notes that these questions enable patients to provide 
the pharmacist with up-to-date information about their medical histories.  
 
5.3.3 Giving Information to Patients 
This section discusses the quality of information given to patients. In practice, 
participants form opinions about how to communicate and frame information 
about the side effects of drugs. Some participants do not wish to overload 
patients with too much information, and others believe that giving patients too 
much information about side effects might scare the patient. The participants in 
this study were willing to provide information that enhanced medicine 
adherence. The participants valued their skills for giving the patients opportunity 
to talk because this enables them to be able to listen actively to patients and 
pick up patient cues. The outcome of communicating effectively with patients is 
building positive relationships with them (Black et al., 2009). However, 
communication between professional and patient was a key factor to increase 
adherence to anti-depressants. The majority of physicians reported that they 
informed patients to continue anti-depressants (Bull et al., 2002). 
 
Information sharing about anti-depressants (Sub-category L1) 
 
Participant 1 said that patients prefer to get advice about their medicines rather 
than mention non-medication treatments to for promoting patients. The 
participant said that this decision resulted from his experience working in a 
‘mental illness setting’. He said patients were more willing to receive information 
about the effects and safety of medications than lifestyle support. 
 
Participant 1: (5 yrs.; qualified; M): my background is mental health 
and I’ve worked quite a lot, extensively, with, you know, depressed 
patients. Which is, I think the expectations of patients from day one? 
I see you know in mental health, it’s one of them areas where 
patients want clarity. Because it’s important obviously with this type  
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of treatment to make sure, the patients aware that for the first days 
it’s gonna because initial worsening.  
 
Participant 2 said he was knowledgeable about anti-depressants and talked 
about the ‘terms of the pharmacy and the pharmacist’. This indicates that he 
has good knowledge of medication related information and this knowledge 
would probably satisfy the needs of patients concerning anti-depressants. This 
participant’s knowledge also covered evidence-based information, which 
supported his provision to patients.  
 
Participant 2: (12 yrs.; qualified; M): I know the kind of information 
that I want to give to a patient and I just need them to take that on 
board…but in terms of the Pharmacy and the Pharmacist in getting 
that medication to the patient…I know what I know from the 
medication and from the research and the information. 
 
Participant 6, (an MPharm Student), said he elicits information about patient 
self-harm. In this research, he was the only participant who involved himself in 
obtaining sensitive information about suicidal intentions.   
 
Participant 6: (MPharm Student; M): Yes it’s I’ve just studied the 
NICE guidelines and it’s like right at the front is the suicidal tendency 
part.  
 
Participant 6 refers to standard guidelines saying that health care providers 
should ask patients if they intend to harm themselves. Participant 9 said that 
anti-depressants might take few weeks to reach full therapeutic effect, and 
noted that the non-adherence rate was high at this stage. This participant said 
that he always encouraged patients to continue adherence in order to reduce 
the symptoms of depression and avoid withdrawal symptoms when they 
stopped taking their medication. This participant’s phrase ‘I always’ could 
indicate that he has experience with patients who are non-adherent in the early 
stages of receiving anti-depressant medication. 
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Participant 9: (4 yrs.; qualified; M): I always tend to go through in a 
little bit more detail and spend with the patient at least about two or 
three minutes just going through what they’ve got, you know what 
they can actually expect the side effects usually with something like 
this it’s, you do get some unwanted side effects but people do get 
alarmed and go, phew I aint taking them. 
 
Participant 8 said his intention was to explain the most frequent side-effects to 
patients because this enhances adherence to medications. He said that during 
a first meeting his motivation is to provide information but not to scare the 
patient with negative information.  
 
Participant 8: (7 yrs.; qualified; M): … I mean with regards to sort of 
side effects, could well have gone through some of the more sort of 
serious side effects, which you’ll find, on the label if you open it.  
You’ll find loads in there.  That would probably put them off straight 
away, so just more or less the main ones what. 
 
Participant 8 said that patient information leaflets could reduce adherence to 
anti-depressants. Therefore, his motivation was to put patient at ease when 
reporting the side effects. Participant 15 said that training about the safety of 
medications is required in order to deliver information that matches patient 
needs. The participants in this study felt that information about mental illness 
differs from information about physical diseases, and that the negative side 
effects of anti-depressants can discourage patients from adhering to their 
medications. 
 
 
Participant 15: (3 yrs.; qualified; M):… having the right amount of 
information and obviously, I think the most important thing, I think I 
don’t want to labour the point but if I place depression on the same 
category as diabetes, asthma, gout for goodness sake, all these type 
of things, if I put it on the same level as that then the patient maybe   
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will register that this is just any other illness this is.  There’s no need 
for me to think that other people will think bad about me. 
 
Participant 6 said that the positive framing of side-effects could improve the 
behaviour of patients towards their medication. Participant 6 said he is more 
willing to ask patients if they experience the need to self-harm and said that he 
does not use jargon in case this scares the patient. 
 
Participant 6: (MPharm Student; M): …without using the word 
suicide…and then you’ll start to notice this effect in a couple of 
weeks’ time…and then the full effects will be four to six weeks. 
 
To summarise this section, the participants were aware of anti-depressants and 
the need to enhance patients’ well-being. Their knowledge covers different 
specialities and this increases the potential for individual responsibilities. 
However the participates less able to provide advice which enhance the quality 
of life, possibly lack engagement with patients make the participants more 
medicine focus. In accordance with, a study by Chong et al. (2013 C) uses 
audio recordings to assess pharmacist–standardised patient interaction. The 
authors conclude that pharmacists mainly provide advice about the safe and 
effective use of anti-depressants, rather than trying to understand the patients’ 
medical conditions or give out other non-medication advice for depression. 
However, Winstanley (2011) recommends that pharmacists take an overview of 
a patient’s history and this includes personal information, lifestyle, including 
home circumstances, relationships with friends, and beliefs about long-term 
health issues. 
 
Giving patients’ opportunity to talk (Sub-category L2)  
 
Participants 3, 8, 11, 14, 17, 18 and 21 said that giving patients the opportunity 
to talk enables the participants to understand patients. 
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Participant 8 said that he usually encourages patients to talk. He said that 
listening to patients helps build relationships; he values the chance to give 
patients the opportunity to speak because this results in enhanced satisfaction 
when communicating with patients.   
 
Participant 8: (33 yrs.; qualified; M): …the patient was very 
forthcoming in sort of the discussion. I didn’t real have to kind of pick 
at anything or kind of lead in that sense. I always give the patient the 
option, which was good, but I mean that’s not to say that would be 
the case every time. 
 
Participant 18 said that patients can be passive and it is his responsibility to 
take pro-active behaviour and encourage patients to talk. This happens when 
with open questions that encourage patients to tell their stories.  
 
Participant 18: (3 yrs.; qualified; F): …regarding these open question 
and you should give chance for the patient to talk about it first and 
get all the information out of him but once you go there, out there in 
the Pharmacy you start just like, you know it’s; some patient like to 
talk about things or they sometimes talk but most of them they don’t 
like to talk about it so you start. 
 
Chong et al. (2014) assess the characteristic communication between 
pharmacist-patient during the consultation. Pharmacists showed fewer 
instances of inquiring about the opinions of patients and open questioning; 
these were important skills to elicit patient concern and feeling of partnership 
relationship. 
 
Picking up the patients’ cues (Sub-category L3) 
 
Participants 2, 14, and 15 perceived the importance of picking the verbal and 
nonverbal behaviour of patients during the consultation. 
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Participants 2 said that reflecting on the responses of patients was his ‘style’ 
when communicating with patients but he changes his approach if the patient 
does not show any cues so he can meet the needs of patients. 
 
Participant 2: (12 yrs.; qualified; M): … some people you can have a 
bit more of an in-depth conversation, some people you know really 
want somebody to talk to and really want to get a bit more 
information or some help and so you have to just try and match that 
to the individual patient and what you get back from them and what 
they appear to want. It might not be what they really want or it might 
not be what they really need but you can at least meet them half way 
with it. 
 
In accordance with Participant 2, Participant 14 said that he uses 
communication not only for giving information but to gain the patient’s attention; 
this encourage patient to raise their hidden concerns. 
 
Participant 14: (3 yrs.; qualified; M): …what he’s saying so not to feel 
too robotic like I’m trying to get something out of him but more that 
I’m trying to help him by catering my questions towards what he’s 
saying.   
 
Checking patients’ understanding (Sub category L4) 
 
Participants 2, 11, 16 and 19 said that they took a more explicit approach when 
asking patients if they understood information. Participant 19 said that closed 
questions do not work to help a patient indicate their understanding, but that 
patients were unlikely to hide misunderstandings. However, she said that she 
used closed questions to avoid upsetting patients. She avoided using ‘telling 
back’ because some patients perceive this as a test to see if they have 
understood information. 
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Participant 19: (3 yrs.; qualified; F): During the consultation I asked 
the patient do you understand what I mean because some people 
don’t like to you know, ask questions, some people don’t like to 
question.  You know if they don’t understand something they’re a bit 
scared to say I didn’t understand that so that’s why I thought I’d put 
the first, make the first move on you know explain something and 
then say do you understand that? 
 
Less information sharing about social treatments (Sub-category L5) 
 
Half of the participants made comments in this section. Participant 14 said that 
the role of the physician is to provide information about lifestyle but he is less 
likely to check his patients’ awareness of non-medical information. 
 
 
Participant 14 (14 yrs.; qualified; M): I didn’t mention lifestyle but I 
probably could have mentioned a bit more because with depression 
going to gym, having healthy balanced diet, that does really help as 
well and it’s focussing on your lifestyle. What we do is relay the 
information to the doctor and help patients on a medication level and 
a lifestyle level.  
 
Participant 19 felt that her patients are less interested in information about anti-
depressants or lifestyle, but patients are aware of their treatment and so are 
less likely to ask for more information. However, this comment might reflect the 
individual perceptions of Participant 19 rather than actual patient preferences.  
 
Participant 19: (3 yrs.; qualified; F): I think, most of the time, I know 
that they probably know more about the medicine than I know 
because they’re the ones that are actually taking it. 
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Participant 21 indicated that she is less decisive when giving out information to 
enhance her patients’ well-being for example the participant, aware of the 
information about lifestyle.  
 
Participant 21: (2 yrs.; qualified; F): I didn’t know whether someone 
might be, you know, not wanting me to ask personal questions about 
their lifestyle and stuff, even though it might have helped, in 
hindsight. 
 
Participant 21 perceives that patients are less likely to be responsive to 
information about things other than anti-depressants. The pharmacist made 
judgments based on his perception that patients were more willing to receive 
advice about anti-depressants than about lifestyle. Patients possibly have 
different views and so pharmacists should be non-judgmental (Grimes and 
Barnette, 2014). 
 
To summarise this theme, the participants valued the skills for communicating 
and giving advice to patients. The participants’ advice is mostly to maximise the 
efficacy and safety but they are less willing to support patients with information 
about lifestyle. In contrast, pharmacists spent time giving advice and but 
listened less to the patients, and patients took a less active role in making 
choices about their treatments (Chong et al., 2014). The next theme will 
illustrate the staging of advice to patients 
 
 Staging Advice to Patients 5.4
This theme illustrates the quality and quantity of information giving to patients. 
The participants were more paternalistic at the early stage of treatment. This 
kind of paternalistic approach is due to various reasons. An eagerness to 
establish an agenda early on encourages participants to be passive and closes 
down opportunities for patients. This approach raises issues about the quality of 
information exchanged between the participants and the patients (Anderson 
and Roy, 2013). Building relationships is the second category in this theme; the 
participants were more likely to build trust and respect with patients over time 
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and this facilitates the provision of the service. The participants appreciated the 
verbal and non-verbal cues given by patients and positive communication with 
patients (Riley et al., 2013). This section will also cover the opinions of the 
participants when they offer patient advice (Guerreiro et al., 2010) and have a 
second meeting with patients during which they are more able to provide non-
medical information (Wells et al., 2014). 
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Figure 5.4: Participants dividing advice and information, which suits the patients’ health status
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5.4.1 The Quality of Information at First-Time Consultation 
Participants 1, 3, 4, 7, 8, 9, 10, 11, 15 and 17 tended to focus on giving out 
medication related information rather than information about lifestyle. The 
participants perceived that patients are not willing to listen to information about 
lifestyle and are less likely to remember this information. 
 
Participant 1 thought that the cognition of patients is more likely to be affected 
by the symptoms of depression and that patients are less likely to remember all 
the information they are given. He said that giving the right amount of 
information helps patients understand their instructions. 
 
Participant 1: (5 yrs.; qualified; M): I know Jim might not take on most 
of the stuff that I said and that’s why I tried, you know have you 
understood what I’m saying.  If I had, I’d usually have literature to 
give as well you know like leaflets and say look this is the websites.  
I’d write them down, look try you’re Mind, and try depression, good 
support groups. 
 
Participant 9 said that he frames his explanations based on the ‘positive, 
negative, positive’ model, which balances between the negative and positive 
actions of anti-depressants. He uses this explanation to enhance patient 
perceptions about the effectiveness of anti-depressants.  
 
Participant 9: (4yrs.; qualified; F): I tend to do that sort of thinking 
yes, look this is a positive, the negative but here is a positive. You 
know if you do take it, it will go hence why we draw the charts. You’ll 
fall down but then you will peak up and it will kind of level off after a 
while which is the case.  
 
Participant 3 said that giving out information about lifestyle does not help 
patients, especially during a first-time meeting. She said that patients might be  
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confused by their diagnoses, and giving out information about non-medical 
information makes patients less willing to accept the information.  
 
Participant 3: (15 yrs.; qualified; F): …if somebody’s depressed and 
really depressed, they’re not going to start playing squash until 
they’re on their way back up. What planet are you on?  
 
This participant said that he reflects on the responses of patients during the 
consultation and that he picks up cues from patients, reading these as 
indicators of satisfaction or that patients are not ready to receive more 
information.  
 
Participant 11: (18 yrs; qualified; M): …yes, but at the same time 
you’ve got to look at how much information you’re giving to the 
patient as well, and I felt maybe at that point we were trying to 
possibly terminate the consultation at some point… 
  
To summarise this section, the participants appear to prioritise information that 
relates to the safety and efficacy of anti-depressants over lifestyle and other 
non-medication based information. In accordance with, Crump, et al. (2011) find 
that community pharmacists tailor information so as not to overwhelm patients 
and they find that information that is tailored to the needs of patients enables 
patients to absorb and process information. However, Salter et al. (2007) find 
that pharmacists do not consider the knowledge and competence of patients 
and tend to deliver information not tailored to the needs of patients; this 
behaviour makes the patient think that the knowledge or competence of the 
pharmacist is limited. 
 
The next section will explain the role of the pharmacist-patient relationship when 
advising patients. 
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5.4.2 Relationships with Patients during Consultation 
All participants, except Participants 1, 2, 3, 7, 15, 11, 14, 17, 19 and 21 were 
more likely to be directive when advising patients about their anti-depressants, 
and they were likely to form an agenda in advance of their interaction with 
patients, which they believed matched the patients’ needs. Furthermore, they 
felt that patients are unwilling to discuss issues concerning lifestyles because 
this is something they do with their physicians.   
 
Paternalistic attitude (Sub-category N1) 
 
The extract below quotes Participant 2. His agenda is not to decide upon mutual 
communication, but to set an agenda for communication in advance.  
 
Participant 2: (12 yrs.; qualified; M): …am probably quite closed in 
terms of the questioning… yes I freely admit that I’ll rail road patients 
into stuff…the goal was probably quite narrow... I don’t necessarily, 
that is more what is gonna set the tone of the consultation and I will 
lead it in the direction that I wanna lead it with that particular person 
more than actually having, like you say, a way of getting a more open 
consultation with every patient. 
 
Participant 2 said that he often decides on the advice he gives about the 
effectiveness and safety of medications in advance and avoids talking about 
non-medication issues with a patient. Therefore, this participant makes 
assumptions about the values of the patients. 
 
Participant 3: (15 yrs.; qualified; F): I think I waffled more than I would 
because I didn’t, I didn’t act well, well it’s not about acting but you 
know in a normal Pharmacy what I would have tended to have done 
it would have come to a more natural close quicker…I covered what I 
wanted to cover… But it wasn’t opened up either 
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Moreover, participant 3 felt she was less likely to listen to patients’ preferences. 
This implies that this participant is less willing to encourage mutual discussions 
with patients. Nonetheless, her approach takes authority away from patients, 
and so her patients become passive. Furthermore, Participant 15 said that his 
directive style of consultation results from his perception of being a professional 
who knows more about essential medicines than he knows about his patients.  
 
Participant 15: (3 yrs.; qualified; M): I think I focussed a little bit too 
much on the medication, the treatment, the course rather than may 
be focussing on some of the grey areas of the conversation.  Again, 
that might be reticence in terms of my own personality or it may be 
something to do with the fact that well I’m a Pharmacist and that 
there’s a certain degree of professionalism that prevents you from 
being a little bit more probing. It might be one of the two. 
 
Participant 15 said that he has had vast experience in practice with patients, but 
it became clear that this encourages the participant to make decisions on behalf 
of patient. It might be that the participant thinks patients are less likely to be 
able to make decisions, especially in the early stages of their treatment, and, 
therefore, he takes responsibility for talking about treatments. However, this 
approach does not consider the patient’s individual needs. The participant in 
this study showed a paternalistic attitude during the consultation. Nonetheless, 
Riley et al. (2013) assess the cues and concerns of patients by comparing their 
dealings with their GPs, pharmacists and nurses. This study finds that 
pharmacists respond positively to the cues of patients and they are able to 
reassure patients and acknowledge cues concerning lifestyle and medication 
 
Passive behaviour of the participants (Sub-category N2) 
 
Participant 2 is less likely to use pro-active behaviour to decide if a patient is 
able to take their anti-depressants. This participant felt that patients already 
have agendas before they visit their health care professionals and that patients 
do not always communicate these agendas to the participant. These   
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perceptions mean that the participant is less likely to share information with 
patients. 
 
Participant 2: (12 yrs.; qualified; M): I don’t probably know whether 
you would take the tablets or not …they know what their situation is 
up to that point. They know they went to see the doctor. They might 
not have gone to see the doctor about depression.  They might have 
gone because they couldn’t sleep particularly. 
 
Participant 15 is less interested in providing advice about lifestyle and 
enhancing social relationships. This participant made judgments that young 
people can usually manage themselves and, as a person, said he is more prone 
to opening up consultations with the elderly, mainly because he thinks that the 
elderly lifestyle is more complex and they receive less support from other 
relatives. This participant said he is more passive with some patients than with 
others.  
 
Participant 15: (3 yrs.; qualified; M): Yes, I think that is one thing that 
obviously, I think that’s a blind spot.  I don’t think I mentioned that but 
I think looking at the age of the patient like for example if this person 
was maybe, maybe I don’t maybe 10/15 yrs. older, they might have 
triggered something like maybe 20 yrs. older like in their 70s or 80s, 
loneliness in the elderly population. With this gentleman 
(standardised patient), I wouldn’t consider him to be elderly. 
 
Moreover, participant 20 said that physicians advise patients about their 
medication and other health related treatment, and so he is not pro-active and 
assertive when dealing with patients. He said ‘I don’t know whether he did or 
not’ and this indicates that the participant is less responsible for his patients’ 
treatment. Here, the participant makes assumptions about the role of the 
physician, the treatment prescribed, and his interactions with patients. 
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Participant 20: (3 yrs.; qualified; M): I’m sure the doctor would have 
listened to any of his problems and then because he must have 
explained some information to him, but I don’t think that much in 
depth. I don’t know whether he did or not. Because I’m assuming the 
doctors must have, they probably thought all the information that they 
needed, they’ve got it from the doctors…  
 
To summarise this section, the participants in this study were reluctant to build 
up relationships with patients and were more likely to be directive when 
communicating with patients. The participants were less likely to offer 
opportunities for patients to talk during a consultation. This resulted in the 
patients feeling less empowered about their medications. Chong et al. (2014) 
note that pharmacists spend time giving advice to patients but less time 
listening to patients, and those patients take a less active role in being involved 
in and making choices about their treatments. Furthermore, Assa-Eley and 
Kimberlin (2005) find that 43% of patients agree that pharmacists are passive 
when they are dispensing prescriptions, while 22% of patients state that 
pharmacists always ask them if they have had any medical related issues 
between when they last collected their prescription and the current time. 
 
Building relationships with patients (Sub-category N3). 
 
Participants 3, 7, 9, 15 and 17 said that building relationships with patients is 
important for communicating information. The participants recognised that 
people with depression might perceive stigma and confusion, and that empathy 
may enhance their relationship with the patients. Participant 4 said that doing 
this shows empathy with patients and helps to form friendships that build trust. 
This could imply that relationships between participants and patients may not 
only be therapeutic but also social. 
 
Participant 4: (MPharm Student; F): …not to upset them… I’m quite 
friendly with them. You don’t want people to think that you think 
anything negative.   
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Participant 11 said that building good relationships, especially when trying to 
eliminate patient concerns about side effects, is important because the 
successful engagement with patients is an indication of positive communication.  
 
Participant 11: (18 yrs.; qualified; M): I seem to be seeing those.  
There was quite a good engagement. I seemed to have his attention 
you know, he seemed to be quite compliant and willing to, but I felt 
there was sort of a good communication there and asking me 
questions after, and I also would have felt that there’s a good chance 
he would have called me. 
 
Participant 11 felt that establishing good relationships encourages patients to 
visit the pharmacy to help. Likewise, Participant 3 gives patients the opportunity 
to make decisions about their treatments rather than giving out orders to 
patients. 
 
Participant 3: (15 yrs.; qualified; F): … and I wanted to make sure 
that they left; I really wanted to make sure the patient felt this is their 
choice.  I am not telling you. You must take (sigh) but at the same 
time, I want you to encourage it to give it a go. And I still think I would 
like to say you don’t have to share because I actually think that’s 
quite intimidating. 
 
Participant 3’s intentions were to empower patients by respecting their 
legitimacy and avoiding a non-judgemental manner. This might make patients 
feel that they are the owners of their treatment and appreciate interaction with 
the pharmacist. Another Participant 11 said that the severity of a medical 
condition was not only the reason why the participant should prioritise patient 
care; he said he did this to take responsibility for patients. The participant felt 
that the legitimacy of patients has to respected, and these views might reflect 
on the participant’s actual role in helping patients. 
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Participant 11: (18 yrs.; qualified; M): You’ve got to understand, no 
matter whether you have …a slight issue with a headache or 
whatever, you’ve got to treat everything within the same level. 
 
In agreement, participant 9 said that physicians lack time to give advice about 
anti-depressants to patients. He felt that it his responsibility to give more 
attention to patients, and educate patients about their medication. This possibly 
creates good opportunity to enhance the patient’s trust in his competence. 
 
Participant 9: (28 yrs.; qualified; M): …the second one kind of fills 
that gap up, and makes sure there is no barrier between the patient 
themselves and the healthcare professional.   
 
Relationship management for regular patients (Sub category N 4) 
 
Participants 1, 2, 3, 4, 7, 8, 10, 11, 14, 17 and 22 felt comfortable holding 
discussions with people who regular come into the pharmacy. This regularity 
helps to build up a good relationship for both the participants and patients.  
Participant 1 said that he is less likely to talk about the more severe symptoms 
of depression with patients, for example suicidal thoughts, during a first 
meeting, but he might mention these during the second visit.  
 
Participant 1: (5 yrs.; qualified; M): I would just have the same 
conversation you know, oh okay, oh Jim you’ve had some surgery, 
you know you get onto a level with them, a rapport with the patient 
and you can then delve more deeper into the personal type of issues 
whereas if it’s a one off prescription of a person who’s just come and 
presented and you’ve not even got them on your record and it’s the 
first time the patients come to your Pharmacy. 
 
Participant 1 said that dealing with patients regularly enhances trust for the 
patients and the provider. In addition, participant 2 said that patients might not 
involve themselves in the discussion unless they have high expectations of the   
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provider, and that they are more likely to raise their concerns and preferences 
when they have a good relationship with the participant. 
 
Participant 2: (12 yrs.; qualified; M): You can get a lot of things, 
particularly the patients that I do see on a more regular basis. 
 
Participant 3 noted that patients are more willing to chat about their feelings on 
their second visit. Participant 3 said that he is more likely to advise about well-
being after the patient is better and, in this way, the participant is able to 
enhance the promotion of health care and signpost to medical charities were 
applicable to facilitate self-management. Participant 22 said that stigma makes 
patients less willing to receive information about lifestyle, but that enhanced 
relationships with patients facilitates her ability to give advice about health and 
well-being. The participants said they value the role of building relationships for 
communicating information because it encourages participants to open-up 
during the consultation. Building relationships enables the participants to pick 
up patients’ cues and to communicate information they are unable to impart 
without establishing a relationship. Crump et al. (2011) believe that pharmacists 
feel it is essential to develop trust and be empathetic with people with 
depression. They find that building good relationships with patients is a basic 
behaviour for delivering successful care Grimes and Barnette (2014) explain 
that pharmacists should be able to understand their patients’ feelings and 
situations and that depression exacerbates due to inconsistent relationships. 
They also note that pharmacists should exhibit empathy when communicating 
with patients. 
 
5.4.3 The Follow-up Service 
This section examines the accessibility of pharmacies in comparison to other 
health care settings. All the participants believe they are approachable and that 
this provides opportunities for patients to raise their concerns. Accessibility 
encourages participants to support patients and one of these support services is 
MUR, which promotes the adherence to medications. This service provides   
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opportunity to review a patient’s adherence to their medication and review other 
health issues and it enables participants to signpost the patient if they need 
more support. The participants in this study routinely conduct this service for 
patients and it is part of the extended role of the pharmacist (Pharmaceutical 
Services Negotiating Committee, 2013). 
 
Accessibility of the pharmacist to the patient (Sub-category O1) 
 
Participants 3, 7, 8, 9, 10, 11, 17, and 21 made comments in this section. 
Participants 9 said they understood the importance of being accessible to 
patients in order to improve relationships with patients who may be less willing 
to visit the pharmacy. This section discusses the behaviour demonstrates by the 
participants for making themselves approachable to patients. 
 
Participant 9 said that, generally, patients are aware of his role in health 
optimisation and this means he can communicate with patients more flexibly 
than the patient can with physician and other health care professionals who 
place time constraints on appointments. This unique position encourages 
patients to visit. 
 
Participant 9: (4 yrs.; qualified; M):  …because you know you see a 
pharmacist as quite a leading role in the public eye, so it’s best to 
actually, you know, portray that as much as possible. Say like, look 
you know if you do have any problems you can come back and 
…see us because obviously seeing doctors it’s a bit of a challenge 
itself.  You know, you don’t get appointments till about 3-4 weeks 
later. 
 
Similarly, participant 11 said that patients are often busy and do not have 
enough time to receive advice.  
 
Participant 11: (18 yrs.; qualified; M): …look I know you’re quite busy 
at the moment, you don’t want to know any more information but feel   
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free to come. My telephone number’s on the actual label there. If 
there’s any information you’d like to ask me come at a later date. 
 
Participant 11 offers opportunities for patients to contact the pharmacy, 
opportunities for patients to meet in the pharmacy, and makes time to call 
patients on the phone for a follow-up. Offering opportunities for patients to 
contact the pharmacy or telephoning the patient might reminds patients of their 
appointments. This behaviour resembles that of a social relationship rather than 
just a professional act. Moreover, Participant 10 strives to support people with 
depression and this may increase their patients’ awareness of health promotion 
at pharmacies.  
 
Participant 10: (11yrs.; qualified; M): …I also spoke about, you know, 
for like a GP you’ve got make an appointment.  Ours is like a walk-in 
service, so always feel welcome, and I always say that to any of my 
patients…look, we’re obviously here.  We’re obviously medicine 
experts so you know, please feel free to just pop in anytime if you 
don’t feel too well. 
 
Participant 10 was confident giving advice about anti-depressants in order to 
meet the needs of the patients and their expectations. Accessibility encouraged 
pharmacists to dedicate more time to patients, which possibly changes their 
attitude towards providing more services to patients. Guerreiro et al. (2010) 
reports that pharmacies are more accessible than the clinical setting because 
patients are able to make appointments that fit into their schedule and the 
availability of the service. The Pharmacy Guild of Australia (2010) explains that 
the responsibilities of the pharmacist include health promotion, disease 
prevention, to reassure about the proper use of medications, and general health 
management. Pharmacies are always the first primary care units, after their 
GPs, that patient intend to visit. 
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Advanced services (Sub-category O2) 
 
All participants except participants 2, 4, 7, 9, 12, 17 and 20 talked about their 
involvement in Medicine Use Review. Participant 4 said Medicine Use Review 
encourages him to dedicate more time and attention to patients. Even though a 
review of patient medications recommended for patients with physical diseases, 
the participants thought this presented a good opportunity to understand 
patients’ satisfaction with anti-depressants. 
 
Participant 4: (MPharm Student; F): … when I’ve been in that 
situation they’ll be on other medication and they’ll be having an MUR 
so it will be speaking to them privately for another reason but then 
they’ve got the space to speak, really open up to you on how they 
really feel about the medication and other things. 
 
In accordance, The Pharmaceutical Services Negotiating Committee (2013) 
explains that other services may be unique to pharmacists, such as the 
Medicine Use Review (MUR). This helps patients get the best out of their 
medications. This service is undertaken periodically, or when there is a need to 
make an intervention to enhance adherence to medications. This service 
targets patients who use multiple medicines. The participants staged 
information to encourage patients to understand information and build 
relationships with these patients. This helps the participants gain the trust of 
patients and encourages patients to visit for the monitoring of their medications.  
In accordance, in Wells et al. (2014) community pharmacists felt that MUR 
provides the opportunity to demonstrate their professional skills and increases 
patient awareness of the pharmacist’s role in health care. In a study by Niquille 
et al. (2010), the majority of patients were unaware of the medication review 
service provided by pharmacists, but 41% agreed to a review of their 
medication led by the pharmacists, and to the exchange of clinical data between 
community pharmacists and their physicians. 
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 Summary 5.5
In our study, patients with depression indicated that they wanted more attention 
from the participants. However, in order to achieve this, it is more than likely 
that the participants will need to enhance their understanding of depression in 
the future. The symptoms of depression influence how patients engaged with 
the participants, and the silence of patients often resulted in the participants 
encountering challenging circumstances when managing people with 
depression in comparison to managing people with physical diseases. 
Moreover, a lack of time availability when working in the pharmacy and low 
incentives for the participants were obstacles which contributed towards 
circumstances where the participants were less willing to dedicate time to 
patients. Unfortunately, this dynamic served to enhance feelings of 
stigmatisation among patients, especially when less attention was paid and less 
privacy offered. However, these were not only the barriers that worked to lower 
standards of service for the patients. It became clear that our participants 
needed more training to engage with patients in order to improve patient 
perceptions of the extended role of the pharmacist. Difficulties engaging with 
patients also resulted from a lack of collaboration with other health care 
professionals, as well as perceptions held about different levels of authority 
operating within a professional hierarchy. This meant it was less likely for the 
participants to open up channels of communication between themselves and 
people with depression. If there is pharmacist-physician collaboration, then this 
may enhance physician and patient awareness of the extended role of the 
pharmacist, and then pharmacists can share mutual discussions with patients. 
 
In addition to the lack of collaboration with other health care professionals, our 
participants lacked an effective computer networking system to link their 
pharmacies with other health care settings. Introducing, such a system may 
help to contribute towards overcoming difficulties encountered when engaging 
with patients. Furthermore, in our study, patients were less likely to tailor 
services to meet the needs of individual patients, and they showed paternalistic 
behaviour when dealing with patients generally. Mostly, the participants fostered  
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one-way communication, which is less likely to work to build up a good 
relationship with patients. This directive approach also means that pharmacists 
might not be listening carefully to patient concerns, and this approach makes it 
more likely for pharmacists to presume patient needs. Staging information is 
one method that our participants could use to tackle professional challenges, in 
order to facilitate negotiation between participants and patients. 
 
The next chapter will discuss how the opinions (accounts) and quantitative 
result integrate to facilitate more in depth understanding of the participants 
when approaching patients. The data will be synthesised to support the themes, 
and to show shared characteristics between themes. Figure 5.5 illustrates the 
decisions of the pharmacists when offering consultations.  
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Figure 5.5: The intentions of the participants to give advice about medication 
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Chapter 6  Discussion  
In this study, the number of the participants proved to be limited and this may 
have made this sample somewhat unrepresentative of Pharmacists at large.  
This bias was seen as the majority of the pharmacists in the current study were 
male and the number of female was small. All the results in this study should be 
read with this caveat. 
 The Integration of Qualitative and Quantitative Results 6.1
 
This chapter will describe how data was synthesised in order to develop 
meaning and to support the qualitative evidence. The quantitative data outlined 
in Chapter 4 included information about the attitudes, knowledge, observed 
behaviours, and decisions (performance) of the participants during the 
simulated consultations. Furthermore, patient satisfaction levels are included 
the supporting evidence. In this Chapter, the researcher will review the 
qualitative accounts of participants through reflection (CPD), and will treat this 
data in a quantitative way. 
 
 The descriptive quantitative data relates to the experiences, feelings and 
decisions of the participants when they offered services to people with 
depression. Chapter 4 outlines the knowledge, attitudes, skills and 
patient satisfaction levels assessed.  
 
 The qualitative findings relate to everyday practice, simulation 
performance, the participants’ reasons for participation, and intended 
CPD (the motivation to change or develop practice) (see Chapter 5). 
 
The intention of this chapter is to outline and explore associations between the 
different patterns of behaviour demonstrated by the participants (community 
pharmacists) when they practice in their pharmacies. This analysis of 
association will include group and sub-group associations and theme 
associations. When the research detected links between a set of patterns, the 
researcher sought explanations for the possible reasons as to why the   
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participant might be engaging in this behaviour. For example, when a 
participant said that depression had a negative impact on patients, then 
possible reasons for this opinion were analysed. One reason why a participant 
might hold this opinion could be due to holding negative attitudes about people 
with depression. However, integration of the qualitative and quantitative findings 
too place in order to support the interpretation. 
 
One recurring theme that became apparent when the findings were analysed 
was the difficulty the participants had engaging with people with depression and 
this theme worked as a linking theme to other themes. Although other factor, 
such as a lack of time and issues surrounding stigma, for example, were main 
reasons why pharmacists failed to provide a good service to patients was due to 
difficulties they experienced when engaging with patients. Difficulty encouraging 
patients to share information led to participants focusing information provision 
on the action and side effects of anti-depressants. Furthermore, the relationship 
between the participants and patients was paternalistic, and the reasons for this 
explored.  
 
The quantitative results and qualitative findings are located in the relevant 
literature.
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 The Attitudes of the Participants in Practice 6.2
 
Overview of the theme 
Life events and significant lifestyle changes can often be predicting factors for 
depression. Bereavement, divorce, illness, problems associated with 
employment, and financial issues or stress following trauma can all trigger an 
episode of depression. Furthermore, adverse psychosocial factors resulting 
from deficient parent nurture, emotional and physical abuse, neglect, and 
parental separation may also induce adult depression (Moy, 2009). Attitudes 
towards coping with and managing depression are also relevant to this theme 
(Brosan et al., 2010). The participants also mentioned issues about actual and 
perceived stigma, and this influenced communication between the participant 
and the patient (British Psychological Society, 2014).  Also, attitudes towards 
and the ability to provide a private consultation influenced this theme. NICE 
recommends that a patient-pharmacist consultation environment should be 
conducive to discussion to make the patient feel respected, particularly when 
discussing sensitive and personal issues (NICE, 2012 C). 
6.2.1 The Nature of Depression 
A wide range of psychological and social factors have a significant impact on 
the causes of depression and responses to treatment (NICE, 2009 A). This 
category examines actual and perceived causes of depression including patient 
coping mechanisms and the perceptions of the participants. The quantitative 
results found that 68% of the participants thought that negative life events was 
among the causes of depression (Section 4.2.4, Domain 4). These findings 
might indicate that the participants have substantial experience dealing with 
patients with social or life problems, and this is why they identified these causes 
as being primary. The same opinions also emerged in the qualitative research, 
during discussions with participants about the nature of depression, when it 
became clear that they thought lifestyle was a main risk factor in depression.  
One-third of the participants thought that social environments enhance the risk 
of depression. Participant 15 shared common opinions about the cause of   
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depression. He felt that stressful events such as the loss of a job, the death of a 
friend or relative, and an erratic lifestyle causes depression. The participant 
highlighted that poor social relationships are a risk factor for depression. A third 
of participants cited these reasons as the main causes of depression. 
 
Participant 15: (3 yrs.; qualified; M): The lifestyle yes. Just simple 
things like do you live at home and then that triggers an alarm bell. 
This person lives at home, they don’t have much contact with other 
people … these are all things that are contributing towards the 
depression. 
 
Although the participants could not pinpoint exact causes, they felt that social 
environment influences the incidence of depression. Indeed, social factors, such 
as a change in personal circumstances and life events are among the highest 
risk factors for depression: long-term unemployment, long-term isolation, and 
stress can all cause symptoms of depression (Beyond Blue, 2015). Sometimes 
there may be an obvious reason for becoming depressed, and sometimes not. 
The reasons may sometimes seem obvious, for example, a relationship 
breakdown or bereavement (Royal College of Psychiatrists, 2012). The 
quantitative results showed that 27% of participants thought anti-depressants 
are addictive, while 12% remained undecided. It is probable that they believe 
the medication may harm the people, even though the percentage was low. 
This may indicate that the participants agree about the impact of social events 
and it is better if the patients receive psychotherapeutic treatments. 
 
The participants commented that people with depression had less self-esteem 
and felt more hopelessness. However, the participants were unlikely to be 
willing to raise patients’ concerns, and this might lead to patients being less 
likely to make decisions about their treatment. Physicians being less likely to 
involve patients in decision-making. The quantitative results showed that about 
68% of the participants reported that patients do not receive all necessary 
information about depression from their general practitioners or psychiatrists 
(Section 4.2.3).   
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Less than half of participants said that depression has a negative impact on a 
patient’s decision to take their medication. They explained that some patients 
refuse to take their medication because they think they do not have depression. 
Participants said that patients who do not feel they have depression are the 
least likely to take their anti-depressants, and the patient’s decision not to take 
anti-depressants is usually revealed when the participant is interacting with the 
patient. This could imply that sharing quality information with patients may 
encourage them to make the decision to take their medication. 
 
Some patients may benefit from other treatments apart from drugs. It was found 
50% of our participants said that people with depression did not want to talk to 
them (Section 4.2.3; Domain 3), but the quotation below indicates that patients 
do make decisions about their medications, and so a wider range of choices for 
treatment might facilitate better outcomes. However, only a minority of patients 
held this view.  
Participant 8 (7 yrs.; qualified; M): …but some people might not take 
it. “No I don’t suffer from depression”. You get them with a lot of 
people... “No I don’t suffer from depression. If the doctor’s given me 
that, I’m going. I’m never going to take this medicine again.”  
 
Van Geffen et al. (2011) find that patients use decision-making when they are 
engaged in decisions about their treatment. In their study, Van Geffen et al. 
identify patterns of behaviour that indicate the patient’s discontinuation or 
continuation of medications; they find that patients discontinue anti-depressants 
when they are less involved in the decision making process. In our study, 
Participant 8 did not explain the safety and evidence based benefits of anti-
depressants to his patients and he used a passive approach with his patients. 
This behaviour might be linked to evidence outlined in (Section 5.2.3; Sub-
category H1) when participants said that the superior authority of physicians 
often influenced them to not take action when patients raised their concerns. 
Even so, the participant still has the decision to signpost the patient to the most 
suitable health care setting so they can get support.  
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The perceptions of some participants about coping mechanisms did not 
necessarily reflect behaviour of patients, it showed in participants’’ attitudes 
toward people with depression and anti-depressant drugs. These participants, 
for example Participant 9, felt the intensity of dealing with depressive illness 
was more significant than with physical disease. The quantitative results 
showed that 32% percent of participants could not decide whether anti-
depressants can change the personality (Section 4.2.4; Figure 4.7). These 
findings may imply that the participants are less optimistic about the outcomes 
of the use of anti-depressants, and think that people with depression may 
require further support to recover from depression.  
 
Participant 9 shared the view that patients with severe symptoms of depression 
are more at risk of committing suicide, but the participants did not think this 
about patients who have physical diseases. Furthermore, Participant 9 felt that 
a patient’s emotions when dealing with mental illness were more intense than 
those who are suffering from physical illnesses. This could indicate perceptions 
about depression as a mental illness in comparison to physical illnesses. 
 
Participant 9: (4 yrs.; qualified; M): Okay but if you compare that to 
something like anti-depression as such, it’s, I believe it’s a bit more, 
and sometimes people find that very grasping. They’ve got to control 
their emotions inside which can take a bit longer. You’re more at risk 
of like suicidal thoughts compared to say, someone like, say, you 
know, hypertension or diabetes. 
 
The quantitative data collected in this study showed that participants had good 
(knowledge) about managing depression. They were aware of safety issues and 
the efficacy of anti-depressants (see Table 4.2). However, the knowledge of the 
participants about managing depression was not good enough to sway negative 
opinions about mental illness, and, therefore, additional training might be 
needed to change attitudes and to promote a positive attitude among the 
participants. 
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O'Reilly et al. find that, in general, pharmacists show more discrimination 
towards people with depression in comparison with other health care 
professionals. This might be because pharmacists lack opportunities to arrange 
follow-up time with patients and they do not have access to the full medical 
histories of the patients. Greater access to records might lead to less 
discrimination (O'Reilly et al., 2010 B). When Dipaula et al. 2011 assessed third 
year pharmacy students (completing elective course work activity) to discover 
the social distance that is created between people with depression and 
pharmacists, social distance was recorded as lower than before the participants 
started their course work, and lower than those recorded among a comparator 
group who did not complete the course work. The intervention group work 
included dealing with personal information relating to mental illness, interaction 
with patients in a hospital setting, and a discussion of their activities with other 
classmates. The intervention group was smaller than the control group. 
However, in a study by Liekens et al. (2013), participants received consumer 
education and one-day training to improve attitudes towards stigma and 
attitudes towards care. 
 
Bell et al. (2006 A) finds no differences in attitude between third year pharmacy 
students and pharmacists in Australia with regard to stereotypes held about 
people with depression. The participants in the study held negative perceptions 
and preferred to maintain social distance from patients. However, Bell et al. 
(2006 B) notes that attitudes towards social distance improved after intervention 
training, including patient led education and tutorial classes, in comparison to 
the attitudes shown among a comparator group. The greatest improvement 
seen was that students were less judgemental of people with depression and 
less inclined to believe that patients were difficult to talk with.  These results 
imply that training can positively change the attitude of students.  
 
Our quantitative results showed that 58% held positive attitudes towards people 
with depression (see Section, 4.2.4; Domain 4). However, the lowest 
percentages were recorded when participants scored their ability to provide 
additional support. Only 46% of participants thought they could provide quality   
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consultations to patients. The participants felt that physicians do not provide 
satisfactory information to patients, and the participants themselves were less 
keen to support physicians or to explore patient needs. This indicates that the 
participants who took part in our research feel that patients experience difficulty 
coping with depression and this is comes out in their attitude when dealing with 
people with depression.  
6.2.2 Managing Depression 
This section will outline the attitudes of the participants towards the 
management of depression in comparison with other physical diseases. In the 
section previous, participants felt that patients experience difficulty coping with 
depression, and these perceptions sometimes reflect in the participants’ attitude 
towards patients with depression and their management of patients with 
depression. The next section explores the reasons why the participants do not 
enjoy providing pharmaceutical care to people with depression. Few 
participants said that the side effects of anti-depressants are difficult to monitor 
and that educating patients about their condition is harder when dealing with 
people who have mental illness in comparison to those who have physical 
diseases. However, only a minority held this opinion. Participant 20 expressed 
beliefs about the harmful nature of anti-depressants. He said that anti-
depressants can cause harm to patients and he did not feel that prescribing 
anti-depressants in isolation was a good decision. This might imply a belief that 
psychotherapy and other therapies are better than anti-depressants, but this 
might also imply that the participant feels that depression is less serious than 
physical illness and not require medication. 
 
Participant 20: (3 yrs.; qualified; M): My honest feeling, to be honest 
with you, is I felt instead of the doctors giving the medication 
quickly… that’s honestly how I feel about every anti-depressants that 
I give out… the last thing I want to do is get patients stuck on a 
medication for the rest of their lives or for short-term, so whenever I 
see any anti-depressants, especially if they’ve not had it before, my  
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first thought is could the doctor not have done like CBT, cognitive 
behavioural therapy or talk to the actual patient first.  
 
The quantitative results showed that 27% felt that anti-depressants are 
addictive (Section 4.2.1; Figure 4.1). It appears, therefore, that our participants 
were not only less motivated to manage people with depression (provide 
evidence about safety), but also less eager to provide additional services, which 
include support to patients and meeting patient related health issues. By 
contrast, in a study by Cates et al. (2005), pharmacists held positive attitudes 
towards providing pharmaceutical services to similar patients, and some even 
said they were more comfortable providing services to mentally ill patients than 
to physically ill patients. The authors suggest that continuing education 
programmes might contribute towards enhancing pharmacist motivation for 
helping patients with mental illness. Black et al. (2009) note a gap between the 
perceptions of patients (in the outpatients’ clinic) about the important services 
they want community pharmacists to offer, and the actual services offered. 
However, the pharmacists had received training about monitoring anti-
depressants, maximising their effects and educating patients about safety of 
medications. The authors do not give reasons why their sample of pharmacists 
decided not to offer more help to people with depression, but they suggest a 
possible mismatch between the pharmacists and the patients about 
expectations. This links back to our findings (Section 4.4.1; Skills Section1) that 
show our participants are less willing to negotiate an agenda with patients and 
identify their beliefs. Possibly, the participants in our study need more training, 
which may change their attitude towards engaging with patients. 
 
Crockett et al. (2009) note how the attitudes of community pharmacists changed 
after they received training involving physicians and psychologists. Their study 
reports that community pharmacists who were able to engage with patients 
about their anti-depressants were more motivated to refer customers who 
exhibited symptoms of depression to physicians and medical charities. 
However, the author use pharmacist self-report as indicator for improvement of 
their attitude , while in our study patients were involved . Similarly, Scheerder et   
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al. (2008) note that a lack of education about mental illness acts as a barrier to 
community pharmacists when they try to provide additional information to 
patients, and when they try to extend their role. The authors suggest that if 
pharmacists wish to expand their role in this field, then they need up-to-date 
training on a regular basis. However, the sample size in this study was small 
and, therefore, the results might not be reliable.  
 
In Gardner et al (2001), when patients visited to collect their medications they 
remained unaware that pharmacists could provide advice about monitoring 
medications. However, the study did not make comparisons with other 
conditions. This implies that pharmacists might be less willing to take active 
action with people with depression. The majority of pharmacists recalled having 
had formal training about anti-depressants in the previous five to ten years, and 
this result might indicate the necessity for introducing regular training in order to 
enhance their ability to consult with people with depression. Similarly, in a study 
by Sleath (2002) only 10% of their sample of patients had received education 
about anti-depressants. The main reason suggested for this was that both 
patients and pharmacists are uncomfortable talking about anti-depressants, and 
that patients might have higher levels of adherence to their medications if they 
received better quality information from their physicians. Some patients had 
taken anti-depressants previously and it might be that the pharmacist assumed 
that patients already had information about their anti-depressants. Chong et al 
(2013 C) argue that shared decision-making influences patient behaviour and 
attitudes. They state that the social stigma surrounding depression often leads 
to negative perceptions and prevents patients being motivated to share 
decision-making. The authors also find that the stigma surrounding depression 
can sometimes lead a patient to conclude they are not suffering from 
depression, and not to seek medical help or discuss any concerns they have 
about anti-depressants. 
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6.2.3 The Stigma Associated with Depression 
The participants perceived that people with depression feel stigma when visiting 
their pharmacy (Section 5.1.3; Sub-category, C1). Worries relating to these 
perceptions meant that the participants were less willing to take a proactive role 
in offering a consultation to patients.  Half of the participants highlighted the 
issue of patient self-stigmatisation and said that this is sometimes aggravated 
when patients visit the pharmacy to collect medicines. These participants 
explained that ‘non-verbal cues’ can act as indicators that patients are not 
willing to talk about their medications.  
 
Participant 2: (12 yrs.; qualified; M): They’ve just been through it all 
with the doctor, they’ve just, you know, been faced with something 
they don’t want to be faced with probably… I think it’s probably the 
experiences I’ve had with patients that don’t wanna talk to me and 
patients who do wanna talk to me… its maybe how they come in and 
how they appear to begin with. 
 
The participants were more likely to take a negative approach and not offer a 
consultation, and, therefore, patients with more severe symptoms do not 
receive the correct help from the participants when needed. This behaviour 
indicates that participants take non-verbal cues from patients in order to make 
the decision to engage or not to engage with patients, rather than asking 
patients if they need more information. However, not knowing about the 
availability of a consultation room at the pharmacy prompted this reaction. 
Furthermore, the participants admitted they made decisions based on ‘non-
verbal cues’. They said they often take the decision not to discuss medications 
or offer a consultation when they thinks the patient has a ‘weird frown’ or was 
‘less active’ (among other cues). This indicates that participants might not be 
interested managing people with depression in comparison to those with 
physical illnesses and this make them less inclined to communicate with people 
with depression. In consistence with this, a study carried out by The Royal 
Australian and New Zealand College of Psychiatrists (2009) finds that some 
patients with depression believe they are a burden to other people and do not   
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deserve to live; this study also finds that people with depression can be 
reluctant to raise their concerns. 
 
A cross sectional study by Bell, et al. (2008) assesses the attitudes of pharmacy 
students towards people with depression. Students across six countries hold 
negative stereotypes about people with depression. Although the authors 
initially suggest that people working in developing countries display more 
prejudice against people with depression, the results showed that even students 
in developed countries stigmatise people with depression. The author indicates 
a need to increase student and patient interaction during initial training in order 
to promote better attitudes towards patients with depression. In contrast, a 
cross sectional study in Canada by Black et al. (2009) which assesses patient 
satisfaction and perceptions at an outpatient clinic finds that most patients do 
not experience significant levels of stigma or discrimination at their community 
pharmacies, but these results might reflect that the outpatients have already 
been receiving treatment that gives them relief from their symptoms.  A study by 
Lam et al (2015) finds that practitioners who have a diploma in mental illness 
hold more positive attitudes about people with depression than professionals 
who have not had training. The authors used self-assessment to record results 
in this study, and, therefore, if the professionals had undertaken observation in 
practice then the results might have been different. These results indicate that 
our participants might benefit from practical on-the-job training about mental 
illness.  
 
In a study using descriptive statistics to compare the attitudes of medical 
(pharmacy and nursing) and non-medical students (studying mathematics and 
applied social sciences) towards mental illness and patients who had 
depression, nearly a quarter of the participants held negative attitudes about 
mental illness. The main stereotypes held by the participants were that patients 
with depression are dangerous and aggressive. However, the medical students 
surveyed showed more positive attitudes toward mental illness than those not 
studying medicine. The authors suggest that medical students are more 
knowledgeable about mental illness and this leads them to greater self-  
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awareness when communicating with people with mental illness (El Magd and 
Al Zamil, 2013). Although our participants possessed good knowledge about the 
management of depression, they showed a negative attitude towards managing 
people with depression. This may imply that acquiring further knowledge about 
depression may encourage a more positive attitude towards patients with 
depression. When Patten et al. (2012 A) studied two randomised groups of 
students, one group had early intervention training and another group had late 
intervention mental health education. The group who received late intervention 
training did not participate in contact-based education, whilst the early group 
had contact with patients who had experience of depression or who were in a 
period of recovery. The students who received contact-based education 
recorded significantly fewer tendencies towards the stigmatisation of people 
with depression in comparison with the other study group. However, in this 
study, 73 percent of the participants were female, and so these results might 
have been different if the sample demographic had included more men. O’Reilly 
et al. (2010 A) use a self-reporting method to collect data to explore the effects 
of consumer and caregiver-led education for pharmacy students on the 
exploration of goals and challenges. They studied a focus group for between six 
and eight weeks, and, over time, patients showed a more positive attitude to the 
pharmacy students. The contact with mental health consumers in a safe 
educational setting provided the pharmacy students with greater insight into the 
challenges surrounding mental illness, and contributed to a self-reported 
decrease in their tendency towards stigmatising mental health problems. The 
students also self-reported behaviour changes in their professional pharmacy 
practice. 
 
Using semi-structured interviews, Knox et al. (2013) found that patients 
sometimes experience stigmatisation from staff and other patients in the 
pharmacy. The authors suggest that the attitude of health care providers might 
improve if they enhanced their knowledge about mental illness. The authors did 
not make a distinction between the pharmacist and other staff, identifying 
instead the ‘health care giver’ in the pharmacy. Our participants felt that the skill 
mix (Section 5.1.3; Sub-category C2) in the pharmacy might possibly increase   
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the incidence of patient stigmatisation. A third of the participants felt that 
support or technical personnel might demonstrate negative attitudes towards 
people with depression, or might not be able to communicate effectively with 
these patients. Other participants noted passive behaviour among support staff, 
which might possibly come across as an unwillingness to help patients. This 
might lead some patients to feel they are not welcome in the pharmacy. Most 
shared views similar to Participant 17, who said that support workers are often 
busy in the pharmacy and so do not have time to give a great deal of attention 
to patients. This participant said that patients seem to feel more comfortable 
when no other members of staff are around to ‘overhear’ conversations. 
However, this participant did not perceive stigma to be an issue, or that the 
presence of other people generally, including other professionals, might make a 
patient feel uncomfortable. 
 
Participant 17: (5 months; qualified; M): Other staff tend to be doing 
their own jobs in the back, and it depends on the size of the 
dispensary. Generally speaking, staff see this all the time anyway, 
and they get to know their patients well, and they know exactly what 
medication they’re on, cus they label and dispense them all the 
time…if the patient was uncomfortable with having that sort of 
discussion with me in front of my staff. 
 
Participant 19 supported the idea that feelings of stigma may result from the 
presence of support staff in the pharmacy. However, this participant did not feel 
that complete privacy for patients was essential, and she assumed that patients 
were comfortable as long as other support staff were busy.  
 
Participant 19: (28yrs.; qualified; F): And there’s other members of 
staff in the shop area doing the work that they, that they, do so the 
reason why I stood there is because there was nobody else 
there…you get like a little window on the side of the bench where the 
pharmacist can speak to patients like face to face, not going into the 
consultation room. 
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Hattingh et al. (2015) use semi-structured interviews to explore Australian 
consumers who suffer from chronic disease. Consumers had limited recognition 
of the technical role of the dispensary assistant, and some consumers felt that 
pharmacy support employees were unqualified. These consumers probably 
came in to see pharmacists because of chronic diseases. However, it was 
unclear in the study why these consumers felt unsatisfied with the support staff. 
In another study, patients with mental illness were concerned that pharmacists 
and support staff would over hear their medical issues, or become involved in 
the conversation during the pharmacy dispensing process (where one support 
staff member takes the prescription and another staff member hands the 
medication to the consumer). However, this convenience sample may not be 
representative of other patients’ opinions (McMillan, et al., 2014). In our study, 
support staff did not take part in the research, and so it may be worth exploring 
their opinions in the future. 
 
A varied skills mix in the pharmacy is more likely to enhance stigma when staff 
have not received training to interact with mental illness. However, the stigma 
may increase when the professional (pharmacists) pay less attention to 
patients. This means that patient may feel less prioritised and time pressure is 
one of the issues to affect this feeling. The next section discusses these issues. 
 
6.2.4 Time for Providing Services in the Pharmacy 
This section explores the participants’ attitudes towards time. In the main, the 
participants noted that GPs experience time pressures, so have less time to 
dedicate to patients. 
 
The majority of participants felt that pressures on GP time resulted in GPs being 
less involved with patients and their treatments. For example, participant 13 
said that many patients visiting his pharmacy did not possess enough 
information about their diagnosis and did not know how to take their 
medications. However, the participant also said he did not have enough time to 
dedicate to patients in order to fill the gap in patient care.  
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Participant 13: (5 months; qualified; M): Sometimes doctors just give 
it out … No they’re under time constraints as well… In real life, they’ll 
just give that out without exploring it in great detail. Patients do not 
know about their treatment and their diagnosis, not much intention, 
take your medicine and go away. 
 
In agreement, Anderson and Roy (2013) find that patients are dissatisfied with 
their communication with their GPs. Patients said that their GPs did not pay 
much attention to them and did not give them the opportunity to talk. However, 
the participants in this study were young and were not representative of other 
ages. Furthermore, Lussier and Richard (2009) claim that patients prefer it 
when GPs listen to their concerns and patients give out cues to indicate they 
need more attention from health care professionals. Indeed, Lussier and 
Richard (2009) find that patients sometimes test providers to see if they 
respond to their cues, and this strategy helps patients decide if they can discuss 
issues with providers. Likewise, Malpass et al. (2011) find that patients who 
take anti-depressants do not often voice their opinions or agendas; they are not 
ready to tell their general practitioners about suicidal thoughts in order to protect 
general practitioners from panicking. Possibly, therefore, offering more time 
might help to promote the patients’ agenda. One limitation of this study, 
however, is that patients had to record their GP consultations. Nonetheless, 
these findings agree with our study where the participants reported that a lack 
of time is one of the obstacles encountered by physicians. Over 68% of our 
participants disagreed that patients with depression receive all necessary 
information about their disease (Section 4.2.3; Figure 4.5). Moreover, less than 
half of the participants agreed that patients receive all necessary information 
about their anti-depressants while a third of the participants’ were undecided 
about this. In agreement, Tarn et al. (2009) find that GPs acknowledge the 
importance of explaining the side effects of drugs to patients and try to build up 
relationships with patients. However, they report that time pressure is a barrier 
to providing enough advice, and that GPs often signpost patients to receive 
information from pharmacists. 
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Although the participants in our study reported that physicians have limited time, 
the participants also said that workloads in the pharmacies acted as a barrier to 
them being able to provide enough time for patients. Even though the 
participants felt it was important to find the time to dedicate to patients, planning 
for time took place in advance and was typically short in span. The quantitative 
results found that only 57% of patients agreed that participants were available 
to answer their questions (Section, 4.7; Table 4.8). 
  
The participants reported that it was difficult to have coherent consultations with 
patients. This was due the many different services offered at the pharmacy, and 
the need to multi-task. The participants explained that support staff often 
interrupted consultations to ask pharmacists to check prescriptions. This implies 
that the environment in the pharmacy is very different to the setting of the 
physician’s office and that, sometimes, it is difficult to offer one-to-one quality 
consultations with patients without experiencing interruptions. They said that 
they could not provide patients with their full attention during consultations, and 
that they are not always able to pick-up on patient cues. 
  
However, the participants that did not offer private consultations might have 
encouraged negative patient perceptions about time pressures, for example: 
 
Participant 8: (7 yrs.; qualified; M): …so the flow of the conversation 
wouldn’t be as good as a physician… but there’s also the, the 
dispensing role which is again…but there is still that dispensing…and 
I’m not in a position to discuss clinical things or important…and got 
interrupted …and there’s always that risk of right I’m gonna get 
pulled into the dispensary again. 
 
Mehralian et al. (2014) argues that one barrier to developing the pharmacist-
patient relationship is the commercial nature of pharmacies. The authors argue 
that pharmacy owners sometimes encourage their staff to focus on making 
profits rather than providing services. This implies that the commercial and 
business obligations motivate pharmacist when providing patient care.   
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However, this study took place in Asia. Linking in with this, Harding and Wilcock 
(2010) suggest that time constraints and work pressures influence the quality of 
services in UK pharmacies. Their study assesses the opinions of pharmacists 
relating to the integration of MUR in their practice. They find that a lack of time 
was one of the main reasons for introducing MUR in order to encourage 
pharmacists to focus on medication related issues, but engaging in MUR means 
that pharmacists have even less time to address concordance issues. 
 
Puspitasari et al. (2009), the majority of pharmacists reported spending more 
time on counselling for new than regular prescriptions. About 58% estimated 
that they generally spent two to five minutes with each consumer collecting new 
prescriptions, while those collecting regular prescriptions did so for about one to 
two minutes by 46% of respondents. This may indicate that pressure of time 
identify the intention of the pharmacists but no the needs of patients. In our 
study, trying to provide services other than consultations might generate 
professional conflicts, for example conflicts relating to a pharmacist trying to 
meet the requirements of the organisation by ordering and checking a 
prescription for accuracy. 
 
The majority of our participants said they did not have enough time to dedicate 
to patients, and when they did have time, this time was planned and short. The 
majority of the participants said this. Participant 14, who shared the majority 
view, said that he wanted to devote more time to patients and less time to 
repeat prescription work. However, he allocates time to patients to suit him 
rather than the patient. He acknowledged that spending more time with patients 
is more likely to encourage them to take medications properly, but he said that 
the time he spends with patients does not focus on patient needs due to time 
schedule constraints.  
 
Participant 14: (3 yrs.; qualified; M): Just another couple of minutes 
of my time could make a difference, and see if there’s any changes 
been made from the doctor’s part…You know, I could chase up on 
that as well but yes, it did feel like someone was in need for help,   
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because, one they didn’t have enough information, and about the 
condition as well as the medication.  There was a lot to go through 
and as I, from a person who didn’t know anything.  
 
Gardner et al. (2001) evaluated the communications between community 
pharmacists and anti-depressant users in Canada to find that pharmacists are 
less keen to spend time educating patients about anti-depressants and are 
unwilling to consult patients during a first meeting or at the repeat prescription 
stage. The results indicate that pharmacists might perceive their main role as 
supplying medications rather than providing pharmaceutical care to patients.  
 
Using semi-structured face-to-face interviews, Hwang and Young (2015) note 
that time constraints are a barrier to the setting up of adequate consultations for 
pharmacists in Asia. In their study, pharmacists could only find time to provide 
information about the administration of medications. In New Zealand, Crump et 
al. (2011) finds that pharmacists provide core services and extra services. 
However, Sheridan et al. (2012) finds that although devoting extra time to 
patients gives the pharmacist extra confidence that they are doing their job 
properly, time itself does not necessarily mean that quality engagement is 
taking place between patients and their health care providers. Sheridan et al. 
(2012) finds that health care providers can engage in consultations with patients 
without establishing good relationships. 
 
An observational study and interviews with pharmacists and pharmacy staff by 
Latif et al. (2011) finds that support staff are less likely to meet the needs of 
patients when the patients really want to speak to pharmacists. In this study, 
when the pharmacists were busy with other patients performing MURs, support 
employees undertake personal judgments about whether to interrupt 
pharmacists or make patients wait. However, the study covered just two 
pharmacies. Another observational study by Latif et al. (2013) finds that when a 
pharmacist is conducting an MUR they experience workflow interruption. When 
Latif et al. assessed the contribution of the MUR in community pharmacies they 
found that pharmacists conducted their MUR as a quick check activity rather   
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than using mutual discussion with patients. Latif et al. (2013) finds that 
pharmacists are very structured in their approach and that pharmacists direct 
consultations. However, this quick approach does not give patients the 
opportunity to talk about their agenda. One of the reasons for the use of a quick 
approach is because time is limited, and pharmacies do not recruit extra staff. 
This implies that the pharmacists integrate MUR into practice, but very poorly. 
Furthermore, the dispensing staff became frustrated when prescriptions began 
pulling up at the front desk, and so they would often interrupt pharmacists in 
mid-consultation with patients. 
 
Barney and Griffiths (2011) note that time constraints often prevent pharmacists 
from satisfying the needs of patients, but their data only covers online patients.  
Grimes and Barnette (2014) explain that ineffective consultation results in the 
patients’ inability to raise their concerns, even when they want to express their 
feelings about the side effects of anti-depressants. When the patient feels that 
the pharmacist is dedicating their time and prioritising them, then they are more 
likely to raise their concerns. However, in a study by Oparah and Kikanme 
(2006), 56% of consumers rated the availability of their pharmacist as excellent, 
and they indicated that pharmacists placed a high priority on patient 
satisfaction, but this study was conducted in Nigeria with the general public (not 
patients). Therefore, the point of view and context may not be relevant to the 
situation explored in our research.  
 
The previous section described time pressure as an obstacle to providing good 
service for patients. One consequence of time pressure is the lack of privacy 
offered to patients, dealt with in the following section. 
 
6.2.5 Privacy 
 
The participants noted that they experience time constraints, which resulted in 
them being less likely to be able to give enough attention to patients. One area 
affected by time constraints was not having enough time to offer privacy to   
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patients. Patients offer privacy only a few patients. All the participants said that 
offering patient privacy is important because it enhances relationships with 
patients. All the participants agreed that offering privacy facilitates their ability to 
pick-up on patient cues, and encourages patients to feel comfortable enough to 
raise their concerns.  The majority of participants believe that offering privacy 
provides them with the opportunity to discuss concerns with patients, which, in 
turn helps to reduce perceptions of stigma that the patient might feel when 
surrounded by members of staff and other patients in the pharmacy. They felt 
that offering privacy changes the nature of the environment, which shifts from 
the busy dispensing environment to a quiet environment. These participants 
said that privacy makes the patient feel more comfortable. 
 
Participant 11: (18 yrs.; qualified; M): As in you know, what we’ve 
discussed, and that, but like I say it’s, you know, from a setting into 
shop floor to …already gives not just the patient the privacy, yourself 
the privacy… without feeling that the patients thinking one thing or 
thinking they’re being overheard. 
 
They said that the consultation room is a good place to talk because it is quiet 
and no other people can overhear, including non-medical staff and customers. 
The participants implied that talking in the general pharmacy area might make 
patients feel uncomfortable because of the noisy and busy atmosphere and the 
presence of other people who might overhear the conversation. Although the 
participants expressed the desire to offer consultation room to patients and 
seemed to understand that privacy and confidentiality is preferred by patients, 
as noted in the previous section, in reality, the participants did not have enough 
time to devote to patients generally, and this included offering patients private 
consultations.  
 
However, consultation room is not always offered by the participants, for 
example, (half) of the participants agreed with Participant 10 who has the 
choice to hold discussions in consultation room or at the dispensary counter, 
but he usually determines whether consultations should be offered depending   
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on the severity of the patient’s illness and the type of medications prescribed. 
This participant indicated that patients who have taken certain medications 
before already possess knowledge about their medications, and so do not need 
further information. Furthermore, generally, participants said they are more 
likely to offer information to patients when they are first prescribed medication, 
and are less inclined to offer repeat prescription patients advice about 
medications. Patients are also more likely to read information at first 
prescription stage (Raynor, et al., 2007) 
 
Participant 10: (11 yrs.; qualified; M): It depends if the first visit or the 
second visit or depends on the what patients need or want...it 
depends on like high risk drugs I’d say.  So anything that I personally 
think that someone may have overdosed first, or if someone’s having 
something for the first time, especially if they’re elderly and they may 
forget or, or if I can sort of see that the patient is maybe a bit worried 
or concerned. 
 
Some participants expressed concerns about premises that do not offer 
complete privacy. According to NICE (2009 A), offering a consultation room can 
make the patient feel respected and comfortable. When Krska and Morecroft 
(2010) conducted a study to determine the views of healthy adults on the 
importance of activities aimed at improving public health, patients told them that 
pharmacies are not places where they feel private. Patients in this study felt 
insecure about sharing personal information with pharmacy staff due to fears 
about confidentiality; but the majority of respondents were not frequent 
pharmacy users, with 57% visiting a pharmacy only once or twice a year.  
However, the experience may change when they have a chronic disease and 
have consultation in a private room.  
 
When Saramunee et al. (2014) studied the experiences of a focus group 
including pharmacists, the public and physicians, a significant number of 
pharmacies provided MUR and pharmacists expected the public to have 
awareness of the availability of a consultation room, and some patients   
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admitted they were not aware of the existence of the private room. One 
drawback of this study was that the sample was exploratory, and, therefore, it is 
limited to one small geographic area. 
 
In consistence with our findings, in a qualitative study by Gardner et al. (2001) 
finds that pharmacies lacked privacy and this impaired communication with 
people with depression. However, the authors also suggest that consultation 
rooms were under-utilised, and the pharmacists in this study were more likely to 
offer new patients privacy over those coming in for repeat prescriptions. More 
recently, O'Reilly et al. (2015) claim that private consultation works to facilitate 
the screening of patients who might be at risk of suicide, and provides the 
pharmacist with an opportunity to make a patient feel comfortable and address 
the barrier of stigma. Indeed, Hattingh et al. (2015) find that patient privacy is 
one of the main concerns of mental health patients, and that privacy helps to 
facilitate confidentiality.  
 
In our study, the quantitative results found half of the participants saying that 
people with depression did not want to talk to them (Section 4.2.3; Domain, 3). 
It may be that patients were not aware of the consultation room and that 
participants are not motivated to enhance patients’ expectations about the 
availability of the consultation room. In agreement, a Norwegian study by 
Mamen et al. (2015) finds that elderly patients have a high requirement for 
information about medications and one third of patients said that privacy was 
one of their main concerns, but that the kind of privacy offered in pharmacies 
differs from that offered in other health care settings. The study also finds a high 
correlation between the offer of privacy and acceptance of the MUR. 
Furthermore, the authors found that patients had less interest in using the 
consultation room because they did not expect the pharmacists to add any 
other information to that which they received from their physicians. The next 
section will further explore participants’ perceptions of patients’ expectations. 
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 The Participants’ Engagement with Patients 6.3
 
The majority of the participants said it was difficult to engage with people with 
mental illness but that understanding patients and providing additional 
information was a main concern of most participants.  This section can be read 
in conjunction with (Section 6.2.2) relating to the management of people with 
depression and can be considered alongside the participants’ views about 
professional self-insight, which were found to be ambiguous and unclear.  
 
6.3.1 The Training Needed to Engage with Patients 
Participants said they were less likely to make shared decisions about 
consultations. They lacked the motivation because they need more education to 
engage with patients. They perceived that, during the initial stages of treatment, 
patients are less inclined to involve themselves in mutual discussion. Lifestyle is 
one of the aspects of an extended therapeutic discussion, which they were not 
able to advice the patient about. The majority of the participants shared 
Participant 10 told of his experiences with a patient who had Obsessive 
Compulsive Disorder and said he felt this patient was not interested in 
discussing the condition with him. Therefore, Participant 10 formed the opinion 
that patients are not enthusiastic to share information. 
 
Participant 10: (11 yrs.; qualified; M): But how do you change that? I 
mean sort of, you know, like, I was saying if you sort of put an animal 
in a cage it may heighten it you know?  If I ask you a lot of personal 
questions, you’re gonna turn round and say well it’s the first time 
we’ve met. I spoke to one of my patients who has actually got OCD. 
 
It is likely that the above illustrates the opinion of the participant when he casts 
judgment on people with depression. He may have had experience with some 
patients who are not very interested in receiving information, but NICE 
guidelines state that health care professionals should tailor information to   
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patient needs. This means that the patient’s beliefs and preferences are met 
(NICE, 2009 A).  
 
In agreement with our study, a survey in Canada by Phokeo et al. (2004) finds 
that community pharmacists prefer to engage with patients who have physical 
diseases rather than with patients who have mental illness. The pharmacists 
identified a lack of training at undergraduate level about engaging with people 
with mental illness, and this might account, in part, for reticence shown when 
engaging with people with depression. However, the authors of this study do not 
differentiate between different classes of medication prescribed, for example, 
antipsychotic and anxiety. Therefore, it is possible that training about engaging 
with mental illness is required for our participants in order to enhance their 
confidence when meeting people with depression. A study by O'Reilly et al. 
(2015) develops a two-hour purpose designed interactive training programme 
for pharmacists relating to depression screening from case studies. This training 
programme enhances pharmacists’ skills to screen people at risk of depression. 
The pharmacists demonstrated capabilities to screen patients and provide a risk 
assessment service for depression. Skills required learned included referral to 
other care professionals when necessary. This programme was inspired by a 
previous study of Australian community pharmacists which demonstrated that 
pharmacists had good understanding about the treatments for mental illness 
and were able to identify a person at risk of suicide and refer them onto 
appropriate health services (O'Reilly, 2010 B). 
 
In the main, participants said they were unable to perform the expanded role of 
the pharmacist and they felt that consulting with patients about non-medication 
issues was outside of their role. Furthermore, they said they are reluctant to 
hold two-way consultations with patients. The participants disagreed about the 
boundaries for eliciting information.  
 
Participant 1: (28 yrs.; qualified; M): You know, there is a fine line 
with the pharmacist… personal details…how do we get an overview 
of you? Can we get all that personal information out of you? So   
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what’s happening for example, in your private life? Is it workload 
stress, or whether it’s marital or private relationship stuff that is going 
on, and that’s what’s caused the depression, depressive episode. 
 
Liekens et al. (2012) say that pharmacists are confident to provide information 
about the side effects and medical treatment options for depression, but are 
less willing to provide social advice to patients who have depression, in 
comparison to giving out information to those with physical disease. The 57% of 
pharmacists studied lacked education about mental illness (Liekens et al. 2012 
B). This may support a view that our participants need some training to be able 
to provide non-medical information to patients. Chong et al. (2013 C) suggest 
that, in order for pharmacists to involve themselves in decision making with 
patients, they need to learn interpersonal and positive communications skills. 
Moreover, pharmacists need to undertake continuous professional development 
in their area of practice. Liekens et al (2014) who studied the impact of one day 
training for pharmacists in Belgium, supports this view. The pharmacists in the 
intervention group asked more questions about anti-depressants and 
lifestyle/psychosocial concerns compared to the control group. Despite the 
positive impact of training, the pharmacists seemed to avoid gathering and 
giving information on lifestyle and psychosocial concerns. The control group 
received no lifestyle information. However, the modest information given by the 
intervention group encouraged patients to discuss lifestyle and psychosocial 
concerns, but the authors did not outline why the pharmacists in the intervention 
group avoided talking about lifestyle. The authors suggest that it might be the 
lack privacy at the pharmacy counter (Liekens et al., 2014). Our participants 
said that they have private space, but (see Section 6.2.5) revealed that they 
offer less privacy in order to avoid expanded discussions with patients, and they 
felt less able to control the consultation.  
 
Crockett et al. (2009) compares pharmacists given extra training with those who 
not given extra training. The training concerned the nature and management of 
depression by a psychiatrist, psychologist and GP, and the intervention group 
showed improvements in their discussions with patients when they discussed   
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the safety of anti-depressants. However, the study finds that pharmacists are 
less likely to engage with patients in order to avoid saying or doing the wrong 
thing and, thus, risk losing the trust of the patients. This evidence can be linked 
to our findings showing that participants think that a lack of liaison with other 
health care professionals hinders communications with patients. The 
participants were concerned that the physicians may withhold the diagnosis and 
possibly the side effects of treatment from patients and it would be difficult for 
the participants to raise this kind of information. The hierarchy within 
professions can lead to conflicts about the type and extent of information given 
to patients. 
 
The above explanation illustrates the benefit of skills training to engage with 
people with depression. However, our participants need more training to 
engage with people with depression and this may serve to change the 
orientation (role conflict) of the participants about their responsibilities. The role 
of the pharmacist–patient relationship is investigated in a cross-sectional study 
by Worley et al. (2007) and in this study, pharmacists were uncertain if they 
could start a conversation with patients when the patients did not ask for any 
help. The authors suggest that pharmacists may need effort to start a 
conversation if it goes beyond the traditional role of the pharmacist. 
Furthermore, a qualitative study by Murphy et al. (2014) finds that pharmacy 
students are unclear about the boundaries between their social and technical 
roles. The students’ experiences were characterised by ‘identity pluralism’. 
Students discussed the enactment of multiple roles in their pharmacies, 
including the role of ‘technician’, ‘pharmacy student’ and ‘future pharmacist’. 
Each of these roles had a self or externally imposed suite of knowledge, 
attitudes, behaviours, skills, level of responsibility and decision-making 
authority, but the study only recruited students from one Canadian university. 
 
Our study finds that role conflict contributed to patients being less aware of the 
participants’ role. The quantitative findings show that approximately 46% of 
patients had confidence in the participants’ knowledge about depression and its 
treatment. This may indicate that patients do not see the participants as   
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a source of additional information, for example, information about lifestyle. 
Similarly, in Moja et al. (2013) pharmacists perceived conflict when they tried to 
advice patients about medications, enforce restrictions on medicine dispensing, 
and offer consultations. The pharmacists had difficulties in carrying out these 
various roles, especially at times when patients were able to perceive this and 
forget the relationship of trust initiated or the provision of counselling. However, 
the majority of the pharmacists in this study were owners, and so they might 
have had different agendas to employee community pharmacists. Moreover, the 
median age studied was 48 years, and due to age and experience, the 
pharmacists may have held different perceptions to those of newly graduated 
pharmacists. 
 
When Hercelinskyj et al. (2014) explored how mental health nurses perceived 
their professional identity the nurses said they sometimes felt their role was 
rather ambiguous or unclear due to constant changes in government policy or 
organisational changes. The government wants to play bigger role in training 
participants and implementing this training in practice. Therefore, it appears that 
a lack of training of our participants about mental illness can be a barrier to 
pharmacists engaging with people with depression. This situation exacerbates 
when role conflict occurs and this serves to prevent the patient being aware of 
the extended role of the pharmacist.   
 
6.3.2 Lack of Patient Knowledge about the Role of the Pharmacist 
 
The majority of the participants said that many patients did not understand their 
extended role in practice. They said patients felt that the pharmacist’s role was 
to dispense rather than to give advice about medications. This attitude 
confirmed that the participants perceived their role as that of a dispenser. 
Furthermore, one participant said that patients are more trusting of other health 
care professionals than the pharmacist is because patients perceive that 
pharmacists cannot make decisions that conflict with those of the GP.  
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The participants referred to ethical issues in order to articulate perceptions 
about the responsibilities of the GP.  
 
Participant 10: (11 yrs.; qualified; M): If you ask any person on the 
street, they’ll say yes, the pharmacy offers that, the pharmacy offers 
that. If you ask a normal person, does your pharmacist talk about 
mental issues? No. They’d be like, no, I have to go to my 
psychiatrist…I have to see my GP …You know, well, why are you 
asking me so many questions? 
 
During the study, a perception that some patients were unaware of the 
participants’ ability to provide additional roles became apparent. This view did 
not derive from personal opinion but was drawn from experience. For example, 
Participant 20 said that people with depression are not keen on his involvement 
in decisions because they see the role of the physician as a paramount. He said 
that patients were not generally aware of the function of MUR and, therefore, 
patients are not receptive to advice from pharmacists. However, the participant 
did not refer to what patients thought after they had experienced MUR.  
 
Participant 20: (11 yrs.; qualified; M): The patients don’t expect the 
pharmacist to ask those personal kinds of questions. Something 
called the Medicine Use Review, whenever we ask sometimes, some 
of the patients to come in for a medicine use review, the first thing 
they’ll answer is, ‘Oh it’s a doctor’s job. I’ve just had a consultation 
with the doctor. Why do I need to chat with you?’ So that’s why 
sometimes pharmacists tend not to go down that road? 
 
The participants said that patients were less aware of the pharmacist’s role and 
the standard of education possessed by the pharmacist in mental health 
matters. This possibly indicates that a new system of managing patients may 
enhance patient expectations of the participants. Youssef et al. (2010) find that 
patients exhibit positive feelings after they have had an MUR. This study finds 
that more than half of the patients surveyed learned more about the side effects   
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of their medications after they had an MUR; patients over 65 years of age 
reported more benefits from MUR than patients under 65 years of age, 
especially in relation to the administration and correct timing for taking 
medications. However, the majority of patients had physical diseases and only a 
small number had mental illness. This may indicate that patients are aware of 
the knowledge of the participants, but the participants are less interested in 
increasing patient expectation or taking an active approach. 
 
Carter et al. (2012) find that patients are more willing to receive a home 
medicine review when their physicians had recommended one for them. The 
study also finds that patients are more interested in asking their GPs about 
concerns they have with medications than in talking to pharmacists. This 
indicates that patients still hold traditional views about the role of the pharmacist 
and do not like to speak to pharmacists about issues they perceive are beyond 
the role of the pharmacist.  
 
Worley et al. (2007) find that pharmacists agree more than patients do about 
the responsibilities of the pharmacist to meet patients’ health care needs. The 
authors suggest that patients feel some responsibilities lie with GPs rather than 
pharmacists. This reflects patient perceptions about the pharmacist’s role, but 
this relationship may influence by many factors including the experience of 
patients, the type of diseases and the location of the pharmacist in the hospital 
or community. In Bissell et al. (2008), a random controlled trial compares 
patients who have coronary heart disease with usual care patients. The findings 
show that patients feel uncomfortable when pharmacists make 
recommendations after conducting an MUR because of perceptions held that 
making recommendations are part of the GP’s job. This view reflects the 
perceptions of patients that physicians are the dominant professionals and the 
professionals who carry out the task of clinical and diagnosis. However, Hughes 
and McCann (2003) find that this orientation changes when physicians become 
more involved in community practice and make recommendations to patients to 
seek pharmacist support. Nonetheless, semi-structured interviews conducted by 
Morton et al (2015) finds that workloads in the pharmacy sometimes act   
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as a barrier to pharmacists being able to practice their extended role, but this 
study is limited in that it includes telephone and face-to-face interviews. A 
survey conducted in Liverpool suggests that two thirds of the public seek advice 
from pharmacists about health and medications, but only one-third view 
pharmacists as a source of advice relating to general health. Furthermore, the 
patients rated their pharmacy as poor for sharing advice about lifestyle and 
screening. The patients studied were not generally aware of their pharmacy’s 
capacity for offering to advice about medications, and although the respondents 
felt that support for people with depression is important, they only felt this was 
due to pharmacist input to a moderate extent (Krska and Morecroft, 2010).  
 
In the United Arab Emirates, Hamoudi et al. (2011) finds that approximately five 
to twenty consultations per month relate to drug administration and dose 
recommendation. They claim this is because patients still hold traditional views 
about the role of the pharmacist and have not yet accepted the idea that 
pharmacists can provide cognitive and health management advice, but in 
United Arab of Emirates (UAE) physicians are available and have time to 
provide information to patients. It might be that pharmacists in the UAE tend to 
provide only basic information, and this approach does not promote patient 
expectations, unlike in UK where pharmacists have the responsibility of 
providing an additional role, but patients are more amenable to professionals 
they are more familiar with. Similarly, Sunderland et al. (2006) report that only a 
small number of people receive information from their pharmacist relating to 
lifestyle, but, in spite of this, patients are happy to receive preventive advice. 
The authors suggest this might be because patients can obtain preventive 
advice from other sources apart from the pharmacy, and are more comfortable 
receiving this kind of advice from pharmacists also. Consistence with our study 
only 39% who agreed that pharmacist is willing to talk about patients symptoms 
of depression and progress with treatment, this may induce less expectation of 
patient about our participants, while the majority divided into disagreed and 
undecided (4.8). However, questionnaires and semi-structured interviews 
conducted in a study by Hoch, et al. (2011) found that pharmacists have a good 
knowledge of medications and mental illness. Half of the patients surveyed said   
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they expected courtesy from a pharmacist. In this study, patients came from a 
social assistance and counselling setting and it is possible that the pharmacists 
had more contact with patients than our participants did.  
 
In McMillan et al. (20014 B) a focus group comprising Australians with chronic 
illness took place in order find out how they viewed the role of their pharmacist. 
The participants in this study said that the primary role of the pharmacist is to 
dispense medications and patients were unsure or unaware of other the 
services the pharmacist provides, such as signposting to other services or a 
Home Medicine Review. The participants were not sure how the pharmacists 
could help them. The authors suggest that, maybe, patients do not feel 
comfortable taking up the pharmacist’s time in case this prevents the 
pharmacist from dispensing medications. In (Section 6.2.4) our participants said 
they did not have enough time to dedicate to patients. However, in Wheeler et 
al. (2012) patients said they knew that pharmacists are part of the group of main 
decision makers involved in their care in a secondary care setting. However, the 
patients experienced limited contact time and had minimum experience of using 
a community pharmacist, because their experiences came from the secondary 
care environment. 
 
The idea of conflict in ‘role theory’ relates to when a person holds expectations 
that are incongruent with those of another person, professional or organisation. 
This situation can cause stress and encourage people to adapt behaviour in 
order to cope (Biddle, 1986). When Hercelinskyj et al. (2014) conducted semi-
structured interviews to assess the perceptions of mental health nurses about 
their role they found that nurses experienced role conflict and stress about 
structural issues in the workplace and conflicts between their expectations, 
responsibilities and the need to perform in the mental health setting. In our 
study, participants felt role conflict in relation to their roles as dispenser and 
provider of advice, support services (including consultations), and their 
commercial role. This indicates that the participants experienced role conflict 
due to the many responsibilities they are required to provide, therefore, there is  
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less time to prioritise patients, and, consequently, this influences the 
expectations of patient about the role of the participants. 
 
In a qualitative study by Niquille et al. (2010), the majority of patients studied 
were unaware of the existence of the Medication Review as a service provided 
by pharmacists. However, 41% of patients agreed to undertake a review of their 
medication led by pharmacists and exchange clinical data between their 
community pharmacists and their physicians. Nonetheless, most patients were 
generally unaware of the services provided in the pharmacy. It seems that good 
number of patients (a) agreed that pharmacists share patient personal 
information with physicians (b) had accepted a MUR from the pharmacist, but 
the study did not consider mental illness.  
 
Knox et al. (2014) conducted telephone based interviews were undertaken with 
patients to assess satisfaction with the services provided in the pharmacy, 
patients were satisfied with the services provided at their pharmacy, although 
some services were missed. This indicates that patients might not always be 
fully aware of the kind of services offered at their pharmacy and the abilities of 
the pharmacist to provide them. However, when patients described what they 
liked most about their pharmacy visit, functional qualities (how information is 
distributed in terms of interaction quality and positive attitudes and behaviours) 
featured more frequently than technical qualities. 
 
It appears that attitudes about role perception can influence a pharmacist’s 
decision whether or not to practice their extended role. This may not help 
patients who are not aware of the extended role of pharmacists. However, 
collaboration between the pharmacist and other health care professionals may 
raise awareness about pharmacist’s role in helping patients, and this might 
enhance patient expectations. 
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6.3.3 A Lack of Liaison with Other Health Care Professionals 
Two participants said that they did not have much contact with other health care 
professionals, but felt that collaboration with other physicians would improve 
therapeutic outcomes, as well as provide opportunities to follow-up patients and 
enhance their quality of life. Participants said that a lack of liaison with other 
health care professionals reduces opportunities for managing patient therapies. 
These participants said they were not fully aware of the information physicians 
give to patients, and said that communicating information without knowing the 
patient’s needs is not very effective. The participant said that physicians are 
sometimes reluctant to tell patients about their diagnoses and he voiced 
concerns about information withheld by physicians.  
 
Participant 2: (12 yrs.; qualified; M): And you don’t know exactly, from 
that what the doctors said, what they’ve said to the doctor, what other 
people around them are doing, and those sorts of things. 
 
However, the lack of liaison with other health care providers is only one possible 
barrier to providing good care. Professional conflict between health care 
providers can also contribute to less engagement between pharmacists and 
people with depression. A third of our participants made comments associated 
with a hierarchy of health care professionals. The participants reported that 
decisions fell under the influence of higher authorities, for example, GPs and 
other physicians. Some participants thought they could not take action relating 
to medications when GPs had already decided upon a course of treatment. The 
participants felt that, sometimes, patients were not responsive to advice given 
by them and preferred to consult their GP instead. These participants’ 
experience ranges from 1-18 which may indicate that they hold this concern and 
the experience does not necessarily tackle the professional conflict with other 
health care professionals.  
 
Only a minority shared the views of participant 11 who showed disinclination to 
become involved in raising questions about medication with patients or GPs 
even when a patient raises concerns because this might bring him into conflict   
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with the GP. He said that patients perceive the role of the pharmacist as a 
dispenser who is not active in health care treatment decisions. 
 
Participant 11: (18 yrs.; qualified; M): I cannot change the 
medication, the decision was made with the physicians, and I 
suppose it not our responsibility to check if patients are happy with 
their treatments. We are pharmacists. We have to know our 
boundary. Encroaching on the role of physicians is hard. 
 
In agreement with our study, Chong et al. (2013C) find that Australian 
community pharmacists often defer to the decisions of GPs and encounter 
challenges when they have to raise issues about dosage or conflicting 
medications. Likewise, Harding and Taylor (2002) find that pharmacists’ 
decisions fall under the influence of other health care professionals, even when 
the decisions made are less likely to lead to therapeutic outcomes. The general 
perception is that physicians perform clinical assessments and make 
therapeutic decisions, and so physicians have more authority to make decisions 
about patients’ health conditions. This recalls the findings of our study when the 
participants perceived role conflict whenever they felt inclined to give out 
lifestyle information, and that undertaking their extended role requires significant 
encouragement. This is possibly link with our own (Section 6.3.2) that people 
with depression lacked knowledge about the role of pharmacist which make the 
mutual discussion difficult with patients. 
 
When Kalvemark et al. (2004) conducted a focus group with nurses they 
identified the moral distress and painful feelings that occur when constraints on 
nurses meant that he/she do not do what is perceived as morally correct and 
necessary. In our study, decisional conflicts between physicians and 
pharmacists had an effect on the professional performance of pharmacists who 
felt they had less power to make decisions, and must take orders from 
physicians. Crump et al. (2011) support this view when they explore the 
services provided by community pharmacists and barriers to care. They find 
that other health care providers do not always recognised the role of the   
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community pharmacist, and that medical practitioners are unaware of the 
training and knowledge of pharmacists. Furthermore, Crump et al. (2011) find 
that physicians experience role conflict with community pharmacists who work 
as health care providers and sellers of medications. However, in this study, 
some of the participants spoke by telephone and the topic guide was about 
psychotropic drugs, and so these perceptions may differ when talking about 
physical diseases. This possibly indicates why only few of our participants who 
elicit social history of patients (Section 4.4.2; Skills Section 2). 
 
Role conflict between health care professionals can lead to patient needs 
remaining unmet. A study by Tarn et al. (2009) shows that elderly patients who 
took part in a focus group were unclear about the role of the pharmacist, and 
they held different opinions about which care providers are allowed to explain 
side effects. The study finds that some patients accept information about side 
effects from pharmacists, others are comfortable receiving information from the 
physician and pharmacist, and some prefer to talk with their clinician about side 
effects. However, the patients in this study were elderly, and it is possible that 
carers play the main role in collecting their medications, and this may have 
contributed to why they were unable to decide about the role of the pharmacist. 
The findings of Tarn et al. (2009) are in line with Gidman et al. (2012) who 
report that supplying medications is the main role of the pharmacist. Gidman et 
al. (2012) find that although some participants visit community pharmacies often, 
they have a relatively limited view of the extended role of the pharmacist and 
their awareness of the extended role of the pharmacist was low. Gidman et al. 
(2012) find that patients hold very traditional expectations about the role of 
pharmacists and are more likely to place trust in what is already familiar to them. 
The study focuses on sociological theory and the patients’ familiarity with the 
services, but it does not address the actual behaviour of the pharmacists. 
However, in focus groups conducted by White et al. (2012) including patients 
and carers, the Home Medicine Review (HMR) provides pharmacists with the 
opportunity to build better pharmacists-physician relationships. Australian 
recipients of this service said that the HMR enables pharmacists and physicians 
to collaborate effectively, and this includes sharing information about   
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appropriate therapeutic plans for patients. These findings link with our own 
(Section 6.5.2) in that the participants developed paternalistic relationships with 
patients. This paternalistic approach avoids making any decisions that may not 
have been in line with those made by the physician.   
  
When Wheeler et al. (2012) conducted semi-structured interviews with health 
care providers and patients in a specialist mental health facility, the care 
providers recognised the skills of clinical pharmacists in the management of 
medications for enhancing care delivery in mental illness. In this study, the 
participants were aware of the pharmacist’s role and collaboration with other 
health care professionals. However, when Niquille et al. (2010) conducted a 
qualitative survey they found that one of the biggest problems faced when 
implementing MUR is maintaining effective collaboration with physicians. The 
pharmacists in this study said that physicians have little time for this service, 
and physicians view pharmacists primarily as retailers of drugs; but the data 
showed that a high number of pharmacists who participated agreed that time 
pressure is an obstacle, and this creates a barrier between the pharmacist and 
the physician when collaborating to identify each other’s role.  
The above shows that a lack of liaison with other health care professionals 
creates extra challenges for the participants. However, collaboration with other 
health care professionals means that pharmacists can share expertise in 
promoting medications. Furthermore, a lack of information sharing about the 
backgrounds of the patients can also create barriers to good care.  
 
6.3.4 Organisational Barriers 
Approximately half of the participants noted a lack of access to the medical 
backgrounds of patients as a creating a barrier to good service. Participants 
noted that physicians prescribe anti-depressants for different kinds of diseases 
and conditions, not just for depression itself, and, therefore, providing the right 
support is difficult when gaps in information exist. This situation exacerbates 
when patients do not share information about their illnesses or conditions, and, 
in this study, this resulted in the participants deciding not to share as much   
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information as they could. The participants preferred to practise one way 
communication in order to avoid misunderstandings that might result in losing 
the patient’s trust. Another barrier to providing good service as noted by the 
participants was the patients’ use of multiple pharmacies. Some participants 
noted that patients sometimes visit different pharmacies, depending on 
convenience, and did not stick to using just one. They explained that, 
sometimes, they are not immediately aware if GPs have changed patient 
medications, and that monitoring a patient over time is sometimes impossible.  
 
Part. 11: (18 yrs.; qualified; M): You don’t have access to the 
records…You don’t know whether this patient is, you know, suffering 
from long-term…and you may not get the important information out of 
the patient. 
 
Semi-structured interviews carried out in Australia by Chong et al (2013 C) 
involved medical practitioners (psychiatrists and general practitioners), 
pharmacists, nurses, occupational therapists, psychologists and social workers. 
Chong et al. (2013 C) argue that it is essential to have a web-based network set 
up in primary care because this can improve regular inter-professional 
teamwork and help to facilitate integrated care plans and discussions among 
team members, but this study took place only in one part of Australia. McDonald 
et al. (2010) find that community pharmacists are uncomfortable with using 
outdated technology in the pharmacy because this means that pharmacists are 
not able to monitor patient adherence to medications. Moreover, Gordon et al. 
(2007) claim that using outdated software means that pharmacists are less 
likely to be approached as a source of independent advice. This means that 
patients were less satisfied with their system because it is did not transfer 
medical information between different healthcare settings. They cited instances 
of confusion and inconsistency occurring between primary and secondary care 
advisers which made patients less decisive about what medications should be 
taken, and when.  There were similar results our study (Section 6.3.4) when 
patients said they felt less engaged with people with depression because of the 
lack of background information they had about patients.  
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Crump et al. (2011) raise concerns about communication between pharmacists 
and claim that some pharmacists think some mental health patients have 
transient living situations, and this creates barriers to providing continuity of 
care. This result is similar to that of our quantitative study Section 4.4.2 (Skills 
Section 2). Participants were less open to offering consultations without 
knowing the backgrounds of patients. In line with this, in a mixed method study 
conducted by Guirguis (2011), pharmacists receive brief training before 
undergoing integration into the 3PQs approach for two weeks. This is a patient-
focused approach designed to assess the patient’s knowledge and identify 
information needs, before providing education; the pharmacists recorded their 
perceptions of patient interactions, completed a survey addressing self-efficacy 
and role beliefs toward the 3PQs, and participated in a focus group. However, 
some pharmacists made incorrect assumptions about the indication for the 
medication. These decisions have safety and efficacy implications. The majority 
of the pharmacists in this study were community pharmacists. 
 
It appeared that participants were less likely to engage with people with 
depression, and many factors influence their practice for example environment 
factor and self-efficacy factors. However, Chapman (2015) argues that some 
people resist progressing from the stage of unconscious incompetence to 
conscious competence, because they refuse to accept and acknowledge the 
relevance of a particular ability or skill. Chapman (2015) explains that some 
people maintain certain communication styles out of fear, and they would rather 
feel secure in what they already do than try out something new. Furthermore, 
Chapman (2015) suggests that some people are happy try to develop their 
competence but struggle in doing so. Fisher (2012) argues that people are often 
reluctant to accept change and deny their abilities to change their behaviour in 
any way; sometimes this happens whilst ignoring evidence, and when it is 
contrary to someone’s belief system. 
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 Tailoring the Consultation 6.4
The Royal Pharmaceutical Society promotes the concept of ‘medicine 
optimisation’, which involves patient-focused care to achieve the best use of 
anti-depressants. This requires a holistic approach and mutual sharing between 
the pharmacist and patients (Royal Pharmaceutical Society, 2013 A). When 
Slade et al. (2009) studied patients in a focus group, patients preferred care 
providers to ask them about their opinions and goals; all the participants wanted 
their care provider to develop a comprehensive picture of individual values and 
preferences.  
 
The responsibility of health care professionals is to acknowledge the 
individuality of each patient and try to tailor services to meet the needs of 
individual patients. Values and preferences influence patient expectations and 
how they use services (NICE, 2012 C). In our research, half of our participants 
in the qualitative results who made their opinion about initial rapport with patient 
concerning negotiated agenda, but not other skills of initiating the session. 
 
6.4.1 Initiating the Session 
The quantitative results in our research showed that none of the participants 
introduced themselves to patients when conducting consultations. The 
participants demonstrated poor quality skills in this area. The only positive 
behaviour noted was inviting patients to discuss medicines. The participants did 
not demonstrate other skills, such as outlining the structure of the consultation 
and finding out the agenda of the patient. The participants did not feel it was 
important to provide an introduction by name, (Section 4.4.1; Skills Section 1). 
This kind of behaviour creates a barrier to communication as noted previously, 
such as patients not visiting the same pharmacy. Therefore, the participants 
greeted patients in ways they saw fit. Mahesh and Parthasarathi (2004) 
explained that it is possible to create powerful first impressions when meeting 
patients and these impressions can affect how patients view their pharmacists. 
Decisions made about communication can encompass both verbal and   
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non-verbal communication and unconscious behaviours, and successful 
introductions can affect the fluency of the consultation. 
 
In a structured observation made by Hussain and Ibrahim (2011), patients were 
more enthusiastic to greet pharmacists than pharmacists were to greet patients. 
In this study, 48% of patients greeted their dispenser; but the study involved 
covert observation, which raises ethical issues of not letting the participants 
know that they were being observed and it may give unclear response of the 
pharmacist-patient communication, it is possibly explained data subjected to the 
observer interpretation, but not to actual communion. Greenwood et al. (2006) 
evaluated the impact of home visits by pharmacists to patients with heart failure. 
It also shows that pharmacists do not greet patients before a consultation. 
However, the authors note that, possibly, some pharmacists greeted the 
patients before recording started; but the tool used (skill checklist) in the study 
was designed for the physicians and possibly not suite the pharmacists skills. 
However, in a cross sectional study by Worley et al. (2007) pharmacists 
preferred to just say ‘hello’ rather than provide a personal introduction. This 
implies that pharmacists do not always observe professional behaviour or 
demonstrate good soft-skills when they first meet patients. However, the 
authors note that the pharmacist might not always be the first point of contact in 
the pharmacy; the patient might well have been greeted by other professional or 
support staff before meeting the pharmacist. The authors also suggest that if 
pharmacists were not as focused on dispensing, then they may have more time 
to greet patients, as well as provide better consultations and information sharing 
services. This may apply to our study in that our participants often see the 
patients after the technician who has already greeted patients.  
 
Participants lacked interest in greeting patients, or did not recognise its 
importance. This may also mean that they were less inclined to explore the 
agenda of patients. Our participants noted that physicians do not have enough 
time to advise patients about health services, and this hinders the physician’s 
delivery of an effective service. Participants commented that the number of 
patients waiting discourages physicians from engaging with patients about their   
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treatments, and that physicians rely on pharmacists to provide some information 
to patients. Therefore, half of the participants perceived that initial rapport was 
more likely to build good relationships with patients, which facilitates advice 
giving, but they did not intend to build this initial rapport with patients.  
 
The participants thought negotiating agendas provides a good opportunity to 
enhance patient expectation about the knowledge the participants. This 
performance encourages patients to clarify their agenda and helps to structure 
the consultation.  
 
Participant 1: (5 yrs.; qualified; M): I can’t see how a GP can come in, 
in 8 minutes, meet and greet the patient, understand the patient, why 
they’re presenting, take an effective history as to why they’re 
presenting with low mood and the whole social context that it’s 
presenting in… then make a diagnosis on that, then make a 
prescribing and say I’m going to prescribe you Sertraline. 
 
However, as noted in the quantitative results (Section 4.4.1; Skills Section 1), in 
practice, the participants did intend to establish the patient’s agenda; but their 
use of closed questions (Section 4.4.5; Skills Section 5), and possibly, 
therefore, the participants were less able to understand the needs of patients. 
The short time (5.1.4; Sub-category D2) allocated to consultations shows that 
the participants usually dictate their own agenda, and do not give time for 
patients to form their agenda. This (brief) pre-planned participants’ agenda 
sways more towards therapeutic efficacy and the safety of medications. 
Therefore, in practice, the participants fail to negotiate agendas with patients, 
and this includes structuring consultations to ensure that the patient gets what 
they expect from the consultation. In consistence with this, Greenwood et al. 
(2006) finds that pharmacists fail to negotiate patient agendas to enable 
consultation structuring and establish patient expectations. This emerges in a 
study to assess the skills of pharmacist when visiting patients at home. 
  
 
 
 
260 
The authors suggested that the pharmacists talk to patients about their 
treatment before recording the consultation. Similarly, a study carried out in the 
UK found that health care providers (counsellors) do not encourage patients to 
form their agenda while these providers promoted their own agenda (medicine). 
This reminds us in (Section 5.2.4; organisational barriers) that the participants 
lack electronic communication systems agenda with other health care 
professionals, which reduces motivation to negotiate an agenda with patients. It 
has been found (Pilnick, 2002) that patients were unable to formulate their 
agenda if they were not encouraged to do so, and were unwilling to participate 
in the discussion if they did not understand the background about what will be 
considered. This study used a dynamic qualitative method (conversation 
analysis) rather than content analysis (Pilnick, 2002).  
 
In agreement, Latif et al. (2011) find that pharmacists are not responsive to 
patients and tend to use a checklist approach to MURs. In this study, 
pharmacists offered MUR without planning, which resulted in the pharmacist 
lacking an agenda and subsequently not being able to encourage the patient to 
establish an agenda. However, pharmacists were able to summarise 
information given to patients. The author suggested that pharmacists’ heavy 
commitment to the dispensing process meant there was poor integration of the 
MUR service into their routine workload; but the study did not show the 
demographics of the pharmacists, they might not have had training about MUR. 
A recent study by Chong et al (2014) in Australia, to characterize community 
pharmacist–patient interactions during consultations involving use of anti-
depressants used simulated patients initiate or previously took anti-
depressants. The pharmacists did not encourage patient to negotiate their 
agenda. Patients were passive whilst pharmacists were dominant during 
consultations. The pharmacists demonstrated low levels of questioning open 
questions. In this study, 25 % percent of pharmacies did not offer private 
consultations, and this might have contributed to the tendency of pharmacists 
not to use open questions during interviews.  
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Falvo (2010) find that pharmacists are able to encourage patients to raise an 
agenda by asking open-ended questions, which enables them to encourage 
patients to respond more easily. This approach also enables pharmacists to 
gather information about the patients’ understanding of their medications and 
illnesses. Open questions assess verbal and non-verbal behaviour. It appeared 
that our participants did not encourage patients to establish their own agenda, 
but the participants’ agenda was to give basic information about anti-
depressants without giving more attention to patient concerns. 
 
6.4.2 Giving Information to Patients 
Participants said they are competent when giving out information about anti-
depressants. They said their priority is to educate patients about the actions and 
effectiveness of anti-depressants. The participant said they are keen to 
enhance the expectations of patients and ensure they understand their 
medications.  
 
Participant 8: (7 yrs.; qualified; M):… and it was a discussion on what 
the tablets are for, and just to, kind of, give the patient as much 
information as possible, predominantly on the tablets and how they 
work…so this patient needs to leave here with the information with 
regards to his tablets…that was my initial thinking, so that was my 
aim, to have this patient leave with all the possible knowledge they 
need. 
 
They said sharing information provided a good opportunity to communicate with 
patients, especially patients who may be taking medications for months, and 
when the risk of non-adherence is high. Participants said they are keen to 
increase awareness about the side effects of anti-depressants, which can lead 
to eventual non-adherence. They said that giving out information about the side 
effects is good practice behaviour, but said that if this information tailors to 
individual lifestyle then this might enhance the positive action of anti-
depressants.   
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The study showed that participants were more likely to provide advice about 
anti-depressants and less about social treatment (see Section 4.4.3, Figure 
4.12). Consistent with our evidence, a study used unannounced simulated 
patients to assess the pharmacist-patient communication in a 6-month period. 
The study found most pharmacists (90%) explained that it would take 4–6 
weeks for antidepressant medications to show an optimum effect, while only 
20% of discussions involved lifestyle/psychosocial activities. The authors used 
three simulated patient visits concerning antidepressant adherence-related 
scenarios at different phases of treatment, two scenarios involved patients on 
established therapy (Chong et al., 2013 A), which is unlike to our simulation of a 
new patients.  
 
In Tarn et al. (2009) patients registered dissatisfaction with their care providers 
for not explaining side effects for medications. The study noted disagreements 
between health care providers about information provided to patients. The 
pharmacists placed emphasis on explaining the side effects rather than the 
benefits of medications because they wanted to promote safe medicines use. 
The prescribers’ role covered talking about the rational and therapeutic 
effectiveness of medications and the pharmacists’ role was to provide 
cautionary information; but the study did not define the health condition. This 
reminds us (Section 6.3.4, organisational barriers) that the participants felt it 
difficult to provide information to patients because they lack a proper 
communication system with other health care professionals. This would allow 
them to be aware of patients’ health background, especially for older patients. 
Dyck et al. (2005) argue that this might explain why pharmacists are not keen to 
name all the side effects of drugs, but patients who did not receive information 
about the side effects of drugs registered dissatisfaction with the pharmacist’s 
care and they were more likely to have a negative experience.  
 
Grimes and Barnette (2014) argue that pharmacists made judgments based on 
their perception that patients were more willing to receive advice about anti-
depressants than about lifestyle. Patients possibly have different views, but a 
pharmacist should be non-judgmental and put the consumer at the centre of the   
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consultation, which aims at empowering patients and shared decision-making; 
this made them feel appreciated and redressed the balance of responsibility 
within the consultation. 
 
However, in our qualitative work few participants felt that they check patient 
understanding, but this did not happen in the quantitative results (Section 4.4.3, 
Figure 4.12). Hassell et al. (1998) present similar findings in an ethnographic 
study combining patient interviews with non-participant observation of 
interactions between consumers and pharmacy staff. Pharmacists used 
unsolicited instructions (closed questions) to talk about medicines, and did not 
use extended explanations. The pharmacists’ advice comprised brief and 
directive messages about dosage and administration. This possibly indicates 
that the pharmacists were unwilling to meet the patients’ needs. Similarly, an 
observational study by Latif et al. (2011) found that pharmacists did not check 
patient understanding at the repeat prescription stage and assumed that 
patients already had knowledge of the side effects of medications. The busy 
environment in the pharmacy made the pharmacists less willing to provide extra 
support to patients, and pharmacists perceived that patients received education 
from their physicians. Time pressures (Section 5.1.4; Sub-category D2) may 
also have hindered the participants in our study when checking patient 
understanding. 
 
Similarly, Collum et al. (2013 A), used a cross-sectional design (telephone 
interview) to collect information about the pharmacists’ use of health literacy 
based communication techniques for example, teach back, patients’ 
expectations for their use, and overall satisfaction with communication. They 
found 20% of patients said that the pharmacist asked questions to check that 
patients knew how to take their medication. However, this percentage recorded 
first time prescriptions and checks made at the repeat prescription stage 
recorded as low. This study found that patients did not expect the pharmacists 
to engage in consulting behaviour. This reminds us (Section 6.3.2) the 
participants felt that patients were less aware of their role; and both pharmacist 
and patient lacked motivation to engage with each other. The study finds that   
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58% of interactions between pharmacist and patients did not involve checking 
patient understanding of instructions. There was a tendency to give information 
without repeating back and the study took place in an Arabic country. The 
authors did not state if patients had taken their medications previously, and the 
pharmacists may have thought their patients were already aware of their 
medications (Alomar, et al., 2011). 
 
In Puspitasari et al. (2009) the majority of pharmacists felt they were not 
required to provide information to patients who visited at the repeat prescription 
stage, but they felt that giving out information was important at the first 
prescription stage. The pharmacists assumed that patients taking regular 
medications were aware of the side effects of their medicines and so there was 
no need for further consultation. This may link to our findings (Section 5.2.3) 
showing that a lack of liaison with other health carer professionals is one the 
main factors leading to participants’ assumptions about patients’ needs. 
Likewise, Schommer and Wiederholt (1994) find that pharmacists make 
decisions about whether or not to give out information depending on whether 
the patient visited for a first prescription or for a repeat prescription, and those 
calling in at the first prescription stage were less familiar with medications 
prescribed. However, Gordon, et al. (2007) find that patients who take regular 
medications do not always understand their medications. Out of 98 patients with 
chronic conditions, 28 had a poor understanding of their regular medicines due 
to the lack of advice given out about the use of medicines. They reported that 
physicians appeared reluctant to communicate information or to use 
understandable terms. They also said that advice and information from other 
sources was not a substitute for information from health professionals as it was 
not specific to their needs. 
 
Consistent with our study, Farrel et al. (2009) find that 72% of interactions 
between physicians and patients lack the use of teach back, and during the 
majority of patient-physician interactions physicians use closed questions. To 
check agreement or understanding 21% used the word ‘OK’. This is similar to 
our quantitative study (Section 4.2.3, Figure 4.5), that 18% of the participants   
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agreed that people with depression did not receive necessary information about 
depression from their general practitioners and psychiatrist. 
 
Negarandeh et al. (2013) conducted a randomized controlled trial to study the 
use of teach back techniques (using pictorial images and verbal instructions) 
and an assessment of knowledge and adherence (in relation to diabetes and 
medication) pre and post intervention. The patients in the intervention group 
showed more improvement in their knowledge and in adherence to their 
treatment than in the control group. However, the study used self-reporting 
rather than objective measurement, and so this might have affected the results. 
This may relate to our findings (Section 5.2.1) that the participants need more 
training to engage with people with depression. 
 
Although the participants in our study were aware of the importance of teach 
back to ensure patient understanding, they were less likely use this technique 
with patients. They may feel less comfortable to use it with people with 
depression. It might be the participants found new patients less interested in 
listening to them and therefore reduced the amount of information for (and/or 
perceived stress on) the patients. The participants were motivated to break 
down information to enable patients to understand advice and encourage 
adherence to their anti-depressants.  
 
 The Staging of Advice to Patients 6.5
The staging of advice refers to the measures taken by pharmacists to give out 
advice to patients. It includes taking measures to reduce the stress for patients 
and making them feel comfortable enough to be able to absorb information. 
First time consultations provide the opportunity to give out information about the 
side effects of drugs, and pharmacists must think about how to frame talking 
about these side effects. Follow-up visits provide pharmacists with the 
opportunity to gather more information with the aim of building a relationship of 
trust.  
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6.5.1 The Quality of Information at First Time Consultation  
Guidelines for pharmacists to break bad news are less common than those 
issued for physicians and nurse, and pharmacists may find this challenging. 
Participants said that soft skills frame side effects and offering medication 
advice. They said that patients become concerned if they perceive that side 
effects will influence their lifestyle. The said that achieving a balance between 
negative and positive information was more likely to result in a reduction of 
patient stress and help patients to remember their instructions. Participants 
explained how it was important to frame the side effects to reduce the fears of 
patients. They said that competent providers are able to build therapeutic 
relationships with patients. The said that giving out the correct information to 
reassure patients about experiencing side effects not only makes the patients 
feel at ease, but also helps to develops trust in the provider. 
 
Participant 2: (12 yrs.; qualified; M): I’m gonna be sleeping a lot more 
now. If you say to somebody well actually it’s gonna make you really 
really drowsy, they might say I don’t want that...I wanna be alert.... 
You might not feel like you wanna eat and actually that sounds like a 
negative thing. And so saying to somebody you’re gonna get 
insomnia. I explain things in a way that I think most people will 
understand. 
 
Consistent with our study, Garfield et al. (2004) show that at a first meeting the 
pharmacist usually gives out advice about potential side effects and the 
expected benefits of taking anti-depressants, this encourages patients to make 
decisions about their treatment and addresses concerns in the context of 
patients’ lifestyles. According to Rabow and McPhee (1999), physicians were 
less likely to focus on emotional distress, but rather focus on relieving patients' 
bodily pain. Physicians possibly view suffering as beyond their professional 
responsibilities. However, by concentrating on physical pain, clinicians may be 
ignoring important elements of meaning to the patient as a person, thereby 
intensifying suffering (Rabow and McPhee, 1999).  
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Gallagher et al. (2010) conducted semi-structured interviews in which mental 
health service users recounted key moments when good or bad news gets to 
them and described the impact of that news on their psychological well-being. 
They found that psychiatrists are happier to use terms such as anxiety and 
depression in discussion, but are less happy to use the term schizophrenia in 
conversation. Furthermore, Shaw et al. (2013) find that, during hospital 
encounters, physicians find it difficult to ‘break the news’ to patients and some 
physicians try to distance themselves from news which may trigger emotional 
responses with patients. Physicians avoid talking about feelings by placing the 
conversational focus on bio-medical information (Shaw et al., 2013). This may 
reminds us (Section 5.3.3) that the participants focused on anti-depressants 
and were less willing to give advice about social information. This avoided any 
uncontrolled patient emotion, which was beyond to the (perceived) skills of the 
participants. 
 
Bays et al. (2014) use patient simulation to assess the skills and emotions of 
subspecialty and practitioner nurses; feedback gained from patients highlighted 
improvements in communicating bad news and expressing empathy. However, 
the sample size was small. There is a lack of studies about breaking bad news 
with regard to pharmacists’ practice. It may be possible to design a format for 
pharmacists to break bad news to people with mental illness. 
 
Pharmacists lack guidance about how to discuss the negative actions of anti-
depressants. NICE (2012 C) recommends that when explaining risk and benefit 
factors to patients, absolute risk is better than relative risk: for example, saying 
that the risk of side effects is 1 in 1000, rather than double the (background) 
risk. The guidelines also recommend using frequency rather than percentages, 
for example 10 in 100 rather than (10%). Moreover, the guidelines state that 
patients can interpret the meaning of descriptive terms in different ways, and so 
expressing risk numerically makes information easier to understand. 
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6.5.2 The participant’s Relationship with Patients during the Consultation 
 
NICE (2012 C) guidelines state that professionals should actively involve 
patients in discussions and enable them to make informed choices about their 
treatment in order to reflect its importance. This section explores this 
relationship. 
 
In this category the results showed that participants were not very successful in 
negotiating agendas and initial relationships with patients, see (Section 4.4.1; 
Skills Section 1 ), and 73% of our participants did not use open and closed 
questions appropriately which enabled the participants to build up relationship 
with patients (4.4.5, Skills Section 5). However, this might imply that the 
participants feel that establishing a narrow relationship with a patient is 
acceptable at the initial treatment stage. 
 
Participant 2: (12 yrs.; qualified; M): In terms of feedback from the 
patient, I didn’t expect too much…So if I can get the information over 
in a fairly quick, fairly succinct way, but also not, you know, say right 
I’ve got your medication here. I’ve made you a cup of tea…but 
actually, I’m the boss, I’m in my environment, you’re coming into my 
environment and I’ve got a job to do and I want to give you some 
information and you’re to take that information.  
 
The behaviour that the participants exhibited was not only about judging the 
needs of patient about anti-depressants. There was also less willingness to 
listen to patients’ preferences. This might indicate that patients do not receive 
opportunity to discuss important matters with the participants. 
 
Pharmacists and patients completed a questionnaire from multiple perspectives 
using an interpersonal perception approach assessing their perceptions of the 
benefits of pharmaceutical care (Assa-Eley and Kimberlin, 2005). In accordance 
with our findings, Assa-Eley and Kimberlin found 43% of patients agreed that 
their pharmacists are passive when dispensing prescriptions, but 22% of   
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patients said that their pharmacists usually ask them if they have any medical 
related issues when they issue repeat prescriptions. The patients had a 
prescription dispensed during the previous 6 months, and there may be some 
recall bias.  
 
Furthermore, a study by Knox et al. (2014) finds that 66% percent of Australia 
patients do not speak with pharmacists about anti-depressants and other 
related health issues at all. Out of 22% of patients who do speak to pharmacists, 
pharmacists initiated two-thirds of these conversations. Patients were satisfied 
with services, but the author suggested that expectations about pharmacy 
services related primarily to technical service qualities. However, when 
participants described what they liked most about their pharmacy visit, 
functional qualities featured more frequently than technical qualities, this may 
mean that patient value the relationship behaviour and not only information 
given about the medications. This may contrast the previous argument (Section 
6.3.2) when our participants felt that patients lack knowledge about the 
pharmacists’ role, and do not know what to expect from of our participants. In 
contrast, in a study by Riley et al. (2013) pharmacists and nurses responded 
more positively to patients’ concerns and cues than general practitioners did. 
‘Prescriber pharmacists’ acquired skills and experience when interacting with 
patients; but this was in a more clinical environment than the typical community 
pharmacy. Our participants were still keen to build up relationships, but more at 
subsequent visits when they perceived the patients would be ready to 
communicate them. A cross-sectional study by Street et al. (2007) finds that 
practitioners who were more patient centred and had positive emotions toward 
patients were more active and showed better communication skills. The 
practitioners surveyed were unaware that patients who were not actively 
involved needed more assistance than the active patients. Indeed, Greenhill et 
al. (2011) supports these findings when they studied a group of pharmacists 
who did not demonstrate good skills to encourage patient participation. Perhaps 
patients had taken their medications previously and pharmacists thought 
patients were not ready to discuss them. Nevertheless, our participants were 
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less likely to engage with newly prescribed patients. Indeed when Hassell et al. 
(1998)  
studied the nature of advice giving to patients, their results showed that 
pharmacists use unsolicited instructions and ‘closed questions’ when talking 
about medicines, and peripheral advice or further explanation is not always 
given. They characterise pharmacists’ advice giving as being brief and directive 
about dosage and administration, and this indicates that the pharmacists were 
unwilling to meet their patients’ needs.  
 
Gordon et al. (2007) report that their study group of patients were not greatly 
involved in their treatment and physicians used a paternalistic approach. They 
also report that patients did not understand physician instructions because too 
much jargon passed between them, and physician responses were limited to 
the questions that patients asked. Some patients described situations where 
their questions received inadequate responses; but this study used audio 
recording and it is possible that patients showed different nonverbal behaviour, 
which may not be addressed in the study. Biddle (1986) reports that conflict 
forms when professionals find it difficult to perform their roles due to a lack of 
skills and inconsistencies that exist between expectations of the role and 
personal characteristics, and these circumstances create pressure for the 
individual. Indeed, in our study some participants adopted a paternalistic 
approach in order to avoid emotional situations and to maintain control. A 
patient centred approach equals a lack of control. This is supported by Sheridan 
et al. (2012) who report that among their study group patient interaction with 
physicians tended to be paternalistic in style rather than involving discussion, 
they felt a hierarchy of social and professional roles, the patients were elderly 
and possibly the physicians felt it difficult to involve them in decision making. 
 
In a focus group examined by Guillaumie et al. (2014), the aim was to describe 
pharmacists’ perceptions with respect to their practice and patients’ anti-
depressant treatments. Pharmacists were more likely to be directive at the first 
meeting with a patient when giving out information about anti-depressants, and 
would ask questions to obtain necessary information. The author used field   
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notes, which may be highly subjective. In consistence, Boeni et al. (2015) found 
pharmacist-patient interaction centred on advice about medication 
administration and dosage, and only 6% patients received counselling about 
adherence to their medications (concordance).  
 
Knox et al. (2014) show that patients rate technical information less highly than 
the quality of the services they receive and that patients are eager to have a 
positive relationship with pharmacists. This supports the findings of Latif et al. 
(2011) who suggest that although MUR services provide pharmacists with an 
opportunity to demonstrate their competence, pharmacists often used closed 
questions when meeting patients. This means that patients often provide limited 
responses and are less encouraged to involve themselves in discussion (Latif et 
al., 2011). Patients were passive whilst pharmacists were dominant during 
consultations. The pharmacists demonstrated low levels of open questioning. 
The study 25% of pharmacies did not offer private consultations, and this might 
have contributed to the tendency of pharmacists not to use open questions 
during interviews. This may reminds us (Section 5.1.5) that the participants 
were less likely offer private consultation even thought they were aware of the 
importance of this service. It appeared the decision to offer consultation room 
taken by our participants but not offering patients this service  
 
Over half the participants used a paternalistic approach, while a minority (5) 
demonstrated relationship building with patients. Mahesh and Parthasarath 
(2004) explain that communication skills are at the heart of building 
relationships with patients, because good communication skills work to help 
patients understand health conditions and open up about their feelings during 
consultations. Empathetic communication helps to promote trusting 
relationships between pharmacists and people with depression. Our participants 
said successful providers are able to demonstrate a good attitude towards 
people with depression, and one not based on stereotypes. For example, 
Participant 9 said that a good attitude helps to create good perceptions among 
patients, and makes them feel welcome. The participants showed a keenness 
to build trusting relationship with patients and to understand their values. She   
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said that exhibiting empathy and understanding the feelings of patients is more 
likely to make patients comfortable and encourage them to talk about their 
situation.  
 
Participant 9: (4 yrs.; qualified; F): Obviously you’ve got to be 
sympathetic, understand what they’re going through. So you’ve got to 
show a bit of emotion. Yes I mean patients do feel like, as if, they, 
you know, they’re been looked at in a different way as such but 
(sigh)…I just try to make them feel as comfortable as possible, make 
them feel cosy, and the most important thing out of everything I think 
is making them feel at ease. 
 
However, Participant 15 also perceived that patients listen more to physicians’ 
instructions rather than to pharmacist recommendations. This might be because 
patients visit the same physician on a regular basis, and this regularity helps to 
build trusting relationships. In contrast, visiting different pharmacists and 
different pharmacies does not promote the formation of good professional 
relationships.  
 
Participant 15: (3 yrs.; qualified; M): They view it in the sense that, 
they take medicine based on trust in that the doctor has said I have 
depression. A lot of it is based on trust. 
 
Indeed, regular patient visits to the pharmacy help to facilitate better 
consultations and discussions. Half of participants said that patients who visited 
regularly were more likely to receive information and advice about lifestyle. This 
indicates that accessibly to pharmacies can help build better professional 
relationship with patients. Participants said that patients are more likely to be 
open to sharing and receiving information during a second visit. This is because 
patient symptoms are beginning to be resolved and, thus, the patient is in better 
health. The participants implied that second visits promote relationships with 
patients and provide an opportunity for the discussion of the management of 
patient treatments.    
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Participant 3: (15 yrs.; qualified; F): So patients that you’ve seen a 
couple of times, that you can see, are a little bit brighter, and if 
somebody’s higher up already, that we’re talking about building up 
enough energy, because at that second one is where I’m like, right 
come on, is it working, is it not?  
 
Bentley, et al. (2005) find that pharmacist attire matters less than the caring and 
listening skills and levels of respect a pharmacist has for a patient. There were 
higher levels of patient satisfaction for inter-personal skills over attire on patient 
evaluations. Kielmannet et al. (2010) find that establishing trust and promoting 
good relationships results in higher levels of patient satisfaction, which, in turn, 
helps patients become more motivated to manage their condition 
independently. Furthermore, Crump et al. (2011) find that empathetic and 
trusting relationships are important to clients, and are the basic framework for 
delivering successful care. Crump et al (2011) also find that pharmacists should 
articulate advice to patients in a style that does not overload them, and that 
matches the patient’s ability to understand and process information. 
 
In a study by Hamoudi et al (2011), 52% of patients in the United Arab Emirates 
trusted pharmacists to provide pharmaceutical consultations and 55% regard 
pharmacists as their friend. These results are promising and show that 
pharmacists who seek to offer consultation are able to gain patients’ trust and 
promote the role of the pharmacist generally. However, this study focuses on 
the more technical aspects of handing out information, and the authors do not 
prove whether good consultation alone can improve patient satisfaction.  
 
The participants showed a paternalistic approach and less engagement of 
patients in open discussion. Qualitative and quantitative findings agreed that 
participants did not (sufficiently) build up relationship with patients. Participants 
were, however, aware of the importance of building relationships when gaining 
the trust of patients and facilitating patient comfort. This reason for this 
discrepancy is more likely to be difficulties building relationships during a first 
visit, whereas regularity helps both patients and the participants to promote   
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therapeutic relationships. A study by Carter et al. (2015) finds that implementing 
a structural equation model (SEM) (Listening, Outcomes, Communication 
efficacy and Willingness) encourages patients to re-use the Home Medicine 
Review service, and this has a direct and indirect impact on patients. This 
implies that listening to patients enhances positive outcomes (the evaluation) 
and communication efficacy (indirect), and encourages a willingness (direct) to 
re-use the service. Moreover, taking direct action improves patient perceptions 
about pharmacists listening and enhances their willingness to engage 
regardless of whether they perceive positive outcomes or feel confidence.  
 
Receiving attention during medication management interviews can help to 
facilitate the patient’s decision about whether or not to persist with the services. 
White et al. (2012) find that the Home Medicine Review encourages 
pharmacists to develop good relationships with patients. In this study, a semi-
structured focus group assessed consumer perceptions of the Home Medicine 
Review. Many participants said that the HMR improves relationships with their 
pharmacists because the pharmacist gives them more attention and spends 
more time with them. Patients said the HMR gives them an opportunity to raise 
concerns and ask questions.  
 
The above explanation implies that good communication with patients is 
important. However, regularity facilitates successful relationships with patients. 
The approachable manner of pharmacists and open access to pharmacies 
needs improving.  
 
6.5.3 The Follow-Up Service 
 
The Pharmacy Guild of Australia (2010) claims that the first point of call for 
patients seeking medical advice is the pharmacy and the Royal Pharmaceutical 
Society (2015) suggest that improving pharmacist provider services may 
enhance patient adherence to medications and promote maximum efficacy. 
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Participants said that the accessibility of pharmacies generally provides 
advantages over other care settings, where (most often) booked appointments 
meet health care professionals. Participants said that meeting patients regularly 
enhances patients’ awareness of the availability of services in the pharmacy, 
and this might encourage patients to seek help from the pharmacist. For 
example, Participant 3 mentioned that patient motivated action also encourages 
the pharmacist to dedicate more time to better patient care. Reduction of the 
symptoms and willingness of patients to collect their medications probably 
encourages the participants to provide more information about lifestyle. 
 
Participant 3: (15 yrs.; qualified; F): So patients that you’ve seen a 
couple of times, that you can see, are a little bit brighter, and if 
somebody’s higher up already, that we’re talking about building up 
enough energy, because at that second one is where I’m like, right 
come on, is it working, is it not?  
 
Although accessibility is an advantage, this means that pharmacists are, 
sometimes, involved in work outside of their boundaries. The participants said 
that patients might visit their pharmacies to ask for interpretations of clinical 
tests when this role was part of the job of the physician. Moreover, they said 
some patients request medicines without consulting their physicians, as noted 
by Moja et al. (2013). Mehralian et al. (2014) find that the attitude of the 
pharmacist transforms when they gain an awareness of the community they 
work in, through knowledge or experience. Mehralian et al (2014) find that 
pharmacists in Iran lack professional status in society in comparison with other 
health care professionals. This may imply that some pharmacists cannot easily 
create a professional image for themselves in comparison to that enjoyed by 
other health care professionals in their communities. AbuRuz et al. (2012) 
explain that many pharmacists think that lack of access to patients is the major 
barrier to providing good pharmaceutical care.  
 
Pharmacists often provide advanced services which include medicine reviews 
(MURs) aimed at enhancing the patient’s knowledge of their medications in   
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order to make sure the patient is using medicines appropriately and to address 
patient concerns (Pharmaceutical Services Negotiating Committee, 2013). 
Participant 17 raised the question of obtaining the opportunity to open-up 
discussions with patients. He said that a good relationship with the patients is 
the key for opening up consultations.   
 
Participant 17: (5 months.; qualified; M):  Well we do tend to do that 
but that’s normally in a MUR setting – medicine use review and we 
sit down with the patient, we talk about those sort of questions but 
realistically and in reality that is what happens unfortunately. 
 
Participant 17 thought that this service is for people who take medicines for 
physical diseases, but he is prone to taking this opportunity to discuss 
adherence to anti-depressants. The participant said that a planned ’MUR’ 
meeting encourages patients to disclose their health issues. Some participants 
in the current research claimed they did not always have enough time to help 
every patient, and that when they do dedicate time to patients this is more likely 
to be planned time rather than ad hoc time. Indeed, McDonald et al. (2010) find 
that pharmacists undertaking MURs often experience interruptions from another 
staff member. This is mainly because it is important for the pharmacist in the 
dispensary to check prescriptions. Therefore, time dedicated to MUR often 
means less time for other activities. Although the MUR service is an opportunity 
for pharmacists to demonstrate their competence, pharmacists often use closed 
questions when meeting with patients In Australia, McMillan et al. (2014) find 
that many participants with chronic disease are unaware of and do not receive 
the Home Medicine Review. However, the responsibility of the pharmacist is to 
enhance a patient’s awareness of health care services that can promote a 
better quality of life.  
 The Satisfaction of Patients with Services Provided 6.6
 
Continuing Professional Development (CPD) (see Section 4.6) involves a 
learning activity that encourages pharmacists to reflect after observation. The   
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majority of the participants who engaged in our study said it was their intention 
to try to build good relationships with patients, and a key part of doing this was 
establishing trust. Trust happens by opening up consultations with patients and 
encouraging shared negotiation. However, this kind of learning activities does 
not always help to increase patient satisfaction. A longer period of activity was 
needed and repeated feedback might improve their practice. Wiedenmayer 
argues that it is not only important to try to improve the skills and attitudes of 
pharmacists through training, but also to implement this training in daily practice 
(Wiedenmayer et al., 2006). Indeed, pharmacists often lack time to achieve the 
goals of CPD (Power et al., 2008).  
 
It might be the pharmacists’ personal intentions influence motivation to change. 
There are many processes for individuals to pass through to change their 
behaviour. In the pre-contemplative/unaware stage people are not interested in 
change, cannot see the need to change, and have no intention of doing 
anything differently and are not aware that their life could be better. 
Contemplative is the stage in which individuals intend to change in the next six 
months. Individuals begin to think about concerns and the possible need to 
make some changes. They recognise that there are issues and that they can 
and should do something about to make their lives better (Miller, and Rollnick, 
2002) It may be that the satisfaction of patients did not increase because our 
participants are more likely to respond to workload, and are less likely to 
dedicate enough time to patients. This includes offering fewer private 
consultations to patients. Patients were dissatisfied that the pharmacists did not 
offer privacy, and this finding is supported by Chong et al. (2013 A) who state 
that less than half of patients are offered a private room and that pharmacists 
are more likely to deal with patients at the dispensary counter. Time constraints 
are the greatest barrier to facilitating good communication with people with 
depression.   
In our study, patients were less satisfied with pharmacist performance possibly 
because the participants were concerned about crossing professional 
boundaries and because the participants were not proactive in their behaviour. 
This supports a study by Morken, et al. (2008) which finds that role conflict is   
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a barrier to self-efficacy and that role conflict negatively influences the ability of 
pharmacists to counsel patients. However, Fleming et al. (2015) find that 
patients who have less expectations of the pharmacist accept less intervention 
by pharmacist. The study also finds that patients who lack familiarity with 
medication therapy management services do, at some stage, intend to ask their 
pharmacist about the management of medications. Tarn et al. (2012) find that 
patients view pharmacists as experts on medication rather than support 
services, but that patients often ask pharmacists about the appropriateness of 
the medications GPs prescribe. The patients said that pharmacists play a key 
role as intermediary between patients and physicians. However, this study does 
not address mental illness. 
 
Qualitative findings show that our participants give out information about anti-
depressants and side effects, and the few of them who do this are motivated to 
respond by patient cues. Furthermore, the results show that the participants do 
not use teach back when dealing with patients and prefer to rely on one way 
conversations and are less likely to check patient understanding, see (Section 
4.4.3; Figure 4.12); but this makes patients less satisfied. Just over half of 
patients said they were happy with the advice given about the proper use of 
medications, and less than half said they were aware of treatment related 
needs. These findings are supported by Chong et al. (2013 A) who conclude 
that pharmacists mainly provide advice about the safe and effective use of anti-
depressants rather than try to understand the patients’ medical conditions, or 
give out other non-medication advice for depression. AbuRuz et al. (2012) find 
that although community pharmacists have a positive attitude towards providing 
pharmaceutical care in Jordan, they needed more training; 80% of pharmacists 
are worried about their skills but not about knowledge they possess.  
 
There are many reasons why our participants were less willing to provide good 
service to patients. Zanna and Rempel (1988) said that the attitude is influenced 
by many cues including:  cognition (knowledge), feeling (stigma) and past 
behaviours (reluctant patients). According to self-efficacy theory, beliefs provide 
the foundation for human motivation and personal accomplishment; unless   
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people believe that their actions can produce the outcomes they desire they are 
less likely to perform them (Bandura, 1995). This may indicate that our 
participants had low levels of interest to manage depression and lacked skills. 
This discouraged the participants to place the patient at the centre of the 
consultation. Social cognitive theory states that behaviour, personal factors and 
environment factors may have an impact on willingness to provide service to 
patients. It is possible that our participants feel that the owners of the pharmacy 
encourage them to sell medications rather than offer cognitive advice (Bandura, 
1991). 
 
Learning and cognitive theory states that many different approaches influence 
people to change their behaviour, for example reinforcement, incentive and 
exposure. This may be associated with our finding that the participants are less 
likely to engage with people with depression due to lack of training 
(reinforcement) and they did not have time to offer consultation, while they were 
more willing to other profitable services(incentives), and from participants past 
experience patients were not interested to learn from our participants 
(exposure). These determinants may make our participants feel low level of 
motivation (Ogden, 2012). 
 
 Summary of Themes 6.7
 
The synthesis of data revealed issues concerning the practices of the 
participant pharmacists. 
 
The knowledge held by the participants about anti-depressants was 
satisfactory, and the participants demonstrated that they knew about the 
management of anti-depressants. However, it appeared that the participants 
prioritised giving advice about the effectiveness and safety of anti-depressants 
over providing information and advice about lifestyle. The results obtained by 
means of consultation observation and using the self-styled questionnaire 
support these findings. The quantitative data showed that our participants held   
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positive attitudes towards people with depression. However, the participants did 
not demonstrate a multi-faceted approach, and were more likely to hold 
negative views toward the management of patients’ medications. Both the 
qualitative and quantitative results show that the participants think anti-
depressants are not as safe as other social treatments that may make 
management of people with depression harder. It is more likely that the 
participants did not possess enough confidence to engage with patients 
effectively. The participants felt they found it more difficult to engage with 
people who had mental illness in comparison with those who had physical 
diseases. 
 
Another issue of current practice was time restrictions in the pharmacy. Often, 
the patients did not have enough time to dedicate to patients. The quantitative 
results show that patients were not satisfied with the amount of time the 
participants spent with them and patients indicated that they would be more 
satisfied if they had more time with the participants. The participants explained 
that, sometimes, they were not able to spend time with patients due to other 
responsibilities in the pharmacy, including undertaking work that contributed 
more directly towards pharmacy profits. This negatively influenced the 
motivation of the participants to provide additional services and to offer 
consultation services. However, the participants were often aware that they 
lacked time to spend with patients and expressed concerns that this approach 
might add to feelings of stigma experienced by patients.  
 
Other participants felt that their role was ambiguous and that they were not 
aware of some of the responsibilities of their extended role. Furthermore, the 
accounts given by the participants showed that they lacked training for talking to 
patients about depression. The participants felt that they needed extra training 
to deal with patients with depression, and these comments were consistent with 
the findings of the observations where the participants did not demonstrate 
adequate skills for engaging patients into conversation, and the participants 
were reluctant to initiate consultations. Difficulties engaging with patients 
properly did not only occur due to a lack of training or a lack of time. Another   
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factor that affected the performance of the participants was a lack of 
collaboration with other health care professionals, due to concerns about of 
professional conflict. Both patients and participants were more likely to defer to 
the authority of the physician, even when the patient and/or the participant had 
concerns about medications. 
 
Additionally, the lack of a follow-up system negatively influenced the ability of 
our participants to understand their patients and this presented challenges 
when attempting to promote patient wellbeing. Not knowing the medical history 
of patients meant that the participants were not able to tailor advice as 
effectively as they wanted to. The participants were concerned that they might 
give out information that was not relevant to the patient, or that the patient had 
anti-depressants for other conditions. Not knowing the medical backgrounds of 
patients meant that it was more difficult to undertake valuable consultations 
because pharmacists did not tailor information to patient needs. 
Although the participants claimed that they tailored information to suit individual 
patient needs, it became apparent that only a few participants actually did this.  
These results were consistent with the observation sessions with simulated 
patients. Overall, the participants were not confident when trying to individualise 
information given out to patients, and the participants used a paternalistic 
approach, rather than encouraging mutual discussion with patients. The 
participants did not try to build rapport with the patients and were more likely to 
follow their own agendas rather than prioritising the agendas of patients. The 
participants chose to focus information on guidelines about taking anti-
depressants rather than offer lifestyle or non-drug related advice. 
 
The majority of the participants did not practice using open-ended questions 
and did not implore patients to share information. Moreover, the participants 
were not very responsive to patient cues, and relied on the physician to gain the 
trust of patients. This approach negatively affected the ability of the participants 
to gain the trust of patients because it reinforced the primary authority and trust 
relationship between the physician and patient, rather than encouraging a 
similar relationship between the pharmacist and the patient, and emphasised   
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a discrepancy between patient and participant expectations. Our participants 
were most likely to make decisions on behalf of the patients. A variety of 
factors, including organisational barriers; a lack of training; a lack of confidence 
among the participants; time constraints; and perceptions about professional 
conflict meant that the participants were not able to put patients at the centre of 
a consultation. These factors served to reduce the motivation of the participants 
to provide a service that satisfied patient needs. 
 
 Implications of the Research 6.8
6.8.1 Investigating and Understanding Pharmacist Behaviour 
The study aimed to explore the current practices of the participant pharmacists 
and provide an opportunity for the participants to reflect on their practice. The 
use of multiple methods in this study ensured the validity and reliability of the 
study. The combination of methods used provided rich data, and the use of self-
reporting, interviews and observation revealed the intentions and actions of the 
participants when communicating with people with depression. The comparison 
between different themes discovered provided a greater understanding of the 
data collected. 
 
The study found that the participants were able to maximise the efficacy of anti-
depressants and reduce side effects. The accounts of the participants gained 
via interview, and through observed consultations, indicated that the 
participants had a good understanding of patient medications and that they 
could enhance the expectations of patients. However, the attitudes shown by 
the participants towards providing additional services were not as impressive as 
the pharmaceutical knowledge they possessed. 
 
The attitudes of the participants influenced their behaviour when dealing with 
patients in the pharmacy. This was evident from their audio-recorded accounts 
and the self-reporting questionnaires completed. The results showed that the 
participant pharmacists were less inclined to provide services associated with   
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the extended role of the pharmacist, and, in some situations, the participants did 
not offer consultations because of the beliefs they held. Overall, the participant 
pharmacists showed a positive attitude towards people with depression but a 
negative attitude towards carrying out the extended role of the pharmacist. 
 
Audio recording proved to be a good tool for collecting the participants’ opinions 
about patients and the services provided in the pharmacy. Furthermore, the 
recordings demonstrated that the participants were less likely to interact with 
patients who had mental illness. When dealing with people with depression, the 
participant pharmacists found it difficult to make decisions to open up the 
consultation. This may imply that they need to gain a greater understanding of 
mental illness and undertake further training in order to improve their attitude 
and approach. The links made between themes provided a rich summary of the 
approaches used by the participants. 
Another finding of the study was that the participant pharmacists often lacked 
time to dedicate to patients in the pharmacy, due to heavy workloads. This 
meant that patients were less likely to raise their concerns. Furthermore, 
organisational barriers, such as the varying skills mix between staff working in 
the pharmacy, also contributed to feelings of stigma experienced by patients. 
Patients sometimes gained a bad first impression from other pharmacy and 
non-pharmacy staff working in the pharmacy (such as till servers and 
assistants). One solution to this problem would be for all staff working in a 
pharmacy to receive training about how to deal with patient customers. Only a 
few participants acknowledged that they checked whether a patient understood 
the information given out, and the interview and observation sessions revealed 
that the majority of participant pharmacists did not check to verify whether a 
patient had understood information given out. 
 
One drawback of conducting interviews or observations is that people may 
change their behaviour or modify their opinions. However, in this research it 
became apparent that the participant pharmacists did not decide to change their 
behaviour from normal, and they appeared to provide consultations to the 
volunteer patients as if they would usually do in a real pharmacy. This finding   
 
 
 
284 
may imply that the participant pharmacists were comfortable and so did not feel 
the need to change their agenda. The application of the (MRCF) model suited 
the methods of observation used in this research. This model was useful and 
detailed enough to distinguish between the specific skills that the pharmacist 
uses. Nevertheless, some pharmacist skills rely on collaboration with physicians 
and other health care professionals in order to involve patients in their treatment 
plans. 
 
Overall, the methods used in this study assisted a successful approach towards 
gathering detailed data about pharmacist-patient communication during 
consultations, and the same methods could be used in future studies which aim 
to investigate pharmacist communication skills. 
 
6.8.2 Developing Pharmacist Training 
The participant pharmacists acknowledged that they lacked training about 
engaging with people with depression. Some of the participants were not 
confident enough to place patients at the centre of the consultation. There is the 
possibility that the participant pharmacists used the excuse of not having 
received enough training as a way of reducing negative perceptions of them 
when they showed poor communication skills. Alternatively, these participant 
pharmacists might have mentioned that they lacked training because they 
genuinely wanted to bring this issue to the attention of the researcher and 
because it would help them practically when encountering awkward situations. 
Although governments have set out policies to increase the responsibilities of 
pharmacists, there is still little available pharmacist training that specifically 
deals with the issue of mental health. However, this lack of formal pharmacist 
training may also contribute towards patients never becoming fully aware of the 
extended role of the pharmacist. 
 
A lack of collaboration with other health care professionals and with other health 
care systems made the participants feel isolated professionally. Although the 
pharmacists who took part in our study had differing levels of experience   
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working as community pharmacists, the data showed that a greater level of 
experience in the job did not necessarily correlate with increased confidence 
when dealing with patients with depression. This indicates that training at 
university incorporated early on in the training of pharmacists might be of value. 
Continuous learning (CPD) should also form an important part of ongoing 
training, as well as self-reflection for dealing with people who have mental 
illness. Patient feedback would also prove useful as part of initial and CPD 
training. The simulated patients were not shy to provide feedback by means of 
the questionnaire and did not appear to modify their answers to favour their 
pharmacist. This helped the researcher to collect rich data about the decisions 
made by the pharmacists to offer consultations, and during the consultations 
held with patients. 
 
Additional training as part of CPD would be valuable, but targeted specifically at 
dealing with people with mental illness and/or depression in order to meet 
patient needs. Furthermore, time-management or time-effectiveness training 
may be useful in order to help pharmacists meet the challenges they face when 
trying to prioritise patients, especially when they have other tasks to fulfil. The 
MRCF model demonstrates that this kind of training can be implemented into 
further research and teaching.  
 
6.8.3 Improving Pharmacy Practice 
 
The study found that possessing good communication skills are essential when 
trying to build effective relationships with patients. This includes building good 
relationships with patients at initial consultation stage and during a consultation. 
Building good relationships helps pharmacists to deliver quality and tailored 
advice confidently. Moreover, building good relationships enhances the patients’ 
willingness to receive information because good communication skills help to 
build relationships of trust. As previously discussed, pharmacists perceived that 
their patients had more trust in their physicians, and that their patients were  
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more likely to follow the advice of physicians concerning drugs, than the advice 
given by the pharmacist. 
 
However, in addition to communication skills, other factors influence the trust 
between the pharmacist and the patient, such as the familiarity the patient has 
with the pharmacist, the service and the pharmacy. All these things contribute 
towards the success a pharmacist has when approaching a patient in order to 
try to meet their needs. The pharmacists mentioned that patients sometimes 
lack an awareness of the professional abilities of the pharmacist, and this lack 
of awareness made it more difficult for the pharmacists to establish good 
relationships with their clients.  
 
Our study found that, overall, the participant pharmacists failed to offer privacy 
to patients with depression when they came into the pharmacy, and this is, 
possibly, another reason why the participant pharmacists failed to establish a 
good relationship of trust between themselves and the patients. However, the 
general environment of the pharmacy makes it less possible to offer privacy in 
comparison to other health care settings, such as the physician’s surgery, for 
example. This is why it is so important for pharmacists to use a private 
consultation room if one is available, because this helps to create a comfortable 
and confidential environment for patients to discuss their concerns. In this way, 
the patient feels respected. The patients questioned in our study said that 
privacy meant that nobody could overhear conversations taking place in the 
dispensary area. They felt that the dispensary was a place for selling and that 
the consultation room was where professional work took place. The value of a 
consultation room is that it can help to reduce the stigma felt by patients, and 
provide a welcoming environment.  
 
The participant pharmacists in our study mainly used one-way communication 
methods that did not encourage patients to express their agendas. In the 
structured consultations used in our study, the participant pharmacists were 
more likely to display paternalistic behaviour, and they did not give patients the 
opportunity to share their concerns (6.5.2). In turn, patients were not able to   
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raise concerns about their medications. This paternalistic approach reduced the 
likelihood of patients adhering to medications. The patients looked for other 
treatments to fit in with their lifestyles and reduced their symptoms, and one of 
the best ways to ensure this set of circumstances is to encourage pharmacists 
to engage with patients in mutual sharing in order to optimise the benefit of 
medications.  
 
 Future Work 6.9
The results found that the participant pharmacists experienced time constraints 
when working in their pharmacies, and this affected their communication style 
and performance. Future studies might wish to observe and compare 
communication styles using a simulated patient scenario covering both 
conversations held at the dispensing counter (in the presence of other people), 
and those held privately in the consultation room.  This might provide feedback 
to the pharmacists about the feelings of the simulated patients in both situations 
(when they receive advice in the consultation room and at the dispensary).  
 
Another suggestion for further study is monitoring the documentation completed 
by the pharmacist during consultations, including computerised record input 
and/or manual entries in a diary. In our study, when the participant pharmacists 
asked patients about their medical histories, they mostly relied on memory to 
construct consultations and this did not help when they were trying to build 
rapport with patients. Sometimes they forgot what patients had previously told 
them. Written and computerised record keeping is essential in pharmacy 
practice, but it is also possible for pharmacists to become distracted from 
keeping accurate records, and this is another area worth investigation. This 
study identified the MRCF model as applicable for assessing pharmacist-patient 
consultations. It is valid model and it suited the pharmacist led consultation 
sessions, unlike other models that have a rigid design for the study of 
physicians, and their skills.  
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 Strengths and Limitations 6.10
As with any other research, there are several limitations to this study. The 
sample of the pharmacist participants recruited to take part in the qualitative 
study were not necessarily representative of the wider population, because the 
research aimed to collect rich information connected to the profession of 
community pharmacist.  The community pharmacists recruited to the study 
expressed a wish to enhance their practice in areas such as offering 
consultation services, and as part of the study, the pharmacist participants were 
responsible for recruiting patient participants. However, this approach opened 
up the research to bias because the pharmacists were freely able to recruit 
patients with whom they have good relationships, and who may have favourable 
views of the services offered by the pharmacists. 
 
The researcher had difficulty recruiting pharmacist participants. When piloting 
the study, this problem did not occur, but upon commencement of the actual 
research, it was difficult to recruit the required number of pharmacist 
participants, even when the researcher sent out emailed invitations to many 
people, and to different community pharmacies. This posed a problem because 
the researcher had a limited amount of time to conduct the research. However, 
sending out emailed reminders and expanding circulation of the invitation email 
to different pharmacies helped to solve this problem. 
 
Overall, the pharmacists who took part co-operated with the researcher in order 
to dedicate time to assess the questionnaires prior to starting the recorded 
mock pharmacy sessions, and they were punctual in attending the sessions. 
However, some pharmacists did not want to participate in the study for a 
number of reasons, including a lack of time and nervousness due to the process 
of recording and observation. None of the pharmacists approached indicated a 
lack of interest in the study, and put forward other reasons for not wishing to 
take. Difficulty experienced engaging pharmacists in this kind of research have 
been reported by other researchers (Mehralian et al., 2014). Previous 
researchers note similar reasons for non-participation. The exact reasons why 
some pharmacists are reluctant to take part in research is unclear, and can be   
 
 
 
289 
due to a variety of reasons, including a lack of interest, being busy, or lack of 
remuneration, but these are inevitable barriers. 
 
The participant pharmacists did not find it difficult to recruit patients to complete 
the before and after intervention questionnaire, mainly due to the high number 
of people suffering from depression who came into their pharmacies. 
Pharmacists chose patient samples according to convenience rather than in a 
random fashion, and this system of choosing is one of the limitations of the 
research. This system of choosing has the potential to introduce bias into the 
research, because the pharmacist may well have chosen patients whom they 
felt might give them a favourable review.  
 
The study combined a quantitative and quantitative approach in order to ensure 
robustness and strength, and to facilitate a thorough exploration of the opinions 
and perceptions of the patients. The use of different methods enhanced validity 
and reliability. As previously discussed in the chapter dealing with methodology, 
the presence of a researcher during the recorded consultations may have 
influenced the behaviour of the pharmacist participants. It is possible that the 
participants tried to perform at their best, and/or displayed particular 
characteristics due to the presence of the researcher. Furthermore, the 
participants may have felt nervous because they were being audio recorded, 
and this might have affected their behaviour. Prior to starting the mock 
pharmacy sessions, the researcher spoke to all the participant pharmacists to 
explain the benefits and aims of the study, and in order to build up a rapport 
with the participants in order to make them feel more comfortable. Furthermore, 
ensuring the comfort, confidentiality and agreement of the patients who took 
part in the research was also important.   
 
The researcher in this study did not have any direct contact (in the role of 
pharmacist) with the patients during the consultations. Instead, the researcher 
worked out in the pharmacy to make some noise similar to the real pharmacy. 
The same researcher conducted all data collection and analysis throughout the 
study, so that there were, therefore, no problems with inter-researcher reliability.  
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However, this situation can serve to introduce an element of bias, based on the 
thoughts and ideas of the researcher, and so a volunteer supervisor checked 
the coded data to enhance reliability and check for researcher bias. 
 
The study collected a large amount of valuable data. A large sample of patients 
took part, totalling 160. This provided substantial and valuable data about their 
experiences and levels of satisfaction with the services provided by the 
participant pharmacists. As part of the experience questionnaire, the patients 
indicated that they wanted a greater degree of mutual shared decision making 
to occur between themselves and the pharmacists, this occurred when patients 
less satisfied with the provision of the pharmacists, possibly it was found only of 
patients who were generally satisfied from the services received by 
pharmacists. 
 
The sample size of participant pharmacists was small, totalling 22 pharmacists, 
but the data obtained indicated that audio recording the pharmacist’s opinions 
was a reliable method to adopt in addition to the use of patient self-reporting. 
The data collected showed that the pharmacists had good knowledge about the 
effectiveness and safety of anti-depressants, but data collected about attitudes 
indicates that the pharmacists need to modify their views about certain aspects 
of depression and their behaviour towards patients in order to meet the 
standards of NICE guidelines. Overall, the participants demonstrated a positive 
attitude towards depression, but were not able to translate these beliefs into 
good service practice. 
 
This is the first study to enable a comprehensive analysis of the services 
community pharmacists provide to people with depression. As part of the 
research, participants were able to reflect on their current practices when using  
the MRCF (3.3.8). Previous research uses models for consultation designed for 
physicians, but for this study employs a model designed for pharmacists. 
Furthermore, the accounts obtained from the pharmacists using audio recording 
facilitated an in-depth analysis and revealed the many challenges that 
community pharmacists face when dealing with people with depression.  
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 Conclusion 6.11
In this study, the participant pharmacists showed they had substantial 
knowledge about anti-depressants and were able to provide information about 
anti-depressants to patients. The pharmacists were able to answer patients’ 
questions concerning their treatments, and, in order to set the scene for the 
consultation, all of the pharmacists asked patients about their reasons for taking 
medications and about the patients’ experiences with their medications. This 
initial engagement was one of the strengths of the participant pharmacists. 
However, although the majority were keen to give advice to patients about anti-
depressants, very few were interested in trying to raise patients’ awareness of 
social and lifestyle treatments. It is more than likely that the pharmacists held 
prejudices about people with depression, and this influenced the pharmacists’ 
willingness to provide additional support.  In the study, the pharmacists failed to 
take proactive behaviour, and, so, patients were less involved in the 
consultation.  The current study proves that patients are most likely to collect 
their medications from the pharmacy (which may be located far from their 
home) and they do not linger talking to pharmacists in the pharmacy. However, 
this behaviour does not give pharmacists the chance to initiate conversations 
about the quality of care, and it encourages pharmacists to be judgemental 
about the needs of patients.  
 
The participant pharmacists experienced time constraints and so were not able 
to give enough time to patients. This approach served to enhance perceptions 
of stigma among patients. Furthermore, adequate liaison with other healthcare 
professionals did not take place for a variety of reasons, including the inability of 
physicians and patients to perceive the extended role of the pharmacist. This 
led to hierarchical conflicts and low expectations from patients. In turn, this 
affected the participant pharmacists’ style of communication. It is more than 
likely that collaboration with other healthcare professionals can enhance 
patients’ expectation about the pharmacist’s extended role, especially if 
pharmacists need to work with patients and physicians to design treatment 
plans for patients. The participants in this study lacked self-efficacy when 
consulting people with depression and lacked the confidence to open up mutual   
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discussions with patients, and this led to discrepancies in expectations between 
pharmacists and patients about individual responsibilities. 
 
Pharmacists encounter many challenges when communicating with people with 
depression. The balanced use of closed and open questions is crucial to 
pharmacists’ effective communication with patients and for building good 
pharmacist-patient relationships. This balanced approach helps to make the 
patient comfortable and more confident to discuss certain subjects with the 
pharmacist. Building good relationships enables the pharmacist to encourage 
patients to form and communicate agendas, and enhances patient expectations 
of the abilities of pharmacists. Building good relationships is also important for 
improving pharmacists’ awareness of the responsibilities of their extended roles. 
However, pharmacists must take care to ensure the privacy of patients. 
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 Appendices 
Appendix-1: Anti-depressants Medications for Treatment of Depression 
Class of anti-depressants Date of 
Introduction 
Type of side effects 
Selective serotonin reuptake 
inhibitors (SSRIs) (Healy, 1997) 
 e.g.: Sertraline and Citalopram 
1987  Sexual effects 
 Gastrointestinal effects 
Serotonin and noradrenaline 
reuptake inhibitors (SNRIs) (Beck 
and Alford, 2014) 
 e.g.: Duloxetine and Venlafaxine  
1993  Increase blood pressure 
 Nausea 
 Dry mouth 
 
Tricyclic antidepressants (TCAs) 
(Beck and Alford, 2014) 
e.g.: Imipramine and Desipramine 
 
1957  Slight tremor  
 Fast heartbeat 
 Constipation, sleepiness 
Monoamine oxidase inhibitors 
(MAOIs) (Beck and Alford, 2014) 
e.g.: Phenelzine and Isocarboxazid 
1957  Dry mouth 
 Nausea, diarrhoea or 
constipation 
 Headache 
 Drowsiness 
 Food interaction 
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Appendix-2: Self-help Charities Signpost 
 
 
 
  
Title Online address 
1. Centre  for 
Mental Health  
http://www.centreformentalhealth.org.uk/ 
2. MIND http://www.mind.org.uk/information-
support/legal-rights/clinical-negligence/ 
3. Mindfulness  https://www.mentalhealth.org.uk/a-to-
z/m/mindfulness 
4. Rethink Mental 
Illness 
https://www.rethink.org/about-us 
5. SANE http://www.sane.org.uk/how_you_can_help/san
e_community/ 
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Appendix-3: Search Strategy 
  
In the current study the researcher focused on four databases: Web of Science, 
PsycINFO , Medline and the Cochrane Library. Web of Science, PsycINFO and Medline 
are databases where primary research is indexed. The Cochrane Library is associated 
with systematic and meta-analyses, which explore the answer to precise questions in 
critical appraised articles. The search terms used in these databases included both 
free text terms and thesaurus terms (e.g. MeSH). The free text terms were used with 
truncation; while the thesaurus terms (as suggested by the subject librarian) were 
used without truncation. In PsycINFO the terms used were: (pharmacist* AND MM 
"Communication Skills" OR MM "Language Proficiency" OR MM "Rhetoric" OR MM 
"Writing Skills" AND MM "Major Depression" OR MM "Dysthymic Disorder" OR MM 
"Endogenous Depression" OR MM "Postpartum Depression" OR MM "Reactive 
Depression" OR MM "Recurrent Depression" OR MM "Treatment Resistant 
Depression") (depress* OR antidepressant* OR anti-depressant* AND pharmacist* 
AND communication*). The search terms in Medline were: (depress* OR 
antidepressant* OR anti-depressant* AND pharmacist* AND adheren* OR complian* or 
concordan*). The Web of Science terms used were: (community pharm* AND 
consultation AND willingness) (Attitude AND knowledge AND pharmacist AND 
depression) (communication* skill* AND pharmacist* OR pharmacy OR pharmacies) 
AND (depress* or antidepressant* or anti-depressant*). (Pharm* AND confidence* AND 
depress*) (Pharmacist and communication skills and consultation)  (Pharmacist AND 
consultation AND depression). In the Cochrane Library the terms used were: 
pharmacist* AND (depress* OR antidepressant* OR anti-depressant*). All these 
searches identified 153 articles and 2 systematic reviews. Of these 153 articles, 23 
were fully reviewed because they are relevant to the current research. All studies 
published in databases were included except those based only on personal 
experience and non-English studies if they were not translated to English. 
Furthermore, thesis and books were included. Randomised controlled studies were 
chosen if they were relevant to the current research project and relevant to the United 
Kingdom’s context, e.g. European studies. However, studies conducted in Middle East 
countries (whilst counter-cultural) enable us to make comparisons with the United 
Kingdom and were used. Survey methods were included, for example to assess the 
attitude of the pharmacist in the pharmacy. This type of study is relevant to one This 
type of study is relevant to one objective of current study i.e to assess the attitude of 
pharmacists in practice. 
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Appendix-4: Meeting Conducted with People who had Depression in 
‘Mind’ 
 
 
I met with recovering people in ‘Mind’, which is a medical charity aimed at 
providing advice and support that empowers individuals experiencing mental 
health problems. The aim of the meeting was to engage these people as 
collaborators in developing our study, and enhance awareness of the patient’s 
requirement concerning health care services. One of the assessment tools for 
the services provided to the patients was a satisfaction questionnaire, which is 
used in the current research. This assessment tool provides a view about the 
extent to which people with depression are satisfied with the ‘consultation’ 
service provided by the pharmacist. Some of Mind members raised their 
concern about pharmacists not being helpful and not showing proactive 
behaviour to help patients. Rather, they viewed the pharmacists as just a 
dispenser who tended to be busy and avoided helping the patients. Even 
though the pharmacist was available to help the patients, sometimes the 
patients were likely to be nervous to ask him or her anything. They would also 
think the pharmacist was not interested in delivering health care services. 
Many of the patients revealed not knowing about the pharmacy consultation 
room and wondered whether the room was actively used for pharmacy 
consultations. They stated that they perceived high stigma and were not happy 
to ask the pharmacist for a consultation or for any advice. Moreover, having 
some symptoms of depression and having negative moods associated with 
this played a large impact when asking the pharmacist for help. They stated 
that the issue of not knowing what the pharmacist could offer, this attitude 
reduce their expectation of services pharmacists could provide. This issue of 
pharmacists not offering a consultation service to patients, was not only 
associated with new patients visiting the pharmacy for a prescription, but also 
with regular patients who visited the pharmacist for refilling prescriptions, 
without being asked if they were happy with the medication. In addition, 
pharmacists did not ask the patients for any signs of improvement they had. 
This could add to their concern that the pharmacists were not interesting in 
monitoring and managing them. Some of these patients take many medicines 
at the same time, and have growing concern whether they will receive 
medication that will work well together. 
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Appendix-5: Informal Interview with Practitioner 
 
  
Interview with J T 
I met with J T, Pharmacist and Participant 2, on the 17 August 2015 to ask 
him some questions about how he deals with patients with depression who 
come into his pharmacy. The interview covered what kind of information he 
provides about anti-depressants, his communication style, and what skills 
he uses when he talks to people with depression. 
1. Initial Communication with the Patient 
He said that he tries to focus on patients who have recently been 
prescribed anti-depressants but he also tries not to forget repeat 
prescription patients. He always asks patients ‘Are you OK?’ He said he is 
keen to meet with newly prescribed patients personally, rather than leaving 
them to be dealt with by another technician. On first meeting a patient, the 
first thing he does is to find out if the prescription relates to the person he is 
speaking to, rather than someone else. Then, if he is speaking to the 
patient themselves, he will offer a consultation.  
2. Communication with the Depressed Patient 
He said that he prefers to invite patients for a consultation rather than 
insisting on having one in order not to inflame the temper of patients or to 
trigger symptoms which might prevent the patient from accepting the offer. 
He said that the patient needs to be willing to listen in order to elicit a 
positive result. If the patient feels reluctant to engage in a consultation then 
said he tries to find an opportunity to give out important and basic 
information to the patient about their course of treatment. He said this 
helps to build trust for when the patient comes to the pharmacy again. said 
that, in his experience, patients remember critical pieces of information 
supplied to them and this information can be used to good effect on their 
next visit.  
 
 
 
 
 
319 
He explained that if the patient shows no co-operation then he will try to be 
as acessible as possible so as to encourage them, on some level, to be 
able to enquire about problems and obstacles comfortably in the future. 
Also, He said that some issues need the patient to be able to collect their 
thoughts between their first and their next visit in order for a positive 
outcome to be achieved.  He said that the next patient visit might be better 
than the first visit, and this helps him to be able to bridge the gap and to 
offer a consultation that will be accepted. The aim is to help the patient to 
understand the necessity and goals of a consultation in order to optimise 
treatment for those who take anti-depressants. 
3. The Use of Non-verbal Contact (Such as ‘Eye Contact’) 
He observed that some of the newly prescribed patients look worried when 
they first visit the pharmacy, so he uses eye contact to create a rapport 
with the patient and to try to ascertain whether the patient is trying to seek 
help, and this helps him in his professional work and to communicate with 
the patient efficiently.  
4. Initial Communication between the Pharmacist and the Patient when 
Dispensing  
He said that he identifies himself to the patient and asks ‘Are you Ok’ in 
order to get the patient’s attention so he can evaluate the patient’s 
responses quickly. Then, this contact is used in order to frame advice and 
to offer a consultation. He said that he feels that posture and gestures are 
important when standing at the counter and that he changes posture and 
uses gestures to convey openness or to indicate there is a private room to 
talk in. This helps him to communicate that any information shared will 
remain private and confidential, should the patient wish to use the 
consultation room. 
5. The Reflections and Responses of the Pharmacist 
He explained that some clients are shy when visiting a new pharmacy. He 
said, ‘Some patients say that they usually pick up prescriptions from a 
pharmacist that is far away from their home.’  
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He said that picking up on these kinds of messages helps him to 
establish whether the patient is shy or feels any stigma.  If he feels that 
the patient lacks important information, has not had a consultation 
before, or shows concerns and fears, then he will offer a consultation. 
He said that patients often visit pharmacies further away from home so 
that they are not recognised by others locally. 
6. The best ways of communicating with a patient when providing a 
consultation: He said it was important for a pharmacist to use empathy 
particularly with new patients and to convey knowledge but that neither 
of these skills is sufficient to build up trust with a patient. Patients using 
anti-depressants suffer from symptoms that concern them both 
clinically and socially, and they need a provider to be sympathetic.  He 
said it is important to show genuine compassion and empathy because 
pharmacists who fake empathy can lose their customers to other 
providers. He said that if patients perceive they are being criticised or if 
the pharmacist forgets that the patient can recognise real compassion 
from fake compassion then this might impact on whether the patient 
takes their medication, and this can have a negative outcome. Also, 
this behaviour can have a negative effect on the professional life of the 
pharmacist. 
7. Conducting an MUR: The Perception of the Patient : He said that 
patients are now becoming more familiar with receiving an invitation to 
come and have a Medicine Use Review and so they are more willing 
to engage with the pharmacist when asked. However, patient 
responses very much depend on how this review is conducted. Time 
can limit the opportunity to relate meaningfully with a patient, but small 
pieces of information relating to their medication and giving the patient 
a sense that you ‘do care’ can make a big difference to the individual. 
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8. The Patient’s View towards the Pharmacist: He said that patients now 
view the pharmacist as more than just the person who ‘dispenses their 
prescription’ but that this perception is usually built over time. The longer 
you have served at an individual pharmacy, and the more accessible you 
are, then the greater the trust and respect that is shared between the 
patient and the pharmacist. However, He mentioned that some patients 
convey the attitude that no-one listens to their expectations or concerns, 
and, therefore, it is important to ensure that this kind of patient receives 
good knowledge about their treatment. 
 
However, He mentioned that some patients convey the attitude that no-
one listens to their expectations or concerns, and, therefore, it is 
important to ensure that this kind of patient receives good knowledge 
about their treatment. 
 
9.The style of Communication Used  
He said that every patient has their own communication style and that for 
every reaction from the patient there is an individual response from the 
pharmacist. This means that communication should be tailored for every 
patient. 
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For patients who feel stigma, then the pharmacist should try to focus on 
confidentiality at the beginning to build up comfort, but for a patient who is 
unsure of the role of the pharmacist, then the pharmacist should seek to 
reassure the patient that they are working side by side with doctors and 
nurses to treat the patient well, and this includes providing information 
about the correct use of medicines and how to cope with the treatment in 
their lives.  Moreover, for patients who show concern and are worried, the 
pharmacist must use empathetic behaviour to encourage socialisation.  
10. Conclusion 
From the interview conducted with His, conclusions can be drawn as 
follows: 
1. Patients can memorise some information from the provider, and they 
can gather and set insights for their next visit to the pharmacy relating to 
the impact of symptoms and vital information they need from the 
pharmacist. 
2. Patients are looking for help from a person they can trust and they 
want to obtain information under conditions of privacy otherwise they are 
reluctant to enter into a consultation. Additionally, patients who take anti-
depressants are sensitive and can differentiate between genuine 
empathy and faked empathy, and this is important for the pharmacist to 
know because it can affect outcomes.  
3. Pharmacists who are skilful can offer consultations and advice using 
the right soft skills that are necessary to be empathetic, provide 
knowledge, and to deliver knowledge well. The pharmacist must be able 
to consider the most appropriate behaviour to acquire the satisfaction of 
the patient, and be able to deliver accurate information at the same time. 
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Appendix-6: Scenario Designed for an Actor  
To perform the role of depressed patient Information for the simulated patient 
 
 
1- Patient profile 
 You are male, your name is Jim (you could say your name 
silently and if the pharmacist asks you again, try to be slightly 
nervous) 
 You are 50 years old and British 
 You live alone and you have no children 
2- What you are suffering from: 
 
 You have visited the pharmacy to collect your prescription for 
anti-depressants and the G.P. said you have depression. 
 
Do not reveal information unless the pharmacist asks. 
 
3- Symptoms: 
 Feeling constantly tired, disturbed sleep 
 Complaining of various aches and pains 
 Want to stay in bed because it feels ‘safe’ 
4- History: 
 No allergies 
 You have never been diagnosed with depression 
 You are often tired, which may be related work ‘you are not 
sure as to the cause’ 
 If the pharmacist asks you about sleep, say sometimes I feel 
it’s difficult to get off to sleep and early morning waking 
 You normally sleep around ‘9’ hours but now you sleep nearly 
5 hours and even when you sleep you do not feel refreshed 
5-  Treatment 
 You have not had any treatment before 
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 Now: Ask the pharmacist what the prescribed treatment is? 
o S/he may answer, “The treatment is sertraline once a 
day. It belongs to a group called selective serotonin 
reuptake inhibitor.” 
 Then ask the pharmacist about the medicine in detail 
o How does this medicine work? 
o Will I get any side-effects? 
o How bad will the side effects be? 
o How many times a day should I take the medicine? 
o When am I going to feel better? 
o How long should I take the medicine for? 
6- Consultation 
During consultation be aware: 
 The pharmacist should give you enough information about the 
treatment such as, the duration of the treatment to feel the 
efficacy, some side effects. 
 The pharmacist should advice you about food and life style 
 The pharmacist should tell you how to approach him/her. 
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Appendix-7: Pharmacist Knowledge Questionnaire  
The following statements are about your knowledge of depression and its 
management. When options are provided, please mark (X) the box to indicate 
your answer(s). For other questions, please write you answer in the space 
provided. 
Please answer these questions briefly 
 
1. State the names of three classes of anti-depressant medication. 
 
 
 
 
2. What is the mechanism of action for SSRI medication to treat 
depression? 
                   Mark (X) 
Serotonin-norepinephrine reuptake inhibitor  
                  Selective serotonin reuptake inhibitor  
        Norepinephrine and dopamine reuptake inhibitor  
 
3. State three clinical indications for SSRI medication. 
 
 
 
 
 
 
4. After starting SSRI medication, how soon will a typical patient 
experience the full therapeutic effect? 
                 Mark (X) 
Within one month  
1-2 months  
 3 or more months  
 
 
5. Are newer classes of anti-depressant medication (e.g. SSRIs) more or 
less effective than older classes (e.g. TCAs)? 
                  Mark (X) 
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                   ‘Yes’ newer are more effective  
                    ‘No’ newer are less effective  
                    Classes have similar effectiveness  
 
6. Do newer classes of anti-depressants medication (e.g. SSRIs) have 
fewer side effects than older classes (e.g. TCAs)? 
 Mark (X) 
‘Yes’ newer have fewer side effects  
‘No’ newer have more side effects  
Classes have ‘similar’ side effect profiles  
 
7. Do newer classes of anti-depressants medication (e.g. SSRIs) have 
less harmful side effects than older classes (e.g. TCAs)? 
 Mark (X) 
‘Yes’ newer class have less harmful side effects  
‘No’ newer class have more harmful side effects  
Classes have ‘similarly’ harmful side effects  
 
8. Many side effects are common to both SSRIs and TCAs. Please mark 
(X) the appropriate column(s) to show which medication causes which 
side effect(s). 
 
 SSRIs TCAs 
 a dry mouth   
 nasty indigestion   
 fast heartbeat   
 sexual function   
 constipation   
 weight gain   
 sleepiness   
 a slight tremor   
 
9. Do anti-depressant medications affect the patient’s ability to drive or 
operate machinery? 
 Mark (X) 
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Yes  
No  
Don’t know  
 
10. Can patients become addicted to anti-depressant medication? 
 Mark (X) 
Yes  
No  
Don’t know  
 
11. Can SSRIs anti-depressants, promote suicidal feelings? 
 Mark (X) 
Yes  
No  
Don’t know  
 
11a. If ‘Yes’, then when?  
 
12. For a typical patient, how long is a course of anti-depressant 
medication? 
 Mark (X) 
3-6 months  
7-8 months  
More than 8 months  
 
13. What other forms of treatment are recommended by NICE for 
depression? 
 
 
 
Thanks 
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Appendix-8: Pharmacist Attitude Questionnaire  
The following themes and statements are about your attitude towards 
depression and its management. For each statement, please mark (X) the box 
that most closely matches your own level of agreement. 
1= Strongly Disagree, 2 = Disagree, 3 = Uncertain, 4= Agree, 5= Strongly Agree 
 
Themes and Statements 1 
SD 
2 
D 
3 
UC 
4 
A 
5 
SA 
Attitudes towards the nature and 
treatment of depression (treatment 
approach) 
 
1. Patients with depression need to pull 
themselves together to get over it. 
     
2. Depression mainly has psychological 
causes. 
     
3. Anti-depressants are addictive.      
4. Most patients with depression will get better 
without treatment. 
     
5. Children cannot suffer from a severe 
depression. 
     
6. Patients with depression need support and 
understanding from the people around them. 
     
7. Depression is not a real disease.      
8. Patients with depression generally do not 
understand information about their 
medication. 
     
Attitudes toward the course of depression 
(prognosis, evitable versus inevitable) 
 
9. Depression mainly has biochemical causes.      
10. Depression cannot be completely cured      
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 1 
SD 
2 
D 
3 
UC 
4 
A 
5 
SA 
11. Patients with depression benefit most 
from treatment with anti-depressants 
rather than psychotherapy. 
     
12.   Symptoms of depression are normal in 
older age. 
     
Attitude towards the pharmacists' role in 
care (role) 
 
13. Patients with depression receive all 
necessary information about this disease 
from their general practitioner or 
psychiatrist. 
     
14. Patients with depression do not want to 
talk about this with a pharmacist. 
     
15. Depression is a disease like any other.      
16. Patients with depression receive all 
necessary information about their 
medication from their general practitioner 
or psychiatrist. 
     
17. Patients with depression generally do 
not stick to advice given by providers 
about their medication. 
     
18. Patients with depression benefit most 
from psychotherapeutic treatment rather 
than anti-depressants. 
     
Attitude toward patients with depression 
(patients) 
 
19. ADs can change one's personality.      
20. Patients with depression put a strain on 
pharmacists. 
    
21. Patients with depression are unreliable.      
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22. Most episodes of depression stem from 
negative life events. 
     
23. Weakness of character can cause 
symptoms of depression. 
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Appendix-9: Patients’ Satisfaction Questionnaire before the Action Plan 
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Appendix-10: Simulation Venue: A Mock Pharmacy 
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Appendix-11: Skills Checklists during the Simulations 
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Appendix-12: Gibbs’ Model of Reflection ‘post-simulation’ 
 
The reason/s for participating 
 
Description This is the context of the event e.g.  
 Who was there? 
 Why were you there? 
 What was happening? 
 
Feelings 
thoughts 
 
This is self-awareness e.g.  
 How did you feel at the time?  
 What did you think at the time?  
 What did you think about the incident 
afterwards? 
 
Evaluation Consider your judgments e.g. about what has 
happened. Consider 
 What was good and not so good about your 
experience or did not go so well? 
 
Analysis  What went well? 
 What did you do well? 
 What went wrong or did not turn out? 
 How it should have done? 
 
Conclusion  What you could have done differently? 
 
 
Action plan  Would you act differently or would you be likely 
to do the same? 
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Appendix-13: Action Plan 
 
Structure for CPD recording for entries starting at reflection 
Name of entry:  
Date entry started:  
Reflection on practice (Identifying what you want to learn and why). 
 
What do you want to learn? 
What you need to learn may be new knowledge, skill(s), or a new attitude – 
anything that you think will make you better able to do your job as a 
pharmacy professional or prepare you for a new service or role. You should 
be as specific as possible. 
 
 
 
 
 
 
How is this learning relevant to the safe and effective practice of pharmacy 
and to your own scope of practice? Explain how you chose what to learn and 
why. this bit of learning is relevant to your practice as a pharmacy 
professional. 
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Tick one or more methods that you used to identify what you needed to 
learn.  
Critical incidents   
Audit 
Appraisal   
Feedback from users of service/products 
Peer review/talking to colleagues  
 Reading 
Personal interest  
Other 
 
Planning your learning activities (Identifying priorities) 
 
When will you need to have achieved this learning? (dd/mm/yy) 
Putting an estimated date may help you to set priorities for your learning. Be 
as specific as possible, but do not worry if the date is just an approximation. 
Why is this learning important to you and your practice? 
Write a brief description of how this learning will affect you, your service 
users, your colleagues and your organisation. If you do not think that your 
learning will have a significant impact on anyone, you might want to consider 
why you are undertaking and recording this learning. 
 
 
 
 
 
You can use the scale below to rate the importance of this learning, but you 
also need to fill in the box above too. 
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What might you need to do in order to achieve this learning?  
It is important for you to consider a range of options for achieving your 
learning. Aim to list a few different options e.g. attend workshops, study 
open learning packs, talk to colleagues. Outline what you think are the 
advantages and disadvantages of each option. You may not choose to 
complete all the options that you have listed, but it is important to show that 
you have considered them. 
 
 
 
 
 
 Low Moderate High Very 
high 
None     
Importance to you     
Importance to the users of 
your services or products 
    
Importance to colleagues     
Importance to organisation      
Option  Description of 
different options  
 
Advantages  
 
Disadvantages  
 
Select ✓or x 
1.      
2.      
3.      
4.      
5.      
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Action: 
When did you complete the activities outlined in your plan? 
Record the date you completed the activities that you chose from your plan. 
If you need to keep a continuing education record for other organisations 
then you may find it useful to jot down how long each activity took, but this is 
not a requirement. The number in the option column should correspond to 
the options you selected in the question above (P3). 
 
What have you learnt? 
Describe what specific skill, knowledge, attitudes and/or behaviours you 
have gained from your learning. This may be different to what you originally 
set out to learn. 
 
 
 
 
 
 
Evaluation (Reflecting on learning) 
 
 
Have you been successful, what are the benefits? 
To what extent did you learn what you set out to learn at the start of this 
CPD cycle?  
Option  
 
Description of what you did  
 
Date completed  
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You may find it useful to revisit the ‘Reflection’ page and decide on what you 
originally wanted to learn before you decide to what extent you have 
achieved that learning.  
 Fully  
 Partly 
 Not at all  
If you ticked fully or partly, give an example of how you have applied or how 
you intend to apply what you have learnt to your practice. 
Putting learning into practice is a good way to prove that you have actually 
learnt what you set out to. It may be a while before you apply what you have 
learnt. It is fine to leave this box blank and come back to it when you have 
had a chance to put your learning into practice. 
 
 
 
 
 
 
 
 
If you ticked ‘fully’ or ‘partly’, what have been or what will be the benefits of 
this learning to your practice?  
You might find it useful to revisit your ‘Planning’ page and consider how you, 
your service users, your colleagues and your organisation have actually 
benefited or will benefit from your learning. Do include any feedback about 
your practice, formal or informal, that you have had from other people. 
 
 
 
 
 
 
If you ticked ‘partly’ or ‘not at all’, describe what it is you still have to learn.  
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You may find it useful to revisit the ‘Reflection’ page and check on what it is 
you originally wanted to learn before you describe what it is you still need to 
learn. 
 
 
 
 
 
 
If you ticked ‘partly’ or ‘not at all’, explain why you think you did not achieve 
your learning.  
You may find it useful to revisit the ‘Reflection’ and ‘Planning’ pages to work 
out why you did not achieve everything you set out to learn. It is all right for 
you not to have achieved all of your learning, but it is important that you 
explain why. 
 
 
 
 
 
 
If you ticked ‘partly’ or ‘not at all’, what do you intend to do next? 
o Nothing, I’ve learnt enough for what I need 
o Review to see if I can complete what I want to learn within this CPD cycle 
o Start a new CPD cycle and complete what I want to learn. 
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Appendix-14: Patients’ Satisfaction Questionnaire after Action Plan 
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Appendix-15: The Demographics of the Participants 
 
 
  
Participants Age  
(Yrs.) 
Gender Total 
qualified 
experience 
(Yrs.)  
Experience in 
community 
pharmacy 
(Yrs.) 
Experience in 
other health 
settings (Yrs.) 
Academic 
experience 
(Yrs.) 
1 28 Male 5 5  3 (hospital) 2 
2 35 Male 12 12  7 
3 37 Female 15 15  5 
4 23 Female - -   
5 24 Male - -   
6 24 Male - -   
7 32 Male 8 8   
8 33 Male 7 7   
9 28 Male 4 4   
10 33 Male 11 11   
11 42 Male 18 18   
12 28 Male 2 2   
13 24 Male 0.5 0.5   
14 24 Male 3 1   
15 28 Male 3 3   
16 35 Male 8 8   
17 24 Male 0.5 0.5   
18 28 Female 3 3   
19 28 Male 3 3   
20 29 Male 3 3   
21 26 Female 2 2   
22 33 Female 10 10   
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Appendix-16(A): Approval of Ethics Reviews for Community Pharmacists 
Participation 
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Appendix-16(A): Approval of Ethics Reviews for Community Pharmacists 
Participation 
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Appendix-16(B): Approval of Ethics Reviews for Community Pharmacists 
Participation 
 
 
 
 
349 
Appendix-16(B): Approval of Ethics Reviews for Community Pharmacists 
Participation 
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Appendix-17: Application form for Research Ethics Approval  
 
    
 
APPLICANT’S ETHICS CHECKLIST 
 
This checklist is designed to help you to decide whether or not ethics approval is required 
and, if required, to decide on the appropriate ethics review procedure –  
please read guidance on page 5 before you complete the form 
 
Who should use the checklist?      
A checklist should be completed for all empirical research projects involving people, by the 
Principal Investigator [PI] or the Principal Supervisor [PS] in the case of a supervised student 
research project.  
 
Guidance on the 2 different ethics review procedures that together make up the University’s 
Ethics Review System (i.e. ‘University’ and ‘NHS’) is available on the University Ethics website 
 
If the project involves human tissue/biological fluids you should contact the University human 
tissue bank for advice in the first instance.  Contact Ethical Tissue on 01274 235897 or visit 
www.ethicaltissue.org  
_____________________________________________________________________
_______ 
 
Project Title: Improving communication between pharmacists and people with 
depression 
………………………………………………………………………………………… 
 
Name of Principal Supervisor: Dr. Jonathan Silcock 
……………………………………... 
 
Contact Details – email address j.silcock@bradford.ac.uk 
 
Department/School:  School of Pharmacy, Pharmacy Practice Research 
………………………………………………………………………………. 
 
Name of Student/Principal Investigator: Adel Alshammari(PhD Student) 
 
Contact Details – email address aalshamm@student.bradford.ac.uk 
……………………… 
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Summary of Project (max 150 words): 
 
  
SUMMARY OF PROJECT (max  150 words) 
 
Depression is one of the most common mental illnesses affected people of all ages and social class. The 
incidence of depression may be influenced by gender, poverty, bereavement, and genetics among other 
factors. The symptoms of depression may include loss of interest in life and loss of appetite. However, 
detecting depression may not be easy and clinicians may fail to make a proper diagnosis. After diagnosis 
lack of understanding and the symptoms of depression may be barriers to patient adherence. If patients 
do not take medication as prescribed, then this may prolong the illness and increase healthcare workload. 
Pharmacists are in a good position to reinforce key messages about adherence and monitor some aspects 
of patient recovery. Experience suggests pharmacists do not proactively adopt this role and do not 
always communication effectively with depressed patients. This research exhibit a simulation exercise to 
assess the pharmacists’ communication skills and confidence when dealing with people who have 
depression. Community pharmacists will be recruited from NHS. 
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Q1 
 
Is the proposed project an empirical research project involving people?    
 will the project include primary data collection from human subjects, their data or 
their tissue?   
 Will it constitute an ‘investigation undertaken in order to gain knowledge and 
understanding’?  
(this includes work of educational value designed to improve understanding of the 
research process)   
A more detailed definition of Research, Audit and Service Evaluation is available on the 
University Ethics website.   
 
If you answer ‘Yes’ to Q1 ethical approval may be required, move to Q2. 
If you answer ‘No’ to Q1 then a research ethics review is not required. 
 
Note:  there may be occasions where a project is not defined as research but still raises 
ethical issues – please submit for review in these cases. 
 
YES 
   
 
Q2 
 
Will the research project involve the NHS?   
See See guidelines on the University Ethics website 
If you answer ‘No’ to Q2 move on to Q3 
If you answer ‘Yes’ to Q2 ethical approval will be required by NHS Research Ethics 
Committee (REC) 
Contact Ethical Tissue on 01274 235897 or visit www.ethicaltissue.org  
 
YES 
   
 
Q3 
 
Will the research project involve any of the following in the UK: 
Testing a medicinal product  
Investigating a medical device 
Taking samples of human biological material (e.g. blood, tissue) 
Prisoners or others in custodial care (e.g. young offenders) as participants 
Adults with mental incapacity as participants 
Other vulnerable groups (e.g. vulnerable children) as participants 
 
If you answer ‘Yes’ to Q3 ethical approval will usually be required by Ethical Tissue or 
NHS Research Ethics Committee (REC) or where the project includes participants which 
need approval under the Mental Capacity Act approval will be required by the Social Care 
REC.  
 
See information specific to research in Social Care on the University Ethics website 
 
If you answer ‘No’ to Q3 move on to Q4 
 
 
NO 
   
 
Q4 
 
Will the research project involve human participants and/or human data (but not 
accessed through the NHS)? 
 
If you answer ‘Yes’ to Q4 University ethical approval is required unless data/participation 
is uncontentious (see guidance overleaf) 
If you answer ‘No’ to Q4 move on to Q5 
 
Please give brief explanation below of type of data/participation in cases which you 
consider to be uncontentious (see guidance on page 5): 
 
YES 
 
 
 
 
353 
 
 
PLEASE COMPLETE and SIGN ONE of the boxes below: 
 
 
1. I have discussed this project with my student and  
2. confirm that there are no ethical issues requiring further consideration. 
 
(Any subsequent changes to the nature of the project will require a review of the ethical 
considerations) 
 
Name (Principal Investigator/Principal Supervisor):  
Signature:     Date: 
 
Name (Student):  
 
Signature:            Date: 
 
 
 
I confirm that there are ethical issues requiring further consideration and will refer the 
proposal either to Ethical Tissue or fill in and submit a full ethics application to be 
considered by the appropriate Research Ethics Panel. 
 
Name Principal Supervisor   Dr Jonathan Silcock 
 
Name Principal Investigator  Adel Alshammari (PhD Student) 
 
Signature:  Adel      Date: 5/10/2013 
  
   
 
Q5 
 
 
 
 
 
 
 
 
 
 
Q5a 
 
Will the research project involve human tissue (but not requiring NHS approval – 
see Q3)? 
 
 
If you answer ‘Yes’ to Q5 University ethical approval is required 
 
If you require advice on human biological material please contact Human Tissue Act 
(HTA) Designated Individual: Professor Diana Anderson on ext 3569 or email: 
d.anderson1@bradford.ac.uk) 
Contact Ethical Tissue on 01274 235897 or visit www.ethicaltissue.org 
 
If you answered ‘Yes’ to Q5, is the human material over 100 years old and 
archaeological? 
 
If ‘YES’ please refer to the Biological Anthropology Research Centre (BARC) guidelines at 
http://www.barc.brad.ac.uk/BARC_human_remains_policy.pdf 
 
 
NO 
 
 
 
 
 
 
 
 
 
 
NO 
 
If you answer ‘No’ to Q5 and have answered ‘No’ to Q2, Q3 and Q4 ethical approval is not required. 
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Checked by Chair of Research Ethics Panel 
 
Annex 1 
Ethical Scrutiny by a University Research Ethics Panel is not required if: 
 
 The project is NOT a research project. 
 
 The research project will only involve unlinked or aggregated human data 
which was collected and which was, at the time, subject to relevant 
research ethics panel approval. 
However, where this is the case the researcher should at least confirm this in an 
email to the Research Support Unit’s Ethics Administrator so that the Ethics 
Administrator has a record and can inform the Chair of the appropriate Research 
Ethics Panel that the researcher plans to go ahead without ethics approval. The 
email should confirm that the research project does not require ethics approval 
because it only involves unlinked or aggregated data, which when originally 
obtained from people was obtained in accordance with the protocol as approved at 
the time by an appropriate research ethics panel. The email should also briefly 
explain how the researcher now plans to use the unlinked or aggregated data.  
 
 The research is Public Domain Data: 
 The Economic and Social Research Council’s (ESRC) Research Ethics Framework 
states that ethics approval may not be required for data sets that exist in the public 
domain (e.g. datasets that are available from the Office for National Statistics or 
from the ESRC’s Data Archive) so long as the appropriate permissions from 
individuals have already been obtained (i.e. informed consent) and where it is not 
possible to identify the individuals from the information provided.  It must be 
remembered that public domain data is still covered by the laws of copyright.  
 
 The research involves Simple Uncontentious Questionnaires: 
If a research project’s only involvement with human subjects is a simple brief 
questionnaire with uncontroversial content it may not require ethical approval.  It is 
the Principal Investigator or Principal Supervisor’s responsibility to decide whether 
a project comes under this category and must indicate this on the form and attach 
the document for information. 
 
Guidance on supervisor and principal investigator sign off of uncontentious 
research 
 
Audit and service evaluation are usually uncontentious, and guidance on how to 
differentiate between research, audit and service evaluation is given at: University Ethics 
website.  
 
Even where a project is clearly research, as a supervisor or principal investigator, you can 
sign off simple, ethically uncontentious projects as not needing further ethical scrutiny.  To 
do this, you should consider the level of risk to participants and researchers, the level of 
effort required by participants, the level of intrusion into participants’ lives and the level of 
sensitivity of both the general subject matter and the information requested of participants. 
Basically, the lower these levels, the more likely the research is to be uncontentious and 
the more confident you should feel about signing off. 
 
The following examples may help.   
 
These studies can almost always be signed off by the supervisor or principal investigator: 
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 Brief questionnaires asking opinions about matters which are clearly not sensitive 
(attitudes to a product, beliefs about the usefulness of a course).   
 Brief interviews about such topic. 
 Observational studies about everyday behaviour in public places which involve no risk 
to subjects or the researcher. 
 
But the following studies almost always need further scrutiny by a University Ethics Panel: 
 
 Long questionnaires (these require considerable potential inconvenience to subjects). 
 Long interviews 
 Any questionnaires which ask subjects about intimate behaviours or issue likely to 
cause distress or would in other ways normally be regarded as contentious or sensitive 
(e.g. illegal activities, attitudes to abortion, capital punishment, immigration, 
euthanasia). 
 Any interviews which examine these matters. 
 Observational studies which involve intimate behaviours, behaviours which are not 
normally public or which might normally be considered contentious or sensitive 
(Activities of ethics committees, appointment committees, etc; professional 
consultations). 
Naturally, this list is for illustration only, and should not be considered in any way 
exhaustive, permissive or prescriptive.  For example, there are many categories of 
research not mentioned here which would definitely require ethics approval (e.g. treatment 
research).  Rather the list demonstrates the issue of proportionality.  Thus, even though the 
method may be the same for activities requiring and not requiring further scrutiny, the 
content in some way distinguishes between the two categories. 
 
At the same time, there is obviously some middle ground.  Are ethics committees not 
public?  Is what is discussed so sensitive that the proposal needs further scrutiny?  What 
about asking people about their views on the actions of senior members of staff in their 
organisation?  Probably, it is in these middle ground areas that further advice should be 
sought from a Panel Chair about whether the project can be signed off by the supervisor or 
principal investigator alone.  Given that, in so doing, the supervisor or PI is attesting to the 
ethical probity of the study, it is usually best to err on the side of caution where there is 
uncertainty.  Panel chairs are very happy to advise. 
 
(Dr Martin Brinkworth, Chair, Biomedical, Natural and Physical Sciences Research Ethics 
Panel, m.h.brinkworth@bradford.ac.uk, ext. 3584 
 
Andy Scally, Chair, Humanities, Social and Health Sciences Research Ethics Panel, 
a.j.scally@bradford.ac.uk, ext. 6431) 
 
 
 
 
  
Please return Checklist to:  
 
Lynda Nuttall, Ethics Administrator, Research Support Unit , 
Research and Knowledge Transfer Support,  ext. 3170, [l.d.nuttall@bradford.ac.uk]  
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Appendix-18: Participant’s’ Agreement to Take Part in Research  
Study title:  
Name of the researcher:  
 
Please tick each box to agree with the statements 
 
1. I have read the information sheet for this study.  
2. I have had the chance to ask questions about the study.  
3. I understand the reasons for this study and how I will be 
involved. 
 
4. I understand that I may not gain any direct personal benefit 
from the study and I accept this.                 
 
5. I understand that all information collected will be treated                    
confidentially.  
 
6. My personal details will be removed from any publications or 
presentations. 
 
7. I confirm that I am taking part in this study of my own free 
will. I am free to withdraw from the study at any time and for 
any reason. 
 
8. If I withdraw from the study, then I may ask for my video and 
any other personal information to be destroyed. 
 
9. I agree to take part in this study.  
 
Participant Name   Signature     Date 
__________________   _______________   
 _________ 
Researcher Name   Signature     Date 
__________________   _______________   
 _________ 
You (the participant) will keep one copy of this consent form, and the 
researcher will keep another copy 
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Appendix-19: Participants’ Information Sheet 
 
Improving community pharmacy consultations for people with depression 
 
 
Dear Pharmacist 
 
My name is   Adel Alshammari. I am a PhD student in pharmacy practice 
research. I invite you to take part in my research project. Please read this 
information carefully before you decide what to do. Please contact me (or my 
supervisor) if you have any questions. 
 
Why have I been invited to take part? 
You have been invited to take part because you are a practicing community 
pharmacist. We have piloted the study procedures with students and teacher 
practitioners at the University of Bradford. 
 
What is purpose of the project? 
The purpose of this research is to assess the communication skills of 
community pharmacists when talking to people with depression. We don’t think 
we can assess this directly in your practice, so we have designed a simulation 
exercise (role play). Assessing the simulation performance will provide us with 
information about the professional standard of care without the need to 
inconvenience or recruit patients 
Do I have to participate?  
 You are free to decide whether or not to participate. 
 If you agree, I will give you this information letter to keep, and you must sign 
a consent form to say that you have read the information and agree to the 
conditions. 
 If you do not agree, you are still free to change your mind at any time and 
without giving a reason. 
 If you do withdraw at any time, then you may also ask for any data already 
collected to be destroyed, and we will do this for you. 
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Who is conducting the investigation? 
The investigation will be carried out by me (Adel Alshammari), under the 
supervision of Dr Jon Silcock, Dr Josie Fraser and Prof Alison Blenkinsopp. 
Please contact me or Dr Silcock if you have any questions 
(aalshamm@student.bradford.ac.uk; J.Silcock@bradford.ac.uk). This study has 
been reviewed by a University of Bradford ethics panel. 
What will I have to do if I take part? 
 We will give you some satisfaction questionnaires to distribute to your 
patients before and after an assessment of your consultation skills. 
 You will complete two questionnaires, one about knowledge of depression 
and a second about attitudes towards people with depression. 
 You will come to the University of Bradford to consult with a simulated patient 
in our mock community pharmacy. 
 The simulated patient will act out a realistic scenario, in which you dispense a 
prescription and give any necessary advice. 
 The patient is an experienced actor, and not a member of academic staff. 
 The consultation will be video recorded and you will be able to watch it back. 
 There will then be a short interview with the researcher and the actor. 
 The interview will be audio and/or video recorded, so that a transcript can be 
made. 
 The whole process should take about 1 hour. 
 You will get feedback and may be asked if you want to repeat the simulation 
at a later date (this will be optional). 
 We will analyse responses from your patient satisfaction questionnaires and 
provide you with a summary. 
 
What are the probable benefits? 
 You will be helping us to develop this model of practice assessment. 
 After simulation you might become confident helping people with depression. 
 You may benefit from the consultation skills practice. 
 We will give you a summary of your performance and the overall results, 
which may help to guide your professional development and complete a CPD 
cycle. 
Are there any risks? 
 You may find the role play experience a little stressful, but we are not really 
judging your performance. 
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 We will make a recording, but this will only be used for research purposes. It 
will not be used for teaching or broadcast in any way. 
 You may stop at any point for break or if you want to withdraw from the study. 
  
Will my response be kept confidential? 
All responses will be strictly confidential. Your personal data and video will be 
destroyed but not until the study has been completed and any papers 
published, which may be in about 3 years’ time.  
Can I withdraw from the investigation? 
You may withdraw at any time and ask for your data or recordings to be 
destroyed. Please just ask any member of the research team. 
 
Thank you for reading this information. If you agree to participate, then you will 
be provided with a copy of this information sheet and a signed consent form to 
keep. 
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Appendix-20: Definitions of Themes and Categories 
 
Terms Definition 
1. The Attitude of the 
Participants 
An individual's favourable or unfavourable feelings 
about performing the behaviour (Fox, 2005). 
A. Nature of 
Depression 
The severity of the disease and the extent to which 
it can affect the patient’s mood, body, and ability to 
function in the community and receive treatment. 
A1. Causes of 
Depression 
Beliefs held by the participants about the causes of 
depression. 
A2. Coping with 
Depression 
The perspective of the participants of behaviour of 
patients when taking their medications and 
communicating with other people in the society. 
B. Managing People 
with Depression 
The participants’ perception of anti-depressants in 
comparison to drugs used for physical diseases. 
B1. Positive Beliefs 
about Managing 
Depression 
The ability of the participants to manage mental 
illness and it is beliefs using the same approach 
taken for physical diseases.   
B2. Negative Beliefs 
about Managing 
Depression. 
The inability to manage people with depression in 
comparison to managing people with physical 
diseases. 
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C. Stigma Associated 
with Depression 
The feeling of being judged and stereotyped in 
the community and by health care providers. 
C1. Stigma Attached to 
Depression from the 
Perspective of 
Professionals 
Feelings experienced by the patient triggered by 
the presence of other people in the pharmacy, for 
example participants. 
C2. Stigma Attached to 
Depression from the 
Perspective of Non- 
pharmacy Staff. 
Feelings experienced by the patient triggered by 
the presence of other people working in the 
pharmacy, for example serving staff.  
D. Time Allocated for 
Providing Services to 
Patients 
Management of time in the pharmacy. 
D1. Participants’ 
Perception of GPs’ Time 
Participants’ view of GP time. 
D2. Experience of Time 
Constraints When Trying 
to Help Patients 
The limitations on time which hinder the 
participants’ ability to provide proper standards of 
service. 
D3. Dedicated Time to 
Help Patients 
The keenness to provide a service and to 
prioritise patients by giving them enough time to 
explain their problem fully. 
E. Privacy of Patients Effect of privacy on participants-patient 
interaction.  
E1. Offering  Privacy Willingness of the participants to offer privacy to 
patients. 
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E2. Offering Less Privacy Less willing to offer privacy to patients 
consultation. 
E3. Environment of 
Privacy Compared to 
other Health Care Setting 
The opinion of the participants about the privacy 
of pharmacy compared to other clinical setting. 
2. Participants’ 
Engagement with 
Patients 
Participants encouraging patients to participate 
in the discussion. 
F. Training Needed to 
Engage with Patients 
A lack of confidence demonstrated by 
participants to involve themselves with patient 
queries. 
F1. Role Perception Self-insight of the participant’s role in health care 
promotion. 
G. Lack of Patient 
Knowledge about the 
Role of the Pharmacist 
Patients’ awareness or unawareness of the 
pharmacist’s role.  
H. Lack of Liaison with 
Other Health Care 
Professionals 
The participant’s lack the connection with other 
health care professionals for follow up for 
patients. 
H1. Hierarchy of Health 
Care Professionals 
Participants who are less engaged in decision 
making about a patient’s treatment in 
comparison with other health care professionals. 
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I. Organisational 
Barriers 
The lack of a facility to systematically link up 
with other health care professionals. 
3. Tailoring the 
Consultation  
The competency of the participants when 
communicating information which match to 
patients’ needs.  
J. Developing Skills in 
the Practice 
Being unconscious of skills developed through 
long time practice when providing services. 
K. Initiating the Session The initial rapport of participants- patients. 
K1. Negotiating the 
Patient’s Agenda 
Pharmacists exploring patients’ concerns, 
expectations and awareness of their treatment. 
L. Giving Information to 
Patients 
The ability of the participant to provide medical 
and non-medical information, listening to patients 
and checking their understanding. 
L1. Information Sharing 
about Anti-
Depressants. 
Enhancing patients’ awareness of the use, efficacy 
and safety of anti-depressants. 
L2. Giving Patients’ 
Opportunity to Talk. 
Listening to patient concerns and encouraging 
them to share information with the participants 
about their treatments. 
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L3. Picking up the 
Patient’s Cue 
Understanding the patient’s vocal and non-
vocal behaviour. 
L4. Checking Patients’ 
Understanding 
The ability of the participants to encourage patient 
to tell back. 
L5. Less Information 
Sharing about Social 
Treatment. 
Unwilling to support patient with information about 
social information. 
4. Staging Advice to 
Patients 
Giving the correct amount of information to patients 
to match the stage of treatment. 
M. Quality of 
Information at First 
Time Consultation 
The quality and quantity of information tailored to 
the patients’ satisfaction. 
N. Relationship of 
Participants with 
Patients  
The direction of the participant’s relationship with 
patients when meeting them - one way/two ways.  
N1.Paternalistic Attitude A participant who take the responsibility on behalf 
of patient about their treatment. 
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N2. Passive 
Behaviour of the 
Participants 
When the participant is unwilling to take an action to 
help or support patients. 
N3. Building up 
Relationships 
with Patients 
The importance of building relationships and offering 
advice to people with depression. 
N4. Relationship 
Management for 
Regular Patients 
Regular visiting of patients to enhance the relationship with 
the participant to enabled them to provide health care to 
patients comfortably. 
O. Follow Up 
Service 
The willingness of the participants to promote health care. 
O1. Accessibility 
of the pharmacist 
to the patient 
Offering accessibility to enhance patient awareness of the 
service provide in the pharmacies and the role building 
relationship. 
O2. Advanced 
Services 
 
The service recommend by health care systems to 
encourage enhancing patients to adhere to taking their 
medications on schedule. 
